data_2m7t_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m7t _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.471 0.609 0 N-CA-C 113.406 0.891 . . . . 50.0 113.406 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -77.56 69.47 7.25 Favored 'Trans proline' 0 C--O 1.209 -0.94 0 CA-C-O 122.202 0.834 . . . . 50.0 113.849 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -123.88 12.63 9.12 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.246 -0.888 . . . . 50.0 109.127 173.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.63 51.54 0.44 Allowed Glycine 0 CA--C 1.496 -1.098 0 C-N-CA 119.941 -1.123 . . . . 25.0 114.094 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -112.38 176.49 5.0 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 107.152 -1.425 . . . . 50.0 107.152 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.98 -57.52 10.95 Favored Glycine 0 C--O 1.207 -1.551 0 O-C-N 125.282 1.614 . . . . 25.0 114.173 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -100.59 12.63 36.96 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 117.784 0.792 . . . . 25.0 110.596 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -116.5 79.22 1.29 Allowed 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 106.633 -1.617 . . . . 25.0 106.633 176.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.52 150.99 96.87 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 105.994 -1.854 . . . . 25.0 105.994 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -72.85 166.46 29.93 Favored 'Trans proline' 0 CA--C 1.499 -1.249 0 C-N-CA 115.629 -2.447 . . . . 50.0 115.681 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.6 m -100.03 127.16 46.28 Favored 'General case' 0 C--O 1.261 1.663 0 O-C-N 121.014 -1.054 . . . . 25.0 111.074 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.5 p -66.16 132.83 49.38 Favored 'General case' 0 C--O 1.261 1.698 0 N-CA-C 106.311 -1.737 . . . . 50.0 106.311 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.7 p -141.32 170.07 16.41 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.207 1.003 . . . . 50.0 111.033 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.1 m -128.76 -14.61 4.53 Favored 'General case' 0 C--O 1.193 -1.906 0 CA-C-N 114.105 -1.407 . . . . 25.0 107.954 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -150.68 164.13 36.87 Favored 'General case' 0 C--O 1.26 1.648 0 N-CA-C 109.612 -0.514 . . . . 50.0 109.612 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -61.34 -30.23 70.39 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.32 1.012 . . . . 50.0 113.281 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.8 t -62.5 -23.28 66.85 Favored 'General case' 0 C--O 1.248 0.975 0 O-C-N 121.715 -0.616 . . . . 50.0 111.556 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -71.83 -9.9 58.99 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 118.307 0.503 . . . . 50.0 111.236 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.9 m -107.85 170.23 8.12 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 115.27 1.581 . . . . 50.0 115.27 -172.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.417 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 64.1 mt -71.19 167.83 18.53 Favored 'General case' 0 C--O 1.253 1.25 0 CA-C-O 121.579 0.704 . . . . 50.0 109.769 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.3 128.0 34.54 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 114.547 1.314 . . . . 25.0 114.547 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.63 -7.53 81.67 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 121.04 -0.6 . . . . 50.0 112.238 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 3.4 m -100.96 155.77 17.78 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 105.742 -1.947 . . . . 50.0 105.742 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.0 m -128.89 166.98 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.441 1.096 . . . . 50.0 108.279 -177.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.5 t -87.97 115.22 25.29 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 105.567 -2.012 . . . . 50.0 105.567 173.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.88 179.88 52.89 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.551 -0.749 . . . . 50.0 113.571 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.53 -13.54 22.53 Favored 'Trans proline' 0 C--O 1.201 -1.364 0 CA-C-O 124.915 1.964 . . . . 50.0 112.732 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -78.07 -7.43 56.93 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 113.365 -1.743 . . . . 50.0 110.931 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.98 22.95 62.52 Favored Glycine 0 C--O 1.251 1.182 0 CA-C-O 123.573 1.651 . . . . 25.0 112.587 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -131.87 150.09 52.26 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 112.108 -2.046 . . . . 50.0 108.325 -174.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.4 m -66.05 147.76 52.85 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 123.878 0.736 . . . . 25.0 110.443 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.479 -2.194 0 CA-C-O 117.415 -1.769 . . . . 50.0 112.767 177.949 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.475 0.798 0 CA-C-O 117.242 -1.361 . . . . 50.0 109.226 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.34 69.25 7.25 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 N-CA-C 115.54 1.323 . . . . 50.0 115.54 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -122.51 6.2 9.54 Favored 'General case' 0 C--O 1.206 -1.205 0 N-CA-C 108.175 -1.046 . . . . 50.0 108.175 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.7 55.89 0.45 Allowed Glycine 0 CA--C 1.496 -1.128 0 C-N-CA 120.616 -0.802 . . . . 25.0 113.986 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -116.35 -169.85 1.7 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 105.889 -1.893 . . . . 50.0 105.889 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.91 -70.76 0.91 Allowed Glycine 0 C--O 1.196 -2.252 0 O-C-N 125.267 1.605 . . . . 25.0 112.288 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -86.54 4.29 40.64 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 118.071 0.936 . . . . 25.0 110.768 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -104.58 82.49 1.91 Allowed 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.072 -1.455 . . . . 25.0 107.072 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.55 151.02 96.78 Favored Pre-proline 0 C--O 1.253 1.27 0 N-CA-C 105.732 -1.951 . . . . 25.0 105.732 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.55 166.06 30.26 Favored 'Trans proline' 0 CA--C 1.496 -1.397 0 C-N-CA 115.41 -2.593 . . . . 50.0 115.92 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 m -102.08 127.86 48.8 Favored 'General case' 0 C--O 1.266 1.926 0 O-C-N 121.064 -1.023 . . . . 25.0 109.766 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.6 p -68.88 140.37 55.17 Favored 'General case' 0 C--O 1.255 1.393 0 N-CA-C 106.238 -1.764 . . . . 50.0 106.238 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.3 p -145.74 168.51 20.57 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.513 -0.767 . . . . 50.0 110.254 -174.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.5 m -131.46 -5.81 3.74 Favored 'General case' 0 C--O 1.198 -1.625 0 CA-C-N 115.244 -0.889 . . . . 25.0 108.651 176.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -154.91 159.88 40.76 Favored 'General case' 0 C--O 1.261 1.692 0 N-CA-C 108.522 -0.918 . . . . 50.0 108.522 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -63.54 -29.3 70.58 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.627 0.58 . . . . 50.0 112.04 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.3 t -63.92 -20.47 65.88 Favored 'General case' 0 C--O 1.254 1.339 0 N-CA-C 112.026 0.38 . . . . 50.0 112.026 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -72.98 -20.9 60.94 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-O 121.734 0.778 . . . . 50.0 110.769 177.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.5 m -94.99 172.88 7.88 Favored 'General case' 0 C--O 1.252 1.203 0 N-CA-C 116.485 2.031 . . . . 50.0 116.485 -170.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 60.8 mt -71.16 166.7 20.93 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 122.169 0.985 . . . . 50.0 109.716 176.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.97 128.71 36.9 Favored 'General case' 0 C--O 1.25 1.126 0 O-C-N 121.581 -0.7 . . . . 25.0 112.689 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.91 3.38 73.69 Favored Glycine 0 C--N 1.34 0.767 0 C-N-CA 121.177 -0.535 . . . . 50.0 112.21 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.42 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 4.0 m -112.92 164.41 13.46 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 105.792 -1.929 . . . . 50.0 105.792 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.8 m -134.93 170.97 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 108.001 -1.111 . . . . 50.0 108.001 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.2 t -89.51 122.12 32.38 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 105.043 -2.206 . . . . 50.0 105.043 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.02 -179.44 45.74 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.257 -0.746 . . . . 50.0 114.349 -172.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -77.11 -13.19 17.3 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 CA-C-O 125.583 2.243 . . . . 50.0 113.198 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -75.54 -11.62 60.06 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 113.241 -1.8 . . . . 50.0 110.605 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.41 17.44 62.34 Favored Glycine 0 C--O 1.251 1.207 0 CA-C-O 123.285 1.492 . . . . 25.0 113.499 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -127.72 150.54 49.73 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 112.711 -1.745 . . . . 50.0 108.661 -174.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 86.7 m -62.29 148.8 43.87 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.642 1.214 . . . . 25.0 110.577 172.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.48 -2.13 0 CA-C-O 118.745 -1.031 . . . . 50.0 110.552 177.214 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 114.231 1.197 . . . . 50.0 114.231 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -78.49 66.24 8.51 Favored 'Trans proline' 0 CA--C 1.555 1.563 0 O-C-N 123.034 1.018 . . . . 50.0 113.992 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -119.69 -0.88 10.67 Favored 'General case' 0 C--O 1.197 -1.683 0 CA-C-N 114.689 -1.141 . . . . 50.0 108.607 172.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -136.89 50.87 0.82 Allowed Glycine 0 CA--C 1.502 -0.724 0 N-CA-C 115.007 0.763 . . . . 25.0 115.007 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -117.35 170.96 8.3 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.209 -1.404 . . . . 50.0 107.209 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.5 -51.65 53.2 Favored Glycine 0 C--O 1.215 -1.041 0 O-C-N 124.783 1.302 . . . . 25.0 113.415 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -94.74 11.17 32.31 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.836 1.318 . . . . 25.0 111.568 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -123.64 83.91 2.2 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 107.202 -1.407 . . . . 25.0 107.202 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.83 148.62 98.75 Favored Pre-proline 0 CA--C 1.563 1.476 0 N-CA-C 105.425 -2.065 . . . . 25.0 105.425 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -73.81 166.94 28.47 Favored 'Trans proline' 0 N--CA 1.481 0.773 0 C-N-CA 115.803 -2.331 . . . . 50.0 116.404 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.6 m -96.88 130.05 44.22 Favored 'General case' 0 C--O 1.26 1.622 0 O-C-N 121.576 -0.703 . . . . 25.0 110.437 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.9 p -70.07 137.67 51.41 Favored 'General case' 0 C--O 1.255 1.373 0 N-CA-C 106.03 -1.841 . . . . 50.0 106.03 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.8 p -141.38 170.84 14.96 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-O 122.027 0.918 . . . . 50.0 110.505 -175.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.4 m -123.6 -16.62 6.69 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.369 -1.287 . . . . 25.0 108.448 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -152.15 160.28 43.44 Favored 'General case' 0 C--O 1.266 1.921 0 N-CA-C 108.639 -0.874 . . . . 50.0 108.639 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -57.45 -35.13 69.72 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 124.144 0.902 . . . . 50.0 112.564 177.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -14.42 61.93 Favored 'General case' 0 C--O 1.259 1.576 0 O-C-N 120.944 -1.097 . . . . 50.0 113.775 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -77.67 -9.11 58.8 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 121.517 0.675 . . . . 50.0 109.407 175.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.1 m -104.37 172.46 6.79 Favored 'General case' 0 CA--C 1.555 1.161 0 O-C-N 119.912 -1.743 . . . . 50.0 114.981 -174.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 74.7 mt -71.7 166.96 20.87 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.318 0.58 . . . . 50.0 111.896 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.93 118.98 5.12 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 114.099 1.148 . . . . 25.0 114.099 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.2 -1.96 80.62 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 120.99 -0.624 . . . . 50.0 112.272 175.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.0 m -105.48 161.01 14.71 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.011 -2.218 . . . . 50.0 105.011 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.1 m -132.01 171.53 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 124.287 0.992 . . . . 50.0 109.368 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 29.8 t -94.72 115.45 27.54 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 105.852 -1.907 . . . . 50.0 105.852 174.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.8 176.69 52.24 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 119.268 -0.74 . . . . 50.0 114.1 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.46 -12.07 20.64 Favored 'Trans proline' 0 C--O 1.211 -0.835 0 CA-C-O 124.45 1.771 . . . . 50.0 114.204 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -74.47 -10.0 59.13 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-N 114.437 -1.256 . . . . 50.0 110.049 173.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.45 18.71 47.96 Favored Glycine 0 CA--C 1.498 -1.023 0 CA-C-O 122.693 1.163 . . . . 25.0 112.899 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -135.88 153.28 51.51 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 112.48 -1.86 . . . . 50.0 110.486 -174.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.7 m -60.34 147.08 41.82 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.936 0.772 . . . . 25.0 110.469 173.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -2.015 0 CA-C-O 118.312 -1.271 . . . . 50.0 110.788 179.622 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.4 p . . . . . 0 C--O 1.221 -0.398 0 N-CA-C 113.62 0.97 . . . . 50.0 113.62 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.94 61.85 7.23 Favored 'Trans proline' 0 CA--C 1.554 1.522 0 N-CA-C 114.836 1.052 . . . . 50.0 114.836 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -120.83 24.61 10.14 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 105.323 -2.103 . . . . 50.0 105.323 172.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.1 69.32 0.16 Allowed Glycine 0 CA--C 1.497 -1.039 0 C-N-CA 120.395 -0.907 . . . . 25.0 112.368 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 44.4 mmt-85 -131.6 -177.67 4.52 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.227 -1.027 . . . . 50.0 108.227 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.68 -60.18 9.46 Favored Glycine 0 C--O 1.199 -2.078 0 O-C-N 125.18 1.55 . . . . 25.0 112.845 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -99.28 13.82 31.76 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 118.515 1.157 . . . . 25.0 111.088 -175.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -119.5 88.29 2.9 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 106.704 -1.591 . . . . 25.0 106.704 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.14 150.56 97.38 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 104.461 -2.422 . . . . 25.0 104.461 175.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -70.86 164.65 34.89 Favored 'Trans proline' 0 CA--C 1.487 -1.83 0 C-N-CA 115.156 -2.763 . . . . 50.0 115.184 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.1 m -98.19 130.76 44.92 Favored 'General case' 0 C--O 1.254 1.327 0 CA-C-N 116.103 -0.498 . . . . 25.0 111.606 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.1 p -71.06 139.67 50.48 Favored 'General case' 0 C--O 1.251 1.151 0 N-CA-C 105.842 -1.91 . . . . 50.0 105.842 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.3 p -141.9 173.23 11.7 Favored 'General case' 0 CA--C 1.572 1.805 0 CA-C-O 122.386 1.088 . . . . 50.0 110.35 -175.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.8 m -132.74 -12.06 3.0 Favored 'General case' 0 C--O 1.201 -1.496 0 CA-C-N 114.407 -1.27 . . . . 25.0 108.064 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -149.42 157.17 43.07 Favored 'General case' 0 C--O 1.257 1.457 0 N-CA-C 107.946 -1.131 . . . . 50.0 107.946 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -60.09 -33.62 72.35 Favored 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 123.99 0.806 . . . . 50.0 111.489 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -63.1 -22.82 67.12 Favored 'General case' 0 C--O 1.248 1.026 0 O-C-N 121.246 -0.909 . . . . 50.0 111.804 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -63.57 -27.16 69.06 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.855 0.836 . . . . 50.0 109.031 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.6 m -89.14 176.03 7.14 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 114.414 1.265 . . . . 50.0 114.414 -172.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 78.5 mt -77.64 167.01 22.28 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-O 122.019 0.914 . . . . 50.0 110.359 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.62 125.02 22.9 Favored 'General case' 0 C--O 1.252 1.21 0 N-CA-C 113.213 0.82 . . . . 25.0 113.213 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.12 -8.73 57.58 Favored Glycine 0 C--O 1.244 0.756 0 N-CA-C 110.643 -0.983 . . . . 50.0 110.643 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -113.06 157.55 21.43 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 107.67 -1.234 . . . . 50.0 107.67 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.9 m -131.89 167.89 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 123.787 0.835 . . . . 50.0 109.708 -176.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.1 t -88.15 110.93 21.06 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 106.135 -1.802 . . . . 50.0 106.135 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.21 174.2 54.65 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.323 -0.853 . . . . 50.0 113.314 -173.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.76 -14.75 19.44 Favored 'Trans proline' 0 C--O 1.207 -1.036 0 CA-C-O 124.505 1.794 . . . . 50.0 114.803 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -70.34 -15.68 62.9 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 113.489 -1.687 . . . . 50.0 109.649 172.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.63 16.42 36.74 Favored Glycine 0 C--O 1.255 1.424 0 O-C-N 124.455 1.097 . . . . 25.0 112.846 176.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -131.57 151.46 51.58 Favored 'General case' 0 C--O 1.203 -1.386 0 CA-C-N 113.557 -1.322 . . . . 50.0 113.16 -174.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 86.2 m -60.02 143.48 51.78 Favored 'General case' 0 C--N 1.311 -1.066 0 O-C-N 124.076 0.86 . . . . 25.0 111.075 173.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.48 -2.126 0 CA-C-O 118.346 -1.252 . . . . 50.0 111.474 179.203 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 106.839 -1.541 . . . . 50.0 106.839 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.83 49.71 2.27 Favored 'Trans proline' 0 CA--C 1.563 1.963 0 CA-C-N 120.71 1.289 . . . . 50.0 114.527 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -121.6 -2.86 9.35 Favored 'General case' 0 C--O 1.204 -1.34 0 C-N-CA 125.01 1.324 . . . . 50.0 107.524 170.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -142.61 50.61 0.7 Allowed Glycine 0 C--O 1.236 0.249 0 N-CA-C 115.208 0.843 . . . . 25.0 115.208 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -119.9 176.17 5.54 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.558 -1.275 . . . . 50.0 107.558 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.76 -48.55 65.71 Favored Glycine 0 C--O 1.214 -1.137 0 O-C-N 125.402 1.688 . . . . 25.0 114.282 -176.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -103.8 7.99 37.11 Favored 'General case' 0 C--O 1.249 1.069 0 CA-C-N 119.136 1.468 . . . . 25.0 109.842 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.8 m-90 -113.54 84.51 2.03 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.827 -1.175 . . . . 25.0 107.827 -176.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.48 151.68 96.93 Favored Pre-proline 0 CA--C 1.566 1.585 0 CA-C-N 113.428 -1.715 . . . . 25.0 106.793 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -76.64 169.18 22.29 Favored 'Trans proline' 0 CA--C 1.511 -0.638 0 N-CA-C 116.205 1.579 . . . . 50.0 116.205 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.3 m -105.93 131.43 53.24 Favored 'General case' 0 C--O 1.254 1.307 0 O-C-N 121.178 -0.952 . . . . 25.0 110.355 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.1 p -67.29 136.76 55.39 Favored 'General case' 0 C--O 1.257 1.47 0 N-CA-C 106.727 -1.582 . . . . 50.0 106.727 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.3 p -142.2 169.85 16.82 Favored 'General case' 0 CA--C 1.555 1.135 0 CA-C-O 122.747 1.26 . . . . 50.0 110.873 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.3 m -128.42 -15.01 4.65 Favored 'General case' 0 C--O 1.198 -1.653 0 CA-C-N 114.02 -1.446 . . . . 25.0 108.19 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -148.59 159.27 44.24 Favored 'General case' 0 C--O 1.258 1.506 0 N-CA-C 108.511 -0.922 . . . . 50.0 108.511 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -62.32 -29.54 70.52 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.134 0.896 . . . . 50.0 112.212 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.9 t -66.59 -16.29 64.07 Favored 'General case' 0 C--O 1.254 1.336 0 O-C-N 120.843 -1.161 . . . . 50.0 111.673 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -73.21 -15.19 61.45 Favored 'General case' 0 CA--C 1.557 1.216 0 CA-C-O 121.657 0.741 . . . . 50.0 109.999 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.4 m -99.55 176.04 5.62 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 115.187 1.551 . . . . 50.0 115.187 -172.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 79.4 mt -78.07 170.9 15.84 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.659 0.742 . . . . 50.0 110.538 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.63 121.58 14.26 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 113.25 0.833 . . . . 25.0 113.25 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.07 0.01 63.9 Favored Glycine 0 CA--C 1.525 0.659 0 O-C-N 124.275 0.985 . . . . 50.0 112.263 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.6 m -113.29 159.51 19.29 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 108.033 -1.099 . . . . 50.0 108.033 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.2 m -132.58 170.34 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 124.276 0.985 . . . . 50.0 109.872 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.1 t -89.39 111.65 22.56 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 107.016 -1.475 . . . . 50.0 107.016 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.51 177.7 48.8 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 114.525 0.57 . . . . 50.0 114.525 -173.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.35 -10.17 19.02 Favored 'Trans proline' 0 C--O 1.21 -0.919 0 CA-C-O 124.867 1.945 . . . . 50.0 114.085 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -78.43 -13.68 59.73 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 112.919 -1.946 . . . . 50.0 110.879 171.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.55 20.31 45.05 Favored Glycine 0 CA--C 1.501 -0.785 0 CA-C-N 115.728 -0.669 . . . . 25.0 113.533 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -131.71 146.88 52.4 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.964 -1.118 . . . . 50.0 110.831 -174.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.7 m -64.44 145.52 55.95 Favored 'General case' 0 C--N 1.317 -0.835 0 O-C-N 124.253 0.971 . . . . 25.0 112.917 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.735 0 CA-C-O 118.355 -1.247 . . . . 50.0 110.708 174.442 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.7 p . . . . . 0 N--CA 1.472 0.655 0 CA-C-O 118.433 -0.794 . . . . 50.0 111.675 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.42 73.2 5.66 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 N-CA-C 114.616 0.968 . . . . 50.0 114.616 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -127.82 30.14 5.33 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.47 -1.678 . . . . 50.0 106.47 173.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.55 50.26 0.21 Allowed Glycine 0 CA--C 1.497 -1.055 0 C-N-CA 119.618 -1.277 . . . . 25.0 113.398 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -121.55 174.03 7.04 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.932 -0.766 . . . . 50.0 108.932 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -51.19 -50.44 39.91 Favored Glycine 0 C--O 1.207 -1.576 0 O-C-N 125.317 1.635 . . . . 25.0 113.722 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -101.62 0.59 36.53 Favored 'General case' 0 CA--C 1.558 1.27 0 CA-C-N 119.578 1.689 . . . . 25.0 110.917 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.1 m-90 -116.17 81.07 1.55 Allowed 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 107.352 -1.351 . . . . 25.0 107.352 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.03 154.63 94.07 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 104.394 -2.447 . . . . 25.0 104.394 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -72.39 172.5 14.85 Favored 'Trans proline' 0 CA--C 1.508 -0.813 0 N-CA-C 116.713 1.774 . . . . 50.0 116.713 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -106.25 133.23 51.27 Favored 'General case' 0 C--O 1.266 1.958 0 CA-C-N 115.887 -0.597 . . . . 25.0 110.458 176.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.0 p -70.29 141.64 52.35 Favored 'General case' 0 C--O 1.259 1.567 0 N-CA-C 107.286 -1.376 . . . . 50.0 107.286 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.9 p -144.48 172.29 13.16 Favored 'General case' 0 CA--C 1.556 1.177 0 CA-C-N 114.574 -1.193 . . . . 50.0 109.814 -175.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.1 m -128.1 -12.87 5.16 Favored 'General case' 0 C--O 1.2 -1.517 0 CA-C-N 114.619 -1.173 . . . . 25.0 107.915 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -151.13 162.66 40.46 Favored 'General case' 0 C--O 1.258 1.52 0 C-N-CA 124.116 0.967 . . . . 50.0 110.185 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -63.07 -29.25 70.66 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.5 1.125 . . . . 50.0 112.877 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 t -71.4 -12.39 61.39 Favored 'General case' 0 C--O 1.253 1.258 0 O-C-N 121.919 -0.488 . . . . 50.0 110.682 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -76.03 -12.7 60.17 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 121.639 0.733 . . . . 50.0 110.969 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.3 m -101.27 172.89 6.72 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.917 1.821 . . . . 50.0 115.917 -170.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.83 168.14 15.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.674 0.749 . . . . 50.0 110.077 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.9 122.0 11.23 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 115.138 1.533 . . . . 25.0 115.138 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.37 -9.51 76.71 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 123.983 0.802 . . . . 50.0 112.876 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.1 m -95.68 151.88 18.96 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.469 -1.308 . . . . 50.0 107.469 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 m -124.34 165.69 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.844 0.858 . . . . 50.0 110.463 -176.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.2 t -86.83 114.88 23.86 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 105.198 -2.149 . . . . 50.0 105.198 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.17 178.39 53.88 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 115.883 -0.598 . . . . 50.0 112.888 -173.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.52 -11.78 18.73 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 CA-C-O 124.432 1.763 . . . . 50.0 114.213 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -78.18 -8.28 58.11 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 113.381 -1.736 . . . . 50.0 110.412 172.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.53 17.98 63.0 Favored Glycine 0 C--O 1.25 1.097 0 CA-C-O 122.82 1.234 . . . . 25.0 112.858 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -126.31 149.76 48.94 Favored 'General case' 0 C--O 1.206 -1.208 0 CA-C-N 112.962 -1.619 . . . . 50.0 109.079 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.5 m -64.5 149.82 47.86 Favored 'General case' 0 C--N 1.317 -0.822 0 O-C-N 124.41 1.069 . . . . 25.0 110.316 174.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.647 0 CA-C-O 118.641 -1.088 . . . . 50.0 113.44 175.332 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 117.089 -1.434 . . . . 50.0 108.804 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -78.59 57.72 6.45 Favored 'Trans proline' 0 N--CA 1.486 1.039 0 N-CA-C 115.844 1.44 . . . . 50.0 115.844 -174.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -124.42 8.12 8.39 Favored 'General case' 0 C--O 1.2 -1.519 0 N-CA-C 108.905 -0.776 . . . . 50.0 108.905 170.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.94 46.93 0.68 Allowed Glycine 0 C--O 1.218 -0.878 0 C-N-CA 120.664 -0.779 . . . . 25.0 114.939 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 mmp_? -108.79 -164.27 0.93 Allowed 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 105.632 -1.988 . . . . 50.0 105.632 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.02 -72.78 0.57 Allowed Glycine 0 C--O 1.205 -1.709 0 O-C-N 125.197 1.561 . . . . 25.0 112.755 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -97.86 10.94 38.95 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.431 1.115 . . . . 25.0 110.209 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -95.61 79.28 3.37 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 105.447 -2.057 . . . . 25.0 105.447 176.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.64 148.49 96.8 Favored Pre-proline 0 CA--C 1.558 1.288 0 CA-C-N 113.821 -1.536 . . . . 25.0 106.936 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.5 171.89 17.37 Favored 'Trans proline' 0 N--CA 1.482 0.795 0 N-CA-C 116.853 1.828 . . . . 50.0 116.853 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.0 m -106.62 130.0 54.44 Favored 'General case' 0 C--O 1.261 1.686 0 CA-C-N 115.184 -0.917 . . . . 25.0 110.55 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.7 p -68.48 130.53 43.15 Favored 'General case' 0 C--O 1.26 1.652 0 N-CA-C 105.735 -1.95 . . . . 50.0 105.735 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.6 p -136.39 173.23 11.93 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 122.574 1.178 . . . . 50.0 110.966 -173.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.5 m -131.31 -14.3 3.36 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 114.264 -1.334 . . . . 25.0 107.833 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -151.02 161.45 42.71 Favored 'General case' 0 C--O 1.253 1.262 0 O-C-N 121.026 -1.046 . . . . 50.0 109.977 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -63.36 -30.57 71.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 124.316 1.01 . . . . 50.0 112.58 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.1 t -65.51 -19.73 66.05 Favored 'General case' 0 C--O 1.252 1.19 0 O-C-N 121.648 -0.657 . . . . 50.0 111.487 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -72.61 -17.62 61.66 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-O 121.802 0.811 . . . . 50.0 110.169 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.1 m -103.54 176.39 5.17 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 115.221 1.563 . . . . 50.0 115.221 -170.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.3 mt -74.98 168.56 19.72 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 122.081 0.943 . . . . 50.0 111.159 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.01 136.21 53.51 Favored 'General case' 0 C--O 1.268 2.031 0 O-C-N 121.271 -0.893 . . . . 25.0 109.604 172.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.86 -9.9 76.43 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 111.831 -0.508 . . . . 50.0 111.831 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.2 m -108.54 158.42 17.57 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 104.518 -2.401 . . . . 50.0 104.518 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.07 171.21 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 106.523 -1.658 . . . . 50.0 106.523 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.8 t -84.69 115.06 22.47 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 105.338 -2.097 . . . . 50.0 105.338 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.24 175.56 54.6 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 112.397 -0.281 . . . . 50.0 112.397 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.92 -13.86 19.41 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 CA-C-O 125.358 2.149 . . . . 50.0 114.592 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -75.75 -10.73 59.68 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 113.595 -1.639 . . . . 50.0 111.151 172.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.47 18.83 51.42 Favored Glycine 0 CA--C 1.494 -1.276 0 CA-C-O 122.535 1.075 . . . . 25.0 112.794 174.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -127.9 150.7 49.75 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.644 -1.278 . . . . 50.0 109.146 -177.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.4 m -61.64 146.79 47.91 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 123.723 0.64 . . . . 25.0 110.555 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.905 0 CA-C-O 117.56 -1.689 . . . . 50.0 111.716 174.954 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.177 -1.392 . . . . 50.0 108.823 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.85 55.03 5.09 Favored 'Trans proline' 0 N--CA 1.488 1.167 0 N-CA-C 115.338 1.246 . . . . 50.0 115.338 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -115.37 19.36 15.55 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 106.607 -1.627 . . . . 50.0 106.607 175.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -158.46 40.53 0.51 Allowed Glycine 0 C--N 1.319 -0.394 0 C-N-CA 119.253 -1.451 . . . . 25.0 116.649 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -93.97 171.39 8.89 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.663 -1.606 . . . . 50.0 106.663 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.22 -55.73 14.9 Favored Glycine 0 C--O 1.201 -1.957 0 O-C-N 125.303 1.627 . . . . 25.0 113.413 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -105.35 27.6 8.15 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 117.867 0.834 . . . . 25.0 112.195 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -120.71 85.88 2.47 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 105.697 -1.964 . . . . 25.0 105.697 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.58 137.36 95.14 Favored Pre-proline 0 C--O 1.261 1.688 0 N-CA-C 106.943 -1.503 . . . . 25.0 106.943 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.28 168.51 24.57 Favored 'Trans proline' 0 CA--C 1.505 -0.958 0 N-CA-C 117.017 1.891 . . . . 50.0 117.017 -175.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.5 m -94.71 129.03 41.79 Favored 'General case' 0 C--O 1.263 1.769 0 CA-C-N 115.301 -0.863 . . . . 25.0 111.453 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 p -72.01 134.31 45.83 Favored 'General case' 0 C--O 1.255 1.365 0 N-CA-C 106.065 -1.828 . . . . 50.0 106.065 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.7 p -138.16 170.13 16.58 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-O 121.872 0.844 . . . . 50.0 109.715 -173.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.1 m -125.84 -16.78 5.58 Favored 'General case' 0 C--O 1.204 -1.331 0 N-CA-C 106.879 -1.526 . . . . 25.0 106.879 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -149.29 160.76 43.12 Favored 'General case' 0 C--O 1.262 1.716 0 CA-C-N 118.7 0.682 . . . . 50.0 109.335 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -59.76 -30.26 68.74 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.816 0.817 . . . . 50.0 112.296 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -1.67 22.85 Favored 'General case' 0 C--O 1.264 1.857 0 O-C-N 121.186 -0.946 . . . . 50.0 112.958 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -87.2 -9.57 54.83 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 121.683 0.754 . . . . 50.0 109.629 170.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.7 m -103.31 175.64 5.41 Favored 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 116.028 1.862 . . . . 50.0 116.028 -170.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.36 162.6 29.17 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.441 0.639 . . . . 50.0 110.034 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.97 124.55 19.06 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 114.863 1.431 . . . . 25.0 114.863 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.17 -7.94 80.96 Favored Glycine 0 CA--C 1.529 0.933 0 O-C-N 124.28 0.987 . . . . 50.0 112.634 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.7 m -98.82 159.37 15.0 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 107.914 -1.143 . . . . 50.0 107.914 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.1 m -127.76 166.53 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.691 1.196 . . . . 50.0 109.895 -175.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.3 t -87.54 116.41 25.64 Favored 'General case' 0 C--O 1.255 1.355 0 N-CA-C 105.424 -2.065 . . . . 50.0 105.424 172.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.38 176.21 49.86 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 116.753 -0.203 . . . . 50.0 112.786 -173.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -75.25 -14.17 20.68 Favored 'Trans proline' 0 C--O 1.204 -1.185 0 CA-C-O 124.103 1.626 . . . . 50.0 114.068 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -72.16 -14.46 61.82 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 113.763 -1.562 . . . . 50.0 111.033 173.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.83 12.96 54.88 Favored Glycine 0 CA--C 1.503 -0.699 0 CA-C-O 122.207 0.893 . . . . 25.0 113.238 174.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -130.47 155.74 45.95 Favored 'General case' 0 C--O 1.206 -1.212 0 CA-C-N 113.415 -1.392 . . . . 50.0 110.284 -174.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 94.0 m -61.92 148.92 42.06 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 124.033 0.833 . . . . 25.0 109.532 173.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.837 0 N-CA-C 109.745 -1.342 . . . . 50.0 109.745 179.382 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 118.201 -0.904 . . . . 50.0 110.915 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.9 70.21 5.27 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 N-CA-C 115.194 1.19 . . . . 50.0 115.194 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -124.26 8.61 8.51 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.904 0.859 . . . . 50.0 110.203 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.39 49.02 0.48 Allowed Glycine 0 CA--C 1.497 -1.08 0 N-CA-C 116.415 1.326 . . . . 25.0 116.415 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 71.1 mtp85 -105.75 174.41 5.89 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.6 -2.0 . . . . 50.0 105.6 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -42.37 -61.59 2.39 Favored Glycine 0 C--O 1.209 -1.45 0 O-C-N 125.099 1.5 . . . . 25.0 114.668 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -99.26 4.41 46.58 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.243 1.022 . . . . 25.0 111.656 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -98.09 80.85 2.74 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 106.198 -1.778 . . . . 25.0 106.198 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.64 147.76 98.9 Favored Pre-proline 0 CA--C 1.559 1.308 0 N-CA-C 104.806 -2.294 . . . . 25.0 104.806 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.94 166.98 28.54 Favored 'Trans proline' 0 CA--C 1.503 -1.046 0 C-N-CA 115.73 -2.38 . . . . 50.0 116.295 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.1 m -94.31 125.93 39.25 Favored 'General case' 0 C--O 1.266 1.94 0 O-C-N 121.33 -0.857 . . . . 25.0 110.395 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 p -67.12 136.28 54.88 Favored 'General case' 0 C--O 1.257 1.49 0 N-CA-C 106.643 -1.614 . . . . 50.0 106.643 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.6 p -143.98 171.82 13.73 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-O 122.824 1.297 . . . . 50.0 110.843 -175.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -130.52 -13.43 3.81 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 114.133 -1.394 . . . . 25.0 108.438 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -150.82 159.33 44.61 Favored 'General case' 0 C--O 1.259 1.602 0 C-N-CA 123.947 0.899 . . . . 50.0 109.218 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -60.64 -31.75 70.94 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 114.062 1.134 . . . . 50.0 114.062 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -15.98 64.05 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 113.036 0.754 . . . . 50.0 113.036 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -73.88 -18.21 60.95 Favored 'General case' 0 CA--C 1.563 1.478 0 O-C-N 124.042 0.838 . . . . 50.0 110.648 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.2 m -95.25 178.24 5.59 Favored 'General case' 0 CA--C 1.557 1.249 0 O-C-N 120.03 -1.669 . . . . 50.0 114.975 -170.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.2 mt -75.58 167.85 21.11 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 121.61 0.719 . . . . 50.0 109.373 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.72 121.78 11.24 Favored 'General case' 0 C--O 1.251 1.163 0 N-CA-C 114.815 1.413 . . . . 25.0 114.815 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.74 -7.29 82.35 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.08 -0.581 . . . . 50.0 113.633 175.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.2 m -95.31 160.43 14.54 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 105.521 -2.029 . . . . 50.0 105.521 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.4 m -129.21 169.36 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.758 0.823 . . . . 50.0 110.429 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 19.3 t -90.54 114.26 26.43 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 106.677 -1.601 . . . . 50.0 106.677 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.85 174.66 53.99 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 115.651 -0.704 . . . . 50.0 114.076 -173.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -73.41 -15.09 25.15 Favored 'Trans proline' 0 C--O 1.213 -0.762 0 CA-C-O 124.552 1.813 . . . . 50.0 114.603 -177.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -74.94 -7.78 54.59 Favored 'General case' 0 CA--C 1.559 1.315 0 CA-C-N 113.896 -1.502 . . . . 50.0 111.157 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.4 12.65 58.24 Favored Glycine 0 C--O 1.247 0.966 0 CA-C-O 122.657 1.143 . . . . 25.0 113.494 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -130.92 154.66 47.87 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 113.491 -1.355 . . . . 50.0 111.402 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 86.2 m -63.71 146.87 53.02 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.855 0.722 . . . . 25.0 110.628 174.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.649 0 N-CA-C 110.171 -1.172 . . . . 50.0 110.171 -178.649 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.476 0.843 0 CA-C-O 117.481 -1.247 . . . . 50.0 108.554 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -77.55 59.95 6.93 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 N-CA-C 115.67 1.373 . . . . 50.0 115.67 -175.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -131.26 19.25 4.87 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 106.251 -1.759 . . . . 50.0 106.251 174.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.46 50.81 0.32 Allowed Glycine 0 CA--C 1.495 -1.175 0 C-N-CA 119.766 -1.207 . . . . 25.0 114.344 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -119.19 -169.31 1.72 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.982 -0.748 . . . . 50.0 108.982 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.94 -64.34 4.27 Favored Glycine 0 C--O 1.201 -1.96 0 O-C-N 125.036 1.46 . . . . 25.0 113.183 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -102.77 26.72 7.7 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.758 1.279 . . . . 25.0 110.354 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -127.81 81.12 2.0 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 105.668 -1.975 . . . . 25.0 105.668 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.88 152.75 95.37 Favored Pre-proline 0 C--O 1.254 1.292 0 CA-C-N 112.889 -1.959 . . . . 25.0 105.875 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.58 170.45 20.26 Favored 'Trans proline' 0 CA--C 1.506 -0.925 0 C-N-CA 116.145 -2.103 . . . . 50.0 115.579 -178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.6 m -108.73 129.21 55.36 Favored 'General case' 0 C--O 1.26 1.639 0 O-C-N 121.7 -0.625 . . . . 25.0 110.899 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.8 p -66.28 133.63 50.97 Favored 'General case' 0 C--O 1.262 1.763 0 N-CA-C 106.245 -1.761 . . . . 50.0 106.245 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.6 p -139.81 176.58 8.62 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 122.143 0.973 . . . . 50.0 110.258 -174.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.0 m -132.39 -15.9 2.78 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 114.484 -1.235 . . . . 25.0 108.68 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -153.37 162.93 40.77 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 108.031 -1.1 . . . . 50.0 108.031 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -62.96 -32.22 73.49 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 113.806 1.039 . . . . 50.0 113.806 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.89 -10.15 59.08 Favored 'General case' 0 C--O 1.252 1.232 0 O-C-N 121.118 -0.989 . . . . 50.0 113.024 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -75.69 -15.67 60.27 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.239 1.019 . . . . 50.0 110.072 172.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 54.1 m -99.91 177.2 5.18 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 115.125 1.528 . . . . 50.0 115.125 -171.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.6 mt -75.57 168.87 19.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.457 -0.792 . . . . 50.0 112.662 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.38 121.56 9.86 Favored 'General case' 0 C--O 1.254 1.312 0 N-CA-C 113.416 0.895 . . . . 25.0 113.416 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.42 -10.38 74.94 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 120.0 -0.333 . . . . 50.0 113.043 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.4 m -89.26 156.3 18.84 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 106.413 -1.699 . . . . 50.0 106.413 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.8 m -129.38 164.55 31.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 106.581 -1.637 . . . . 50.0 106.581 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 18.3 t -87.59 115.07 24.78 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 104.4 -2.444 . . . . 50.0 104.4 174.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.37 179.3 53.21 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 120.668 -0.777 . . . . 50.0 114.408 -172.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.41 -13.63 22.8 Favored 'Trans proline' 0 C--O 1.206 -1.102 0 CA-C-O 124.868 1.945 . . . . 50.0 113.828 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -74.42 -9.85 58.99 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-N 112.931 -1.94 . . . . 50.0 111.816 171.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.46 22.24 58.88 Favored Glycine 0 CA--C 1.498 -0.996 0 CA-C-O 122.605 1.114 . . . . 25.0 112.416 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -135.89 147.28 48.11 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 112.996 -1.602 . . . . 50.0 109.514 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 92.4 m -61.5 147.68 44.49 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.686 0.616 . . . . 25.0 110.607 174.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.824 0 CA-C-O 117.24 -1.867 . . . . 50.0 110.608 175.306 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.481 1.103 0 CA-C-O 117.5 -1.238 . . . . 50.0 108.8 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.33 65.36 7.96 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 N-CA-C 114.762 1.024 . . . . 50.0 114.762 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -124.65 21.08 8.52 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 105.548 -2.019 . . . . 50.0 105.548 170.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.58 53.26 0.31 Allowed Glycine 0 CA--C 1.5 -0.877 0 CA-C-O 122.569 1.094 . . . . 25.0 113.209 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.8 mmm-85 -128.23 164.14 23.2 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 106.024 -1.843 . . . . 50.0 106.024 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -45.91 -55.1 7.57 Favored Glycine 0 C--O 1.203 -1.802 0 O-C-N 125.42 1.7 . . . . 25.0 114.572 -174.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -99.02 17.73 19.0 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 119.101 1.451 . . . . 25.0 110.316 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -126.53 78.6 1.8 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 107.35 -1.352 . . . . 25.0 107.35 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.02 151.06 95.96 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 103.911 -2.625 . . . . 25.0 103.911 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.78 169.56 21.72 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 N-CA-C 116.971 1.873 . . . . 50.0 116.971 -175.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.9 m -100.05 128.76 46.09 Favored 'General case' 0 C--O 1.259 1.572 0 CA-C-N 115.655 -0.702 . . . . 25.0 110.553 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.2 p -68.33 137.72 54.86 Favored 'General case' 0 C--O 1.262 1.762 0 N-CA-C 107.051 -1.463 . . . . 50.0 107.051 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.1 p -142.16 170.39 15.79 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.14 0.971 . . . . 50.0 112.542 -175.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.5 m -128.27 -15.4 4.65 Favored 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 107.476 -1.305 . . . . 25.0 107.476 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -149.36 161.49 41.96 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 123.734 0.814 . . . . 50.0 109.218 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -64.38 -28.14 69.49 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 124.628 1.205 . . . . 50.0 112.496 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.4 t -65.43 -19.83 66.11 Favored 'General case' 0 C--O 1.258 1.529 0 O-C-N 121.63 -0.669 . . . . 50.0 111.137 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -71.0 -17.19 62.65 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 122.28 1.038 . . . . 50.0 111.7 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.3 m -97.52 174.22 6.77 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 120.592 -1.317 . . . . 50.0 114.233 -171.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.3 mt -69.74 167.41 17.17 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 121.588 0.709 . . . . 50.0 109.81 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.41 125.11 21.94 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 113.279 0.844 . . . . 25.0 113.279 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.32 -10.4 74.42 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 120.857 -0.687 . . . . 50.0 113.544 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.2 m -95.32 164.38 12.86 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.685 -1.598 . . . . 50.0 106.685 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 m -131.75 165.27 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.637 0.775 . . . . 50.0 110.503 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.6 t -84.73 119.77 25.65 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 104.304 -2.48 . . . . 50.0 104.304 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.2 175.25 55.15 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 121.396 -0.43 . . . . 50.0 113.44 -174.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -74.79 -14.0 21.78 Favored 'Trans proline' 0 C--O 1.204 -1.176 0 CA-C-O 125.136 2.057 . . . . 50.0 113.845 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -79.45 -9.56 59.63 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-N 113.754 -1.566 . . . . 50.0 111.312 175.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.34 15.31 53.87 Favored Glycine 0 CA--C 1.493 -1.318 0 CA-C-O 122.497 1.054 . . . . 25.0 113.131 175.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -127.68 146.91 50.41 Favored 'General case' 0 C--O 1.203 -1.389 0 CA-C-N 113.928 -1.136 . . . . 50.0 110.835 -176.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.5 m -60.34 147.37 40.81 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.981 0.8 . . . . 25.0 110.268 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -2.062 0 CA-C-O 118.012 -1.438 . . . . 50.0 110.731 179.451 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 118.576 -0.726 . . . . 50.0 110.871 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.67 73.47 5.24 Favored 'Trans proline' 0 C--O 1.211 -0.87 0 N-CA-C 115.204 1.194 . . . . 50.0 115.204 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -121.7 15.65 11.05 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.719 -0.845 . . . . 50.0 108.719 171.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.86 35.24 0.93 Allowed Glycine 0 N--CA 1.467 0.737 0 C-N-CA 119.114 -1.517 . . . . 25.0 116.725 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -94.8 178.24 5.64 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.166 -1.05 . . . . 50.0 108.166 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.18 -54.6 33.04 Favored Glycine 0 C--O 1.201 -1.96 0 C-N-CA 119.712 -1.233 . . . . 25.0 113.083 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -95.57 13.57 25.73 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.208 1.504 . . . . 25.0 110.483 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -122.88 80.17 1.73 Allowed 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 105.989 -1.856 . . . . 25.0 105.989 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.66 148.3 98.23 Favored Pre-proline 0 C--O 1.254 1.298 0 N-CA-C 104.311 -2.477 . . . . 25.0 104.311 175.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.43 168.39 23.65 Favored 'Trans proline' 0 CA--C 1.498 -1.292 0 C-N-CA 114.481 -3.213 . . . . 50.0 114.971 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.6 m -101.39 124.39 46.99 Favored 'General case' 0 C--O 1.255 1.371 0 O-C-N 121.648 -0.657 . . . . 25.0 110.273 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -66.92 140.41 57.76 Favored 'General case' 0 C--O 1.256 1.397 0 N-CA-C 106.666 -1.605 . . . . 50.0 106.666 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 p -150.09 172.0 15.97 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-O 122.767 1.27 . . . . 50.0 111.009 -175.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -132.27 -11.62 3.22 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.215 -1.357 . . . . 25.0 108.452 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -150.19 157.32 42.97 Favored 'General case' 0 C--O 1.262 1.716 0 N-CA-C 107.416 -1.327 . . . . 50.0 107.416 -177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -66.77 -25.33 66.43 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 113.781 1.03 . . . . 50.0 113.781 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 80.3 p -73.83 -9.1 58.31 Favored 'General case' 0 C--O 1.257 1.461 0 O-C-N 121.156 -0.965 . . . . 50.0 111.553 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -73.53 -16.16 61.28 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 108.841 -0.799 . . . . 50.0 108.841 172.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.7 m -100.55 177.51 4.99 Favored 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 116.08 1.881 . . . . 50.0 116.08 -169.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.6 mt -72.84 167.24 21.34 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.657 0.742 . . . . 50.0 110.476 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.27 118.55 7.58 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 114.328 1.233 . . . . 25.0 114.328 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.93 -6.6 64.41 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 111.413 -0.675 . . . . 50.0 111.413 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.1 m -105.7 157.39 17.46 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.103 -1.073 . . . . 50.0 108.103 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.1 m -131.35 167.88 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 123.352 0.661 . . . . 50.0 110.581 -173.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.9 t -89.48 114.98 26.56 Favored 'General case' 0 C--O 1.247 0.958 0 N-CA-C 107.413 -1.329 . . . . 50.0 107.413 175.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.66 179.6 52.3 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 120.848 -0.691 . . . . 50.0 113.655 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -75.77 -13.97 19.69 Favored 'Trans proline' 0 C--O 1.202 -1.3 0 CA-C-N 119.608 1.704 . . . . 50.0 113.54 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -75.57 -8.15 56.04 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 113.639 -1.619 . . . . 50.0 110.607 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.52 15.67 63.49 Favored Glycine 0 CA--C 1.49 -1.515 0 CA-C-O 123.043 1.357 . . . . 25.0 113.269 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -126.43 147.61 49.77 Favored 'General case' 0 C--O 1.195 -1.8 0 CA-C-N 112.88 -1.66 . . . . 50.0 111.361 -175.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.1 m -63.18 148.77 47.12 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 124.692 1.245 . . . . 25.0 109.202 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.479 -2.157 0 CA-C-O 119.352 -0.693 . . . . 50.0 112.984 178.091 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 118.005 -0.997 . . . . 50.0 109.908 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.92 58.0 5.32 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 N-CA-C 115.7 1.385 . . . . 50.0 115.7 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -124.66 6.86 8.18 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 107.714 -1.217 . . . . 50.0 107.714 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.39 58.32 0.42 Allowed Glycine 0 CA--C 1.495 -1.209 0 C-N-CA 120.267 -0.968 . . . . 25.0 115.184 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.8 mtm-85 -126.07 169.49 12.72 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.66 -1.237 . . . . 50.0 107.66 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -38.75 -58.28 1.83 Allowed Glycine 0 C--O 1.212 -1.248 0 O-C-N 125.489 1.743 . . . . 25.0 116.287 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -110.75 31.18 6.19 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.473 1.637 . . . . 25.0 110.888 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -122.95 78.0 1.51 Allowed 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 103.557 -2.757 . . . . 25.0 103.557 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.77 151.67 97.13 Favored Pre-proline 0 CA--C 1.562 1.429 0 N-CA-C 105.743 -1.947 . . . . 25.0 105.743 176.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.81 170.19 20.62 Favored 'Trans proline' 0 CA--C 1.512 -0.621 0 N-CA-C 116.093 1.536 . . . . 50.0 116.093 -176.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.5 m -100.33 131.32 46.32 Favored 'General case' 0 C--O 1.263 1.779 0 CA-C-N 115.73 -0.668 . . . . 25.0 110.877 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.6 p -66.86 130.86 44.54 Favored 'General case' 0 C--O 1.271 2.185 0 N-CA-C 107.003 -1.481 . . . . 50.0 107.003 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.3 p -142.63 175.92 9.44 Favored 'General case' 0 CA--C 1.561 1.396 0 CA-C-O 122.416 1.103 . . . . 50.0 109.161 -177.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 m -130.64 -18.21 3.15 Favored 'General case' 0 C--O 1.189 -2.097 0 CA-C-N 114.321 -1.309 . . . . 25.0 108.509 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -143.17 158.13 43.89 Favored 'General case' 0 C--O 1.259 1.553 0 N-CA-C 108.032 -1.099 . . . . 50.0 108.032 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -62.96 -29.31 70.7 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 124.512 1.133 . . . . 50.0 111.948 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.4 t -71.15 -13.1 61.83 Favored 'General case' 0 C--O 1.249 1.067 0 O-C-N 121.06 -1.025 . . . . 50.0 112.36 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -74.05 -16.08 61.05 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.022 -0.733 . . . . 50.0 109.022 174.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.9 m -100.84 170.68 8.15 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 115.008 1.485 . . . . 50.0 115.008 -170.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.7 mt -66.17 165.63 13.37 Favored 'General case' 0 N--CA 1.424 -1.753 0 O-C-N 123.731 0.644 . . . . 50.0 110.792 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.96 119.72 8.83 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 114.548 1.314 . . . . 25.0 114.548 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.01 -7.74 73.17 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 121.191 -0.528 . . . . 50.0 113.155 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.3 m -99.21 160.7 14.08 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 105.615 -1.994 . . . . 50.0 105.615 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.11 166.72 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 123.199 0.6 . . . . 50.0 109.921 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 21.2 t -91.03 118.84 30.72 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 106.2 -1.778 . . . . 50.0 106.2 174.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.45 177.09 54.23 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.428 -0.892 . . . . 50.0 114.005 -174.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.22 -19.03 23.02 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 CA-C-O 124.995 1.998 . . . . 50.0 113.895 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -72.84 -10.14 59.46 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-N 113.778 -1.555 . . . . 50.0 110.604 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.2 17.02 44.69 Favored Glycine 0 CA--C 1.497 -1.081 0 CA-C-N 115.162 -0.926 . . . . 25.0 113.936 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -130.11 146.81 51.79 Favored 'General case' 0 C--O 1.212 -0.919 0 CA-C-N 114.182 -1.009 . . . . 50.0 113.626 -172.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 96.1 m -63.28 143.38 57.85 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 124.297 1.039 . . . . 25.0 111.532 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.843 0 CA-C-O 117.618 -1.657 . . . . 50.0 110.865 179.432 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 118.096 -0.954 . . . . 50.0 113.154 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.41 70.99 6.04 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 N-CA-C 114.591 0.958 . . . . 50.0 114.591 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -119.85 -2.56 10.32 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-N 115.253 -0.885 . . . . 50.0 108.679 173.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -142.81 60.76 0.53 Allowed Glycine 0 CA--C 1.495 -1.161 0 C-N-CA 120.276 -0.964 . . . . 25.0 114.03 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -131.82 163.41 28.32 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.222 -0.659 . . . . 50.0 109.222 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -42.02 -47.69 5.29 Favored Glycine 0 C--O 1.211 -1.283 0 N-CA-C 116.628 1.411 . . . . 25.0 116.628 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -107.91 18.82 20.82 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 118.912 1.356 . . . . 25.0 109.717 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.7 m-90 -129.54 80.75 1.98 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.226 -1.398 . . . . 25.0 107.226 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.89 148.41 97.93 Favored Pre-proline 0 CA--C 1.57 1.716 0 N-CA-C 104.858 -2.275 . . . . 25.0 104.858 174.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.5 168.36 24.56 Favored 'Trans proline' 0 CA--C 1.491 -1.636 0 N-CA-C 118.477 2.453 . . . . 50.0 118.477 -175.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 80.1 m -97.96 128.7 44.69 Favored 'General case' 0 C--O 1.264 1.861 0 CA-C-N 114.737 -1.12 . . . . 25.0 110.988 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.81 131.73 45.62 Favored 'General case' 0 C--O 1.256 1.407 0 N-CA-C 107.019 -1.474 . . . . 50.0 107.019 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.2 p -138.2 170.21 16.43 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 122.857 1.313 . . . . 50.0 110.461 -176.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.0 m -125.32 -17.24 5.69 Favored 'General case' 0 C--O 1.197 -1.705 0 N-CA-C 107.088 -1.449 . . . . 25.0 107.088 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -151.22 162.14 41.44 Favored 'General case' 0 C--O 1.254 1.33 0 C-N-CA 123.286 0.634 . . . . 50.0 110.041 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -57.63 -32.55 67.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 124.446 1.092 . . . . 50.0 112.805 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.9 t -63.95 -18.9 64.71 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-O 118.91 -0.567 . . . . 50.0 111.669 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -71.77 -13.24 61.64 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 113.27 0.841 . . . . 50.0 113.27 174.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.7 m -101.25 173.03 6.64 Favored 'General case' 0 C--O 1.251 1.148 0 N-CA-C 115.309 1.596 . . . . 50.0 115.309 -169.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.8 mt -67.66 163.92 20.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.033 0.921 . . . . 50.0 110.431 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.16 122.06 12.87 Favored 'General case' 0 C--O 1.252 1.229 0 N-CA-C 113.867 1.062 . . . . 25.0 113.867 -178.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.01 7.01 78.35 Favored Glycine 0 CA--C 1.522 0.505 0 O-C-N 123.195 0.309 . . . . 50.0 112.469 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.5 m -114.04 160.95 18.32 Favored 'General case' 0 C--N 1.354 0.793 0 N-CA-C 106.258 -1.756 . . . . 50.0 106.258 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.3 m -128.84 170.55 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.037 0.935 . . . . 50.0 110.773 -176.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.4 t -91.76 108.92 20.26 Favored 'General case' 0 C--O 1.249 1.03 0 N-CA-C 105.313 -2.106 . . . . 50.0 105.313 174.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.19 175.87 54.4 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 116.255 -0.429 . . . . 50.0 113.956 -173.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.54 -9.26 21.32 Favored 'Trans proline' 0 C--O 1.207 -1.048 0 CA-C-N 119.579 1.69 . . . . 50.0 115.574 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -76.58 -10.04 59.1 Favored 'General case' 0 CA--C 1.565 1.542 0 CA-C-N 113.895 -1.502 . . . . 50.0 110.046 173.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.35 17.46 57.2 Favored Glycine 0 C--O 1.247 0.924 0 CA-C-O 121.851 0.695 . . . . 25.0 112.285 176.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -133.9 151.52 51.54 Favored 'General case' 0 C--O 1.211 -0.962 0 CA-C-N 113.553 -1.324 . . . . 50.0 110.215 -174.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.3 m -60.28 146.86 42.36 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 124.053 0.846 . . . . 25.0 111.174 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.964 0 CA-C-O 118.153 -1.359 . . . . 50.0 111.34 178.888 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 117.261 -1.352 . . . . 50.0 111.359 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.68 68.06 7.74 Favored 'Trans proline' 0 N--CA 1.485 0.993 0 N-CA-C 114.898 1.076 . . . . 50.0 114.898 -175.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -122.78 19.46 10.22 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.676 -1.601 . . . . 50.0 106.676 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.71 42.9 0.56 Allowed Glycine 0 CA--C 1.507 -0.466 0 C-N-CA 119.964 -1.112 . . . . 25.0 114.158 177.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -103.35 -178.13 3.57 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.949 -1.13 . . . . 50.0 107.949 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.08 -62.6 6.18 Favored Glycine 0 C--O 1.212 -1.235 0 O-C-N 124.809 1.318 . . . . 25.0 112.761 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -94.57 10.06 36.2 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-N 118.956 1.378 . . . . 25.0 111.513 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.3 m-90 -111.73 82.09 1.56 Allowed 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 107.682 -1.229 . . . . 25.0 107.682 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.85 149.18 98.56 Favored Pre-proline 0 C--O 1.252 1.202 0 N-CA-C 104.791 -2.3 . . . . 25.0 104.791 174.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.91 164.63 35.07 Favored 'Trans proline' 0 N--CA 1.481 0.759 0 C-N-CA 115.937 -2.242 . . . . 50.0 116.133 -176.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.4 m -94.91 129.74 41.8 Favored 'General case' 0 C--O 1.273 2.322 0 CA-C-N 115.842 -0.617 . . . . 25.0 111.028 177.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.8 p -69.68 132.61 46.42 Favored 'General case' 0 C--O 1.253 1.274 0 N-CA-C 106.699 -1.593 . . . . 50.0 106.699 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.8 p -138.39 172.02 13.52 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.095 0.95 . . . . 50.0 108.975 -174.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.5 m -128.73 -14.81 4.51 Favored 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 107.114 -1.439 . . . . 25.0 107.114 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.41 162.71 40.79 Favored 'General case' 0 C--O 1.255 1.383 0 CA-C-N 118.984 0.811 . . . . 50.0 109.735 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -58.44 -32.24 68.52 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.0 0.812 . . . . 50.0 112.626 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.8 t -66.33 -16.69 64.25 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 112.406 0.521 . . . . 50.0 112.406 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -77.79 -9.51 59.07 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 119.63 -0.828 . . . . 50.0 110.97 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.4 m -104.0 178.57 4.52 Favored 'General case' 0 CA--C 1.552 1.055 0 O-C-N 120.327 -1.483 . . . . 50.0 115.0 -171.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.5 mt -76.3 164.53 25.95 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-O 121.519 0.676 . . . . 50.0 109.711 175.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.8 132.33 53.51 Favored 'General case' 0 C--O 1.259 1.601 0 CA-C-O 119.085 -0.483 . . . . 25.0 110.87 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.54 -7.03 82.75 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 119.502 -0.61 . . . . 50.0 112.124 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.3 m -106.19 155.87 19.03 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.233 -1.765 . . . . 50.0 106.233 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.9 m -129.41 164.98 30.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 C-N-CA 124.937 1.295 . . . . 50.0 107.725 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.6 t -84.04 111.79 19.62 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 105.033 -2.21 . . . . 50.0 105.033 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.84 175.42 52.02 Favored Glycine 0 C--O 1.252 1.256 0 CA-C-N 115.525 -0.761 . . . . 50.0 113.264 -173.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.8 -14.44 19.46 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 CA-C-O 124.286 1.703 . . . . 50.0 114.151 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.2 p-10 -75.82 -8.76 57.65 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-N 114.009 -1.45 . . . . 50.0 110.549 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.24 22.05 39.32 Favored Glycine 0 C--O 1.247 0.966 0 CA-C-O 122.104 0.835 . . . . 25.0 113.463 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -135.79 153.5 51.51 Favored 'General case' 0 C--O 1.208 -1.127 0 CA-C-N 114.019 -1.09 . . . . 50.0 110.67 -173.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 92.0 m -62.31 142.09 57.94 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.389 0.431 . . . . 25.0 110.214 172.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -2.022 0 CA-C-O 118.123 -1.376 . . . . 50.0 111.25 177.867 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.1 p . . . . . 0 CA--C 1.509 -0.6 0 CA-C-O 117.555 -1.212 . . . . 50.0 111.759 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -76.68 58.23 5.87 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 CA-C-N 119.974 1.027 . . . . 50.0 114.674 -176.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -125.17 16.03 8.42 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 104.572 -2.381 . . . . 50.0 104.572 172.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.02 69.74 0.18 Allowed Glycine 0 CA--C 1.49 -1.517 0 N-CA-C 111.053 -0.819 . . . . 25.0 111.053 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -137.27 163.39 31.07 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 105.831 -1.915 . . . . 50.0 105.831 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -41.58 -56.31 3.6 Favored Glycine 0 C--O 1.21 -1.38 0 CA-C-O 118.135 -1.369 . . . . 25.0 114.355 -177.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -97.75 13.81 29.11 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 119.925 1.863 . . . . 25.0 110.867 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -124.72 84.87 2.33 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 108.534 -0.913 . . . . 25.0 108.534 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.27 153.4 95.58 Favored Pre-proline 0 C--O 1.257 1.458 0 O-C-N 125.591 1.807 . . . . 25.0 106.609 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.26 171.01 18.88 Favored 'Trans proline' 0 CA--C 1.493 -1.575 0 N-CA-C 116.71 1.773 . . . . 50.0 116.71 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.7 m -108.21 131.33 54.78 Favored 'General case' 0 C--O 1.259 1.605 0 CA-C-N 115.274 -0.876 . . . . 25.0 110.288 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.14 140.03 56.16 Favored 'General case' 0 C--O 1.253 1.257 0 N-CA-C 106.554 -1.647 . . . . 50.0 106.554 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.1 p -144.79 174.23 11.17 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.234 -1.348 . . . . 50.0 110.778 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 m -132.95 -10.73 3.0 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 107.622 -1.251 . . . . 25.0 107.622 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -152.28 160.84 43.28 Favored 'General case' 0 C--O 1.259 1.598 0 N-CA-C 107.761 -1.2 . . . . 50.0 107.761 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -63.71 -30.25 71.38 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.264 0.554 . . . . 50.0 112.002 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.6 t -68.25 -18.2 64.49 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 119.17 -1.012 . . . . 50.0 112.066 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -70.53 -11.81 61.17 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.301 -0.629 . . . . 50.0 109.301 175.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.3 m -104.05 173.66 6.21 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.988 1.477 . . . . 50.0 114.988 -171.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.86 167.8 20.22 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 121.946 0.879 . . . . 50.0 109.42 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.6 120.73 11.15 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 114.687 1.366 . . . . 25.0 114.687 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.85 -8.92 65.85 Favored Glycine 0 CA--C 1.532 1.151 0 N-CA-C 110.723 -0.951 . . . . 50.0 110.723 175.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.5 m -97.22 163.72 12.79 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 106.028 -1.842 . . . . 50.0 106.028 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.4 m -133.5 168.19 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.387 1.075 . . . . 50.0 109.631 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.2 t -90.62 115.2 27.56 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 105.317 -2.105 . . . . 50.0 105.317 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.59 176.83 50.15 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.884 -0.598 . . . . 50.0 112.69 -175.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.22 -14.71 18.47 Favored 'Trans proline' 0 C--O 1.206 -1.085 0 CA-C-O 124.965 1.985 . . . . 50.0 113.833 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -77.13 -8.73 58.0 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-N 113.518 -1.674 . . . . 50.0 110.221 173.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.24 19.95 56.04 Favored Glycine 0 CA--C 1.495 -1.192 0 CA-C-O 122.004 0.78 . . . . 25.0 113.44 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -122.94 147.33 46.74 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.683 -1.258 . . . . 50.0 110.498 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.3 m -63.13 148.9 46.62 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 124.151 0.907 . . . . 25.0 110.308 173.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.558 0 CA-C-O 117.969 -1.461 . . . . 50.0 112.382 173.68 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 117.567 -1.206 . . . . 50.0 111.936 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.66 70.43 5.74 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 N-CA-C 115.26 1.215 . . . . 50.0 115.26 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -129.72 24.04 5.39 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 104.583 -2.377 . . . . 50.0 104.583 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -165.56 51.78 0.27 Allowed Glycine 0 CA--C 1.502 -0.777 0 C-N-CA 120.223 -0.989 . . . . 25.0 112.871 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.93 177.14 4.73 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 105.749 -1.945 . . . . 50.0 105.749 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -51.22 -56.09 16.28 Favored Glycine 0 C--O 1.21 -1.359 0 O-C-N 125.623 1.827 . . . . 25.0 113.104 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -98.67 -3.68 35.44 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 120.197 1.999 . . . . 25.0 112.563 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -98.24 81.95 2.86 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 106.514 -1.661 . . . . 25.0 106.514 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.09 149.58 98.41 Favored Pre-proline 0 C--O 1.254 1.308 0 N-CA-C 105.242 -2.132 . . . . 25.0 105.242 175.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.94 163.05 39.86 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 116.316 -1.99 . . . . 50.0 114.605 -177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.7 m -97.14 127.67 43.32 Favored 'General case' 0 C--O 1.258 1.531 0 CA-C-N 115.783 -0.644 . . . . 25.0 111.971 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.13 134.29 48.0 Favored 'General case' 0 C--O 1.26 1.616 0 N-CA-C 106.604 -1.628 . . . . 50.0 106.604 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.2 p -139.37 174.77 10.17 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 123.153 1.454 . . . . 50.0 111.817 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.7 m -129.8 -20.48 3.17 Favored 'General case' 0 C--O 1.196 -1.728 0 N-CA-C 107.372 -1.344 . . . . 25.0 107.372 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -144.43 163.13 34.71 Favored 'General case' 0 C--O 1.259 1.605 0 N-CA-C 108.703 -0.851 . . . . 50.0 108.703 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -62.67 -29.77 70.89 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-O 121.885 0.85 . . . . 50.0 111.853 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.4 t -66.06 -19.11 65.74 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.61 -0.723 . . . . 50.0 111.609 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -70.05 -17.94 63.27 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.623 0.725 . . . . 50.0 110.729 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.7 m -97.02 175.26 6.39 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 115.801 1.778 . . . . 50.0 115.801 -171.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.2 mt -74.15 168.78 18.88 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.533 0.682 . . . . 50.0 110.238 175.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.65 128.08 34.24 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 118.509 -0.757 . . . . 25.0 112.889 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.37 -4.22 76.65 Favored Glycine 0 C--N 1.342 0.878 0 C-N-CA 120.533 -0.841 . . . . 50.0 111.303 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.9 m -107.5 159.49 16.38 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.515 -1.661 . . . . 50.0 106.515 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.35 164.24 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 124.267 1.027 . . . . 50.0 109.203 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.5 t -87.36 119.31 27.48 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 105.151 -2.166 . . . . 50.0 105.151 174.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.48 176.44 48.17 Favored Glycine 0 C--O 1.255 1.454 0 C-N-CA 120.894 -0.67 . . . . 50.0 113.352 -173.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.01 -12.52 16.09 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 CA-C-O 124.671 1.863 . . . . 50.0 113.71 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -73.88 -13.17 60.87 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 113.705 -1.588 . . . . 50.0 109.345 173.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.34 14.5 47.74 Favored Glycine 0 C--O 1.251 1.187 0 CA-C-O 122.678 1.155 . . . . 25.0 111.963 174.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -129.06 151.08 50.13 Favored 'General case' 0 C--O 1.204 -1.329 0 CA-C-N 113.474 -1.363 . . . . 50.0 113.098 -173.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 88.1 m -63.27 144.95 56.5 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 123.893 0.746 . . . . 25.0 111.125 172.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -2.088 0 CA-C-O 117.955 -1.47 . . . . 50.0 111.292 178.754 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 113.726 1.01 . . . . 50.0 113.726 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.06 63.9 7.72 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 O-C-N 123.094 1.05 . . . . 50.0 114.753 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.8 mm-40 -123.71 26.55 7.67 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.937 -2.246 . . . . 50.0 104.937 172.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.06 57.22 0.19 Allowed Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.723 -1.227 . . . . 25.0 114.132 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -124.36 172.63 8.98 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 106.743 -1.577 . . . . 50.0 106.743 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.68 -49.27 28.04 Favored Glycine 0 C--O 1.214 -1.147 0 O-C-N 124.895 1.372 . . . . 25.0 114.637 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -104.49 13.77 31.21 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 118.733 1.267 . . . . 25.0 110.357 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -122.37 81.87 1.9 Allowed 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 106.854 -1.536 . . . . 25.0 106.854 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.38 149.7 95.76 Favored Pre-proline 0 CA--C 1.562 1.413 0 N-CA-C 105.779 -1.934 . . . . 25.0 105.779 176.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.33 165.63 32.04 Favored 'Trans proline' 0 CA--C 1.507 -0.87 0 C-N-CA 116.656 -1.762 . . . . 50.0 116.195 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.0 m -97.97 130.64 44.81 Favored 'General case' 0 C--O 1.272 2.252 0 O-C-N 120.918 -1.114 . . . . 25.0 110.609 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 m -66.11 131.19 45.62 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 107.155 -1.424 . . . . 50.0 107.155 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.1 p -136.61 172.14 13.45 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.298 -1.319 . . . . 50.0 110.936 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 m -126.83 -22.06 3.93 Favored 'General case' 0 C--O 1.197 -1.664 0 N-CA-C 106.864 -1.532 . . . . 25.0 106.864 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -145.67 160.85 41.1 Favored 'General case' 0 C--O 1.264 1.863 0 C-N-CA 123.116 0.566 . . . . 50.0 109.684 -175.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -65.51 -27.03 68.18 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.117 0.784 . . . . 50.0 113.117 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 97.4 p -73.1 -12.45 60.91 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 121.173 -0.954 . . . . 50.0 111.078 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -71.13 -19.74 62.4 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 119.109 -1.036 . . . . 50.0 109.363 171.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.6 m -96.92 169.48 9.82 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.913 1.449 . . . . 50.0 114.913 -173.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.2 mt -71.26 168.48 17.22 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.645 -0.707 . . . . 50.0 109.764 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.78 124.95 20.91 Favored 'General case' 0 C--O 1.254 1.311 0 N-CA-C 113.788 1.033 . . . . 25.0 113.788 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.34 -9.82 75.56 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.623 -0.543 . . . . 50.0 112.916 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.8 m -99.86 156.84 16.91 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 106.201 -1.778 . . . . 50.0 106.201 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -128.52 167.78 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.957 0.903 . . . . 50.0 110.134 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.0 t -86.39 113.67 22.54 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 105.844 -1.909 . . . . 50.0 105.844 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.17 -179.13 52.73 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 119.37 -0.683 . . . . 50.0 114.116 -171.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.83 -13.33 21.85 Favored 'Trans proline' 0 C--O 1.21 -0.909 0 CA-C-N 119.652 1.726 . . . . 50.0 114.269 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -81.0 -6.93 59.38 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-N 114.102 -1.408 . . . . 50.0 109.865 174.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.87 20.33 59.75 Favored Glycine 0 C--O 1.254 1.362 0 CA-C-O 122.717 1.176 . . . . 25.0 112.537 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -130.17 149.02 52.06 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.247 -1.476 . . . . 50.0 110.006 -176.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.6 m -62.92 146.87 51.97 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.154 -0.476 . . . . 25.0 112.216 175.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.893 0 CA-C-O 118.691 -1.06 . . . . 50.0 111.308 171.941 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 117.434 -1.269 . . . . 50.0 108.665 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.62 63.78 7.36 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 CA-C-N 120.8 1.321 . . . . 50.0 115.295 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -125.52 11.32 7.96 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 105.508 -2.034 . . . . 50.0 105.508 173.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -154.08 44.97 0.57 Allowed Glycine 0 N--CA 1.468 0.807 0 C-N-CA 120.031 -1.08 . . . . 25.0 114.792 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -104.86 174.47 5.86 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 104.637 -2.357 . . . . 50.0 104.637 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.17 -51.03 60.87 Favored Glycine 0 C--O 1.204 -1.768 0 O-C-N 124.637 1.211 . . . . 25.0 113.812 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.45 0.75 48.23 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 118.579 1.19 . . . . 25.0 111.9 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -105.77 88.14 2.75 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 106.437 -1.69 . . . . 25.0 106.437 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.62 149.35 98.35 Favored Pre-proline 0 CA--C 1.567 1.623 0 N-CA-C 104.518 -2.401 . . . . 25.0 104.518 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.06 168.82 20.85 Favored 'Trans proline' 0 N--CA 1.479 0.621 0 N-CA-C 117.05 1.904 . . . . 50.0 117.05 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.2 m -100.44 128.26 46.55 Favored 'General case' 0 C--O 1.26 1.649 0 O-C-N 121.203 -0.936 . . . . 25.0 111.38 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.4 p -68.57 134.54 50.15 Favored 'General case' 0 C--O 1.26 1.627 0 N-CA-C 106.695 -1.595 . . . . 50.0 106.695 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.1 p -142.55 170.6 15.39 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.883 -1.053 . . . . 50.0 109.32 -176.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.1 m -130.51 -12.03 3.94 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 107.271 -1.381 . . . . 25.0 107.271 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -149.66 159.45 44.32 Favored 'General case' 0 C--O 1.256 1.4 0 C-N-CA 123.947 0.899 . . . . 50.0 108.905 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -61.84 -31.15 71.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 124.145 0.903 . . . . 50.0 111.18 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 t -68.99 -13.27 62.35 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 121.469 -0.769 . . . . 50.0 112.287 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -77.8 -8.25 57.76 Favored 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 120.123 -0.631 . . . . 50.0 110.347 174.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.1 m -104.91 171.74 7.16 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 116.654 2.094 . . . . 50.0 116.654 -172.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.416 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 83.5 mt -68.52 168.43 12.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 122.03 0.919 . . . . 50.0 110.855 177.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.64 124.5 20.88 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 114.011 1.115 . . . . 25.0 114.011 -177.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.19 -12.83 68.01 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 123.349 0.406 . . . . 50.0 112.732 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 4.5 m -90.08 160.13 16.46 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 106.638 -1.616 . . . . 50.0 106.638 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.9 m -128.76 171.89 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 124.617 1.167 . . . . 50.0 108.419 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.5 t -94.9 123.31 38.3 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 106.113 -1.81 . . . . 50.0 106.113 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.98 177.57 46.32 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 114.903 0.721 . . . . 50.0 114.903 -175.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.1 -8.4 16.49 Favored 'Trans proline' 0 C--O 1.211 -0.835 0 CA-C-O 124.414 1.756 . . . . 50.0 113.214 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -79.74 -9.83 59.7 Favored 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 113.909 -1.496 . . . . 50.0 110.201 171.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.92 16.25 58.26 Favored Glycine 0 CA--C 1.486 -1.753 0 CA-C-O 122.708 1.171 . . . . 25.0 113.411 175.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -128.2 153.12 47.26 Favored 'General case' 0 C--O 1.201 -1.495 0 CA-C-N 113.792 -1.204 . . . . 50.0 111.21 -174.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.7 m -60.74 150.48 32.28 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 124.209 0.943 . . . . 25.0 110.432 172.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.728 0 CA-C-O 117.793 -1.559 . . . . 50.0 112.397 177.992 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.9 p . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 117.717 -1.135 . . . . 50.0 108.458 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.43 64.19 5.49 Favored 'Trans proline' 0 CA--C 1.556 1.591 0 N-CA-C 115.936 1.476 . . . . 50.0 115.936 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -118.5 5.14 11.72 Favored 'General case' 0 C--O 1.202 -1.446 0 N-CA-C 107.49 -1.3 . . . . 50.0 107.49 174.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -153.6 42.17 0.64 Allowed Glycine 0 C--O 1.214 -1.119 0 C-N-CA 120.091 -1.052 . . . . 25.0 115.493 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -98.08 167.99 10.54 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 104.651 -2.352 . . . . 50.0 104.651 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -42.38 -56.05 4.22 Favored Glycine 0 C--O 1.206 -1.602 0 O-C-N 125.393 1.683 . . . . 25.0 115.709 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -99.75 14.69 29.36 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 118.383 1.092 . . . . 25.0 112.451 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -115.78 83.71 1.98 Allowed 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 106.063 -1.828 . . . . 25.0 106.063 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.96 147.53 99.08 Favored Pre-proline 0 CA--C 1.561 1.377 0 N-CA-C 106.337 -1.727 . . . . 25.0 106.337 176.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -74.5 171.33 18.34 Favored 'Trans proline' 0 CA--C 1.499 -1.263 0 C-N-CA 116.026 -2.183 . . . . 50.0 116.326 -175.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m -105.24 130.85 53.3 Favored 'General case' 0 C--O 1.278 2.568 0 O-C-N 120.967 -1.083 . . . . 25.0 111.233 178.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 p -69.81 139.51 53.19 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 105.733 -1.951 . . . . 50.0 105.733 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 p -142.65 170.05 16.44 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 113.87 -1.514 . . . . 50.0 108.724 -174.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.1 m -133.03 -8.74 3.04 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-N 114.74 -1.118 . . . . 25.0 108.54 174.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -149.65 159.68 44.13 Favored 'General case' 0 C--O 1.26 1.62 0 N-CA-C 108.398 -0.964 . . . . 50.0 108.398 176.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -63.47 -30.66 71.75 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.457 1.098 . . . . 50.0 111.526 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.1 t -63.15 -21.97 66.55 Favored 'General case' 0 CA--C 1.556 1.2 0 O-C-N 121.142 -0.973 . . . . 50.0 111.933 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -72.6 -9.4 58.54 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 120.023 -0.671 . . . . 50.0 111.15 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.9 m -103.21 -179.6 4.0 Favored 'General case' 0 CA--C 1.562 1.436 0 N-CA-C 114.513 1.301 . . . . 50.0 114.513 -173.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 75.5 mt -76.98 166.43 23.34 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.485 -1.302 . . . . 50.0 107.485 176.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.69 129.13 38.85 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.648 0.61 . . . . 25.0 112.648 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.91 5.85 76.77 Favored Glycine 0 CA--C 1.536 1.367 0 O-C-N 124.287 0.992 . . . . 50.0 111.685 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.6 m -118.73 156.08 29.97 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 106.959 -1.497 . . . . 50.0 106.959 178.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.73 166.57 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.807 0.843 . . . . 50.0 109.678 -175.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.2 t -86.33 110.48 19.7 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 105.715 -1.958 . . . . 50.0 105.715 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.32 178.27 49.14 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 120.885 -0.674 . . . . 50.0 113.389 -171.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -73.71 -10.58 23.53 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 CA-C-O 124.836 1.932 . . . . 50.0 115.238 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -69.13 -15.74 63.49 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-N 113.934 -1.485 . . . . 50.0 111.492 169.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.96 18.21 56.47 Favored Glycine 0 CA--C 1.492 -1.375 0 CA-C-O 123.3 1.5 . . . . 25.0 109.758 176.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -135.27 150.54 50.05 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 112.535 -1.832 . . . . 50.0 108.817 -171.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 91.3 m -61.75 148.78 41.82 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.61 1.194 . . . . 25.0 110.805 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.756 0 CA-C-O 119.006 -0.885 . . . . 50.0 111.6 173.457 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.546 0 N-CA-C 109.75 -1.34 . . . . 25.0 109.75 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.8 p -68.4 156.8 89.59 Favored Pre-proline 0 N--CA 1.471 0.609 0 CA-C-N 118.569 1.184 . . . . 50.0 113.406 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -77.56 69.47 7.25 Favored 'Trans proline' 0 C--O 1.209 -0.94 0 CA-C-O 122.202 0.834 . . . . 50.0 113.849 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -123.88 12.63 9.12 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.246 -0.888 . . . . 50.0 109.127 173.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.63 51.54 0.44 Allowed Glycine 0 CA--C 1.496 -1.098 0 C-N-CA 119.941 -1.123 . . . . 25.0 114.094 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -112.38 176.49 5.0 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 107.152 -1.425 . . . . 50.0 107.152 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.98 -57.52 10.95 Favored Glycine 0 C--O 1.207 -1.551 0 O-C-N 125.282 1.614 . . . . 25.0 114.173 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -100.59 12.63 36.96 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 117.784 0.792 . . . . 25.0 110.596 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -116.5 79.22 1.29 Allowed 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 106.633 -1.617 . . . . 25.0 106.633 176.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.52 150.99 96.87 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 105.994 -1.854 . . . . 25.0 105.994 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -72.85 166.46 29.93 Favored 'Trans proline' 0 CA--C 1.499 -1.249 0 C-N-CA 115.629 -2.447 . . . . 50.0 115.681 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.6 m -100.03 127.16 46.28 Favored 'General case' 0 C--O 1.261 1.663 0 O-C-N 121.014 -1.054 . . . . 25.0 111.074 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.5 p -66.16 132.83 49.38 Favored 'General case' 0 C--O 1.261 1.698 0 N-CA-C 106.311 -1.737 . . . . 50.0 106.311 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.7 p -141.32 170.07 16.41 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.207 1.003 . . . . 50.0 111.033 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.1 m -128.76 -14.61 4.53 Favored 'General case' 0 C--O 1.193 -1.906 0 CA-C-N 114.105 -1.407 . . . . 25.0 107.954 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -150.68 164.13 36.87 Favored 'General case' 0 C--O 1.26 1.648 0 N-CA-C 109.612 -0.514 . . . . 50.0 109.612 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -61.34 -30.23 70.39 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.32 1.012 . . . . 50.0 113.281 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.8 t -62.5 -23.28 66.85 Favored 'General case' 0 C--O 1.248 0.975 0 O-C-N 121.715 -0.616 . . . . 50.0 111.556 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -71.83 -9.9 58.99 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 118.307 0.503 . . . . 50.0 111.236 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.9 m -107.85 170.23 8.12 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 115.27 1.581 . . . . 50.0 115.27 -172.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.417 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 64.1 mt -71.19 167.83 18.53 Favored 'General case' 0 C--O 1.253 1.25 0 CA-C-O 121.579 0.704 . . . . 50.0 109.769 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.3 128.0 34.54 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 114.547 1.314 . . . . 25.0 114.547 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.63 -7.53 81.67 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 121.04 -0.6 . . . . 50.0 112.238 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 3.4 m -100.96 155.77 17.78 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 105.742 -1.947 . . . . 50.0 105.742 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.0 m -128.89 166.98 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.441 1.096 . . . . 50.0 108.279 -177.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.5 t -87.97 115.22 25.29 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 105.567 -2.012 . . . . 50.0 105.567 173.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.88 179.88 52.89 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.551 -0.749 . . . . 50.0 113.571 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.53 -13.54 22.53 Favored 'Trans proline' 0 C--O 1.201 -1.364 0 CA-C-O 124.915 1.964 . . . . 50.0 112.732 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -78.07 -7.43 56.93 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 113.365 -1.743 . . . . 50.0 110.931 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.98 22.95 62.52 Favored Glycine 0 C--O 1.251 1.182 0 CA-C-O 123.573 1.651 . . . . 25.0 112.587 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -131.87 150.09 52.26 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 112.108 -2.046 . . . . 50.0 108.325 -174.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.4 m -66.05 147.76 52.85 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 123.878 0.736 . . . . 25.0 110.443 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.479 -2.194 0 CA-C-O 117.415 -1.769 . . . . 50.0 112.767 177.949 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.775 0 CA-C-O 118.12 -1.378 . . . . 25.0 109.66 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -147.14 164.54 22.71 Favored Pre-proline 0 N--CA 1.475 0.798 0 CA-C-O 117.242 -1.361 . . . . 50.0 109.226 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.34 69.25 7.25 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 N-CA-C 115.54 1.323 . . . . 50.0 115.54 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -122.51 6.2 9.54 Favored 'General case' 0 C--O 1.206 -1.205 0 N-CA-C 108.175 -1.046 . . . . 50.0 108.175 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.7 55.89 0.45 Allowed Glycine 0 CA--C 1.496 -1.128 0 C-N-CA 120.616 -0.802 . . . . 25.0 113.986 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -116.35 -169.85 1.7 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 105.889 -1.893 . . . . 50.0 105.889 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.91 -70.76 0.91 Allowed Glycine 0 C--O 1.196 -2.252 0 O-C-N 125.267 1.605 . . . . 25.0 112.288 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -86.54 4.29 40.64 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 118.071 0.936 . . . . 25.0 110.768 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -104.58 82.49 1.91 Allowed 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.072 -1.455 . . . . 25.0 107.072 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.55 151.02 96.78 Favored Pre-proline 0 C--O 1.253 1.27 0 N-CA-C 105.732 -1.951 . . . . 25.0 105.732 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.55 166.06 30.26 Favored 'Trans proline' 0 CA--C 1.496 -1.397 0 C-N-CA 115.41 -2.593 . . . . 50.0 115.92 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 m -102.08 127.86 48.8 Favored 'General case' 0 C--O 1.266 1.926 0 O-C-N 121.064 -1.023 . . . . 25.0 109.766 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.6 p -68.88 140.37 55.17 Favored 'General case' 0 C--O 1.255 1.393 0 N-CA-C 106.238 -1.764 . . . . 50.0 106.238 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.3 p -145.74 168.51 20.57 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.513 -0.767 . . . . 50.0 110.254 -174.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.5 m -131.46 -5.81 3.74 Favored 'General case' 0 C--O 1.198 -1.625 0 CA-C-N 115.244 -0.889 . . . . 25.0 108.651 176.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -154.91 159.88 40.76 Favored 'General case' 0 C--O 1.261 1.692 0 N-CA-C 108.522 -0.918 . . . . 50.0 108.522 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -63.54 -29.3 70.58 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.627 0.58 . . . . 50.0 112.04 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.3 t -63.92 -20.47 65.88 Favored 'General case' 0 C--O 1.254 1.339 0 N-CA-C 112.026 0.38 . . . . 50.0 112.026 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -72.98 -20.9 60.94 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-O 121.734 0.778 . . . . 50.0 110.769 177.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.5 m -94.99 172.88 7.88 Favored 'General case' 0 C--O 1.252 1.203 0 N-CA-C 116.485 2.031 . . . . 50.0 116.485 -170.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 60.8 mt -71.16 166.7 20.93 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 122.169 0.985 . . . . 50.0 109.716 176.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.97 128.71 36.9 Favored 'General case' 0 C--O 1.25 1.126 0 O-C-N 121.581 -0.7 . . . . 25.0 112.689 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.91 3.38 73.69 Favored Glycine 0 C--N 1.34 0.767 0 C-N-CA 121.177 -0.535 . . . . 50.0 112.21 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.42 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 4.0 m -112.92 164.41 13.46 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 105.792 -1.929 . . . . 50.0 105.792 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.8 m -134.93 170.97 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 108.001 -1.111 . . . . 50.0 108.001 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.2 t -89.51 122.12 32.38 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 105.043 -2.206 . . . . 50.0 105.043 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.02 -179.44 45.74 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.257 -0.746 . . . . 50.0 114.349 -172.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -77.11 -13.19 17.3 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 CA-C-O 125.583 2.243 . . . . 50.0 113.198 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -75.54 -11.62 60.06 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 113.241 -1.8 . . . . 50.0 110.605 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.41 17.44 62.34 Favored Glycine 0 C--O 1.251 1.207 0 CA-C-O 123.285 1.492 . . . . 25.0 113.499 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -127.72 150.54 49.73 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 112.711 -1.745 . . . . 50.0 108.661 -174.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 86.7 m -62.29 148.8 43.87 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.642 1.214 . . . . 25.0 110.577 172.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.48 -2.13 0 CA-C-O 118.745 -1.031 . . . . 50.0 110.552 177.214 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.235 0 CA-C-O 118.617 -1.102 . . . . 25.0 110.652 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.8 p -77.92 161.91 69.48 Favored Pre-proline 0 N--CA 1.474 0.745 0 CA-C-N 119.115 1.457 . . . . 50.0 114.231 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -78.49 66.24 8.51 Favored 'Trans proline' 0 CA--C 1.555 1.563 0 O-C-N 123.034 1.018 . . . . 50.0 113.992 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -119.69 -0.88 10.67 Favored 'General case' 0 C--O 1.197 -1.683 0 CA-C-N 114.689 -1.141 . . . . 50.0 108.607 172.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -136.89 50.87 0.82 Allowed Glycine 0 CA--C 1.502 -0.724 0 N-CA-C 115.007 0.763 . . . . 25.0 115.007 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -117.35 170.96 8.3 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.209 -1.404 . . . . 50.0 107.209 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.5 -51.65 53.2 Favored Glycine 0 C--O 1.215 -1.041 0 O-C-N 124.783 1.302 . . . . 25.0 113.415 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -94.74 11.17 32.31 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.836 1.318 . . . . 25.0 111.568 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -123.64 83.91 2.2 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 107.202 -1.407 . . . . 25.0 107.202 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.83 148.62 98.75 Favored Pre-proline 0 CA--C 1.563 1.476 0 N-CA-C 105.425 -2.065 . . . . 25.0 105.425 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -73.81 166.94 28.47 Favored 'Trans proline' 0 N--CA 1.481 0.773 0 C-N-CA 115.803 -2.331 . . . . 50.0 116.404 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.6 m -96.88 130.05 44.22 Favored 'General case' 0 C--O 1.26 1.622 0 O-C-N 121.576 -0.703 . . . . 25.0 110.437 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.9 p -70.07 137.67 51.41 Favored 'General case' 0 C--O 1.255 1.373 0 N-CA-C 106.03 -1.841 . . . . 50.0 106.03 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.8 p -141.38 170.84 14.96 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-O 122.027 0.918 . . . . 50.0 110.505 -175.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.4 m -123.6 -16.62 6.69 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.369 -1.287 . . . . 25.0 108.448 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -152.15 160.28 43.44 Favored 'General case' 0 C--O 1.266 1.921 0 N-CA-C 108.639 -0.874 . . . . 50.0 108.639 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -57.45 -35.13 69.72 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 124.144 0.902 . . . . 50.0 112.564 177.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -14.42 61.93 Favored 'General case' 0 C--O 1.259 1.576 0 O-C-N 120.944 -1.097 . . . . 50.0 113.775 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -77.67 -9.11 58.8 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 121.517 0.675 . . . . 50.0 109.407 175.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.1 m -104.37 172.46 6.79 Favored 'General case' 0 CA--C 1.555 1.161 0 O-C-N 119.912 -1.743 . . . . 50.0 114.981 -174.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 74.7 mt -71.7 166.96 20.87 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.318 0.58 . . . . 50.0 111.896 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.93 118.98 5.12 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 114.099 1.148 . . . . 25.0 114.099 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.2 -1.96 80.62 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 120.99 -0.624 . . . . 50.0 112.272 175.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.0 m -105.48 161.01 14.71 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.011 -2.218 . . . . 50.0 105.011 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.1 m -132.01 171.53 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 124.287 0.992 . . . . 50.0 109.368 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 29.8 t -94.72 115.45 27.54 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 105.852 -1.907 . . . . 50.0 105.852 174.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.8 176.69 52.24 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 119.268 -0.74 . . . . 50.0 114.1 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.46 -12.07 20.64 Favored 'Trans proline' 0 C--O 1.211 -0.835 0 CA-C-O 124.45 1.771 . . . . 50.0 114.204 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -74.47 -10.0 59.13 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-N 114.437 -1.256 . . . . 50.0 110.049 173.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.45 18.71 47.96 Favored Glycine 0 CA--C 1.498 -1.023 0 CA-C-O 122.693 1.163 . . . . 25.0 112.899 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -135.88 153.28 51.51 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 112.48 -1.86 . . . . 50.0 110.486 -174.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.7 m -60.34 147.08 41.82 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.936 0.772 . . . . 25.0 110.469 173.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -2.015 0 CA-C-O 118.312 -1.271 . . . . 50.0 110.788 179.622 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.965 0 CA-C-O 117.633 -1.648 . . . . 25.0 110.988 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.4 p -69.35 159.82 81.72 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 119.462 1.631 . . . . 50.0 113.62 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.94 61.85 7.23 Favored 'Trans proline' 0 CA--C 1.554 1.522 0 N-CA-C 114.836 1.052 . . . . 50.0 114.836 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -120.83 24.61 10.14 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 105.323 -2.103 . . . . 50.0 105.323 172.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.1 69.32 0.16 Allowed Glycine 0 CA--C 1.497 -1.039 0 C-N-CA 120.395 -0.907 . . . . 25.0 112.368 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 44.4 mmt-85 -131.6 -177.67 4.52 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.227 -1.027 . . . . 50.0 108.227 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.68 -60.18 9.46 Favored Glycine 0 C--O 1.199 -2.078 0 O-C-N 125.18 1.55 . . . . 25.0 112.845 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -99.28 13.82 31.76 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 118.515 1.157 . . . . 25.0 111.088 -175.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -119.5 88.29 2.9 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 106.704 -1.591 . . . . 25.0 106.704 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.14 150.56 97.38 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 104.461 -2.422 . . . . 25.0 104.461 175.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -70.86 164.65 34.89 Favored 'Trans proline' 0 CA--C 1.487 -1.83 0 C-N-CA 115.156 -2.763 . . . . 50.0 115.184 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.1 m -98.19 130.76 44.92 Favored 'General case' 0 C--O 1.254 1.327 0 CA-C-N 116.103 -0.498 . . . . 25.0 111.606 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.1 p -71.06 139.67 50.48 Favored 'General case' 0 C--O 1.251 1.151 0 N-CA-C 105.842 -1.91 . . . . 50.0 105.842 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.3 p -141.9 173.23 11.7 Favored 'General case' 0 CA--C 1.572 1.805 0 CA-C-O 122.386 1.088 . . . . 50.0 110.35 -175.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.8 m -132.74 -12.06 3.0 Favored 'General case' 0 C--O 1.201 -1.496 0 CA-C-N 114.407 -1.27 . . . . 25.0 108.064 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -149.42 157.17 43.07 Favored 'General case' 0 C--O 1.257 1.457 0 N-CA-C 107.946 -1.131 . . . . 50.0 107.946 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -60.09 -33.62 72.35 Favored 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 123.99 0.806 . . . . 50.0 111.489 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -63.1 -22.82 67.12 Favored 'General case' 0 C--O 1.248 1.026 0 O-C-N 121.246 -0.909 . . . . 50.0 111.804 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -63.57 -27.16 69.06 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.855 0.836 . . . . 50.0 109.031 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.6 m -89.14 176.03 7.14 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 114.414 1.265 . . . . 50.0 114.414 -172.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 78.5 mt -77.64 167.01 22.28 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-O 122.019 0.914 . . . . 50.0 110.359 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.62 125.02 22.9 Favored 'General case' 0 C--O 1.252 1.21 0 N-CA-C 113.213 0.82 . . . . 25.0 113.213 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.12 -8.73 57.58 Favored Glycine 0 C--O 1.244 0.756 0 N-CA-C 110.643 -0.983 . . . . 50.0 110.643 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -113.06 157.55 21.43 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 107.67 -1.234 . . . . 50.0 107.67 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.9 m -131.89 167.89 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 123.787 0.835 . . . . 50.0 109.708 -176.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.1 t -88.15 110.93 21.06 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 106.135 -1.802 . . . . 50.0 106.135 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.21 174.2 54.65 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.323 -0.853 . . . . 50.0 113.314 -173.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.76 -14.75 19.44 Favored 'Trans proline' 0 C--O 1.207 -1.036 0 CA-C-O 124.505 1.794 . . . . 50.0 114.803 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -70.34 -15.68 62.9 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 113.489 -1.687 . . . . 50.0 109.649 172.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.63 16.42 36.74 Favored Glycine 0 C--O 1.255 1.424 0 O-C-N 124.455 1.097 . . . . 25.0 112.846 176.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -131.57 151.46 51.58 Favored 'General case' 0 C--O 1.203 -1.386 0 CA-C-N 113.557 -1.322 . . . . 50.0 113.16 -174.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 86.2 m -60.02 143.48 51.78 Favored 'General case' 0 C--N 1.311 -1.066 0 O-C-N 124.076 0.86 . . . . 25.0 111.075 173.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.48 -2.126 0 CA-C-O 118.346 -1.252 . . . . 50.0 111.474 179.203 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.543 0 N-CA-C 109.637 -1.385 . . . . 25.0 109.637 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.64 176.0 2.6 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 106.839 -1.541 . . . . 50.0 106.839 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.83 49.71 2.27 Favored 'Trans proline' 0 CA--C 1.563 1.963 0 CA-C-N 120.71 1.289 . . . . 50.0 114.527 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -121.6 -2.86 9.35 Favored 'General case' 0 C--O 1.204 -1.34 0 C-N-CA 125.01 1.324 . . . . 50.0 107.524 170.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -142.61 50.61 0.7 Allowed Glycine 0 C--O 1.236 0.249 0 N-CA-C 115.208 0.843 . . . . 25.0 115.208 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -119.9 176.17 5.54 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.558 -1.275 . . . . 50.0 107.558 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.76 -48.55 65.71 Favored Glycine 0 C--O 1.214 -1.137 0 O-C-N 125.402 1.688 . . . . 25.0 114.282 -176.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -103.8 7.99 37.11 Favored 'General case' 0 C--O 1.249 1.069 0 CA-C-N 119.136 1.468 . . . . 25.0 109.842 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.8 m-90 -113.54 84.51 2.03 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.827 -1.175 . . . . 25.0 107.827 -176.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.48 151.68 96.93 Favored Pre-proline 0 CA--C 1.566 1.585 0 CA-C-N 113.428 -1.715 . . . . 25.0 106.793 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -76.64 169.18 22.29 Favored 'Trans proline' 0 CA--C 1.511 -0.638 0 N-CA-C 116.205 1.579 . . . . 50.0 116.205 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.3 m -105.93 131.43 53.24 Favored 'General case' 0 C--O 1.254 1.307 0 O-C-N 121.178 -0.952 . . . . 25.0 110.355 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.1 p -67.29 136.76 55.39 Favored 'General case' 0 C--O 1.257 1.47 0 N-CA-C 106.727 -1.582 . . . . 50.0 106.727 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.3 p -142.2 169.85 16.82 Favored 'General case' 0 CA--C 1.555 1.135 0 CA-C-O 122.747 1.26 . . . . 50.0 110.873 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.3 m -128.42 -15.01 4.65 Favored 'General case' 0 C--O 1.198 -1.653 0 CA-C-N 114.02 -1.446 . . . . 25.0 108.19 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -148.59 159.27 44.24 Favored 'General case' 0 C--O 1.258 1.506 0 N-CA-C 108.511 -0.922 . . . . 50.0 108.511 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -62.32 -29.54 70.52 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.134 0.896 . . . . 50.0 112.212 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.9 t -66.59 -16.29 64.07 Favored 'General case' 0 C--O 1.254 1.336 0 O-C-N 120.843 -1.161 . . . . 50.0 111.673 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -73.21 -15.19 61.45 Favored 'General case' 0 CA--C 1.557 1.216 0 CA-C-O 121.657 0.741 . . . . 50.0 109.999 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.4 m -99.55 176.04 5.62 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 115.187 1.551 . . . . 50.0 115.187 -172.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 79.4 mt -78.07 170.9 15.84 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.659 0.742 . . . . 50.0 110.538 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.63 121.58 14.26 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 113.25 0.833 . . . . 25.0 113.25 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.07 0.01 63.9 Favored Glycine 0 CA--C 1.525 0.659 0 O-C-N 124.275 0.985 . . . . 50.0 112.263 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.6 m -113.29 159.51 19.29 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 108.033 -1.099 . . . . 50.0 108.033 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.2 m -132.58 170.34 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 124.276 0.985 . . . . 50.0 109.872 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.1 t -89.39 111.65 22.56 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 107.016 -1.475 . . . . 50.0 107.016 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.51 177.7 48.8 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 114.525 0.57 . . . . 50.0 114.525 -173.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.35 -10.17 19.02 Favored 'Trans proline' 0 C--O 1.21 -0.919 0 CA-C-O 124.867 1.945 . . . . 50.0 114.085 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -78.43 -13.68 59.73 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 112.919 -1.946 . . . . 50.0 110.879 171.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.55 20.31 45.05 Favored Glycine 0 CA--C 1.501 -0.785 0 CA-C-N 115.728 -0.669 . . . . 25.0 113.533 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -131.71 146.88 52.4 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.964 -1.118 . . . . 50.0 110.831 -174.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.7 m -64.44 145.52 55.95 Favored 'General case' 0 C--N 1.317 -0.835 0 O-C-N 124.253 0.971 . . . . 25.0 112.917 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.735 0 CA-C-O 118.355 -1.247 . . . . 50.0 110.708 174.442 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.378 0 CA-C-O 118.325 -1.264 . . . . 25.0 110.165 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.7 p -74.35 161.79 76.62 Favored Pre-proline 0 N--CA 1.472 0.655 0 CA-C-N 119.557 1.679 . . . . 50.0 111.675 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.42 73.2 5.66 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 N-CA-C 114.616 0.968 . . . . 50.0 114.616 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -127.82 30.14 5.33 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.47 -1.678 . . . . 50.0 106.47 173.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.55 50.26 0.21 Allowed Glycine 0 CA--C 1.497 -1.055 0 C-N-CA 119.618 -1.277 . . . . 25.0 113.398 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -121.55 174.03 7.04 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.932 -0.766 . . . . 50.0 108.932 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -51.19 -50.44 39.91 Favored Glycine 0 C--O 1.207 -1.576 0 O-C-N 125.317 1.635 . . . . 25.0 113.722 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -101.62 0.59 36.53 Favored 'General case' 0 CA--C 1.558 1.27 0 CA-C-N 119.578 1.689 . . . . 25.0 110.917 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.1 m-90 -116.17 81.07 1.55 Allowed 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 107.352 -1.351 . . . . 25.0 107.352 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.03 154.63 94.07 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 104.394 -2.447 . . . . 25.0 104.394 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -72.39 172.5 14.85 Favored 'Trans proline' 0 CA--C 1.508 -0.813 0 N-CA-C 116.713 1.774 . . . . 50.0 116.713 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -106.25 133.23 51.27 Favored 'General case' 0 C--O 1.266 1.958 0 CA-C-N 115.887 -0.597 . . . . 25.0 110.458 176.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.0 p -70.29 141.64 52.35 Favored 'General case' 0 C--O 1.259 1.567 0 N-CA-C 107.286 -1.376 . . . . 50.0 107.286 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.9 p -144.48 172.29 13.16 Favored 'General case' 0 CA--C 1.556 1.177 0 CA-C-N 114.574 -1.193 . . . . 50.0 109.814 -175.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.1 m -128.1 -12.87 5.16 Favored 'General case' 0 C--O 1.2 -1.517 0 CA-C-N 114.619 -1.173 . . . . 25.0 107.915 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -151.13 162.66 40.46 Favored 'General case' 0 C--O 1.258 1.52 0 C-N-CA 124.116 0.967 . . . . 50.0 110.185 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -63.07 -29.25 70.66 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.5 1.125 . . . . 50.0 112.877 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 t -71.4 -12.39 61.39 Favored 'General case' 0 C--O 1.253 1.258 0 O-C-N 121.919 -0.488 . . . . 50.0 110.682 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -76.03 -12.7 60.17 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 121.639 0.733 . . . . 50.0 110.969 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.3 m -101.27 172.89 6.72 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.917 1.821 . . . . 50.0 115.917 -170.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.83 168.14 15.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.674 0.749 . . . . 50.0 110.077 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.9 122.0 11.23 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 115.138 1.533 . . . . 25.0 115.138 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.37 -9.51 76.71 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 123.983 0.802 . . . . 50.0 112.876 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.1 m -95.68 151.88 18.96 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.469 -1.308 . . . . 50.0 107.469 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 m -124.34 165.69 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.844 0.858 . . . . 50.0 110.463 -176.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.2 t -86.83 114.88 23.86 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 105.198 -2.149 . . . . 50.0 105.198 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.17 178.39 53.88 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 115.883 -0.598 . . . . 50.0 112.888 -173.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.52 -11.78 18.73 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 CA-C-O 124.432 1.763 . . . . 50.0 114.213 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -78.18 -8.28 58.11 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 113.381 -1.736 . . . . 50.0 110.412 172.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.53 17.98 63.0 Favored Glycine 0 C--O 1.25 1.097 0 CA-C-O 122.82 1.234 . . . . 25.0 112.858 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -126.31 149.76 48.94 Favored 'General case' 0 C--O 1.206 -1.208 0 CA-C-N 112.962 -1.619 . . . . 50.0 109.079 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.5 m -64.5 149.82 47.86 Favored 'General case' 0 C--N 1.317 -0.822 0 O-C-N 124.41 1.069 . . . . 25.0 110.316 174.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.647 0 CA-C-O 118.641 -1.088 . . . . 50.0 113.44 175.332 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.992 0 N-CA-C 109.371 -1.491 . . . . 25.0 109.371 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.2 p -141.49 161.75 50.77 Favored Pre-proline 0 N--CA 1.483 1.181 0 CA-C-O 117.089 -1.434 . . . . 50.0 108.804 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -78.59 57.72 6.45 Favored 'Trans proline' 0 N--CA 1.486 1.039 0 N-CA-C 115.844 1.44 . . . . 50.0 115.844 -174.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -124.42 8.12 8.39 Favored 'General case' 0 C--O 1.2 -1.519 0 N-CA-C 108.905 -0.776 . . . . 50.0 108.905 170.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.94 46.93 0.68 Allowed Glycine 0 C--O 1.218 -0.878 0 C-N-CA 120.664 -0.779 . . . . 25.0 114.939 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 mmp_? -108.79 -164.27 0.93 Allowed 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 105.632 -1.988 . . . . 50.0 105.632 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.02 -72.78 0.57 Allowed Glycine 0 C--O 1.205 -1.709 0 O-C-N 125.197 1.561 . . . . 25.0 112.755 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -97.86 10.94 38.95 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.431 1.115 . . . . 25.0 110.209 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -95.61 79.28 3.37 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 105.447 -2.057 . . . . 25.0 105.447 176.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.64 148.49 96.8 Favored Pre-proline 0 CA--C 1.558 1.288 0 CA-C-N 113.821 -1.536 . . . . 25.0 106.936 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.5 171.89 17.37 Favored 'Trans proline' 0 N--CA 1.482 0.795 0 N-CA-C 116.853 1.828 . . . . 50.0 116.853 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.0 m -106.62 130.0 54.44 Favored 'General case' 0 C--O 1.261 1.686 0 CA-C-N 115.184 -0.917 . . . . 25.0 110.55 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.7 p -68.48 130.53 43.15 Favored 'General case' 0 C--O 1.26 1.652 0 N-CA-C 105.735 -1.95 . . . . 50.0 105.735 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.6 p -136.39 173.23 11.93 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 122.574 1.178 . . . . 50.0 110.966 -173.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.5 m -131.31 -14.3 3.36 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 114.264 -1.334 . . . . 25.0 107.833 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -151.02 161.45 42.71 Favored 'General case' 0 C--O 1.253 1.262 0 O-C-N 121.026 -1.046 . . . . 50.0 109.977 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -63.36 -30.57 71.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 124.316 1.01 . . . . 50.0 112.58 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.1 t -65.51 -19.73 66.05 Favored 'General case' 0 C--O 1.252 1.19 0 O-C-N 121.648 -0.657 . . . . 50.0 111.487 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -72.61 -17.62 61.66 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-O 121.802 0.811 . . . . 50.0 110.169 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.1 m -103.54 176.39 5.17 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 115.221 1.563 . . . . 50.0 115.221 -170.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.3 mt -74.98 168.56 19.72 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 122.081 0.943 . . . . 50.0 111.159 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.01 136.21 53.51 Favored 'General case' 0 C--O 1.268 2.031 0 O-C-N 121.271 -0.893 . . . . 25.0 109.604 172.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.86 -9.9 76.43 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 111.831 -0.508 . . . . 50.0 111.831 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.2 m -108.54 158.42 17.57 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 104.518 -2.401 . . . . 50.0 104.518 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.07 171.21 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 106.523 -1.658 . . . . 50.0 106.523 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.8 t -84.69 115.06 22.47 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 105.338 -2.097 . . . . 50.0 105.338 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.24 175.56 54.6 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 112.397 -0.281 . . . . 50.0 112.397 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.92 -13.86 19.41 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 CA-C-O 125.358 2.149 . . . . 50.0 114.592 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -75.75 -10.73 59.68 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 113.595 -1.639 . . . . 50.0 111.151 172.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.47 18.83 51.42 Favored Glycine 0 CA--C 1.494 -1.276 0 CA-C-O 122.535 1.075 . . . . 25.0 112.794 174.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -127.9 150.7 49.75 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.644 -1.278 . . . . 50.0 109.146 -177.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.4 m -61.64 146.79 47.91 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 123.723 0.64 . . . . 25.0 110.555 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.905 0 CA-C-O 117.56 -1.689 . . . . 50.0 111.716 174.954 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.85 0 N-CA-C 109.64 -1.384 . . . . 25.0 109.64 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 p -152.05 162.74 25.76 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-O 117.177 -1.392 . . . . 50.0 108.823 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.85 55.03 5.09 Favored 'Trans proline' 0 N--CA 1.488 1.167 0 N-CA-C 115.338 1.246 . . . . 50.0 115.338 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -115.37 19.36 15.55 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 106.607 -1.627 . . . . 50.0 106.607 175.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -158.46 40.53 0.51 Allowed Glycine 0 C--N 1.319 -0.394 0 C-N-CA 119.253 -1.451 . . . . 25.0 116.649 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -93.97 171.39 8.89 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.663 -1.606 . . . . 50.0 106.663 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.22 -55.73 14.9 Favored Glycine 0 C--O 1.201 -1.957 0 O-C-N 125.303 1.627 . . . . 25.0 113.413 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -105.35 27.6 8.15 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 117.867 0.834 . . . . 25.0 112.195 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -120.71 85.88 2.47 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 105.697 -1.964 . . . . 25.0 105.697 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.58 137.36 95.14 Favored Pre-proline 0 C--O 1.261 1.688 0 N-CA-C 106.943 -1.503 . . . . 25.0 106.943 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.28 168.51 24.57 Favored 'Trans proline' 0 CA--C 1.505 -0.958 0 N-CA-C 117.017 1.891 . . . . 50.0 117.017 -175.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.5 m -94.71 129.03 41.79 Favored 'General case' 0 C--O 1.263 1.769 0 CA-C-N 115.301 -0.863 . . . . 25.0 111.453 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 p -72.01 134.31 45.83 Favored 'General case' 0 C--O 1.255 1.365 0 N-CA-C 106.065 -1.828 . . . . 50.0 106.065 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.7 p -138.16 170.13 16.58 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-O 121.872 0.844 . . . . 50.0 109.715 -173.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.1 m -125.84 -16.78 5.58 Favored 'General case' 0 C--O 1.204 -1.331 0 N-CA-C 106.879 -1.526 . . . . 25.0 106.879 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -149.29 160.76 43.12 Favored 'General case' 0 C--O 1.262 1.716 0 CA-C-N 118.7 0.682 . . . . 50.0 109.335 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -59.76 -30.26 68.74 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.816 0.817 . . . . 50.0 112.296 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -1.67 22.85 Favored 'General case' 0 C--O 1.264 1.857 0 O-C-N 121.186 -0.946 . . . . 50.0 112.958 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -87.2 -9.57 54.83 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 121.683 0.754 . . . . 50.0 109.629 170.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.7 m -103.31 175.64 5.41 Favored 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 116.028 1.862 . . . . 50.0 116.028 -170.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.36 162.6 29.17 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.441 0.639 . . . . 50.0 110.034 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.97 124.55 19.06 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 114.863 1.431 . . . . 25.0 114.863 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.17 -7.94 80.96 Favored Glycine 0 CA--C 1.529 0.933 0 O-C-N 124.28 0.987 . . . . 50.0 112.634 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.7 m -98.82 159.37 15.0 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 107.914 -1.143 . . . . 50.0 107.914 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.1 m -127.76 166.53 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.691 1.196 . . . . 50.0 109.895 -175.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.3 t -87.54 116.41 25.64 Favored 'General case' 0 C--O 1.255 1.355 0 N-CA-C 105.424 -2.065 . . . . 50.0 105.424 172.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.38 176.21 49.86 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 116.753 -0.203 . . . . 50.0 112.786 -173.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -75.25 -14.17 20.68 Favored 'Trans proline' 0 C--O 1.204 -1.185 0 CA-C-O 124.103 1.626 . . . . 50.0 114.068 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -72.16 -14.46 61.82 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 113.763 -1.562 . . . . 50.0 111.033 173.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.83 12.96 54.88 Favored Glycine 0 CA--C 1.503 -0.699 0 CA-C-O 122.207 0.893 . . . . 25.0 113.238 174.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -130.47 155.74 45.95 Favored 'General case' 0 C--O 1.206 -1.212 0 CA-C-N 113.415 -1.392 . . . . 50.0 110.284 -174.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 94.0 m -61.92 148.92 42.06 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 124.033 0.833 . . . . 25.0 109.532 173.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.837 0 N-CA-C 109.745 -1.342 . . . . 50.0 109.745 179.382 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.55 0 N-CA-C 109.55 -1.42 . . . . 25.0 109.55 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.1 p -145.99 161.05 41.42 Favored Pre-proline 0 N--CA 1.481 1.077 0 CA-C-O 118.201 -0.904 . . . . 50.0 110.915 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.9 70.21 5.27 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 N-CA-C 115.194 1.19 . . . . 50.0 115.194 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -124.26 8.61 8.51 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.904 0.859 . . . . 50.0 110.203 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.39 49.02 0.48 Allowed Glycine 0 CA--C 1.497 -1.08 0 N-CA-C 116.415 1.326 . . . . 25.0 116.415 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 71.1 mtp85 -105.75 174.41 5.89 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.6 -2.0 . . . . 50.0 105.6 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -42.37 -61.59 2.39 Favored Glycine 0 C--O 1.209 -1.45 0 O-C-N 125.099 1.5 . . . . 25.0 114.668 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -99.26 4.41 46.58 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.243 1.022 . . . . 25.0 111.656 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -98.09 80.85 2.74 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 106.198 -1.778 . . . . 25.0 106.198 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.64 147.76 98.9 Favored Pre-proline 0 CA--C 1.559 1.308 0 N-CA-C 104.806 -2.294 . . . . 25.0 104.806 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.94 166.98 28.54 Favored 'Trans proline' 0 CA--C 1.503 -1.046 0 C-N-CA 115.73 -2.38 . . . . 50.0 116.295 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.1 m -94.31 125.93 39.25 Favored 'General case' 0 C--O 1.266 1.94 0 O-C-N 121.33 -0.857 . . . . 25.0 110.395 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 p -67.12 136.28 54.88 Favored 'General case' 0 C--O 1.257 1.49 0 N-CA-C 106.643 -1.614 . . . . 50.0 106.643 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.6 p -143.98 171.82 13.73 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-O 122.824 1.297 . . . . 50.0 110.843 -175.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -130.52 -13.43 3.81 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 114.133 -1.394 . . . . 25.0 108.438 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -150.82 159.33 44.61 Favored 'General case' 0 C--O 1.259 1.602 0 C-N-CA 123.947 0.899 . . . . 50.0 109.218 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -60.64 -31.75 70.94 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 114.062 1.134 . . . . 50.0 114.062 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -15.98 64.05 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 113.036 0.754 . . . . 50.0 113.036 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -73.88 -18.21 60.95 Favored 'General case' 0 CA--C 1.563 1.478 0 O-C-N 124.042 0.838 . . . . 50.0 110.648 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.2 m -95.25 178.24 5.59 Favored 'General case' 0 CA--C 1.557 1.249 0 O-C-N 120.03 -1.669 . . . . 50.0 114.975 -170.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.2 mt -75.58 167.85 21.11 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 121.61 0.719 . . . . 50.0 109.373 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.72 121.78 11.24 Favored 'General case' 0 C--O 1.251 1.163 0 N-CA-C 114.815 1.413 . . . . 25.0 114.815 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.74 -7.29 82.35 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.08 -0.581 . . . . 50.0 113.633 175.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.2 m -95.31 160.43 14.54 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 105.521 -2.029 . . . . 50.0 105.521 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.4 m -129.21 169.36 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.758 0.823 . . . . 50.0 110.429 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 19.3 t -90.54 114.26 26.43 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 106.677 -1.601 . . . . 50.0 106.677 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.85 174.66 53.99 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 115.651 -0.704 . . . . 50.0 114.076 -173.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -73.41 -15.09 25.15 Favored 'Trans proline' 0 C--O 1.213 -0.762 0 CA-C-O 124.552 1.813 . . . . 50.0 114.603 -177.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -74.94 -7.78 54.59 Favored 'General case' 0 CA--C 1.559 1.315 0 CA-C-N 113.896 -1.502 . . . . 50.0 111.157 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.4 12.65 58.24 Favored Glycine 0 C--O 1.247 0.966 0 CA-C-O 122.657 1.143 . . . . 25.0 113.494 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -130.92 154.66 47.87 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 113.491 -1.355 . . . . 50.0 111.402 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 86.2 m -63.71 146.87 53.02 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.855 0.722 . . . . 25.0 110.628 174.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.649 0 N-CA-C 110.171 -1.172 . . . . 50.0 110.171 -178.649 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.792 0 N-CA-C 109.684 -1.366 . . . . 25.0 109.684 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -148.15 165.7 17.65 Favored Pre-proline 0 N--CA 1.476 0.843 0 CA-C-O 117.481 -1.247 . . . . 50.0 108.554 -177.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -77.55 59.95 6.93 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 N-CA-C 115.67 1.373 . . . . 50.0 115.67 -175.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -131.26 19.25 4.87 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 106.251 -1.759 . . . . 50.0 106.251 174.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.46 50.81 0.32 Allowed Glycine 0 CA--C 1.495 -1.175 0 C-N-CA 119.766 -1.207 . . . . 25.0 114.344 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -119.19 -169.31 1.72 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.982 -0.748 . . . . 50.0 108.982 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.94 -64.34 4.27 Favored Glycine 0 C--O 1.201 -1.96 0 O-C-N 125.036 1.46 . . . . 25.0 113.183 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -102.77 26.72 7.7 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.758 1.279 . . . . 25.0 110.354 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -127.81 81.12 2.0 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 105.668 -1.975 . . . . 25.0 105.668 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.88 152.75 95.37 Favored Pre-proline 0 C--O 1.254 1.292 0 CA-C-N 112.889 -1.959 . . . . 25.0 105.875 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.58 170.45 20.26 Favored 'Trans proline' 0 CA--C 1.506 -0.925 0 C-N-CA 116.145 -2.103 . . . . 50.0 115.579 -178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.6 m -108.73 129.21 55.36 Favored 'General case' 0 C--O 1.26 1.639 0 O-C-N 121.7 -0.625 . . . . 25.0 110.899 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.8 p -66.28 133.63 50.97 Favored 'General case' 0 C--O 1.262 1.763 0 N-CA-C 106.245 -1.761 . . . . 50.0 106.245 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.6 p -139.81 176.58 8.62 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 122.143 0.973 . . . . 50.0 110.258 -174.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.0 m -132.39 -15.9 2.78 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 114.484 -1.235 . . . . 25.0 108.68 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -153.37 162.93 40.77 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 108.031 -1.1 . . . . 50.0 108.031 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -62.96 -32.22 73.49 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 113.806 1.039 . . . . 50.0 113.806 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.89 -10.15 59.08 Favored 'General case' 0 C--O 1.252 1.232 0 O-C-N 121.118 -0.989 . . . . 50.0 113.024 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -75.69 -15.67 60.27 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.239 1.019 . . . . 50.0 110.072 172.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 54.1 m -99.91 177.2 5.18 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 115.125 1.528 . . . . 50.0 115.125 -171.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.6 mt -75.57 168.87 19.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.457 -0.792 . . . . 50.0 112.662 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.38 121.56 9.86 Favored 'General case' 0 C--O 1.254 1.312 0 N-CA-C 113.416 0.895 . . . . 25.0 113.416 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.42 -10.38 74.94 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 120.0 -0.333 . . . . 50.0 113.043 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.4 m -89.26 156.3 18.84 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 106.413 -1.699 . . . . 50.0 106.413 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.8 m -129.38 164.55 31.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 106.581 -1.637 . . . . 50.0 106.581 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 18.3 t -87.59 115.07 24.78 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 104.4 -2.444 . . . . 50.0 104.4 174.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.37 179.3 53.21 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 120.668 -0.777 . . . . 50.0 114.408 -172.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.41 -13.63 22.8 Favored 'Trans proline' 0 C--O 1.206 -1.102 0 CA-C-O 124.868 1.945 . . . . 50.0 113.828 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -74.42 -9.85 58.99 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-N 112.931 -1.94 . . . . 50.0 111.816 171.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.46 22.24 58.88 Favored Glycine 0 CA--C 1.498 -0.996 0 CA-C-O 122.605 1.114 . . . . 25.0 112.416 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -135.89 147.28 48.11 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 112.996 -1.602 . . . . 50.0 109.514 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 92.4 m -61.5 147.68 44.49 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.686 0.616 . . . . 25.0 110.607 174.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.824 0 CA-C-O 117.24 -1.867 . . . . 50.0 110.608 175.306 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.711 0 CA-C-O 118.159 -1.356 . . . . 25.0 110.087 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.2 p -138.95 163.54 45.67 Favored Pre-proline 0 N--CA 1.481 1.103 0 CA-C-O 117.5 -1.238 . . . . 50.0 108.8 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.33 65.36 7.96 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 N-CA-C 114.762 1.024 . . . . 50.0 114.762 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -124.65 21.08 8.52 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 105.548 -2.019 . . . . 50.0 105.548 170.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.58 53.26 0.31 Allowed Glycine 0 CA--C 1.5 -0.877 0 CA-C-O 122.569 1.094 . . . . 25.0 113.209 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.8 mmm-85 -128.23 164.14 23.2 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 106.024 -1.843 . . . . 50.0 106.024 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -45.91 -55.1 7.57 Favored Glycine 0 C--O 1.203 -1.802 0 O-C-N 125.42 1.7 . . . . 25.0 114.572 -174.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -99.02 17.73 19.0 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 119.101 1.451 . . . . 25.0 110.316 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -126.53 78.6 1.8 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 107.35 -1.352 . . . . 25.0 107.35 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.02 151.06 95.96 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 103.911 -2.625 . . . . 25.0 103.911 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.78 169.56 21.72 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 N-CA-C 116.971 1.873 . . . . 50.0 116.971 -175.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.9 m -100.05 128.76 46.09 Favored 'General case' 0 C--O 1.259 1.572 0 CA-C-N 115.655 -0.702 . . . . 25.0 110.553 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.2 p -68.33 137.72 54.86 Favored 'General case' 0 C--O 1.262 1.762 0 N-CA-C 107.051 -1.463 . . . . 50.0 107.051 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.1 p -142.16 170.39 15.79 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.14 0.971 . . . . 50.0 112.542 -175.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.5 m -128.27 -15.4 4.65 Favored 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 107.476 -1.305 . . . . 25.0 107.476 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -149.36 161.49 41.96 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 123.734 0.814 . . . . 50.0 109.218 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -64.38 -28.14 69.49 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 124.628 1.205 . . . . 50.0 112.496 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.4 t -65.43 -19.83 66.11 Favored 'General case' 0 C--O 1.258 1.529 0 O-C-N 121.63 -0.669 . . . . 50.0 111.137 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -71.0 -17.19 62.65 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 122.28 1.038 . . . . 50.0 111.7 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.3 m -97.52 174.22 6.77 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 120.592 -1.317 . . . . 50.0 114.233 -171.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.3 mt -69.74 167.41 17.17 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 121.588 0.709 . . . . 50.0 109.81 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.41 125.11 21.94 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 113.279 0.844 . . . . 25.0 113.279 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.32 -10.4 74.42 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 120.857 -0.687 . . . . 50.0 113.544 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.2 m -95.32 164.38 12.86 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.685 -1.598 . . . . 50.0 106.685 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 m -131.75 165.27 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.637 0.775 . . . . 50.0 110.503 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.6 t -84.73 119.77 25.65 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 104.304 -2.48 . . . . 50.0 104.304 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.2 175.25 55.15 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 121.396 -0.43 . . . . 50.0 113.44 -174.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -74.79 -14.0 21.78 Favored 'Trans proline' 0 C--O 1.204 -1.176 0 CA-C-O 125.136 2.057 . . . . 50.0 113.845 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -79.45 -9.56 59.63 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-N 113.754 -1.566 . . . . 50.0 111.312 175.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.34 15.31 53.87 Favored Glycine 0 CA--C 1.493 -1.318 0 CA-C-O 122.497 1.054 . . . . 25.0 113.131 175.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -127.68 146.91 50.41 Favored 'General case' 0 C--O 1.203 -1.389 0 CA-C-N 113.928 -1.136 . . . . 50.0 110.835 -176.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.5 m -60.34 147.37 40.81 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.981 0.8 . . . . 25.0 110.268 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -2.062 0 CA-C-O 118.012 -1.438 . . . . 50.0 110.731 179.451 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.665 0 CA-C-O 118.115 -1.38 . . . . 25.0 109.821 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.9 p -145.49 160.81 43.71 Favored Pre-proline 0 C--N 1.356 0.877 0 CA-C-N 118.221 1.011 . . . . 50.0 110.871 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.67 73.47 5.24 Favored 'Trans proline' 0 C--O 1.211 -0.87 0 N-CA-C 115.204 1.194 . . . . 50.0 115.204 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -121.7 15.65 11.05 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.719 -0.845 . . . . 50.0 108.719 171.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.86 35.24 0.93 Allowed Glycine 0 N--CA 1.467 0.737 0 C-N-CA 119.114 -1.517 . . . . 25.0 116.725 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -94.8 178.24 5.64 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.166 -1.05 . . . . 50.0 108.166 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.18 -54.6 33.04 Favored Glycine 0 C--O 1.201 -1.96 0 C-N-CA 119.712 -1.233 . . . . 25.0 113.083 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -95.57 13.57 25.73 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.208 1.504 . . . . 25.0 110.483 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -122.88 80.17 1.73 Allowed 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 105.989 -1.856 . . . . 25.0 105.989 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.66 148.3 98.23 Favored Pre-proline 0 C--O 1.254 1.298 0 N-CA-C 104.311 -2.477 . . . . 25.0 104.311 175.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.43 168.39 23.65 Favored 'Trans proline' 0 CA--C 1.498 -1.292 0 C-N-CA 114.481 -3.213 . . . . 50.0 114.971 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.6 m -101.39 124.39 46.99 Favored 'General case' 0 C--O 1.255 1.371 0 O-C-N 121.648 -0.657 . . . . 25.0 110.273 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -66.92 140.41 57.76 Favored 'General case' 0 C--O 1.256 1.397 0 N-CA-C 106.666 -1.605 . . . . 50.0 106.666 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 p -150.09 172.0 15.97 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-O 122.767 1.27 . . . . 50.0 111.009 -175.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -132.27 -11.62 3.22 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.215 -1.357 . . . . 25.0 108.452 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -150.19 157.32 42.97 Favored 'General case' 0 C--O 1.262 1.716 0 N-CA-C 107.416 -1.327 . . . . 50.0 107.416 -177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -66.77 -25.33 66.43 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 113.781 1.03 . . . . 50.0 113.781 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 80.3 p -73.83 -9.1 58.31 Favored 'General case' 0 C--O 1.257 1.461 0 O-C-N 121.156 -0.965 . . . . 50.0 111.553 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -73.53 -16.16 61.28 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 108.841 -0.799 . . . . 50.0 108.841 172.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.7 m -100.55 177.51 4.99 Favored 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 116.08 1.881 . . . . 50.0 116.08 -169.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.6 mt -72.84 167.24 21.34 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.657 0.742 . . . . 50.0 110.476 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.27 118.55 7.58 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 114.328 1.233 . . . . 25.0 114.328 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.93 -6.6 64.41 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 111.413 -0.675 . . . . 50.0 111.413 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.1 m -105.7 157.39 17.46 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.103 -1.073 . . . . 50.0 108.103 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.1 m -131.35 167.88 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 123.352 0.661 . . . . 50.0 110.581 -173.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.9 t -89.48 114.98 26.56 Favored 'General case' 0 C--O 1.247 0.958 0 N-CA-C 107.413 -1.329 . . . . 50.0 107.413 175.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.66 179.6 52.3 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 120.848 -0.691 . . . . 50.0 113.655 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -75.77 -13.97 19.69 Favored 'Trans proline' 0 C--O 1.202 -1.3 0 CA-C-N 119.608 1.704 . . . . 50.0 113.54 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -75.57 -8.15 56.04 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 113.639 -1.619 . . . . 50.0 110.607 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.52 15.67 63.49 Favored Glycine 0 CA--C 1.49 -1.515 0 CA-C-O 123.043 1.357 . . . . 25.0 113.269 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -126.43 147.61 49.77 Favored 'General case' 0 C--O 1.195 -1.8 0 CA-C-N 112.88 -1.66 . . . . 50.0 111.361 -175.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.1 m -63.18 148.77 47.12 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 124.692 1.245 . . . . 25.0 109.202 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.479 -2.157 0 CA-C-O 119.352 -0.693 . . . . 50.0 112.984 178.091 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.835 0 CA-C-O 118.146 -1.363 . . . . 25.0 110.003 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -149.26 164.74 19.82 Favored Pre-proline 0 N--CA 1.488 1.449 0 CA-C-N 118.823 1.312 . . . . 50.0 109.908 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.92 58.0 5.32 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 N-CA-C 115.7 1.385 . . . . 50.0 115.7 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -124.66 6.86 8.18 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 107.714 -1.217 . . . . 50.0 107.714 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.39 58.32 0.42 Allowed Glycine 0 CA--C 1.495 -1.209 0 C-N-CA 120.267 -0.968 . . . . 25.0 115.184 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.8 mtm-85 -126.07 169.49 12.72 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.66 -1.237 . . . . 50.0 107.66 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -38.75 -58.28 1.83 Allowed Glycine 0 C--O 1.212 -1.248 0 O-C-N 125.489 1.743 . . . . 25.0 116.287 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -110.75 31.18 6.19 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.473 1.637 . . . . 25.0 110.888 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -122.95 78.0 1.51 Allowed 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 103.557 -2.757 . . . . 25.0 103.557 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.77 151.67 97.13 Favored Pre-proline 0 CA--C 1.562 1.429 0 N-CA-C 105.743 -1.947 . . . . 25.0 105.743 176.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.81 170.19 20.62 Favored 'Trans proline' 0 CA--C 1.512 -0.621 0 N-CA-C 116.093 1.536 . . . . 50.0 116.093 -176.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.5 m -100.33 131.32 46.32 Favored 'General case' 0 C--O 1.263 1.779 0 CA-C-N 115.73 -0.668 . . . . 25.0 110.877 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.6 p -66.86 130.86 44.54 Favored 'General case' 0 C--O 1.271 2.185 0 N-CA-C 107.003 -1.481 . . . . 50.0 107.003 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.3 p -142.63 175.92 9.44 Favored 'General case' 0 CA--C 1.561 1.396 0 CA-C-O 122.416 1.103 . . . . 50.0 109.161 -177.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 m -130.64 -18.21 3.15 Favored 'General case' 0 C--O 1.189 -2.097 0 CA-C-N 114.321 -1.309 . . . . 25.0 108.509 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -143.17 158.13 43.89 Favored 'General case' 0 C--O 1.259 1.553 0 N-CA-C 108.032 -1.099 . . . . 50.0 108.032 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -62.96 -29.31 70.7 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 124.512 1.133 . . . . 50.0 111.948 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.4 t -71.15 -13.1 61.83 Favored 'General case' 0 C--O 1.249 1.067 0 O-C-N 121.06 -1.025 . . . . 50.0 112.36 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -74.05 -16.08 61.05 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.022 -0.733 . . . . 50.0 109.022 174.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.9 m -100.84 170.68 8.15 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 115.008 1.485 . . . . 50.0 115.008 -170.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.7 mt -66.17 165.63 13.37 Favored 'General case' 0 N--CA 1.424 -1.753 0 O-C-N 123.731 0.644 . . . . 50.0 110.792 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.96 119.72 8.83 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 114.548 1.314 . . . . 25.0 114.548 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.01 -7.74 73.17 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 121.191 -0.528 . . . . 50.0 113.155 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.3 m -99.21 160.7 14.08 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 105.615 -1.994 . . . . 50.0 105.615 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.11 166.72 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 123.199 0.6 . . . . 50.0 109.921 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 21.2 t -91.03 118.84 30.72 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 106.2 -1.778 . . . . 50.0 106.2 174.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.45 177.09 54.23 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.428 -0.892 . . . . 50.0 114.005 -174.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.22 -19.03 23.02 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 CA-C-O 124.995 1.998 . . . . 50.0 113.895 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -72.84 -10.14 59.46 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-N 113.778 -1.555 . . . . 50.0 110.604 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.2 17.02 44.69 Favored Glycine 0 CA--C 1.497 -1.081 0 CA-C-N 115.162 -0.926 . . . . 25.0 113.936 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -130.11 146.81 51.79 Favored 'General case' 0 C--O 1.212 -0.919 0 CA-C-N 114.182 -1.009 . . . . 50.0 113.626 -172.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 96.1 m -63.28 143.38 57.85 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 124.297 1.039 . . . . 25.0 111.532 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.843 0 CA-C-O 117.618 -1.657 . . . . 50.0 110.865 179.432 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.016 0 N-CA-C 110.575 -1.01 . . . . 25.0 110.575 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.6 p -84.03 161.74 54.25 Favored Pre-proline 0 N--CA 1.47 0.527 0 CA-C-N 118.919 1.36 . . . . 50.0 113.154 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.41 70.99 6.04 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 N-CA-C 114.591 0.958 . . . . 50.0 114.591 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -119.85 -2.56 10.32 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-N 115.253 -0.885 . . . . 50.0 108.679 173.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -142.81 60.76 0.53 Allowed Glycine 0 CA--C 1.495 -1.161 0 C-N-CA 120.276 -0.964 . . . . 25.0 114.03 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -131.82 163.41 28.32 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.222 -0.659 . . . . 50.0 109.222 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -42.02 -47.69 5.29 Favored Glycine 0 C--O 1.211 -1.283 0 N-CA-C 116.628 1.411 . . . . 25.0 116.628 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -107.91 18.82 20.82 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 118.912 1.356 . . . . 25.0 109.717 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.7 m-90 -129.54 80.75 1.98 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.226 -1.398 . . . . 25.0 107.226 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.89 148.41 97.93 Favored Pre-proline 0 CA--C 1.57 1.716 0 N-CA-C 104.858 -2.275 . . . . 25.0 104.858 174.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.5 168.36 24.56 Favored 'Trans proline' 0 CA--C 1.491 -1.636 0 N-CA-C 118.477 2.453 . . . . 50.0 118.477 -175.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 80.1 m -97.96 128.7 44.69 Favored 'General case' 0 C--O 1.264 1.861 0 CA-C-N 114.737 -1.12 . . . . 25.0 110.988 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.81 131.73 45.62 Favored 'General case' 0 C--O 1.256 1.407 0 N-CA-C 107.019 -1.474 . . . . 50.0 107.019 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.2 p -138.2 170.21 16.43 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 122.857 1.313 . . . . 50.0 110.461 -176.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.0 m -125.32 -17.24 5.69 Favored 'General case' 0 C--O 1.197 -1.705 0 N-CA-C 107.088 -1.449 . . . . 25.0 107.088 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -151.22 162.14 41.44 Favored 'General case' 0 C--O 1.254 1.33 0 C-N-CA 123.286 0.634 . . . . 50.0 110.041 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -57.63 -32.55 67.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 124.446 1.092 . . . . 50.0 112.805 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.9 t -63.95 -18.9 64.71 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-O 118.91 -0.567 . . . . 50.0 111.669 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -71.77 -13.24 61.64 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 113.27 0.841 . . . . 50.0 113.27 174.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.7 m -101.25 173.03 6.64 Favored 'General case' 0 C--O 1.251 1.148 0 N-CA-C 115.309 1.596 . . . . 50.0 115.309 -169.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.8 mt -67.66 163.92 20.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.033 0.921 . . . . 50.0 110.431 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.16 122.06 12.87 Favored 'General case' 0 C--O 1.252 1.229 0 N-CA-C 113.867 1.062 . . . . 25.0 113.867 -178.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.01 7.01 78.35 Favored Glycine 0 CA--C 1.522 0.505 0 O-C-N 123.195 0.309 . . . . 50.0 112.469 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.5 m -114.04 160.95 18.32 Favored 'General case' 0 C--N 1.354 0.793 0 N-CA-C 106.258 -1.756 . . . . 50.0 106.258 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.3 m -128.84 170.55 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.037 0.935 . . . . 50.0 110.773 -176.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.4 t -91.76 108.92 20.26 Favored 'General case' 0 C--O 1.249 1.03 0 N-CA-C 105.313 -2.106 . . . . 50.0 105.313 174.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.19 175.87 54.4 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 116.255 -0.429 . . . . 50.0 113.956 -173.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.54 -9.26 21.32 Favored 'Trans proline' 0 C--O 1.207 -1.048 0 CA-C-N 119.579 1.69 . . . . 50.0 115.574 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -76.58 -10.04 59.1 Favored 'General case' 0 CA--C 1.565 1.542 0 CA-C-N 113.895 -1.502 . . . . 50.0 110.046 173.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.35 17.46 57.2 Favored Glycine 0 C--O 1.247 0.924 0 CA-C-O 121.851 0.695 . . . . 25.0 112.285 176.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -133.9 151.52 51.54 Favored 'General case' 0 C--O 1.211 -0.962 0 CA-C-N 113.553 -1.324 . . . . 50.0 110.215 -174.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.3 m -60.28 146.86 42.36 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 124.053 0.846 . . . . 25.0 111.174 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.964 0 CA-C-O 118.153 -1.359 . . . . 50.0 111.34 178.888 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.902 0 N-CA-C 109.634 -1.386 . . . . 25.0 109.634 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.47 160.48 69.97 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-O 117.261 -1.352 . . . . 50.0 111.359 176.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.68 68.06 7.74 Favored 'Trans proline' 0 N--CA 1.485 0.993 0 N-CA-C 114.898 1.076 . . . . 50.0 114.898 -175.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -122.78 19.46 10.22 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.676 -1.601 . . . . 50.0 106.676 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.71 42.9 0.56 Allowed Glycine 0 CA--C 1.507 -0.466 0 C-N-CA 119.964 -1.112 . . . . 25.0 114.158 177.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -103.35 -178.13 3.57 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.949 -1.13 . . . . 50.0 107.949 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.08 -62.6 6.18 Favored Glycine 0 C--O 1.212 -1.235 0 O-C-N 124.809 1.318 . . . . 25.0 112.761 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -94.57 10.06 36.2 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-N 118.956 1.378 . . . . 25.0 111.513 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.3 m-90 -111.73 82.09 1.56 Allowed 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 107.682 -1.229 . . . . 25.0 107.682 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.85 149.18 98.56 Favored Pre-proline 0 C--O 1.252 1.202 0 N-CA-C 104.791 -2.3 . . . . 25.0 104.791 174.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.91 164.63 35.07 Favored 'Trans proline' 0 N--CA 1.481 0.759 0 C-N-CA 115.937 -2.242 . . . . 50.0 116.133 -176.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.4 m -94.91 129.74 41.8 Favored 'General case' 0 C--O 1.273 2.322 0 CA-C-N 115.842 -0.617 . . . . 25.0 111.028 177.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.8 p -69.68 132.61 46.42 Favored 'General case' 0 C--O 1.253 1.274 0 N-CA-C 106.699 -1.593 . . . . 50.0 106.699 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.8 p -138.39 172.02 13.52 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.095 0.95 . . . . 50.0 108.975 -174.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.5 m -128.73 -14.81 4.51 Favored 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 107.114 -1.439 . . . . 25.0 107.114 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.41 162.71 40.79 Favored 'General case' 0 C--O 1.255 1.383 0 CA-C-N 118.984 0.811 . . . . 50.0 109.735 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -58.44 -32.24 68.52 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.0 0.812 . . . . 50.0 112.626 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.8 t -66.33 -16.69 64.25 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 112.406 0.521 . . . . 50.0 112.406 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -77.79 -9.51 59.07 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 119.63 -0.828 . . . . 50.0 110.97 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.4 m -104.0 178.57 4.52 Favored 'General case' 0 CA--C 1.552 1.055 0 O-C-N 120.327 -1.483 . . . . 50.0 115.0 -171.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.5 mt -76.3 164.53 25.95 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-O 121.519 0.676 . . . . 50.0 109.711 175.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.8 132.33 53.51 Favored 'General case' 0 C--O 1.259 1.601 0 CA-C-O 119.085 -0.483 . . . . 25.0 110.87 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.54 -7.03 82.75 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 119.502 -0.61 . . . . 50.0 112.124 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.3 m -106.19 155.87 19.03 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.233 -1.765 . . . . 50.0 106.233 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.9 m -129.41 164.98 30.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 C-N-CA 124.937 1.295 . . . . 50.0 107.725 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.6 t -84.04 111.79 19.62 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 105.033 -2.21 . . . . 50.0 105.033 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.84 175.42 52.02 Favored Glycine 0 C--O 1.252 1.256 0 CA-C-N 115.525 -0.761 . . . . 50.0 113.264 -173.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.8 -14.44 19.46 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 CA-C-O 124.286 1.703 . . . . 50.0 114.151 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.2 p-10 -75.82 -8.76 57.65 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-N 114.009 -1.45 . . . . 50.0 110.549 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.24 22.05 39.32 Favored Glycine 0 C--O 1.247 0.966 0 CA-C-O 122.104 0.835 . . . . 25.0 113.463 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -135.79 153.5 51.51 Favored 'General case' 0 C--O 1.208 -1.127 0 CA-C-N 114.019 -1.09 . . . . 50.0 110.67 -173.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 92.0 m -62.31 142.09 57.94 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.389 0.431 . . . . 25.0 110.214 172.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -2.022 0 CA-C-O 118.123 -1.376 . . . . 50.0 111.25 177.867 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.009 0 CA-C-O 118.124 -1.376 . . . . 25.0 110.532 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.1 p -68.28 162.93 56.97 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 118.719 1.259 . . . . 50.0 111.759 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -76.68 58.23 5.87 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 CA-C-N 119.974 1.027 . . . . 50.0 114.674 -176.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -125.17 16.03 8.42 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 104.572 -2.381 . . . . 50.0 104.572 172.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.02 69.74 0.18 Allowed Glycine 0 CA--C 1.49 -1.517 0 N-CA-C 111.053 -0.819 . . . . 25.0 111.053 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -137.27 163.39 31.07 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 105.831 -1.915 . . . . 50.0 105.831 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -41.58 -56.31 3.6 Favored Glycine 0 C--O 1.21 -1.38 0 CA-C-O 118.135 -1.369 . . . . 25.0 114.355 -177.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -97.75 13.81 29.11 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 119.925 1.863 . . . . 25.0 110.867 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -124.72 84.87 2.33 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 108.534 -0.913 . . . . 25.0 108.534 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.27 153.4 95.58 Favored Pre-proline 0 C--O 1.257 1.458 0 O-C-N 125.591 1.807 . . . . 25.0 106.609 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.26 171.01 18.88 Favored 'Trans proline' 0 CA--C 1.493 -1.575 0 N-CA-C 116.71 1.773 . . . . 50.0 116.71 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.7 m -108.21 131.33 54.78 Favored 'General case' 0 C--O 1.259 1.605 0 CA-C-N 115.274 -0.876 . . . . 25.0 110.288 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.14 140.03 56.16 Favored 'General case' 0 C--O 1.253 1.257 0 N-CA-C 106.554 -1.647 . . . . 50.0 106.554 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.1 p -144.79 174.23 11.17 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.234 -1.348 . . . . 50.0 110.778 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 m -132.95 -10.73 3.0 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 107.622 -1.251 . . . . 25.0 107.622 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -152.28 160.84 43.28 Favored 'General case' 0 C--O 1.259 1.598 0 N-CA-C 107.761 -1.2 . . . . 50.0 107.761 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -63.71 -30.25 71.38 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.264 0.554 . . . . 50.0 112.002 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.6 t -68.25 -18.2 64.49 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 119.17 -1.012 . . . . 50.0 112.066 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -70.53 -11.81 61.17 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.301 -0.629 . . . . 50.0 109.301 175.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.3 m -104.05 173.66 6.21 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.988 1.477 . . . . 50.0 114.988 -171.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.86 167.8 20.22 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 121.946 0.879 . . . . 50.0 109.42 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.6 120.73 11.15 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 114.687 1.366 . . . . 25.0 114.687 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.85 -8.92 65.85 Favored Glycine 0 CA--C 1.532 1.151 0 N-CA-C 110.723 -0.951 . . . . 50.0 110.723 175.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.5 m -97.22 163.72 12.79 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 106.028 -1.842 . . . . 50.0 106.028 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.4 m -133.5 168.19 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.387 1.075 . . . . 50.0 109.631 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.2 t -90.62 115.2 27.56 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 105.317 -2.105 . . . . 50.0 105.317 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.59 176.83 50.15 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.884 -0.598 . . . . 50.0 112.69 -175.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.22 -14.71 18.47 Favored 'Trans proline' 0 C--O 1.206 -1.085 0 CA-C-O 124.965 1.985 . . . . 50.0 113.833 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -77.13 -8.73 58.0 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-N 113.518 -1.674 . . . . 50.0 110.221 173.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.24 19.95 56.04 Favored Glycine 0 CA--C 1.495 -1.192 0 CA-C-O 122.004 0.78 . . . . 25.0 113.44 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -122.94 147.33 46.74 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.683 -1.258 . . . . 50.0 110.498 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.3 m -63.13 148.9 46.62 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 124.151 0.907 . . . . 25.0 110.308 173.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.558 0 CA-C-O 117.969 -1.461 . . . . 50.0 112.382 173.68 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.695 0 CA-C-O 119.905 -0.386 . . . . 25.0 112.818 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.23 160.83 77.08 Favored Pre-proline 0 N--CA 1.473 0.712 0 CA-C-O 117.567 -1.206 . . . . 50.0 111.936 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.66 70.43 5.74 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 N-CA-C 115.26 1.215 . . . . 50.0 115.26 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -129.72 24.04 5.39 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 104.583 -2.377 . . . . 50.0 104.583 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -165.56 51.78 0.27 Allowed Glycine 0 CA--C 1.502 -0.777 0 C-N-CA 120.223 -0.989 . . . . 25.0 112.871 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.93 177.14 4.73 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 105.749 -1.945 . . . . 50.0 105.749 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -51.22 -56.09 16.28 Favored Glycine 0 C--O 1.21 -1.359 0 O-C-N 125.623 1.827 . . . . 25.0 113.104 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -98.67 -3.68 35.44 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 120.197 1.999 . . . . 25.0 112.563 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -98.24 81.95 2.86 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 106.514 -1.661 . . . . 25.0 106.514 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.09 149.58 98.41 Favored Pre-proline 0 C--O 1.254 1.308 0 N-CA-C 105.242 -2.132 . . . . 25.0 105.242 175.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.94 163.05 39.86 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 116.316 -1.99 . . . . 50.0 114.605 -177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.7 m -97.14 127.67 43.32 Favored 'General case' 0 C--O 1.258 1.531 0 CA-C-N 115.783 -0.644 . . . . 25.0 111.971 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.13 134.29 48.0 Favored 'General case' 0 C--O 1.26 1.616 0 N-CA-C 106.604 -1.628 . . . . 50.0 106.604 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.2 p -139.37 174.77 10.17 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 123.153 1.454 . . . . 50.0 111.817 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.7 m -129.8 -20.48 3.17 Favored 'General case' 0 C--O 1.196 -1.728 0 N-CA-C 107.372 -1.344 . . . . 25.0 107.372 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -144.43 163.13 34.71 Favored 'General case' 0 C--O 1.259 1.605 0 N-CA-C 108.703 -0.851 . . . . 50.0 108.703 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -62.67 -29.77 70.89 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-O 121.885 0.85 . . . . 50.0 111.853 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.4 t -66.06 -19.11 65.74 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.61 -0.723 . . . . 50.0 111.609 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -70.05 -17.94 63.27 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.623 0.725 . . . . 50.0 110.729 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.7 m -97.02 175.26 6.39 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 115.801 1.778 . . . . 50.0 115.801 -171.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.2 mt -74.15 168.78 18.88 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.533 0.682 . . . . 50.0 110.238 175.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.65 128.08 34.24 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 118.509 -0.757 . . . . 25.0 112.889 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.37 -4.22 76.65 Favored Glycine 0 C--N 1.342 0.878 0 C-N-CA 120.533 -0.841 . . . . 50.0 111.303 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.9 m -107.5 159.49 16.38 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.515 -1.661 . . . . 50.0 106.515 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.35 164.24 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 124.267 1.027 . . . . 50.0 109.203 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.5 t -87.36 119.31 27.48 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 105.151 -2.166 . . . . 50.0 105.151 174.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.48 176.44 48.17 Favored Glycine 0 C--O 1.255 1.454 0 C-N-CA 120.894 -0.67 . . . . 50.0 113.352 -173.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.01 -12.52 16.09 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 CA-C-O 124.671 1.863 . . . . 50.0 113.71 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -73.88 -13.17 60.87 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 113.705 -1.588 . . . . 50.0 109.345 173.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.34 14.5 47.74 Favored Glycine 0 C--O 1.251 1.187 0 CA-C-O 122.678 1.155 . . . . 25.0 111.963 174.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -129.06 151.08 50.13 Favored 'General case' 0 C--O 1.204 -1.329 0 CA-C-N 113.474 -1.363 . . . . 50.0 113.098 -173.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 88.1 m -63.27 144.95 56.5 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 123.893 0.746 . . . . 25.0 111.125 172.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -2.088 0 CA-C-O 117.955 -1.47 . . . . 50.0 111.292 178.754 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.531 0 CA-C-O 118.629 -1.095 . . . . 25.0 110.459 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.0 p -75.0 162.24 74.24 Favored Pre-proline 0 N--CA 1.471 0.605 0 CA-C-N 118.576 1.188 . . . . 50.0 113.726 -178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.06 63.9 7.72 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 O-C-N 123.094 1.05 . . . . 50.0 114.753 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.8 mm-40 -123.71 26.55 7.67 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.937 -2.246 . . . . 50.0 104.937 172.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.06 57.22 0.19 Allowed Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.723 -1.227 . . . . 25.0 114.132 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -124.36 172.63 8.98 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 106.743 -1.577 . . . . 50.0 106.743 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.68 -49.27 28.04 Favored Glycine 0 C--O 1.214 -1.147 0 O-C-N 124.895 1.372 . . . . 25.0 114.637 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -104.49 13.77 31.21 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 118.733 1.267 . . . . 25.0 110.357 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -122.37 81.87 1.9 Allowed 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 106.854 -1.536 . . . . 25.0 106.854 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.38 149.7 95.76 Favored Pre-proline 0 CA--C 1.562 1.413 0 N-CA-C 105.779 -1.934 . . . . 25.0 105.779 176.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.33 165.63 32.04 Favored 'Trans proline' 0 CA--C 1.507 -0.87 0 C-N-CA 116.656 -1.762 . . . . 50.0 116.195 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.0 m -97.97 130.64 44.81 Favored 'General case' 0 C--O 1.272 2.252 0 O-C-N 120.918 -1.114 . . . . 25.0 110.609 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 m -66.11 131.19 45.62 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 107.155 -1.424 . . . . 50.0 107.155 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.1 p -136.61 172.14 13.45 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.298 -1.319 . . . . 50.0 110.936 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 m -126.83 -22.06 3.93 Favored 'General case' 0 C--O 1.197 -1.664 0 N-CA-C 106.864 -1.532 . . . . 25.0 106.864 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -145.67 160.85 41.1 Favored 'General case' 0 C--O 1.264 1.863 0 C-N-CA 123.116 0.566 . . . . 50.0 109.684 -175.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -65.51 -27.03 68.18 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.117 0.784 . . . . 50.0 113.117 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 97.4 p -73.1 -12.45 60.91 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 121.173 -0.954 . . . . 50.0 111.078 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -71.13 -19.74 62.4 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 119.109 -1.036 . . . . 50.0 109.363 171.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.6 m -96.92 169.48 9.82 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.913 1.449 . . . . 50.0 114.913 -173.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.2 mt -71.26 168.48 17.22 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.645 -0.707 . . . . 50.0 109.764 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.78 124.95 20.91 Favored 'General case' 0 C--O 1.254 1.311 0 N-CA-C 113.788 1.033 . . . . 25.0 113.788 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.34 -9.82 75.56 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.623 -0.543 . . . . 50.0 112.916 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.8 m -99.86 156.84 16.91 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 106.201 -1.778 . . . . 50.0 106.201 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -128.52 167.78 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.957 0.903 . . . . 50.0 110.134 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.0 t -86.39 113.67 22.54 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 105.844 -1.909 . . . . 50.0 105.844 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.17 -179.13 52.73 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 119.37 -0.683 . . . . 50.0 114.116 -171.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.83 -13.33 21.85 Favored 'Trans proline' 0 C--O 1.21 -0.909 0 CA-C-N 119.652 1.726 . . . . 50.0 114.269 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -81.0 -6.93 59.38 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-N 114.102 -1.408 . . . . 50.0 109.865 174.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.87 20.33 59.75 Favored Glycine 0 C--O 1.254 1.362 0 CA-C-O 122.717 1.176 . . . . 25.0 112.537 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -130.17 149.02 52.06 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.247 -1.476 . . . . 50.0 110.006 -176.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.6 m -62.92 146.87 51.97 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.154 -0.476 . . . . 25.0 112.216 175.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.893 0 CA-C-O 118.691 -1.06 . . . . 50.0 111.308 171.941 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.289 0 N-CA-C 109.809 -1.316 . . . . 25.0 109.809 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 p -104.42 166.88 10.79 Favored Pre-proline 0 N--CA 1.487 1.398 0 CA-C-O 117.434 -1.269 . . . . 50.0 108.665 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.62 63.78 7.36 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 CA-C-N 120.8 1.321 . . . . 50.0 115.295 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -125.52 11.32 7.96 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 105.508 -2.034 . . . . 50.0 105.508 173.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -154.08 44.97 0.57 Allowed Glycine 0 N--CA 1.468 0.807 0 C-N-CA 120.031 -1.08 . . . . 25.0 114.792 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -104.86 174.47 5.86 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 104.637 -2.357 . . . . 50.0 104.637 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.17 -51.03 60.87 Favored Glycine 0 C--O 1.204 -1.768 0 O-C-N 124.637 1.211 . . . . 25.0 113.812 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.45 0.75 48.23 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 118.579 1.19 . . . . 25.0 111.9 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -105.77 88.14 2.75 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 106.437 -1.69 . . . . 25.0 106.437 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.62 149.35 98.35 Favored Pre-proline 0 CA--C 1.567 1.623 0 N-CA-C 104.518 -2.401 . . . . 25.0 104.518 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.06 168.82 20.85 Favored 'Trans proline' 0 N--CA 1.479 0.621 0 N-CA-C 117.05 1.904 . . . . 50.0 117.05 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.2 m -100.44 128.26 46.55 Favored 'General case' 0 C--O 1.26 1.649 0 O-C-N 121.203 -0.936 . . . . 25.0 111.38 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.4 p -68.57 134.54 50.15 Favored 'General case' 0 C--O 1.26 1.627 0 N-CA-C 106.695 -1.595 . . . . 50.0 106.695 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.1 p -142.55 170.6 15.39 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.883 -1.053 . . . . 50.0 109.32 -176.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.1 m -130.51 -12.03 3.94 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 107.271 -1.381 . . . . 25.0 107.271 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -149.66 159.45 44.32 Favored 'General case' 0 C--O 1.256 1.4 0 C-N-CA 123.947 0.899 . . . . 50.0 108.905 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -61.84 -31.15 71.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 124.145 0.903 . . . . 50.0 111.18 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 t -68.99 -13.27 62.35 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 121.469 -0.769 . . . . 50.0 112.287 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -77.8 -8.25 57.76 Favored 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 120.123 -0.631 . . . . 50.0 110.347 174.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.1 m -104.91 171.74 7.16 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 116.654 2.094 . . . . 50.0 116.654 -172.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.416 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 83.5 mt -68.52 168.43 12.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 122.03 0.919 . . . . 50.0 110.855 177.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.64 124.5 20.88 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 114.011 1.115 . . . . 25.0 114.011 -177.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.19 -12.83 68.01 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 123.349 0.406 . . . . 50.0 112.732 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 4.5 m -90.08 160.13 16.46 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 106.638 -1.616 . . . . 50.0 106.638 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.9 m -128.76 171.89 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 124.617 1.167 . . . . 50.0 108.419 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.5 t -94.9 123.31 38.3 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 106.113 -1.81 . . . . 50.0 106.113 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.98 177.57 46.32 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 114.903 0.721 . . . . 50.0 114.903 -175.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.1 -8.4 16.49 Favored 'Trans proline' 0 C--O 1.211 -0.835 0 CA-C-O 124.414 1.756 . . . . 50.0 113.214 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -79.74 -9.83 59.7 Favored 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 113.909 -1.496 . . . . 50.0 110.201 171.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.92 16.25 58.26 Favored Glycine 0 CA--C 1.486 -1.753 0 CA-C-O 122.708 1.171 . . . . 25.0 113.411 175.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -128.2 153.12 47.26 Favored 'General case' 0 C--O 1.201 -1.495 0 CA-C-N 113.792 -1.204 . . . . 50.0 111.21 -174.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.7 m -60.74 150.48 32.28 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 124.209 0.943 . . . . 25.0 110.432 172.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.728 0 CA-C-O 117.793 -1.559 . . . . 50.0 112.397 177.992 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.956 0 CA-C-O 118.36 -1.244 . . . . 25.0 110.424 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.9 p -152.22 165.15 18.12 Favored Pre-proline 0 N--CA 1.484 1.264 0 CA-C-O 117.717 -1.135 . . . . 50.0 108.458 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.43 64.19 5.49 Favored 'Trans proline' 0 CA--C 1.556 1.591 0 N-CA-C 115.936 1.476 . . . . 50.0 115.936 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -118.5 5.14 11.72 Favored 'General case' 0 C--O 1.202 -1.446 0 N-CA-C 107.49 -1.3 . . . . 50.0 107.49 174.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -153.6 42.17 0.64 Allowed Glycine 0 C--O 1.214 -1.119 0 C-N-CA 120.091 -1.052 . . . . 25.0 115.493 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -98.08 167.99 10.54 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 104.651 -2.352 . . . . 50.0 104.651 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -42.38 -56.05 4.22 Favored Glycine 0 C--O 1.206 -1.602 0 O-C-N 125.393 1.683 . . . . 25.0 115.709 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -99.75 14.69 29.36 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 118.383 1.092 . . . . 25.0 112.451 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -115.78 83.71 1.98 Allowed 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 106.063 -1.828 . . . . 25.0 106.063 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.96 147.53 99.08 Favored Pre-proline 0 CA--C 1.561 1.377 0 N-CA-C 106.337 -1.727 . . . . 25.0 106.337 176.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -74.5 171.33 18.34 Favored 'Trans proline' 0 CA--C 1.499 -1.263 0 C-N-CA 116.026 -2.183 . . . . 50.0 116.326 -175.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m -105.24 130.85 53.3 Favored 'General case' 0 C--O 1.278 2.568 0 O-C-N 120.967 -1.083 . . . . 25.0 111.233 178.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 p -69.81 139.51 53.19 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 105.733 -1.951 . . . . 50.0 105.733 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 p -142.65 170.05 16.44 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 113.87 -1.514 . . . . 50.0 108.724 -174.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.1 m -133.03 -8.74 3.04 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-N 114.74 -1.118 . . . . 25.0 108.54 174.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -149.65 159.68 44.13 Favored 'General case' 0 C--O 1.26 1.62 0 N-CA-C 108.398 -0.964 . . . . 50.0 108.398 176.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -63.47 -30.66 71.75 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.457 1.098 . . . . 50.0 111.526 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.1 t -63.15 -21.97 66.55 Favored 'General case' 0 CA--C 1.556 1.2 0 O-C-N 121.142 -0.973 . . . . 50.0 111.933 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -72.6 -9.4 58.54 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 120.023 -0.671 . . . . 50.0 111.15 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.9 m -103.21 -179.6 4.0 Favored 'General case' 0 CA--C 1.562 1.436 0 N-CA-C 114.513 1.301 . . . . 50.0 114.513 -173.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 75.5 mt -76.98 166.43 23.34 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.485 -1.302 . . . . 50.0 107.485 176.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.69 129.13 38.85 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.648 0.61 . . . . 25.0 112.648 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.91 5.85 76.77 Favored Glycine 0 CA--C 1.536 1.367 0 O-C-N 124.287 0.992 . . . . 50.0 111.685 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.6 m -118.73 156.08 29.97 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 106.959 -1.497 . . . . 50.0 106.959 178.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.73 166.57 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.807 0.843 . . . . 50.0 109.678 -175.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.2 t -86.33 110.48 19.7 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 105.715 -1.958 . . . . 50.0 105.715 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.32 178.27 49.14 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 120.885 -0.674 . . . . 50.0 113.389 -171.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -73.71 -10.58 23.53 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 CA-C-O 124.836 1.932 . . . . 50.0 115.238 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -69.13 -15.74 63.49 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-N 113.934 -1.485 . . . . 50.0 111.492 169.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.96 18.21 56.47 Favored Glycine 0 CA--C 1.492 -1.375 0 CA-C-O 123.3 1.5 . . . . 25.0 109.758 176.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -135.27 150.54 50.05 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 112.535 -1.832 . . . . 50.0 108.817 -171.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 91.3 m -61.75 148.78 41.82 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.61 1.194 . . . . 25.0 110.805 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.756 0 CA-C-O 119.006 -0.885 . . . . 50.0 111.6 173.457 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.471 0.609 0 N-CA-C 113.406 0.891 . . . . 25.0 113.406 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -77.56 69.47 7.25 Favored 'Trans proline' 0 C--O 1.209 -0.94 0 CA-C-O 122.202 0.834 . . . . 25.0 113.849 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -123.88 12.63 9.12 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.246 -0.888 . . . . 25.0 109.127 173.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.63 51.54 0.44 Allowed Glycine 0 CA--C 1.496 -1.098 0 C-N-CA 119.941 -1.123 . . . . 25.0 114.094 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -112.38 176.49 5.0 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 107.152 -1.425 . . . . 25.0 107.152 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.98 -57.52 10.95 Favored Glycine 0 C--O 1.207 -1.551 0 O-C-N 125.282 1.614 . . . . 25.0 114.173 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -100.59 12.63 36.96 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 117.784 0.792 . . . . 25.0 110.596 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -116.5 79.22 1.29 Allowed 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 106.633 -1.617 . . . . 25.0 106.633 176.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.52 150.99 96.87 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 105.994 -1.854 . . . . 25.0 105.994 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.439 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 52.5 Cg_endo -72.85 166.46 29.93 Favored 'Trans proline' 0 CA--C 1.499 -1.249 0 C-N-CA 115.629 -2.447 . . . . 25.0 115.681 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.6 m -100.03 127.16 46.28 Favored 'General case' 0 C--O 1.261 1.663 0 O-C-N 121.014 -1.054 . . . . 25.0 111.074 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.5 p -66.16 132.83 49.38 Favored 'General case' 0 C--O 1.261 1.698 0 N-CA-C 106.311 -1.737 . . . . 25.0 106.311 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.7 p -141.32 170.07 16.41 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.207 1.003 . . . . 25.0 111.033 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.1 m -128.76 -14.61 4.53 Favored 'General case' 0 C--O 1.193 -1.906 0 CA-C-N 114.105 -1.407 . . . . 25.0 107.954 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -150.68 164.13 36.87 Favored 'General case' 0 C--O 1.26 1.648 0 N-CA-C 109.612 -0.514 . . . . 25.0 109.612 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -61.34 -30.23 70.39 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.32 1.012 . . . . 25.0 113.281 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.8 t -62.5 -23.28 66.85 Favored 'General case' 0 C--O 1.248 0.975 0 O-C-N 121.715 -0.616 . . . . 25.0 111.556 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -71.83 -9.9 58.99 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 118.307 0.503 . . . . 50.0 111.236 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.9 m -107.85 170.23 8.12 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 115.27 1.581 . . . . 25.0 115.27 -172.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.44 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 64.1 mt -71.19 167.83 18.53 Favored 'General case' 0 C--O 1.253 1.25 0 CA-C-O 121.579 0.704 . . . . 25.0 109.769 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.3 128.0 34.54 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 114.547 1.314 . . . . 25.0 114.547 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.63 -7.53 81.67 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 121.04 -0.6 . . . . 25.0 112.238 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 3.4 m -100.96 155.77 17.78 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 105.742 -1.947 . . . . 25.0 105.742 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.0 m -128.89 166.98 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.441 1.096 . . . . 25.0 108.279 -177.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.5 t -87.97 115.22 25.29 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 105.567 -2.012 . . . . 25.0 105.567 173.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.88 179.88 52.89 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.551 -0.749 . . . . 25.0 113.571 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.53 -13.54 22.53 Favored 'Trans proline' 0 C--O 1.201 -1.364 0 CA-C-O 124.915 1.964 . . . . 25.0 112.732 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -78.07 -7.43 56.93 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 113.365 -1.743 . . . . 25.0 110.931 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.98 22.95 62.52 Favored Glycine 0 C--O 1.251 1.182 0 CA-C-O 123.573 1.651 . . . . 25.0 112.587 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.439 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 17.6 m-85 -131.87 150.09 52.26 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 112.108 -2.046 . . . . 25.0 108.325 -174.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.4 m -66.05 147.76 52.85 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 123.878 0.736 . . . . 25.0 110.443 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.479 -2.194 0 CA-C-O 117.415 -1.769 . . . . 50.0 112.767 177.949 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.475 0.798 0 CA-C-O 117.242 -1.361 . . . . 25.0 109.226 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.34 69.25 7.25 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 N-CA-C 115.54 1.323 . . . . 25.0 115.54 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -122.51 6.2 9.54 Favored 'General case' 0 C--O 1.206 -1.205 0 N-CA-C 108.175 -1.046 . . . . 25.0 108.175 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.7 55.89 0.45 Allowed Glycine 0 CA--C 1.496 -1.128 0 C-N-CA 120.616 -0.802 . . . . 25.0 113.986 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -116.35 -169.85 1.7 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 105.889 -1.893 . . . . 25.0 105.889 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.91 -70.76 0.91 Allowed Glycine 0 C--O 1.196 -2.252 0 O-C-N 125.267 1.605 . . . . 25.0 112.288 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -86.54 4.29 40.64 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 118.071 0.936 . . . . 25.0 110.768 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -104.58 82.49 1.91 Allowed 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.072 -1.455 . . . . 25.0 107.072 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.55 151.02 96.78 Favored Pre-proline 0 C--O 1.253 1.27 0 N-CA-C 105.732 -1.951 . . . . 25.0 105.732 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.55 166.06 30.26 Favored 'Trans proline' 0 CA--C 1.496 -1.397 0 C-N-CA 115.41 -2.593 . . . . 25.0 115.92 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 m -102.08 127.86 48.8 Favored 'General case' 0 C--O 1.266 1.926 0 O-C-N 121.064 -1.023 . . . . 25.0 109.766 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.6 p -68.88 140.37 55.17 Favored 'General case' 0 C--O 1.255 1.393 0 N-CA-C 106.238 -1.764 . . . . 25.0 106.238 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.3 p -145.74 168.51 20.57 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.513 -0.767 . . . . 25.0 110.254 -174.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.5 m -131.46 -5.81 3.74 Favored 'General case' 0 C--O 1.198 -1.625 0 CA-C-N 115.244 -0.889 . . . . 25.0 108.651 176.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -154.91 159.88 40.76 Favored 'General case' 0 C--O 1.261 1.692 0 N-CA-C 108.522 -0.918 . . . . 25.0 108.522 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -63.54 -29.3 70.58 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.627 0.58 . . . . 25.0 112.04 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.3 t -63.92 -20.47 65.88 Favored 'General case' 0 C--O 1.254 1.339 0 N-CA-C 112.026 0.38 . . . . 25.0 112.026 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -72.98 -20.9 60.94 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-O 121.734 0.778 . . . . 50.0 110.769 177.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.5 m -94.99 172.88 7.88 Favored 'General case' 0 C--O 1.252 1.203 0 N-CA-C 116.485 2.031 . . . . 25.0 116.485 -170.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.456 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 60.8 mt -71.16 166.7 20.93 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 122.169 0.985 . . . . 25.0 109.716 176.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.97 128.71 36.9 Favored 'General case' 0 C--O 1.25 1.126 0 O-C-N 121.581 -0.7 . . . . 25.0 112.689 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.91 3.38 73.69 Favored Glycine 0 C--N 1.34 0.767 0 C-N-CA 121.177 -0.535 . . . . 25.0 112.21 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 4.0 m -112.92 164.41 13.46 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 105.792 -1.929 . . . . 25.0 105.792 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.8 m -134.93 170.97 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 108.001 -1.111 . . . . 25.0 108.001 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.2 t -89.51 122.12 32.38 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 105.043 -2.206 . . . . 25.0 105.043 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.02 -179.44 45.74 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.257 -0.746 . . . . 25.0 114.349 -172.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -77.11 -13.19 17.3 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 CA-C-O 125.583 2.243 . . . . 25.0 113.198 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -75.54 -11.62 60.06 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 113.241 -1.8 . . . . 25.0 110.605 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.41 17.44 62.34 Favored Glycine 0 C--O 1.251 1.207 0 CA-C-O 123.285 1.492 . . . . 25.0 113.499 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -127.72 150.54 49.73 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 112.711 -1.745 . . . . 25.0 108.661 -174.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 86.7 m -62.29 148.8 43.87 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.642 1.214 . . . . 25.0 110.577 172.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.48 -2.13 0 CA-C-O 118.745 -1.031 . . . . 50.0 110.552 177.214 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 114.231 1.197 . . . . 25.0 114.231 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -78.49 66.24 8.51 Favored 'Trans proline' 0 CA--C 1.555 1.563 0 O-C-N 123.034 1.018 . . . . 25.0 113.992 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -119.69 -0.88 10.67 Favored 'General case' 0 C--O 1.197 -1.683 0 CA-C-N 114.689 -1.141 . . . . 25.0 108.607 172.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -136.89 50.87 0.82 Allowed Glycine 0 CA--C 1.502 -0.724 0 N-CA-C 115.007 0.763 . . . . 25.0 115.007 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -117.35 170.96 8.3 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.209 -1.404 . . . . 25.0 107.209 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.5 -51.65 53.2 Favored Glycine 0 C--O 1.215 -1.041 0 O-C-N 124.783 1.302 . . . . 25.0 113.415 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -94.74 11.17 32.31 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.836 1.318 . . . . 25.0 111.568 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -123.64 83.91 2.2 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 107.202 -1.407 . . . . 25.0 107.202 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.83 148.62 98.75 Favored Pre-proline 0 CA--C 1.563 1.476 0 N-CA-C 105.425 -2.065 . . . . 25.0 105.425 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 70.7 Cg_endo -73.81 166.94 28.47 Favored 'Trans proline' 0 N--CA 1.481 0.773 0 C-N-CA 115.803 -2.331 . . . . 25.0 116.404 -176.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.6 m -96.88 130.05 44.22 Favored 'General case' 0 C--O 1.26 1.622 0 O-C-N 121.576 -0.703 . . . . 25.0 110.437 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.9 p -70.07 137.67 51.41 Favored 'General case' 0 C--O 1.255 1.373 0 N-CA-C 106.03 -1.841 . . . . 25.0 106.03 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.8 p -141.38 170.84 14.96 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-O 122.027 0.918 . . . . 25.0 110.505 -175.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.4 m -123.6 -16.62 6.69 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.369 -1.287 . . . . 25.0 108.448 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -152.15 160.28 43.44 Favored 'General case' 0 C--O 1.266 1.921 0 N-CA-C 108.639 -0.874 . . . . 25.0 108.639 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -57.45 -35.13 69.72 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 124.144 0.902 . . . . 25.0 112.564 177.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -14.42 61.93 Favored 'General case' 0 C--O 1.259 1.576 0 O-C-N 120.944 -1.097 . . . . 25.0 113.775 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -77.67 -9.11 58.8 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 121.517 0.675 . . . . 50.0 109.407 175.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.1 m -104.37 172.46 6.79 Favored 'General case' 0 CA--C 1.555 1.161 0 O-C-N 119.912 -1.743 . . . . 25.0 114.981 -174.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 74.7 mt -71.7 166.96 20.87 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.318 0.58 . . . . 25.0 111.896 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.93 118.98 5.12 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 114.099 1.148 . . . . 25.0 114.099 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.2 -1.96 80.62 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 120.99 -0.624 . . . . 25.0 112.272 175.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.0 m -105.48 161.01 14.71 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.011 -2.218 . . . . 25.0 105.011 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.1 m -132.01 171.53 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 124.287 0.992 . . . . 25.0 109.368 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 29.8 t -94.72 115.45 27.54 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 105.852 -1.907 . . . . 25.0 105.852 174.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.8 176.69 52.24 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 119.268 -0.74 . . . . 25.0 114.1 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.46 -12.07 20.64 Favored 'Trans proline' 0 C--O 1.211 -0.835 0 CA-C-O 124.45 1.771 . . . . 25.0 114.204 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -74.47 -10.0 59.13 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-N 114.437 -1.256 . . . . 25.0 110.049 173.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.45 18.71 47.96 Favored Glycine 0 CA--C 1.498 -1.023 0 CA-C-O 122.693 1.163 . . . . 25.0 112.899 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 42.0 m-85 -135.88 153.28 51.51 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 112.48 -1.86 . . . . 25.0 110.486 -174.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.7 m -60.34 147.08 41.82 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.936 0.772 . . . . 25.0 110.469 173.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -2.015 0 CA-C-O 118.312 -1.271 . . . . 50.0 110.788 179.622 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.4 p . . . . . 0 C--O 1.221 -0.398 0 N-CA-C 113.62 0.97 . . . . 25.0 113.62 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.94 61.85 7.23 Favored 'Trans proline' 0 CA--C 1.554 1.522 0 N-CA-C 114.836 1.052 . . . . 25.0 114.836 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -120.83 24.61 10.14 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 105.323 -2.103 . . . . 25.0 105.323 172.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.1 69.32 0.16 Allowed Glycine 0 CA--C 1.497 -1.039 0 C-N-CA 120.395 -0.907 . . . . 25.0 112.368 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 44.4 mmt-85 -131.6 -177.67 4.52 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.227 -1.027 . . . . 25.0 108.227 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.68 -60.18 9.46 Favored Glycine 0 C--O 1.199 -2.078 0 O-C-N 125.18 1.55 . . . . 25.0 112.845 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -99.28 13.82 31.76 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 118.515 1.157 . . . . 25.0 111.088 -175.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -119.5 88.29 2.9 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 106.704 -1.591 . . . . 25.0 106.704 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.14 150.56 97.38 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 104.461 -2.422 . . . . 25.0 104.461 175.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.466 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 66.5 Cg_endo -70.86 164.65 34.89 Favored 'Trans proline' 0 CA--C 1.487 -1.83 0 C-N-CA 115.156 -2.763 . . . . 25.0 115.184 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.1 m -98.19 130.76 44.92 Favored 'General case' 0 C--O 1.254 1.327 0 CA-C-N 116.103 -0.498 . . . . 25.0 111.606 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.1 p -71.06 139.67 50.48 Favored 'General case' 0 C--O 1.251 1.151 0 N-CA-C 105.842 -1.91 . . . . 25.0 105.842 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.3 p -141.9 173.23 11.7 Favored 'General case' 0 CA--C 1.572 1.805 0 CA-C-O 122.386 1.088 . . . . 25.0 110.35 -175.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.8 m -132.74 -12.06 3.0 Favored 'General case' 0 C--O 1.201 -1.496 0 CA-C-N 114.407 -1.27 . . . . 25.0 108.064 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -149.42 157.17 43.07 Favored 'General case' 0 C--O 1.257 1.457 0 N-CA-C 107.946 -1.131 . . . . 25.0 107.946 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -60.09 -33.62 72.35 Favored 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 123.99 0.806 . . . . 25.0 111.489 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -63.1 -22.82 67.12 Favored 'General case' 0 C--O 1.248 1.026 0 O-C-N 121.246 -0.909 . . . . 25.0 111.804 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -63.57 -27.16 69.06 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.855 0.836 . . . . 50.0 109.031 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.6 m -89.14 176.03 7.14 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 114.414 1.265 . . . . 25.0 114.414 -172.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 78.5 mt -77.64 167.01 22.28 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-O 122.019 0.914 . . . . 25.0 110.359 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.62 125.02 22.9 Favored 'General case' 0 C--O 1.252 1.21 0 N-CA-C 113.213 0.82 . . . . 25.0 113.213 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.12 -8.73 57.58 Favored Glycine 0 C--O 1.244 0.756 0 N-CA-C 110.643 -0.983 . . . . 25.0 110.643 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -113.06 157.55 21.43 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 107.67 -1.234 . . . . 25.0 107.67 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.9 m -131.89 167.89 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 123.787 0.835 . . . . 25.0 109.708 -176.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.1 t -88.15 110.93 21.06 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 106.135 -1.802 . . . . 25.0 106.135 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.21 174.2 54.65 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.323 -0.853 . . . . 25.0 113.314 -173.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.76 -14.75 19.44 Favored 'Trans proline' 0 C--O 1.207 -1.036 0 CA-C-O 124.505 1.794 . . . . 25.0 114.803 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -70.34 -15.68 62.9 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 113.489 -1.687 . . . . 25.0 109.649 172.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.63 16.42 36.74 Favored Glycine 0 C--O 1.255 1.424 0 O-C-N 124.455 1.097 . . . . 25.0 112.846 176.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.466 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 67.2 m-85 -131.57 151.46 51.58 Favored 'General case' 0 C--O 1.203 -1.386 0 CA-C-N 113.557 -1.322 . . . . 25.0 113.16 -174.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 86.2 m -60.02 143.48 51.78 Favored 'General case' 0 C--N 1.311 -1.066 0 O-C-N 124.076 0.86 . . . . 25.0 111.075 173.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.48 -2.126 0 CA-C-O 118.346 -1.252 . . . . 50.0 111.474 179.203 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 106.839 -1.541 . . . . 25.0 106.839 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.83 49.71 2.27 Favored 'Trans proline' 0 CA--C 1.563 1.963 0 CA-C-N 120.71 1.289 . . . . 25.0 114.527 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -121.6 -2.86 9.35 Favored 'General case' 0 C--O 1.204 -1.34 0 C-N-CA 125.01 1.324 . . . . 25.0 107.524 170.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -142.61 50.61 0.7 Allowed Glycine 0 C--O 1.236 0.249 0 N-CA-C 115.208 0.843 . . . . 25.0 115.208 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -119.9 176.17 5.54 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.558 -1.275 . . . . 25.0 107.558 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.76 -48.55 65.71 Favored Glycine 0 C--O 1.214 -1.137 0 O-C-N 125.402 1.688 . . . . 25.0 114.282 -176.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -103.8 7.99 37.11 Favored 'General case' 0 C--O 1.249 1.069 0 CA-C-N 119.136 1.468 . . . . 25.0 109.842 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.8 m-90 -113.54 84.51 2.03 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.827 -1.175 . . . . 25.0 107.827 -176.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.48 151.68 96.93 Favored Pre-proline 0 CA--C 1.566 1.585 0 CA-C-N 113.428 -1.715 . . . . 25.0 106.793 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.424 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 79.6 Cg_endo -76.64 169.18 22.29 Favored 'Trans proline' 0 CA--C 1.511 -0.638 0 N-CA-C 116.205 1.579 . . . . 25.0 116.205 -176.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.3 m -105.93 131.43 53.24 Favored 'General case' 0 C--O 1.254 1.307 0 O-C-N 121.178 -0.952 . . . . 25.0 110.355 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.1 p -67.29 136.76 55.39 Favored 'General case' 0 C--O 1.257 1.47 0 N-CA-C 106.727 -1.582 . . . . 25.0 106.727 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.3 p -142.2 169.85 16.82 Favored 'General case' 0 CA--C 1.555 1.135 0 CA-C-O 122.747 1.26 . . . . 25.0 110.873 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.3 m -128.42 -15.01 4.65 Favored 'General case' 0 C--O 1.198 -1.653 0 CA-C-N 114.02 -1.446 . . . . 25.0 108.19 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -148.59 159.27 44.24 Favored 'General case' 0 C--O 1.258 1.506 0 N-CA-C 108.511 -0.922 . . . . 25.0 108.511 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -62.32 -29.54 70.52 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.134 0.896 . . . . 25.0 112.212 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.9 t -66.59 -16.29 64.07 Favored 'General case' 0 C--O 1.254 1.336 0 O-C-N 120.843 -1.161 . . . . 25.0 111.673 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -73.21 -15.19 61.45 Favored 'General case' 0 CA--C 1.557 1.216 0 CA-C-O 121.657 0.741 . . . . 50.0 109.999 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.4 m -99.55 176.04 5.62 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 115.187 1.551 . . . . 25.0 115.187 -172.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 79.4 mt -78.07 170.9 15.84 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.659 0.742 . . . . 25.0 110.538 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.63 121.58 14.26 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 113.25 0.833 . . . . 25.0 113.25 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.07 0.01 63.9 Favored Glycine 0 CA--C 1.525 0.659 0 O-C-N 124.275 0.985 . . . . 25.0 112.263 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.6 m -113.29 159.51 19.29 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 108.033 -1.099 . . . . 25.0 108.033 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.2 m -132.58 170.34 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 124.276 0.985 . . . . 25.0 109.872 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.1 t -89.39 111.65 22.56 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 107.016 -1.475 . . . . 25.0 107.016 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.51 177.7 48.8 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 114.525 0.57 . . . . 25.0 114.525 -173.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.35 -10.17 19.02 Favored 'Trans proline' 0 C--O 1.21 -0.919 0 CA-C-O 124.867 1.945 . . . . 25.0 114.085 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -78.43 -13.68 59.73 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 112.919 -1.946 . . . . 25.0 110.879 171.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.55 20.31 45.05 Favored Glycine 0 CA--C 1.501 -0.785 0 CA-C-N 115.728 -0.669 . . . . 25.0 113.533 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.424 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 37.1 m-85 -131.71 146.88 52.4 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.964 -1.118 . . . . 25.0 110.831 -174.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.7 m -64.44 145.52 55.95 Favored 'General case' 0 C--N 1.317 -0.835 0 O-C-N 124.253 0.971 . . . . 25.0 112.917 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.735 0 CA-C-O 118.355 -1.247 . . . . 50.0 110.708 174.442 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.7 p . . . . . 0 N--CA 1.472 0.655 0 CA-C-O 118.433 -0.794 . . . . 25.0 111.675 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.42 73.2 5.66 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 N-CA-C 114.616 0.968 . . . . 25.0 114.616 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -127.82 30.14 5.33 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.47 -1.678 . . . . 25.0 106.47 173.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.55 50.26 0.21 Allowed Glycine 0 CA--C 1.497 -1.055 0 C-N-CA 119.618 -1.277 . . . . 25.0 113.398 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -121.55 174.03 7.04 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.932 -0.766 . . . . 25.0 108.932 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -51.19 -50.44 39.91 Favored Glycine 0 C--O 1.207 -1.576 0 O-C-N 125.317 1.635 . . . . 25.0 113.722 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -101.62 0.59 36.53 Favored 'General case' 0 CA--C 1.558 1.27 0 CA-C-N 119.578 1.689 . . . . 25.0 110.917 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.1 m-90 -116.17 81.07 1.55 Allowed 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 107.352 -1.351 . . . . 25.0 107.352 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.03 154.63 94.07 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 104.394 -2.447 . . . . 25.0 104.394 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.438 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 50.9 Cg_endo -72.39 172.5 14.85 Favored 'Trans proline' 0 CA--C 1.508 -0.813 0 N-CA-C 116.713 1.774 . . . . 25.0 116.713 -177.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -106.25 133.23 51.27 Favored 'General case' 0 C--O 1.266 1.958 0 CA-C-N 115.887 -0.597 . . . . 25.0 110.458 176.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.0 p -70.29 141.64 52.35 Favored 'General case' 0 C--O 1.259 1.567 0 N-CA-C 107.286 -1.376 . . . . 25.0 107.286 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.9 p -144.48 172.29 13.16 Favored 'General case' 0 CA--C 1.556 1.177 0 CA-C-N 114.574 -1.193 . . . . 25.0 109.814 -175.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.1 m -128.1 -12.87 5.16 Favored 'General case' 0 C--O 1.2 -1.517 0 CA-C-N 114.619 -1.173 . . . . 25.0 107.915 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -151.13 162.66 40.46 Favored 'General case' 0 C--O 1.258 1.52 0 C-N-CA 124.116 0.967 . . . . 25.0 110.185 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -63.07 -29.25 70.66 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.5 1.125 . . . . 25.0 112.877 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 t -71.4 -12.39 61.39 Favored 'General case' 0 C--O 1.253 1.258 0 O-C-N 121.919 -0.488 . . . . 25.0 110.682 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -76.03 -12.7 60.17 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 121.639 0.733 . . . . 50.0 110.969 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.3 m -101.27 172.89 6.72 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.917 1.821 . . . . 25.0 115.917 -170.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.4 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 83.5 mt -69.83 168.14 15.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.674 0.749 . . . . 25.0 110.077 176.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.9 122.0 11.23 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 115.138 1.533 . . . . 25.0 115.138 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.37 -9.51 76.71 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 123.983 0.802 . . . . 25.0 112.876 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 2.1 m -95.68 151.88 18.96 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 m -124.34 165.69 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.844 0.858 . . . . 25.0 110.463 -176.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.2 t -86.83 114.88 23.86 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 105.198 -2.149 . . . . 25.0 105.198 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.17 178.39 53.88 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 115.883 -0.598 . . . . 25.0 112.888 -173.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.52 -11.78 18.73 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 CA-C-O 124.432 1.763 . . . . 25.0 114.213 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -78.18 -8.28 58.11 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 113.381 -1.736 . . . . 25.0 110.412 172.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.53 17.98 63.0 Favored Glycine 0 C--O 1.25 1.097 0 CA-C-O 122.82 1.234 . . . . 25.0 112.858 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.438 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 39.0 m-85 -126.31 149.76 48.94 Favored 'General case' 0 C--O 1.206 -1.208 0 CA-C-N 112.962 -1.619 . . . . 25.0 109.079 -176.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.5 m -64.5 149.82 47.86 Favored 'General case' 0 C--N 1.317 -0.822 0 O-C-N 124.41 1.069 . . . . 25.0 110.316 174.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.647 0 CA-C-O 118.641 -1.088 . . . . 50.0 113.44 175.332 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 117.089 -1.434 . . . . 25.0 108.804 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -78.59 57.72 6.45 Favored 'Trans proline' 0 N--CA 1.486 1.039 0 N-CA-C 115.844 1.44 . . . . 25.0 115.844 -174.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -124.42 8.12 8.39 Favored 'General case' 0 C--O 1.2 -1.519 0 N-CA-C 108.905 -0.776 . . . . 25.0 108.905 170.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.94 46.93 0.68 Allowed Glycine 0 C--O 1.218 -0.878 0 C-N-CA 120.664 -0.779 . . . . 25.0 114.939 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 mmp_? -108.79 -164.27 0.93 Allowed 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 105.632 -1.988 . . . . 25.0 105.632 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.02 -72.78 0.57 Allowed Glycine 0 C--O 1.205 -1.709 0 O-C-N 125.197 1.561 . . . . 25.0 112.755 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -97.86 10.94 38.95 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.431 1.115 . . . . 25.0 110.209 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -95.61 79.28 3.37 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 105.447 -2.057 . . . . 25.0 105.447 176.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.64 148.49 96.8 Favored Pre-proline 0 CA--C 1.558 1.288 0 CA-C-N 113.821 -1.536 . . . . 25.0 106.936 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.5 171.89 17.37 Favored 'Trans proline' 0 N--CA 1.482 0.795 0 N-CA-C 116.853 1.828 . . . . 25.0 116.853 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.0 m -106.62 130.0 54.44 Favored 'General case' 0 C--O 1.261 1.686 0 CA-C-N 115.184 -0.917 . . . . 25.0 110.55 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.7 p -68.48 130.53 43.15 Favored 'General case' 0 C--O 1.26 1.652 0 N-CA-C 105.735 -1.95 . . . . 25.0 105.735 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.6 p -136.39 173.23 11.93 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 122.574 1.178 . . . . 25.0 110.966 -173.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.5 m -131.31 -14.3 3.36 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 114.264 -1.334 . . . . 25.0 107.833 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -151.02 161.45 42.71 Favored 'General case' 0 C--O 1.253 1.262 0 O-C-N 121.026 -1.046 . . . . 25.0 109.977 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -63.36 -30.57 71.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 124.316 1.01 . . . . 25.0 112.58 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.1 t -65.51 -19.73 66.05 Favored 'General case' 0 C--O 1.252 1.19 0 O-C-N 121.648 -0.657 . . . . 25.0 111.487 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -72.61 -17.62 61.66 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-O 121.802 0.811 . . . . 50.0 110.169 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.1 m -103.54 176.39 5.17 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 115.221 1.563 . . . . 25.0 115.221 -170.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.3 mt -74.98 168.56 19.72 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 122.081 0.943 . . . . 25.0 111.159 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.01 136.21 53.51 Favored 'General case' 0 C--O 1.268 2.031 0 O-C-N 121.271 -0.893 . . . . 25.0 109.604 172.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.86 -9.9 76.43 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 111.831 -0.508 . . . . 25.0 111.831 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.2 m -108.54 158.42 17.57 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 104.518 -2.401 . . . . 25.0 104.518 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.07 171.21 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 106.523 -1.658 . . . . 25.0 106.523 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.8 t -84.69 115.06 22.47 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 105.338 -2.097 . . . . 25.0 105.338 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.24 175.56 54.6 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 112.397 -0.281 . . . . 25.0 112.397 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.92 -13.86 19.41 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 CA-C-O 125.358 2.149 . . . . 25.0 114.592 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -75.75 -10.73 59.68 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 113.595 -1.639 . . . . 25.0 111.151 172.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.47 18.83 51.42 Favored Glycine 0 CA--C 1.494 -1.276 0 CA-C-O 122.535 1.075 . . . . 25.0 112.794 174.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -127.9 150.7 49.75 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.644 -1.278 . . . . 25.0 109.146 -177.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.4 m -61.64 146.79 47.91 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 123.723 0.64 . . . . 25.0 110.555 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.905 0 CA-C-O 117.56 -1.689 . . . . 50.0 111.716 174.954 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.177 -1.392 . . . . 25.0 108.823 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.85 55.03 5.09 Favored 'Trans proline' 0 N--CA 1.488 1.167 0 N-CA-C 115.338 1.246 . . . . 25.0 115.338 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -115.37 19.36 15.55 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 106.607 -1.627 . . . . 25.0 106.607 175.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -158.46 40.53 0.51 Allowed Glycine 0 C--N 1.319 -0.394 0 C-N-CA 119.253 -1.451 . . . . 25.0 116.649 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -93.97 171.39 8.89 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.663 -1.606 . . . . 25.0 106.663 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.22 -55.73 14.9 Favored Glycine 0 C--O 1.201 -1.957 0 O-C-N 125.303 1.627 . . . . 25.0 113.413 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -105.35 27.6 8.15 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 117.867 0.834 . . . . 25.0 112.195 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -120.71 85.88 2.47 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 105.697 -1.964 . . . . 25.0 105.697 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.58 137.36 95.14 Favored Pre-proline 0 C--O 1.261 1.688 0 N-CA-C 106.943 -1.503 . . . . 25.0 106.943 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.424 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 70.0 Cg_endo -73.28 168.51 24.57 Favored 'Trans proline' 0 CA--C 1.505 -0.958 0 N-CA-C 117.017 1.891 . . . . 25.0 117.017 -175.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.5 m -94.71 129.03 41.79 Favored 'General case' 0 C--O 1.263 1.769 0 CA-C-N 115.301 -0.863 . . . . 25.0 111.453 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 p -72.01 134.31 45.83 Favored 'General case' 0 C--O 1.255 1.365 0 N-CA-C 106.065 -1.828 . . . . 25.0 106.065 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.7 p -138.16 170.13 16.58 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-O 121.872 0.844 . . . . 25.0 109.715 -173.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.1 m -125.84 -16.78 5.58 Favored 'General case' 0 C--O 1.204 -1.331 0 N-CA-C 106.879 -1.526 . . . . 25.0 106.879 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -149.29 160.76 43.12 Favored 'General case' 0 C--O 1.262 1.716 0 CA-C-N 118.7 0.682 . . . . 25.0 109.335 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -59.76 -30.26 68.74 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.816 0.817 . . . . 25.0 112.296 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -1.67 22.85 Favored 'General case' 0 C--O 1.264 1.857 0 O-C-N 121.186 -0.946 . . . . 25.0 112.958 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -87.2 -9.57 54.83 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 121.683 0.754 . . . . 50.0 109.629 170.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.7 m -103.31 175.64 5.41 Favored 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 116.028 1.862 . . . . 25.0 116.028 -170.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 87.2 mt -71.36 162.6 29.17 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.441 0.639 . . . . 25.0 110.034 177.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.97 124.55 19.06 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 114.863 1.431 . . . . 25.0 114.863 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.17 -7.94 80.96 Favored Glycine 0 CA--C 1.529 0.933 0 O-C-N 124.28 0.987 . . . . 25.0 112.634 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 3.7 m -98.82 159.37 15.0 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 107.914 -1.143 . . . . 25.0 107.914 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.1 m -127.76 166.53 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.691 1.196 . . . . 25.0 109.895 -175.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.3 t -87.54 116.41 25.64 Favored 'General case' 0 C--O 1.255 1.355 0 N-CA-C 105.424 -2.065 . . . . 25.0 105.424 172.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.38 176.21 49.86 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 116.753 -0.203 . . . . 25.0 112.786 -173.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -75.25 -14.17 20.68 Favored 'Trans proline' 0 C--O 1.204 -1.185 0 CA-C-O 124.103 1.626 . . . . 25.0 114.068 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -72.16 -14.46 61.82 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 113.763 -1.562 . . . . 25.0 111.033 173.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.83 12.96 54.88 Favored Glycine 0 CA--C 1.503 -0.699 0 CA-C-O 122.207 0.893 . . . . 25.0 113.238 174.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.424 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 64.6 m-85 -130.47 155.74 45.95 Favored 'General case' 0 C--O 1.206 -1.212 0 CA-C-N 113.415 -1.392 . . . . 25.0 110.284 -174.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 94.0 m -61.92 148.92 42.06 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 124.033 0.833 . . . . 25.0 109.532 173.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.837 0 N-CA-C 109.745 -1.342 . . . . 50.0 109.745 179.382 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 118.201 -0.904 . . . . 25.0 110.915 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.9 70.21 5.27 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 N-CA-C 115.194 1.19 . . . . 25.0 115.194 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -124.26 8.61 8.51 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.904 0.859 . . . . 25.0 110.203 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.39 49.02 0.48 Allowed Glycine 0 CA--C 1.497 -1.08 0 N-CA-C 116.415 1.326 . . . . 25.0 116.415 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 71.1 mtp85 -105.75 174.41 5.89 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.6 -2.0 . . . . 25.0 105.6 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -42.37 -61.59 2.39 Favored Glycine 0 C--O 1.209 -1.45 0 O-C-N 125.099 1.5 . . . . 25.0 114.668 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -99.26 4.41 46.58 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.243 1.022 . . . . 25.0 111.656 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -98.09 80.85 2.74 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 106.198 -1.778 . . . . 25.0 106.198 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.64 147.76 98.9 Favored Pre-proline 0 CA--C 1.559 1.308 0 N-CA-C 104.806 -2.294 . . . . 25.0 104.806 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.472 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 57.4 Cg_endo -72.94 166.98 28.54 Favored 'Trans proline' 0 CA--C 1.503 -1.046 0 C-N-CA 115.73 -2.38 . . . . 25.0 116.295 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.1 m -94.31 125.93 39.25 Favored 'General case' 0 C--O 1.266 1.94 0 O-C-N 121.33 -0.857 . . . . 25.0 110.395 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 p -67.12 136.28 54.88 Favored 'General case' 0 C--O 1.257 1.49 0 N-CA-C 106.643 -1.614 . . . . 25.0 106.643 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.6 p -143.98 171.82 13.73 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-O 122.824 1.297 . . . . 25.0 110.843 -175.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -130.52 -13.43 3.81 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 114.133 -1.394 . . . . 25.0 108.438 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -150.82 159.33 44.61 Favored 'General case' 0 C--O 1.259 1.602 0 C-N-CA 123.947 0.899 . . . . 25.0 109.218 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -60.64 -31.75 70.94 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 114.062 1.134 . . . . 25.0 114.062 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -15.98 64.05 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 113.036 0.754 . . . . 25.0 113.036 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -73.88 -18.21 60.95 Favored 'General case' 0 CA--C 1.563 1.478 0 O-C-N 124.042 0.838 . . . . 50.0 110.648 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.2 m -95.25 178.24 5.59 Favored 'General case' 0 CA--C 1.557 1.249 0 O-C-N 120.03 -1.669 . . . . 25.0 114.975 -170.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.2 mt -75.58 167.85 21.11 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 121.61 0.719 . . . . 25.0 109.373 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.72 121.78 11.24 Favored 'General case' 0 C--O 1.251 1.163 0 N-CA-C 114.815 1.413 . . . . 25.0 114.815 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.74 -7.29 82.35 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.08 -0.581 . . . . 25.0 113.633 175.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.2 m -95.31 160.43 14.54 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 105.521 -2.029 . . . . 25.0 105.521 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.4 m -129.21 169.36 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.758 0.823 . . . . 25.0 110.429 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 19.3 t -90.54 114.26 26.43 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 106.677 -1.601 . . . . 25.0 106.677 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.85 174.66 53.99 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 115.651 -0.704 . . . . 25.0 114.076 -173.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -73.41 -15.09 25.15 Favored 'Trans proline' 0 C--O 1.213 -0.762 0 CA-C-O 124.552 1.813 . . . . 25.0 114.603 -177.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -74.94 -7.78 54.59 Favored 'General case' 0 CA--C 1.559 1.315 0 CA-C-N 113.896 -1.502 . . . . 25.0 111.157 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.4 12.65 58.24 Favored Glycine 0 C--O 1.247 0.966 0 CA-C-O 122.657 1.143 . . . . 25.0 113.494 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.472 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 57.4 m-85 -130.92 154.66 47.87 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 113.491 -1.355 . . . . 25.0 111.402 -174.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 86.2 m -63.71 146.87 53.02 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.855 0.722 . . . . 25.0 110.628 174.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.649 0 N-CA-C 110.171 -1.172 . . . . 50.0 110.171 -178.649 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.476 0.843 0 CA-C-O 117.481 -1.247 . . . . 25.0 108.554 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -77.55 59.95 6.93 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 N-CA-C 115.67 1.373 . . . . 25.0 115.67 -175.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -131.26 19.25 4.87 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 106.251 -1.759 . . . . 25.0 106.251 174.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.46 50.81 0.32 Allowed Glycine 0 CA--C 1.495 -1.175 0 C-N-CA 119.766 -1.207 . . . . 25.0 114.344 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -119.19 -169.31 1.72 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.982 -0.748 . . . . 25.0 108.982 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.94 -64.34 4.27 Favored Glycine 0 C--O 1.201 -1.96 0 O-C-N 125.036 1.46 . . . . 25.0 113.183 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -102.77 26.72 7.7 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.758 1.279 . . . . 25.0 110.354 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -127.81 81.12 2.0 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 105.668 -1.975 . . . . 25.0 105.668 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.88 152.75 95.37 Favored Pre-proline 0 C--O 1.254 1.292 0 CA-C-N 112.889 -1.959 . . . . 25.0 105.875 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.428 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 73.6 Cg_endo -74.58 170.45 20.26 Favored 'Trans proline' 0 CA--C 1.506 -0.925 0 C-N-CA 116.145 -2.103 . . . . 25.0 115.579 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.6 m -108.73 129.21 55.36 Favored 'General case' 0 C--O 1.26 1.639 0 O-C-N 121.7 -0.625 . . . . 25.0 110.899 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.8 p -66.28 133.63 50.97 Favored 'General case' 0 C--O 1.262 1.763 0 N-CA-C 106.245 -1.761 . . . . 25.0 106.245 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.6 p -139.81 176.58 8.62 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 122.143 0.973 . . . . 25.0 110.258 -174.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.0 m -132.39 -15.9 2.78 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 114.484 -1.235 . . . . 25.0 108.68 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -153.37 162.93 40.77 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 108.031 -1.1 . . . . 25.0 108.031 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -62.96 -32.22 73.49 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 113.806 1.039 . . . . 25.0 113.806 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.89 -10.15 59.08 Favored 'General case' 0 C--O 1.252 1.232 0 O-C-N 121.118 -0.989 . . . . 25.0 113.024 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -75.69 -15.67 60.27 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.239 1.019 . . . . 50.0 110.072 172.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 54.1 m -99.91 177.2 5.18 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 115.125 1.528 . . . . 25.0 115.125 -171.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.6 mt -75.57 168.87 19.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.457 -0.792 . . . . 25.0 112.662 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.38 121.56 9.86 Favored 'General case' 0 C--O 1.254 1.312 0 N-CA-C 113.416 0.895 . . . . 25.0 113.416 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.42 -10.38 74.94 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 120.0 -0.333 . . . . 25.0 113.043 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.4 m -89.26 156.3 18.84 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 106.413 -1.699 . . . . 25.0 106.413 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.8 m -129.38 164.55 31.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 106.581 -1.637 . . . . 25.0 106.581 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 18.3 t -87.59 115.07 24.78 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 104.4 -2.444 . . . . 25.0 104.4 174.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.37 179.3 53.21 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 120.668 -0.777 . . . . 25.0 114.408 -172.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.41 -13.63 22.8 Favored 'Trans proline' 0 C--O 1.206 -1.102 0 CA-C-O 124.868 1.945 . . . . 25.0 113.828 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -74.42 -9.85 58.99 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-N 112.931 -1.94 . . . . 25.0 111.816 171.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.46 22.24 58.88 Favored Glycine 0 CA--C 1.498 -0.996 0 CA-C-O 122.605 1.114 . . . . 25.0 112.416 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.428 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 15.0 m-85 -135.89 147.28 48.11 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 112.996 -1.602 . . . . 25.0 109.514 -173.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 92.4 m -61.5 147.68 44.49 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.686 0.616 . . . . 25.0 110.607 174.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.824 0 CA-C-O 117.24 -1.867 . . . . 50.0 110.608 175.306 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.481 1.103 0 CA-C-O 117.5 -1.238 . . . . 25.0 108.8 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.33 65.36 7.96 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 N-CA-C 114.762 1.024 . . . . 25.0 114.762 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -124.65 21.08 8.52 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 105.548 -2.019 . . . . 25.0 105.548 170.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.58 53.26 0.31 Allowed Glycine 0 CA--C 1.5 -0.877 0 CA-C-O 122.569 1.094 . . . . 25.0 113.209 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.8 mmm-85 -128.23 164.14 23.2 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 106.024 -1.843 . . . . 25.0 106.024 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -45.91 -55.1 7.57 Favored Glycine 0 C--O 1.203 -1.802 0 O-C-N 125.42 1.7 . . . . 25.0 114.572 -174.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -99.02 17.73 19.0 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 119.101 1.451 . . . . 25.0 110.316 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -126.53 78.6 1.8 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 107.35 -1.352 . . . . 25.0 107.35 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.02 151.06 95.96 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 103.911 -2.625 . . . . 25.0 103.911 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.42 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 58.1 Cg_endo -72.78 169.56 21.72 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 N-CA-C 116.971 1.873 . . . . 25.0 116.971 -175.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.9 m -100.05 128.76 46.09 Favored 'General case' 0 C--O 1.259 1.572 0 CA-C-N 115.655 -0.702 . . . . 25.0 110.553 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.2 p -68.33 137.72 54.86 Favored 'General case' 0 C--O 1.262 1.762 0 N-CA-C 107.051 -1.463 . . . . 25.0 107.051 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.1 p -142.16 170.39 15.79 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.14 0.971 . . . . 25.0 112.542 -175.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.5 m -128.27 -15.4 4.65 Favored 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 107.476 -1.305 . . . . 25.0 107.476 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -149.36 161.49 41.96 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 123.734 0.814 . . . . 25.0 109.218 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -64.38 -28.14 69.49 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 124.628 1.205 . . . . 25.0 112.496 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.4 t -65.43 -19.83 66.11 Favored 'General case' 0 C--O 1.258 1.529 0 O-C-N 121.63 -0.669 . . . . 25.0 111.137 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -71.0 -17.19 62.65 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 122.28 1.038 . . . . 50.0 111.7 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.3 m -97.52 174.22 6.77 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 120.592 -1.317 . . . . 25.0 114.233 -171.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.4 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 37.3 mt -69.74 167.41 17.17 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 121.588 0.709 . . . . 25.0 109.81 177.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.41 125.11 21.94 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 113.279 0.844 . . . . 25.0 113.279 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.32 -10.4 74.42 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 120.857 -0.687 . . . . 25.0 113.544 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 7.2 m -95.32 164.38 12.86 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.685 -1.598 . . . . 25.0 106.685 -178.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 m -131.75 165.27 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.637 0.775 . . . . 25.0 110.503 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.6 t -84.73 119.77 25.65 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 104.304 -2.48 . . . . 25.0 104.304 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.2 175.25 55.15 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 121.396 -0.43 . . . . 25.0 113.44 -174.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -74.79 -14.0 21.78 Favored 'Trans proline' 0 C--O 1.204 -1.176 0 CA-C-O 125.136 2.057 . . . . 25.0 113.845 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -79.45 -9.56 59.63 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-N 113.754 -1.566 . . . . 25.0 111.312 175.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.34 15.31 53.87 Favored Glycine 0 CA--C 1.493 -1.318 0 CA-C-O 122.497 1.054 . . . . 25.0 113.131 175.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.42 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 35.5 m-85 -127.68 146.91 50.41 Favored 'General case' 0 C--O 1.203 -1.389 0 CA-C-N 113.928 -1.136 . . . . 25.0 110.835 -176.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.5 m -60.34 147.37 40.81 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.981 0.8 . . . . 25.0 110.268 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -2.062 0 CA-C-O 118.012 -1.438 . . . . 50.0 110.731 179.451 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 118.576 -0.726 . . . . 25.0 110.871 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.67 73.47 5.24 Favored 'Trans proline' 0 C--O 1.211 -0.87 0 N-CA-C 115.204 1.194 . . . . 25.0 115.204 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -121.7 15.65 11.05 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.719 -0.845 . . . . 25.0 108.719 171.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.86 35.24 0.93 Allowed Glycine 0 N--CA 1.467 0.737 0 C-N-CA 119.114 -1.517 . . . . 25.0 116.725 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -94.8 178.24 5.64 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.166 -1.05 . . . . 25.0 108.166 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.18 -54.6 33.04 Favored Glycine 0 C--O 1.201 -1.96 0 C-N-CA 119.712 -1.233 . . . . 25.0 113.083 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -95.57 13.57 25.73 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.208 1.504 . . . . 25.0 110.483 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -122.88 80.17 1.73 Allowed 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 105.989 -1.856 . . . . 25.0 105.989 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.66 148.3 98.23 Favored Pre-proline 0 C--O 1.254 1.298 0 N-CA-C 104.311 -2.477 . . . . 25.0 104.311 175.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 55.9 Cg_endo -71.43 168.39 23.65 Favored 'Trans proline' 0 CA--C 1.498 -1.292 0 C-N-CA 114.481 -3.213 . . . . 25.0 114.971 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.6 m -101.39 124.39 46.99 Favored 'General case' 0 C--O 1.255 1.371 0 O-C-N 121.648 -0.657 . . . . 25.0 110.273 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -66.92 140.41 57.76 Favored 'General case' 0 C--O 1.256 1.397 0 N-CA-C 106.666 -1.605 . . . . 25.0 106.666 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 p -150.09 172.0 15.97 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-O 122.767 1.27 . . . . 25.0 111.009 -175.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -132.27 -11.62 3.22 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.215 -1.357 . . . . 25.0 108.452 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -150.19 157.32 42.97 Favored 'General case' 0 C--O 1.262 1.716 0 N-CA-C 107.416 -1.327 . . . . 25.0 107.416 -177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -66.77 -25.33 66.43 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 113.781 1.03 . . . . 25.0 113.781 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 80.3 p -73.83 -9.1 58.31 Favored 'General case' 0 C--O 1.257 1.461 0 O-C-N 121.156 -0.965 . . . . 25.0 111.553 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -73.53 -16.16 61.28 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 108.841 -0.799 . . . . 50.0 108.841 172.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.7 m -100.55 177.51 4.99 Favored 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 116.08 1.881 . . . . 25.0 116.08 -169.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.6 mt -72.84 167.24 21.34 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.657 0.742 . . . . 25.0 110.476 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.27 118.55 7.58 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 114.328 1.233 . . . . 25.0 114.328 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.93 -6.6 64.41 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 111.413 -0.675 . . . . 25.0 111.413 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.1 m -105.7 157.39 17.46 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.103 -1.073 . . . . 25.0 108.103 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.1 m -131.35 167.88 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 123.352 0.661 . . . . 25.0 110.581 -173.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.9 t -89.48 114.98 26.56 Favored 'General case' 0 C--O 1.247 0.958 0 N-CA-C 107.413 -1.329 . . . . 25.0 107.413 175.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.66 179.6 52.3 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 120.848 -0.691 . . . . 25.0 113.655 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -75.77 -13.97 19.69 Favored 'Trans proline' 0 C--O 1.202 -1.3 0 CA-C-N 119.608 1.704 . . . . 25.0 113.54 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -75.57 -8.15 56.04 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 113.639 -1.619 . . . . 25.0 110.607 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.52 15.67 63.49 Favored Glycine 0 CA--C 1.49 -1.515 0 CA-C-O 123.043 1.357 . . . . 25.0 113.269 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 29.9 m-85 -126.43 147.61 49.77 Favored 'General case' 0 C--O 1.195 -1.8 0 CA-C-N 112.88 -1.66 . . . . 25.0 111.361 -175.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.1 m -63.18 148.77 47.12 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 124.692 1.245 . . . . 25.0 109.202 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.479 -2.157 0 CA-C-O 119.352 -0.693 . . . . 50.0 112.984 178.091 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 118.005 -0.997 . . . . 25.0 109.908 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.92 58.0 5.32 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 N-CA-C 115.7 1.385 . . . . 25.0 115.7 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -124.66 6.86 8.18 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 107.714 -1.217 . . . . 25.0 107.714 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.39 58.32 0.42 Allowed Glycine 0 CA--C 1.495 -1.209 0 C-N-CA 120.267 -0.968 . . . . 25.0 115.184 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.406 ' HB2' ' HB2' ' A' ' 9' ' ' TRP . 15.8 mtm-85 -126.07 169.49 12.72 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.66 -1.237 . . . . 25.0 107.66 178.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -38.75 -58.28 1.83 Allowed Glycine 0 C--O 1.212 -1.248 0 O-C-N 125.489 1.743 . . . . 25.0 116.287 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -110.75 31.18 6.19 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.473 1.637 . . . . 25.0 110.888 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.406 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 5.6 m-90 -122.95 78.0 1.51 Allowed 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 103.557 -2.757 . . . . 25.0 103.557 176.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.77 151.67 97.13 Favored Pre-proline 0 CA--C 1.562 1.429 0 N-CA-C 105.743 -1.947 . . . . 25.0 105.743 176.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 60.7 Cg_endo -73.81 170.19 20.62 Favored 'Trans proline' 0 CA--C 1.512 -0.621 0 N-CA-C 116.093 1.536 . . . . 25.0 116.093 -176.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.5 m -100.33 131.32 46.32 Favored 'General case' 0 C--O 1.263 1.779 0 CA-C-N 115.73 -0.668 . . . . 25.0 110.877 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.6 p -66.86 130.86 44.54 Favored 'General case' 0 C--O 1.271 2.185 0 N-CA-C 107.003 -1.481 . . . . 25.0 107.003 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.3 p -142.63 175.92 9.44 Favored 'General case' 0 CA--C 1.561 1.396 0 CA-C-O 122.416 1.103 . . . . 25.0 109.161 -177.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 m -130.64 -18.21 3.15 Favored 'General case' 0 C--O 1.189 -2.097 0 CA-C-N 114.321 -1.309 . . . . 25.0 108.509 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -143.17 158.13 43.89 Favored 'General case' 0 C--O 1.259 1.553 0 N-CA-C 108.032 -1.099 . . . . 25.0 108.032 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -62.96 -29.31 70.7 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 124.512 1.133 . . . . 25.0 111.948 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.4 t -71.15 -13.1 61.83 Favored 'General case' 0 C--O 1.249 1.067 0 O-C-N 121.06 -1.025 . . . . 25.0 112.36 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -74.05 -16.08 61.05 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.022 -0.733 . . . . 50.0 109.022 174.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.9 m -100.84 170.68 8.15 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 115.008 1.485 . . . . 25.0 115.008 -170.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.7 mt -66.17 165.63 13.37 Favored 'General case' 0 N--CA 1.424 -1.753 0 O-C-N 123.731 0.644 . . . . 25.0 110.792 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.96 119.72 8.83 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 114.548 1.314 . . . . 25.0 114.548 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.01 -7.74 73.17 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 121.191 -0.528 . . . . 25.0 113.155 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.3 m -99.21 160.7 14.08 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 105.615 -1.994 . . . . 25.0 105.615 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.11 166.72 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 123.199 0.6 . . . . 25.0 109.921 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 21.2 t -91.03 118.84 30.72 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 106.2 -1.778 . . . . 25.0 106.2 174.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.45 177.09 54.23 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.428 -0.892 . . . . 25.0 114.005 -174.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.22 -19.03 23.02 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 CA-C-O 124.995 1.998 . . . . 25.0 113.895 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -72.84 -10.14 59.46 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-N 113.778 -1.555 . . . . 25.0 110.604 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.2 17.02 44.69 Favored Glycine 0 CA--C 1.497 -1.081 0 CA-C-N 115.162 -0.926 . . . . 25.0 113.936 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 43.5 m-85 -130.11 146.81 51.79 Favored 'General case' 0 C--O 1.212 -0.919 0 CA-C-N 114.182 -1.009 . . . . 25.0 113.626 -172.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 96.1 m -63.28 143.38 57.85 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 124.297 1.039 . . . . 25.0 111.532 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.843 0 CA-C-O 117.618 -1.657 . . . . 50.0 110.865 179.432 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 118.096 -0.954 . . . . 25.0 113.154 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.41 70.99 6.04 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 N-CA-C 114.591 0.958 . . . . 25.0 114.591 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -119.85 -2.56 10.32 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-N 115.253 -0.885 . . . . 25.0 108.679 173.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -142.81 60.76 0.53 Allowed Glycine 0 CA--C 1.495 -1.161 0 C-N-CA 120.276 -0.964 . . . . 25.0 114.03 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -131.82 163.41 28.32 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.222 -0.659 . . . . 25.0 109.222 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -42.02 -47.69 5.29 Favored Glycine 0 C--O 1.211 -1.283 0 N-CA-C 116.628 1.411 . . . . 25.0 116.628 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -107.91 18.82 20.82 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 118.912 1.356 . . . . 25.0 109.717 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.7 m-90 -129.54 80.75 1.98 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.226 -1.398 . . . . 25.0 107.226 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.89 148.41 97.93 Favored Pre-proline 0 CA--C 1.57 1.716 0 N-CA-C 104.858 -2.275 . . . . 25.0 104.858 174.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 58.1 Cg_endo -72.5 168.36 24.56 Favored 'Trans proline' 0 CA--C 1.491 -1.636 0 N-CA-C 118.477 2.453 . . . . 25.0 118.477 -175.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 80.1 m -97.96 128.7 44.69 Favored 'General case' 0 C--O 1.264 1.861 0 CA-C-N 114.737 -1.12 . . . . 25.0 110.988 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.81 131.73 45.62 Favored 'General case' 0 C--O 1.256 1.407 0 N-CA-C 107.019 -1.474 . . . . 25.0 107.019 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.2 p -138.2 170.21 16.43 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 122.857 1.313 . . . . 25.0 110.461 -176.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.0 m -125.32 -17.24 5.69 Favored 'General case' 0 C--O 1.197 -1.705 0 N-CA-C 107.088 -1.449 . . . . 25.0 107.088 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -151.22 162.14 41.44 Favored 'General case' 0 C--O 1.254 1.33 0 C-N-CA 123.286 0.634 . . . . 25.0 110.041 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -57.63 -32.55 67.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 124.446 1.092 . . . . 25.0 112.805 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.9 t -63.95 -18.9 64.71 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-O 118.91 -0.567 . . . . 25.0 111.669 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -71.77 -13.24 61.64 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 113.27 0.841 . . . . 50.0 113.27 174.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.7 m -101.25 173.03 6.64 Favored 'General case' 0 C--O 1.251 1.148 0 N-CA-C 115.309 1.596 . . . . 25.0 115.309 -169.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.8 mt -67.66 163.92 20.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.033 0.921 . . . . 25.0 110.431 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.16 122.06 12.87 Favored 'General case' 0 C--O 1.252 1.229 0 N-CA-C 113.867 1.062 . . . . 25.0 113.867 -178.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.01 7.01 78.35 Favored Glycine 0 CA--C 1.522 0.505 0 O-C-N 123.195 0.309 . . . . 25.0 112.469 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.5 m -114.04 160.95 18.32 Favored 'General case' 0 C--N 1.354 0.793 0 N-CA-C 106.258 -1.756 . . . . 25.0 106.258 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.3 m -128.84 170.55 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.037 0.935 . . . . 25.0 110.773 -176.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.4 t -91.76 108.92 20.26 Favored 'General case' 0 C--O 1.249 1.03 0 N-CA-C 105.313 -2.106 . . . . 25.0 105.313 174.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.19 175.87 54.4 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 116.255 -0.429 . . . . 25.0 113.956 -173.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.54 -9.26 21.32 Favored 'Trans proline' 0 C--O 1.207 -1.048 0 CA-C-N 119.579 1.69 . . . . 25.0 115.574 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -76.58 -10.04 59.1 Favored 'General case' 0 CA--C 1.565 1.542 0 CA-C-N 113.895 -1.502 . . . . 25.0 110.046 173.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.35 17.46 57.2 Favored Glycine 0 C--O 1.247 0.924 0 CA-C-O 121.851 0.695 . . . . 25.0 112.285 176.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 42.9 m-85 -133.9 151.52 51.54 Favored 'General case' 0 C--O 1.211 -0.962 0 CA-C-N 113.553 -1.324 . . . . 25.0 110.215 -174.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.3 m -60.28 146.86 42.36 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 124.053 0.846 . . . . 25.0 111.174 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.964 0 CA-C-O 118.153 -1.359 . . . . 50.0 111.34 178.888 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 117.261 -1.352 . . . . 25.0 111.359 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.68 68.06 7.74 Favored 'Trans proline' 0 N--CA 1.485 0.993 0 N-CA-C 114.898 1.076 . . . . 25.0 114.898 -175.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -122.78 19.46 10.22 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.676 -1.601 . . . . 25.0 106.676 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.71 42.9 0.56 Allowed Glycine 0 CA--C 1.507 -0.466 0 C-N-CA 119.964 -1.112 . . . . 25.0 114.158 177.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -103.35 -178.13 3.57 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.949 -1.13 . . . . 25.0 107.949 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.08 -62.6 6.18 Favored Glycine 0 C--O 1.212 -1.235 0 O-C-N 124.809 1.318 . . . . 25.0 112.761 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -94.57 10.06 36.2 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-N 118.956 1.378 . . . . 25.0 111.513 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.3 m-90 -111.73 82.09 1.56 Allowed 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 107.682 -1.229 . . . . 25.0 107.682 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.85 149.18 98.56 Favored Pre-proline 0 C--O 1.252 1.202 0 N-CA-C 104.791 -2.3 . . . . 25.0 104.791 174.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.472 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 64.4 Cg_endo -71.91 164.63 35.07 Favored 'Trans proline' 0 N--CA 1.481 0.759 0 C-N-CA 115.937 -2.242 . . . . 25.0 116.133 -176.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.4 m -94.91 129.74 41.8 Favored 'General case' 0 C--O 1.273 2.322 0 CA-C-N 115.842 -0.617 . . . . 25.0 111.028 177.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.8 p -69.68 132.61 46.42 Favored 'General case' 0 C--O 1.253 1.274 0 N-CA-C 106.699 -1.593 . . . . 25.0 106.699 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.8 p -138.39 172.02 13.52 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.095 0.95 . . . . 25.0 108.975 -174.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.5 m -128.73 -14.81 4.51 Favored 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 107.114 -1.439 . . . . 25.0 107.114 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.41 162.71 40.79 Favored 'General case' 0 C--O 1.255 1.383 0 CA-C-N 118.984 0.811 . . . . 25.0 109.735 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -58.44 -32.24 68.52 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.0 0.812 . . . . 25.0 112.626 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.8 t -66.33 -16.69 64.25 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 112.406 0.521 . . . . 25.0 112.406 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -77.79 -9.51 59.07 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 119.63 -0.828 . . . . 50.0 110.97 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.4 m -104.0 178.57 4.52 Favored 'General case' 0 CA--C 1.552 1.055 0 O-C-N 120.327 -1.483 . . . . 25.0 115.0 -171.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.5 mt -76.3 164.53 25.95 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-O 121.519 0.676 . . . . 25.0 109.711 175.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.8 132.33 53.51 Favored 'General case' 0 C--O 1.259 1.601 0 CA-C-O 119.085 -0.483 . . . . 25.0 110.87 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.54 -7.03 82.75 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 119.502 -0.61 . . . . 25.0 112.124 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.3 m -106.19 155.87 19.03 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.233 -1.765 . . . . 25.0 106.233 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.9 m -129.41 164.98 30.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 C-N-CA 124.937 1.295 . . . . 25.0 107.725 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.6 t -84.04 111.79 19.62 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 105.033 -2.21 . . . . 25.0 105.033 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.84 175.42 52.02 Favored Glycine 0 C--O 1.252 1.256 0 CA-C-N 115.525 -0.761 . . . . 25.0 113.264 -173.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.8 -14.44 19.46 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 CA-C-O 124.286 1.703 . . . . 25.0 114.151 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.2 p-10 -75.82 -8.76 57.65 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-N 114.009 -1.45 . . . . 25.0 110.549 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.24 22.05 39.32 Favored Glycine 0 C--O 1.247 0.966 0 CA-C-O 122.104 0.835 . . . . 25.0 113.463 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.472 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 46.9 m-85 -135.79 153.5 51.51 Favored 'General case' 0 C--O 1.208 -1.127 0 CA-C-N 114.019 -1.09 . . . . 25.0 110.67 -173.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 92.0 m -62.31 142.09 57.94 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.389 0.431 . . . . 25.0 110.214 172.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -2.022 0 CA-C-O 118.123 -1.376 . . . . 50.0 111.25 177.867 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.1 p . . . . . 0 CA--C 1.509 -0.6 0 CA-C-O 117.555 -1.212 . . . . 25.0 111.759 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -76.68 58.23 5.87 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 CA-C-N 119.974 1.027 . . . . 25.0 114.674 -176.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -125.17 16.03 8.42 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 104.572 -2.381 . . . . 25.0 104.572 172.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.02 69.74 0.18 Allowed Glycine 0 CA--C 1.49 -1.517 0 N-CA-C 111.053 -0.819 . . . . 25.0 111.053 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -137.27 163.39 31.07 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 105.831 -1.915 . . . . 25.0 105.831 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -41.58 -56.31 3.6 Favored Glycine 0 C--O 1.21 -1.38 0 CA-C-O 118.135 -1.369 . . . . 25.0 114.355 -177.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -97.75 13.81 29.11 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 119.925 1.863 . . . . 25.0 110.867 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -124.72 84.87 2.33 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 108.534 -0.913 . . . . 25.0 108.534 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.27 153.4 95.58 Favored Pre-proline 0 C--O 1.257 1.458 0 O-C-N 125.591 1.807 . . . . 25.0 106.609 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.26 171.01 18.88 Favored 'Trans proline' 0 CA--C 1.493 -1.575 0 N-CA-C 116.71 1.773 . . . . 25.0 116.71 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.7 m -108.21 131.33 54.78 Favored 'General case' 0 C--O 1.259 1.605 0 CA-C-N 115.274 -0.876 . . . . 25.0 110.288 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.14 140.03 56.16 Favored 'General case' 0 C--O 1.253 1.257 0 N-CA-C 106.554 -1.647 . . . . 25.0 106.554 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.1 p -144.79 174.23 11.17 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.234 -1.348 . . . . 25.0 110.778 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 m -132.95 -10.73 3.0 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 107.622 -1.251 . . . . 25.0 107.622 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -152.28 160.84 43.28 Favored 'General case' 0 C--O 1.259 1.598 0 N-CA-C 107.761 -1.2 . . . . 25.0 107.761 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -63.71 -30.25 71.38 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.264 0.554 . . . . 25.0 112.002 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.6 t -68.25 -18.2 64.49 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 119.17 -1.012 . . . . 25.0 112.066 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -70.53 -11.81 61.17 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.301 -0.629 . . . . 50.0 109.301 175.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.3 m -104.05 173.66 6.21 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.988 1.477 . . . . 25.0 114.988 -171.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.423 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 91.5 mt -72.86 167.8 20.22 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 121.946 0.879 . . . . 25.0 109.42 178.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.6 120.73 11.15 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 114.687 1.366 . . . . 25.0 114.687 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.85 -8.92 65.85 Favored Glycine 0 CA--C 1.532 1.151 0 N-CA-C 110.723 -0.951 . . . . 25.0 110.723 175.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 m -97.22 163.72 12.79 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 106.028 -1.842 . . . . 25.0 106.028 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.4 m -133.5 168.19 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.387 1.075 . . . . 25.0 109.631 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.2 t -90.62 115.2 27.56 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 105.317 -2.105 . . . . 25.0 105.317 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.59 176.83 50.15 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.884 -0.598 . . . . 25.0 112.69 -175.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.22 -14.71 18.47 Favored 'Trans proline' 0 C--O 1.206 -1.085 0 CA-C-O 124.965 1.985 . . . . 25.0 113.833 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -77.13 -8.73 58.0 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-N 113.518 -1.674 . . . . 25.0 110.221 173.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.24 19.95 56.04 Favored Glycine 0 CA--C 1.495 -1.192 0 CA-C-O 122.004 0.78 . . . . 25.0 113.44 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -122.94 147.33 46.74 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.683 -1.258 . . . . 25.0 110.498 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.3 m -63.13 148.9 46.62 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 124.151 0.907 . . . . 25.0 110.308 173.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.558 0 CA-C-O 117.969 -1.461 . . . . 50.0 112.382 173.68 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 117.567 -1.206 . . . . 25.0 111.936 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.66 70.43 5.74 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 N-CA-C 115.26 1.215 . . . . 25.0 115.26 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -129.72 24.04 5.39 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 104.583 -2.377 . . . . 25.0 104.583 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -165.56 51.78 0.27 Allowed Glycine 0 CA--C 1.502 -0.777 0 C-N-CA 120.223 -0.989 . . . . 25.0 112.871 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.93 177.14 4.73 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 105.749 -1.945 . . . . 25.0 105.749 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -51.22 -56.09 16.28 Favored Glycine 0 C--O 1.21 -1.359 0 O-C-N 125.623 1.827 . . . . 25.0 113.104 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -98.67 -3.68 35.44 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 120.197 1.999 . . . . 25.0 112.563 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -98.24 81.95 2.86 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 106.514 -1.661 . . . . 25.0 106.514 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.09 149.58 98.41 Favored Pre-proline 0 C--O 1.254 1.308 0 N-CA-C 105.242 -2.132 . . . . 25.0 105.242 175.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 57.1 Cg_endo -69.94 163.05 39.86 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 116.316 -1.99 . . . . 25.0 114.605 -177.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.7 m -97.14 127.67 43.32 Favored 'General case' 0 C--O 1.258 1.531 0 CA-C-N 115.783 -0.644 . . . . 25.0 111.971 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.13 134.29 48.0 Favored 'General case' 0 C--O 1.26 1.616 0 N-CA-C 106.604 -1.628 . . . . 25.0 106.604 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.2 p -139.37 174.77 10.17 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 123.153 1.454 . . . . 25.0 111.817 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.7 m -129.8 -20.48 3.17 Favored 'General case' 0 C--O 1.196 -1.728 0 N-CA-C 107.372 -1.344 . . . . 25.0 107.372 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -144.43 163.13 34.71 Favored 'General case' 0 C--O 1.259 1.605 0 N-CA-C 108.703 -0.851 . . . . 25.0 108.703 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -62.67 -29.77 70.89 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-O 121.885 0.85 . . . . 25.0 111.853 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.4 t -66.06 -19.11 65.74 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.61 -0.723 . . . . 25.0 111.609 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -70.05 -17.94 63.27 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.623 0.725 . . . . 50.0 110.729 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.7 m -97.02 175.26 6.39 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 115.801 1.778 . . . . 25.0 115.801 -171.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.409 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 63.2 mt -74.15 168.78 18.88 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.533 0.682 . . . . 25.0 110.238 175.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.65 128.08 34.24 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 118.509 -0.757 . . . . 25.0 112.889 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.37 -4.22 76.65 Favored Glycine 0 C--N 1.342 0.878 0 C-N-CA 120.533 -0.841 . . . . 25.0 111.303 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 3.9 m -107.5 159.49 16.38 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.515 -1.661 . . . . 25.0 106.515 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.35 164.24 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 124.267 1.027 . . . . 25.0 109.203 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.5 t -87.36 119.31 27.48 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 105.151 -2.166 . . . . 25.0 105.151 174.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.48 176.44 48.17 Favored Glycine 0 C--O 1.255 1.454 0 C-N-CA 120.894 -0.67 . . . . 25.0 113.352 -173.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.01 -12.52 16.09 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 CA-C-O 124.671 1.863 . . . . 25.0 113.71 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -73.88 -13.17 60.87 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 113.705 -1.588 . . . . 25.0 109.345 173.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.34 14.5 47.74 Favored Glycine 0 C--O 1.251 1.187 0 CA-C-O 122.678 1.155 . . . . 25.0 111.963 174.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.425 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 45.4 m-85 -129.06 151.08 50.13 Favored 'General case' 0 C--O 1.204 -1.329 0 CA-C-N 113.474 -1.363 . . . . 25.0 113.098 -173.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 88.1 m -63.27 144.95 56.5 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 123.893 0.746 . . . . 25.0 111.125 172.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -2.088 0 CA-C-O 117.955 -1.47 . . . . 50.0 111.292 178.754 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 113.726 1.01 . . . . 25.0 113.726 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.06 63.9 7.72 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 O-C-N 123.094 1.05 . . . . 25.0 114.753 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.8 mm-40 -123.71 26.55 7.67 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.937 -2.246 . . . . 25.0 104.937 172.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.06 57.22 0.19 Allowed Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.723 -1.227 . . . . 25.0 114.132 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -124.36 172.63 8.98 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 106.743 -1.577 . . . . 25.0 106.743 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.68 -49.27 28.04 Favored Glycine 0 C--O 1.214 -1.147 0 O-C-N 124.895 1.372 . . . . 25.0 114.637 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -104.49 13.77 31.21 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 118.733 1.267 . . . . 25.0 110.357 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -122.37 81.87 1.9 Allowed 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 106.854 -1.536 . . . . 25.0 106.854 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.38 149.7 95.76 Favored Pre-proline 0 CA--C 1.562 1.413 0 N-CA-C 105.779 -1.934 . . . . 25.0 105.779 176.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.472 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 68.4 Cg_endo -73.33 165.63 32.04 Favored 'Trans proline' 0 CA--C 1.507 -0.87 0 C-N-CA 116.656 -1.762 . . . . 25.0 116.195 -177.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.0 m -97.97 130.64 44.81 Favored 'General case' 0 C--O 1.272 2.252 0 O-C-N 120.918 -1.114 . . . . 25.0 110.609 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 m -66.11 131.19 45.62 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 107.155 -1.424 . . . . 25.0 107.155 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.1 p -136.61 172.14 13.45 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.298 -1.319 . . . . 25.0 110.936 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 m -126.83 -22.06 3.93 Favored 'General case' 0 C--O 1.197 -1.664 0 N-CA-C 106.864 -1.532 . . . . 25.0 106.864 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -145.67 160.85 41.1 Favored 'General case' 0 C--O 1.264 1.863 0 C-N-CA 123.116 0.566 . . . . 25.0 109.684 -175.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -65.51 -27.03 68.18 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.117 0.784 . . . . 25.0 113.117 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 97.4 p -73.1 -12.45 60.91 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 121.173 -0.954 . . . . 25.0 111.078 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -71.13 -19.74 62.4 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 119.109 -1.036 . . . . 50.0 109.363 171.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.6 m -96.92 169.48 9.82 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.913 1.449 . . . . 25.0 114.913 -173.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.2 mt -71.26 168.48 17.22 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.645 -0.707 . . . . 25.0 109.764 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.78 124.95 20.91 Favored 'General case' 0 C--O 1.254 1.311 0 N-CA-C 113.788 1.033 . . . . 25.0 113.788 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.34 -9.82 75.56 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.623 -0.543 . . . . 25.0 112.916 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.8 m -99.86 156.84 16.91 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 106.201 -1.778 . . . . 25.0 106.201 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -128.52 167.78 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.957 0.903 . . . . 25.0 110.134 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.0 t -86.39 113.67 22.54 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 105.844 -1.909 . . . . 25.0 105.844 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.17 -179.13 52.73 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 119.37 -0.683 . . . . 25.0 114.116 -171.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.83 -13.33 21.85 Favored 'Trans proline' 0 C--O 1.21 -0.909 0 CA-C-N 119.652 1.726 . . . . 25.0 114.269 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -81.0 -6.93 59.38 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-N 114.102 -1.408 . . . . 25.0 109.865 174.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.87 20.33 59.75 Favored Glycine 0 C--O 1.254 1.362 0 CA-C-O 122.717 1.176 . . . . 25.0 112.537 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.472 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 44.3 m-85 -130.17 149.02 52.06 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.247 -1.476 . . . . 25.0 110.006 -176.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.6 m -62.92 146.87 51.97 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.154 -0.476 . . . . 25.0 112.216 175.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.893 0 CA-C-O 118.691 -1.06 . . . . 50.0 111.308 171.941 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 117.434 -1.269 . . . . 25.0 108.665 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.62 63.78 7.36 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 CA-C-N 120.8 1.321 . . . . 25.0 115.295 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -125.52 11.32 7.96 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 105.508 -2.034 . . . . 25.0 105.508 173.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -154.08 44.97 0.57 Allowed Glycine 0 N--CA 1.468 0.807 0 C-N-CA 120.031 -1.08 . . . . 25.0 114.792 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -104.86 174.47 5.86 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 104.637 -2.357 . . . . 25.0 104.637 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.17 -51.03 60.87 Favored Glycine 0 C--O 1.204 -1.768 0 O-C-N 124.637 1.211 . . . . 25.0 113.812 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.45 0.75 48.23 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 118.579 1.19 . . . . 25.0 111.9 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -105.77 88.14 2.75 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 106.437 -1.69 . . . . 25.0 106.437 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.62 149.35 98.35 Favored Pre-proline 0 CA--C 1.567 1.623 0 N-CA-C 104.518 -2.401 . . . . 25.0 104.518 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.446 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 55.9 Cg_endo -70.06 168.82 20.85 Favored 'Trans proline' 0 N--CA 1.479 0.621 0 N-CA-C 117.05 1.904 . . . . 25.0 117.05 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.2 m -100.44 128.26 46.55 Favored 'General case' 0 C--O 1.26 1.649 0 O-C-N 121.203 -0.936 . . . . 25.0 111.38 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.4 p -68.57 134.54 50.15 Favored 'General case' 0 C--O 1.26 1.627 0 N-CA-C 106.695 -1.595 . . . . 25.0 106.695 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.1 p -142.55 170.6 15.39 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.883 -1.053 . . . . 25.0 109.32 -176.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.1 m -130.51 -12.03 3.94 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 107.271 -1.381 . . . . 25.0 107.271 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -149.66 159.45 44.32 Favored 'General case' 0 C--O 1.256 1.4 0 C-N-CA 123.947 0.899 . . . . 25.0 108.905 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -61.84 -31.15 71.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 124.145 0.903 . . . . 25.0 111.18 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 t -68.99 -13.27 62.35 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 121.469 -0.769 . . . . 25.0 112.287 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -77.8 -8.25 57.76 Favored 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 120.123 -0.631 . . . . 50.0 110.347 174.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.1 m -104.91 171.74 7.16 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 116.654 2.094 . . . . 25.0 116.654 -172.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.435 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 83.5 mt -68.52 168.43 12.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 122.03 0.919 . . . . 25.0 110.855 177.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.64 124.5 20.88 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 114.011 1.115 . . . . 25.0 114.011 -177.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.19 -12.83 68.01 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 123.349 0.406 . . . . 25.0 112.732 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 4.5 m -90.08 160.13 16.46 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 106.638 -1.616 . . . . 25.0 106.638 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.9 m -128.76 171.89 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 124.617 1.167 . . . . 25.0 108.419 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.5 t -94.9 123.31 38.3 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 106.113 -1.81 . . . . 25.0 106.113 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.98 177.57 46.32 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 114.903 0.721 . . . . 25.0 114.903 -175.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.1 -8.4 16.49 Favored 'Trans proline' 0 C--O 1.211 -0.835 0 CA-C-O 124.414 1.756 . . . . 25.0 113.214 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -79.74 -9.83 59.7 Favored 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 113.909 -1.496 . . . . 25.0 110.201 171.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.92 16.25 58.26 Favored Glycine 0 CA--C 1.486 -1.753 0 CA-C-O 122.708 1.171 . . . . 25.0 113.411 175.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.446 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 45.3 m-85 -128.2 153.12 47.26 Favored 'General case' 0 C--O 1.201 -1.495 0 CA-C-N 113.792 -1.204 . . . . 25.0 111.21 -174.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.7 m -60.74 150.48 32.28 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 124.209 0.943 . . . . 25.0 110.432 172.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.728 0 CA-C-O 117.793 -1.559 . . . . 50.0 112.397 177.992 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.9 p . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 117.717 -1.135 . . . . 25.0 108.458 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.43 64.19 5.49 Favored 'Trans proline' 0 CA--C 1.556 1.591 0 N-CA-C 115.936 1.476 . . . . 25.0 115.936 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -118.5 5.14 11.72 Favored 'General case' 0 C--O 1.202 -1.446 0 N-CA-C 107.49 -1.3 . . . . 25.0 107.49 174.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -153.6 42.17 0.64 Allowed Glycine 0 C--O 1.214 -1.119 0 C-N-CA 120.091 -1.052 . . . . 25.0 115.493 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -98.08 167.99 10.54 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 104.651 -2.352 . . . . 25.0 104.651 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -42.38 -56.05 4.22 Favored Glycine 0 C--O 1.206 -1.602 0 O-C-N 125.393 1.683 . . . . 25.0 115.709 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -99.75 14.69 29.36 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 118.383 1.092 . . . . 25.0 112.451 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -115.78 83.71 1.98 Allowed 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 106.063 -1.828 . . . . 25.0 106.063 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.96 147.53 99.08 Favored Pre-proline 0 CA--C 1.561 1.377 0 N-CA-C 106.337 -1.727 . . . . 25.0 106.337 176.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.409 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 54.9 Cg_endo -74.5 171.33 18.34 Favored 'Trans proline' 0 CA--C 1.499 -1.263 0 C-N-CA 116.026 -2.183 . . . . 25.0 116.326 -175.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m -105.24 130.85 53.3 Favored 'General case' 0 C--O 1.278 2.568 0 O-C-N 120.967 -1.083 . . . . 25.0 111.233 178.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 p -69.81 139.51 53.19 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 105.733 -1.951 . . . . 25.0 105.733 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 p -142.65 170.05 16.44 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 113.87 -1.514 . . . . 25.0 108.724 -174.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.1 m -133.03 -8.74 3.04 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-N 114.74 -1.118 . . . . 25.0 108.54 174.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -149.65 159.68 44.13 Favored 'General case' 0 C--O 1.26 1.62 0 N-CA-C 108.398 -0.964 . . . . 25.0 108.398 176.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -63.47 -30.66 71.75 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.457 1.098 . . . . 25.0 111.526 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.1 t -63.15 -21.97 66.55 Favored 'General case' 0 CA--C 1.556 1.2 0 O-C-N 121.142 -0.973 . . . . 25.0 111.933 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -72.6 -9.4 58.54 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 120.023 -0.671 . . . . 50.0 111.15 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.9 m -103.21 -179.6 4.0 Favored 'General case' 0 CA--C 1.562 1.436 0 N-CA-C 114.513 1.301 . . . . 25.0 114.513 -173.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 75.5 mt -76.98 166.43 23.34 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.485 -1.302 . . . . 25.0 107.485 176.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.69 129.13 38.85 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.648 0.61 . . . . 25.0 112.648 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.91 5.85 76.77 Favored Glycine 0 CA--C 1.536 1.367 0 O-C-N 124.287 0.992 . . . . 25.0 111.685 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.6 m -118.73 156.08 29.97 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 106.959 -1.497 . . . . 25.0 106.959 178.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.73 166.57 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.807 0.843 . . . . 25.0 109.678 -175.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.2 t -86.33 110.48 19.7 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 105.715 -1.958 . . . . 25.0 105.715 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.32 178.27 49.14 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 120.885 -0.674 . . . . 25.0 113.389 -171.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -73.71 -10.58 23.53 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 CA-C-O 124.836 1.932 . . . . 25.0 115.238 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -69.13 -15.74 63.49 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-N 113.934 -1.485 . . . . 25.0 111.492 169.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.96 18.21 56.47 Favored Glycine 0 CA--C 1.492 -1.375 0 CA-C-O 123.3 1.5 . . . . 25.0 109.758 176.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.409 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 26.5 m-85 -135.27 150.54 50.05 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 112.535 -1.832 . . . . 25.0 108.817 -171.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 91.3 m -61.75 148.78 41.82 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.61 1.194 . . . . 25.0 110.805 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.756 0 CA-C-O 119.006 -0.885 . . . . 50.0 111.6 173.457 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.546 0 N-CA-C 109.75 -1.34 . . . . 25.0 109.75 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.8 p -68.4 156.8 89.59 Favored Pre-proline 0 N--CA 1.471 0.609 0 CA-C-N 118.569 1.184 . . . . 25.0 113.406 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -77.56 69.47 7.25 Favored 'Trans proline' 0 C--O 1.209 -0.94 0 CA-C-O 122.202 0.834 . . . . 25.0 113.849 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -123.88 12.63 9.12 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.246 -0.888 . . . . 25.0 109.127 173.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.63 51.54 0.44 Allowed Glycine 0 CA--C 1.496 -1.098 0 C-N-CA 119.941 -1.123 . . . . 25.0 114.094 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -112.38 176.49 5.0 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 107.152 -1.425 . . . . 25.0 107.152 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.98 -57.52 10.95 Favored Glycine 0 C--O 1.207 -1.551 0 O-C-N 125.282 1.614 . . . . 25.0 114.173 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -100.59 12.63 36.96 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 117.784 0.792 . . . . 25.0 110.596 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -116.5 79.22 1.29 Allowed 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 106.633 -1.617 . . . . 25.0 106.633 176.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.52 150.99 96.87 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 105.994 -1.854 . . . . 25.0 105.994 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.439 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 52.5 Cg_endo -72.85 166.46 29.93 Favored 'Trans proline' 0 CA--C 1.499 -1.249 0 C-N-CA 115.629 -2.447 . . . . 25.0 115.681 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.6 m -100.03 127.16 46.28 Favored 'General case' 0 C--O 1.261 1.663 0 O-C-N 121.014 -1.054 . . . . 25.0 111.074 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.5 p -66.16 132.83 49.38 Favored 'General case' 0 C--O 1.261 1.698 0 N-CA-C 106.311 -1.737 . . . . 25.0 106.311 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.7 p -141.32 170.07 16.41 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.207 1.003 . . . . 25.0 111.033 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.1 m -128.76 -14.61 4.53 Favored 'General case' 0 C--O 1.193 -1.906 0 CA-C-N 114.105 -1.407 . . . . 25.0 107.954 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -150.68 164.13 36.87 Favored 'General case' 0 C--O 1.26 1.648 0 N-CA-C 109.612 -0.514 . . . . 25.0 109.612 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -61.34 -30.23 70.39 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.32 1.012 . . . . 25.0 113.281 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.8 t -62.5 -23.28 66.85 Favored 'General case' 0 C--O 1.248 0.975 0 O-C-N 121.715 -0.616 . . . . 25.0 111.556 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -71.83 -9.9 58.99 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 118.307 0.503 . . . . 50.0 111.236 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.9 m -107.85 170.23 8.12 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 115.27 1.581 . . . . 25.0 115.27 -172.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.44 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 64.1 mt -71.19 167.83 18.53 Favored 'General case' 0 C--O 1.253 1.25 0 CA-C-O 121.579 0.704 . . . . 25.0 109.769 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.3 128.0 34.54 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 114.547 1.314 . . . . 25.0 114.547 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.63 -7.53 81.67 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 121.04 -0.6 . . . . 25.0 112.238 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 3.4 m -100.96 155.77 17.78 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 105.742 -1.947 . . . . 25.0 105.742 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.0 m -128.89 166.98 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.441 1.096 . . . . 25.0 108.279 -177.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.5 t -87.97 115.22 25.29 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 105.567 -2.012 . . . . 25.0 105.567 173.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.88 179.88 52.89 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.551 -0.749 . . . . 25.0 113.571 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.53 -13.54 22.53 Favored 'Trans proline' 0 C--O 1.201 -1.364 0 CA-C-O 124.915 1.964 . . . . 25.0 112.732 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -78.07 -7.43 56.93 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 113.365 -1.743 . . . . 25.0 110.931 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.98 22.95 62.52 Favored Glycine 0 C--O 1.251 1.182 0 CA-C-O 123.573 1.651 . . . . 25.0 112.587 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.439 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 17.6 m-85 -131.87 150.09 52.26 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 112.108 -2.046 . . . . 25.0 108.325 -174.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.4 m -66.05 147.76 52.85 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 123.878 0.736 . . . . 25.0 110.443 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.479 -2.194 0 CA-C-O 117.415 -1.769 . . . . 50.0 112.767 177.949 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.775 0 CA-C-O 118.12 -1.378 . . . . 25.0 109.66 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -147.14 164.54 22.71 Favored Pre-proline 0 N--CA 1.475 0.798 0 CA-C-O 117.242 -1.361 . . . . 25.0 109.226 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.34 69.25 7.25 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 N-CA-C 115.54 1.323 . . . . 25.0 115.54 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -122.51 6.2 9.54 Favored 'General case' 0 C--O 1.206 -1.205 0 N-CA-C 108.175 -1.046 . . . . 25.0 108.175 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.7 55.89 0.45 Allowed Glycine 0 CA--C 1.496 -1.128 0 C-N-CA 120.616 -0.802 . . . . 25.0 113.986 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -116.35 -169.85 1.7 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 105.889 -1.893 . . . . 25.0 105.889 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.91 -70.76 0.91 Allowed Glycine 0 C--O 1.196 -2.252 0 O-C-N 125.267 1.605 . . . . 25.0 112.288 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -86.54 4.29 40.64 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 118.071 0.936 . . . . 25.0 110.768 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -104.58 82.49 1.91 Allowed 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.072 -1.455 . . . . 25.0 107.072 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.55 151.02 96.78 Favored Pre-proline 0 C--O 1.253 1.27 0 N-CA-C 105.732 -1.951 . . . . 25.0 105.732 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.55 166.06 30.26 Favored 'Trans proline' 0 CA--C 1.496 -1.397 0 C-N-CA 115.41 -2.593 . . . . 25.0 115.92 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 m -102.08 127.86 48.8 Favored 'General case' 0 C--O 1.266 1.926 0 O-C-N 121.064 -1.023 . . . . 25.0 109.766 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.6 p -68.88 140.37 55.17 Favored 'General case' 0 C--O 1.255 1.393 0 N-CA-C 106.238 -1.764 . . . . 25.0 106.238 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.3 p -145.74 168.51 20.57 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.513 -0.767 . . . . 25.0 110.254 -174.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.5 m -131.46 -5.81 3.74 Favored 'General case' 0 C--O 1.198 -1.625 0 CA-C-N 115.244 -0.889 . . . . 25.0 108.651 176.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -154.91 159.88 40.76 Favored 'General case' 0 C--O 1.261 1.692 0 N-CA-C 108.522 -0.918 . . . . 25.0 108.522 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -63.54 -29.3 70.58 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.627 0.58 . . . . 25.0 112.04 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.3 t -63.92 -20.47 65.88 Favored 'General case' 0 C--O 1.254 1.339 0 N-CA-C 112.026 0.38 . . . . 25.0 112.026 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -72.98 -20.9 60.94 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-O 121.734 0.778 . . . . 50.0 110.769 177.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.5 m -94.99 172.88 7.88 Favored 'General case' 0 C--O 1.252 1.203 0 N-CA-C 116.485 2.031 . . . . 25.0 116.485 -170.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.456 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 60.8 mt -71.16 166.7 20.93 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 122.169 0.985 . . . . 25.0 109.716 176.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.97 128.71 36.9 Favored 'General case' 0 C--O 1.25 1.126 0 O-C-N 121.581 -0.7 . . . . 25.0 112.689 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.91 3.38 73.69 Favored Glycine 0 C--N 1.34 0.767 0 C-N-CA 121.177 -0.535 . . . . 25.0 112.21 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 4.0 m -112.92 164.41 13.46 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 105.792 -1.929 . . . . 25.0 105.792 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.8 m -134.93 170.97 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 108.001 -1.111 . . . . 25.0 108.001 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.2 t -89.51 122.12 32.38 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 105.043 -2.206 . . . . 25.0 105.043 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.02 -179.44 45.74 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.257 -0.746 . . . . 25.0 114.349 -172.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -77.11 -13.19 17.3 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 CA-C-O 125.583 2.243 . . . . 25.0 113.198 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -75.54 -11.62 60.06 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 113.241 -1.8 . . . . 25.0 110.605 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.41 17.44 62.34 Favored Glycine 0 C--O 1.251 1.207 0 CA-C-O 123.285 1.492 . . . . 25.0 113.499 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -127.72 150.54 49.73 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 112.711 -1.745 . . . . 25.0 108.661 -174.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 86.7 m -62.29 148.8 43.87 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.642 1.214 . . . . 25.0 110.577 172.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.48 -2.13 0 CA-C-O 118.745 -1.031 . . . . 50.0 110.552 177.214 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.235 0 CA-C-O 118.617 -1.102 . . . . 25.0 110.652 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.8 p -77.92 161.91 69.48 Favored Pre-proline 0 N--CA 1.474 0.745 0 CA-C-N 119.115 1.457 . . . . 25.0 114.231 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -78.49 66.24 8.51 Favored 'Trans proline' 0 CA--C 1.555 1.563 0 O-C-N 123.034 1.018 . . . . 25.0 113.992 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -119.69 -0.88 10.67 Favored 'General case' 0 C--O 1.197 -1.683 0 CA-C-N 114.689 -1.141 . . . . 25.0 108.607 172.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -136.89 50.87 0.82 Allowed Glycine 0 CA--C 1.502 -0.724 0 N-CA-C 115.007 0.763 . . . . 25.0 115.007 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -117.35 170.96 8.3 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.209 -1.404 . . . . 25.0 107.209 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.5 -51.65 53.2 Favored Glycine 0 C--O 1.215 -1.041 0 O-C-N 124.783 1.302 . . . . 25.0 113.415 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -94.74 11.17 32.31 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.836 1.318 . . . . 25.0 111.568 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -123.64 83.91 2.2 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 107.202 -1.407 . . . . 25.0 107.202 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.83 148.62 98.75 Favored Pre-proline 0 CA--C 1.563 1.476 0 N-CA-C 105.425 -2.065 . . . . 25.0 105.425 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 70.7 Cg_endo -73.81 166.94 28.47 Favored 'Trans proline' 0 N--CA 1.481 0.773 0 C-N-CA 115.803 -2.331 . . . . 25.0 116.404 -176.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.6 m -96.88 130.05 44.22 Favored 'General case' 0 C--O 1.26 1.622 0 O-C-N 121.576 -0.703 . . . . 25.0 110.437 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.9 p -70.07 137.67 51.41 Favored 'General case' 0 C--O 1.255 1.373 0 N-CA-C 106.03 -1.841 . . . . 25.0 106.03 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.8 p -141.38 170.84 14.96 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-O 122.027 0.918 . . . . 25.0 110.505 -175.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.4 m -123.6 -16.62 6.69 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.369 -1.287 . . . . 25.0 108.448 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -152.15 160.28 43.44 Favored 'General case' 0 C--O 1.266 1.921 0 N-CA-C 108.639 -0.874 . . . . 25.0 108.639 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -57.45 -35.13 69.72 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 124.144 0.902 . . . . 25.0 112.564 177.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -14.42 61.93 Favored 'General case' 0 C--O 1.259 1.576 0 O-C-N 120.944 -1.097 . . . . 25.0 113.775 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -77.67 -9.11 58.8 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 121.517 0.675 . . . . 50.0 109.407 175.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.1 m -104.37 172.46 6.79 Favored 'General case' 0 CA--C 1.555 1.161 0 O-C-N 119.912 -1.743 . . . . 25.0 114.981 -174.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 74.7 mt -71.7 166.96 20.87 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.318 0.58 . . . . 25.0 111.896 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.93 118.98 5.12 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 114.099 1.148 . . . . 25.0 114.099 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.2 -1.96 80.62 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 120.99 -0.624 . . . . 25.0 112.272 175.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.0 m -105.48 161.01 14.71 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.011 -2.218 . . . . 25.0 105.011 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.1 m -132.01 171.53 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 124.287 0.992 . . . . 25.0 109.368 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 29.8 t -94.72 115.45 27.54 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 105.852 -1.907 . . . . 25.0 105.852 174.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.8 176.69 52.24 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 119.268 -0.74 . . . . 25.0 114.1 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.46 -12.07 20.64 Favored 'Trans proline' 0 C--O 1.211 -0.835 0 CA-C-O 124.45 1.771 . . . . 25.0 114.204 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -74.47 -10.0 59.13 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-N 114.437 -1.256 . . . . 25.0 110.049 173.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.45 18.71 47.96 Favored Glycine 0 CA--C 1.498 -1.023 0 CA-C-O 122.693 1.163 . . . . 25.0 112.899 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 42.0 m-85 -135.88 153.28 51.51 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 112.48 -1.86 . . . . 25.0 110.486 -174.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.7 m -60.34 147.08 41.82 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.936 0.772 . . . . 25.0 110.469 173.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -2.015 0 CA-C-O 118.312 -1.271 . . . . 50.0 110.788 179.622 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.965 0 CA-C-O 117.633 -1.648 . . . . 25.0 110.988 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.4 p -69.35 159.82 81.72 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 119.462 1.631 . . . . 25.0 113.62 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.94 61.85 7.23 Favored 'Trans proline' 0 CA--C 1.554 1.522 0 N-CA-C 114.836 1.052 . . . . 25.0 114.836 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -120.83 24.61 10.14 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 105.323 -2.103 . . . . 25.0 105.323 172.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.1 69.32 0.16 Allowed Glycine 0 CA--C 1.497 -1.039 0 C-N-CA 120.395 -0.907 . . . . 25.0 112.368 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 44.4 mmt-85 -131.6 -177.67 4.52 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.227 -1.027 . . . . 25.0 108.227 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.68 -60.18 9.46 Favored Glycine 0 C--O 1.199 -2.078 0 O-C-N 125.18 1.55 . . . . 25.0 112.845 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -99.28 13.82 31.76 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 118.515 1.157 . . . . 25.0 111.088 -175.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -119.5 88.29 2.9 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 106.704 -1.591 . . . . 25.0 106.704 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.14 150.56 97.38 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 104.461 -2.422 . . . . 25.0 104.461 175.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.466 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 66.5 Cg_endo -70.86 164.65 34.89 Favored 'Trans proline' 0 CA--C 1.487 -1.83 0 C-N-CA 115.156 -2.763 . . . . 25.0 115.184 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.1 m -98.19 130.76 44.92 Favored 'General case' 0 C--O 1.254 1.327 0 CA-C-N 116.103 -0.498 . . . . 25.0 111.606 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.1 p -71.06 139.67 50.48 Favored 'General case' 0 C--O 1.251 1.151 0 N-CA-C 105.842 -1.91 . . . . 25.0 105.842 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.3 p -141.9 173.23 11.7 Favored 'General case' 0 CA--C 1.572 1.805 0 CA-C-O 122.386 1.088 . . . . 25.0 110.35 -175.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.8 m -132.74 -12.06 3.0 Favored 'General case' 0 C--O 1.201 -1.496 0 CA-C-N 114.407 -1.27 . . . . 25.0 108.064 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -149.42 157.17 43.07 Favored 'General case' 0 C--O 1.257 1.457 0 N-CA-C 107.946 -1.131 . . . . 25.0 107.946 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -60.09 -33.62 72.35 Favored 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 123.99 0.806 . . . . 25.0 111.489 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -63.1 -22.82 67.12 Favored 'General case' 0 C--O 1.248 1.026 0 O-C-N 121.246 -0.909 . . . . 25.0 111.804 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -63.57 -27.16 69.06 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.855 0.836 . . . . 50.0 109.031 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.6 m -89.14 176.03 7.14 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 114.414 1.265 . . . . 25.0 114.414 -172.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 78.5 mt -77.64 167.01 22.28 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-O 122.019 0.914 . . . . 25.0 110.359 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.62 125.02 22.9 Favored 'General case' 0 C--O 1.252 1.21 0 N-CA-C 113.213 0.82 . . . . 25.0 113.213 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.12 -8.73 57.58 Favored Glycine 0 C--O 1.244 0.756 0 N-CA-C 110.643 -0.983 . . . . 25.0 110.643 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -113.06 157.55 21.43 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 107.67 -1.234 . . . . 25.0 107.67 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.9 m -131.89 167.89 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 123.787 0.835 . . . . 25.0 109.708 -176.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.1 t -88.15 110.93 21.06 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 106.135 -1.802 . . . . 25.0 106.135 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.21 174.2 54.65 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.323 -0.853 . . . . 25.0 113.314 -173.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.76 -14.75 19.44 Favored 'Trans proline' 0 C--O 1.207 -1.036 0 CA-C-O 124.505 1.794 . . . . 25.0 114.803 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -70.34 -15.68 62.9 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 113.489 -1.687 . . . . 25.0 109.649 172.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.63 16.42 36.74 Favored Glycine 0 C--O 1.255 1.424 0 O-C-N 124.455 1.097 . . . . 25.0 112.846 176.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.466 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 67.2 m-85 -131.57 151.46 51.58 Favored 'General case' 0 C--O 1.203 -1.386 0 CA-C-N 113.557 -1.322 . . . . 25.0 113.16 -174.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 86.2 m -60.02 143.48 51.78 Favored 'General case' 0 C--N 1.311 -1.066 0 O-C-N 124.076 0.86 . . . . 25.0 111.075 173.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.48 -2.126 0 CA-C-O 118.346 -1.252 . . . . 50.0 111.474 179.203 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.543 0 N-CA-C 109.637 -1.385 . . . . 25.0 109.637 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.64 176.0 2.6 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 106.839 -1.541 . . . . 25.0 106.839 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.83 49.71 2.27 Favored 'Trans proline' 0 CA--C 1.563 1.963 0 CA-C-N 120.71 1.289 . . . . 25.0 114.527 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -121.6 -2.86 9.35 Favored 'General case' 0 C--O 1.204 -1.34 0 C-N-CA 125.01 1.324 . . . . 25.0 107.524 170.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -142.61 50.61 0.7 Allowed Glycine 0 C--O 1.236 0.249 0 N-CA-C 115.208 0.843 . . . . 25.0 115.208 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -119.9 176.17 5.54 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.558 -1.275 . . . . 25.0 107.558 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.76 -48.55 65.71 Favored Glycine 0 C--O 1.214 -1.137 0 O-C-N 125.402 1.688 . . . . 25.0 114.282 -176.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -103.8 7.99 37.11 Favored 'General case' 0 C--O 1.249 1.069 0 CA-C-N 119.136 1.468 . . . . 25.0 109.842 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.8 m-90 -113.54 84.51 2.03 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.827 -1.175 . . . . 25.0 107.827 -176.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.48 151.68 96.93 Favored Pre-proline 0 CA--C 1.566 1.585 0 CA-C-N 113.428 -1.715 . . . . 25.0 106.793 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.424 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 79.6 Cg_endo -76.64 169.18 22.29 Favored 'Trans proline' 0 CA--C 1.511 -0.638 0 N-CA-C 116.205 1.579 . . . . 25.0 116.205 -176.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.3 m -105.93 131.43 53.24 Favored 'General case' 0 C--O 1.254 1.307 0 O-C-N 121.178 -0.952 . . . . 25.0 110.355 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.1 p -67.29 136.76 55.39 Favored 'General case' 0 C--O 1.257 1.47 0 N-CA-C 106.727 -1.582 . . . . 25.0 106.727 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.3 p -142.2 169.85 16.82 Favored 'General case' 0 CA--C 1.555 1.135 0 CA-C-O 122.747 1.26 . . . . 25.0 110.873 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.3 m -128.42 -15.01 4.65 Favored 'General case' 0 C--O 1.198 -1.653 0 CA-C-N 114.02 -1.446 . . . . 25.0 108.19 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -148.59 159.27 44.24 Favored 'General case' 0 C--O 1.258 1.506 0 N-CA-C 108.511 -0.922 . . . . 25.0 108.511 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -62.32 -29.54 70.52 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.134 0.896 . . . . 25.0 112.212 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.9 t -66.59 -16.29 64.07 Favored 'General case' 0 C--O 1.254 1.336 0 O-C-N 120.843 -1.161 . . . . 25.0 111.673 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -73.21 -15.19 61.45 Favored 'General case' 0 CA--C 1.557 1.216 0 CA-C-O 121.657 0.741 . . . . 50.0 109.999 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.4 m -99.55 176.04 5.62 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 115.187 1.551 . . . . 25.0 115.187 -172.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 79.4 mt -78.07 170.9 15.84 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.659 0.742 . . . . 25.0 110.538 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.63 121.58 14.26 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 113.25 0.833 . . . . 25.0 113.25 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.07 0.01 63.9 Favored Glycine 0 CA--C 1.525 0.659 0 O-C-N 124.275 0.985 . . . . 25.0 112.263 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.6 m -113.29 159.51 19.29 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 108.033 -1.099 . . . . 25.0 108.033 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.2 m -132.58 170.34 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 124.276 0.985 . . . . 25.0 109.872 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.1 t -89.39 111.65 22.56 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 107.016 -1.475 . . . . 25.0 107.016 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.51 177.7 48.8 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 114.525 0.57 . . . . 25.0 114.525 -173.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.35 -10.17 19.02 Favored 'Trans proline' 0 C--O 1.21 -0.919 0 CA-C-O 124.867 1.945 . . . . 25.0 114.085 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -78.43 -13.68 59.73 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 112.919 -1.946 . . . . 25.0 110.879 171.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.55 20.31 45.05 Favored Glycine 0 CA--C 1.501 -0.785 0 CA-C-N 115.728 -0.669 . . . . 25.0 113.533 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.424 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 37.1 m-85 -131.71 146.88 52.4 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.964 -1.118 . . . . 25.0 110.831 -174.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.7 m -64.44 145.52 55.95 Favored 'General case' 0 C--N 1.317 -0.835 0 O-C-N 124.253 0.971 . . . . 25.0 112.917 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.735 0 CA-C-O 118.355 -1.247 . . . . 50.0 110.708 174.442 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.378 0 CA-C-O 118.325 -1.264 . . . . 25.0 110.165 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.7 p -74.35 161.79 76.62 Favored Pre-proline 0 N--CA 1.472 0.655 0 CA-C-N 119.557 1.679 . . . . 25.0 111.675 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.42 73.2 5.66 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 N-CA-C 114.616 0.968 . . . . 25.0 114.616 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -127.82 30.14 5.33 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.47 -1.678 . . . . 25.0 106.47 173.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.55 50.26 0.21 Allowed Glycine 0 CA--C 1.497 -1.055 0 C-N-CA 119.618 -1.277 . . . . 25.0 113.398 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -121.55 174.03 7.04 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.932 -0.766 . . . . 25.0 108.932 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -51.19 -50.44 39.91 Favored Glycine 0 C--O 1.207 -1.576 0 O-C-N 125.317 1.635 . . . . 25.0 113.722 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -101.62 0.59 36.53 Favored 'General case' 0 CA--C 1.558 1.27 0 CA-C-N 119.578 1.689 . . . . 25.0 110.917 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.1 m-90 -116.17 81.07 1.55 Allowed 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 107.352 -1.351 . . . . 25.0 107.352 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.03 154.63 94.07 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 104.394 -2.447 . . . . 25.0 104.394 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.438 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 50.9 Cg_endo -72.39 172.5 14.85 Favored 'Trans proline' 0 CA--C 1.508 -0.813 0 N-CA-C 116.713 1.774 . . . . 25.0 116.713 -177.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -106.25 133.23 51.27 Favored 'General case' 0 C--O 1.266 1.958 0 CA-C-N 115.887 -0.597 . . . . 25.0 110.458 176.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.0 p -70.29 141.64 52.35 Favored 'General case' 0 C--O 1.259 1.567 0 N-CA-C 107.286 -1.376 . . . . 25.0 107.286 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.9 p -144.48 172.29 13.16 Favored 'General case' 0 CA--C 1.556 1.177 0 CA-C-N 114.574 -1.193 . . . . 25.0 109.814 -175.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.1 m -128.1 -12.87 5.16 Favored 'General case' 0 C--O 1.2 -1.517 0 CA-C-N 114.619 -1.173 . . . . 25.0 107.915 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -151.13 162.66 40.46 Favored 'General case' 0 C--O 1.258 1.52 0 C-N-CA 124.116 0.967 . . . . 25.0 110.185 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -63.07 -29.25 70.66 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.5 1.125 . . . . 25.0 112.877 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 t -71.4 -12.39 61.39 Favored 'General case' 0 C--O 1.253 1.258 0 O-C-N 121.919 -0.488 . . . . 25.0 110.682 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -76.03 -12.7 60.17 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 121.639 0.733 . . . . 50.0 110.969 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.3 m -101.27 172.89 6.72 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.917 1.821 . . . . 25.0 115.917 -170.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.4 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 83.5 mt -69.83 168.14 15.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.674 0.749 . . . . 25.0 110.077 176.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.9 122.0 11.23 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 115.138 1.533 . . . . 25.0 115.138 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.37 -9.51 76.71 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 123.983 0.802 . . . . 25.0 112.876 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 2.1 m -95.68 151.88 18.96 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 m -124.34 165.69 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.844 0.858 . . . . 25.0 110.463 -176.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.2 t -86.83 114.88 23.86 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 105.198 -2.149 . . . . 25.0 105.198 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.17 178.39 53.88 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 115.883 -0.598 . . . . 25.0 112.888 -173.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.52 -11.78 18.73 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 CA-C-O 124.432 1.763 . . . . 25.0 114.213 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -78.18 -8.28 58.11 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 113.381 -1.736 . . . . 25.0 110.412 172.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.53 17.98 63.0 Favored Glycine 0 C--O 1.25 1.097 0 CA-C-O 122.82 1.234 . . . . 25.0 112.858 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.438 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 39.0 m-85 -126.31 149.76 48.94 Favored 'General case' 0 C--O 1.206 -1.208 0 CA-C-N 112.962 -1.619 . . . . 25.0 109.079 -176.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.5 m -64.5 149.82 47.86 Favored 'General case' 0 C--N 1.317 -0.822 0 O-C-N 124.41 1.069 . . . . 25.0 110.316 174.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.647 0 CA-C-O 118.641 -1.088 . . . . 50.0 113.44 175.332 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.992 0 N-CA-C 109.371 -1.491 . . . . 25.0 109.371 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.2 p -141.49 161.75 50.77 Favored Pre-proline 0 N--CA 1.483 1.181 0 CA-C-O 117.089 -1.434 . . . . 25.0 108.804 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -78.59 57.72 6.45 Favored 'Trans proline' 0 N--CA 1.486 1.039 0 N-CA-C 115.844 1.44 . . . . 25.0 115.844 -174.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -124.42 8.12 8.39 Favored 'General case' 0 C--O 1.2 -1.519 0 N-CA-C 108.905 -0.776 . . . . 25.0 108.905 170.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.94 46.93 0.68 Allowed Glycine 0 C--O 1.218 -0.878 0 C-N-CA 120.664 -0.779 . . . . 25.0 114.939 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 mmp_? -108.79 -164.27 0.93 Allowed 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 105.632 -1.988 . . . . 25.0 105.632 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.02 -72.78 0.57 Allowed Glycine 0 C--O 1.205 -1.709 0 O-C-N 125.197 1.561 . . . . 25.0 112.755 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -97.86 10.94 38.95 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.431 1.115 . . . . 25.0 110.209 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -95.61 79.28 3.37 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 105.447 -2.057 . . . . 25.0 105.447 176.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.64 148.49 96.8 Favored Pre-proline 0 CA--C 1.558 1.288 0 CA-C-N 113.821 -1.536 . . . . 25.0 106.936 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.5 171.89 17.37 Favored 'Trans proline' 0 N--CA 1.482 0.795 0 N-CA-C 116.853 1.828 . . . . 25.0 116.853 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.0 m -106.62 130.0 54.44 Favored 'General case' 0 C--O 1.261 1.686 0 CA-C-N 115.184 -0.917 . . . . 25.0 110.55 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.7 p -68.48 130.53 43.15 Favored 'General case' 0 C--O 1.26 1.652 0 N-CA-C 105.735 -1.95 . . . . 25.0 105.735 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.6 p -136.39 173.23 11.93 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 122.574 1.178 . . . . 25.0 110.966 -173.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.5 m -131.31 -14.3 3.36 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 114.264 -1.334 . . . . 25.0 107.833 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -151.02 161.45 42.71 Favored 'General case' 0 C--O 1.253 1.262 0 O-C-N 121.026 -1.046 . . . . 25.0 109.977 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -63.36 -30.57 71.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 124.316 1.01 . . . . 25.0 112.58 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.1 t -65.51 -19.73 66.05 Favored 'General case' 0 C--O 1.252 1.19 0 O-C-N 121.648 -0.657 . . . . 25.0 111.487 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -72.61 -17.62 61.66 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-O 121.802 0.811 . . . . 50.0 110.169 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.1 m -103.54 176.39 5.17 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 115.221 1.563 . . . . 25.0 115.221 -170.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.3 mt -74.98 168.56 19.72 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 122.081 0.943 . . . . 25.0 111.159 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.01 136.21 53.51 Favored 'General case' 0 C--O 1.268 2.031 0 O-C-N 121.271 -0.893 . . . . 25.0 109.604 172.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.86 -9.9 76.43 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 111.831 -0.508 . . . . 25.0 111.831 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.2 m -108.54 158.42 17.57 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 104.518 -2.401 . . . . 25.0 104.518 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.07 171.21 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 106.523 -1.658 . . . . 25.0 106.523 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.8 t -84.69 115.06 22.47 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 105.338 -2.097 . . . . 25.0 105.338 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.24 175.56 54.6 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 112.397 -0.281 . . . . 25.0 112.397 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.92 -13.86 19.41 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 CA-C-O 125.358 2.149 . . . . 25.0 114.592 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -75.75 -10.73 59.68 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 113.595 -1.639 . . . . 25.0 111.151 172.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.47 18.83 51.42 Favored Glycine 0 CA--C 1.494 -1.276 0 CA-C-O 122.535 1.075 . . . . 25.0 112.794 174.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -127.9 150.7 49.75 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.644 -1.278 . . . . 25.0 109.146 -177.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.4 m -61.64 146.79 47.91 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 123.723 0.64 . . . . 25.0 110.555 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.905 0 CA-C-O 117.56 -1.689 . . . . 50.0 111.716 174.954 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.85 0 N-CA-C 109.64 -1.384 . . . . 25.0 109.64 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 p -152.05 162.74 25.76 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-O 117.177 -1.392 . . . . 25.0 108.823 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.85 55.03 5.09 Favored 'Trans proline' 0 N--CA 1.488 1.167 0 N-CA-C 115.338 1.246 . . . . 25.0 115.338 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -115.37 19.36 15.55 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 106.607 -1.627 . . . . 25.0 106.607 175.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -158.46 40.53 0.51 Allowed Glycine 0 C--N 1.319 -0.394 0 C-N-CA 119.253 -1.451 . . . . 25.0 116.649 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -93.97 171.39 8.89 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.663 -1.606 . . . . 25.0 106.663 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.22 -55.73 14.9 Favored Glycine 0 C--O 1.201 -1.957 0 O-C-N 125.303 1.627 . . . . 25.0 113.413 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -105.35 27.6 8.15 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 117.867 0.834 . . . . 25.0 112.195 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -120.71 85.88 2.47 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 105.697 -1.964 . . . . 25.0 105.697 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.58 137.36 95.14 Favored Pre-proline 0 C--O 1.261 1.688 0 N-CA-C 106.943 -1.503 . . . . 25.0 106.943 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.424 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 70.0 Cg_endo -73.28 168.51 24.57 Favored 'Trans proline' 0 CA--C 1.505 -0.958 0 N-CA-C 117.017 1.891 . . . . 25.0 117.017 -175.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.5 m -94.71 129.03 41.79 Favored 'General case' 0 C--O 1.263 1.769 0 CA-C-N 115.301 -0.863 . . . . 25.0 111.453 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 p -72.01 134.31 45.83 Favored 'General case' 0 C--O 1.255 1.365 0 N-CA-C 106.065 -1.828 . . . . 25.0 106.065 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.7 p -138.16 170.13 16.58 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-O 121.872 0.844 . . . . 25.0 109.715 -173.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.1 m -125.84 -16.78 5.58 Favored 'General case' 0 C--O 1.204 -1.331 0 N-CA-C 106.879 -1.526 . . . . 25.0 106.879 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -149.29 160.76 43.12 Favored 'General case' 0 C--O 1.262 1.716 0 CA-C-N 118.7 0.682 . . . . 25.0 109.335 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -59.76 -30.26 68.74 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.816 0.817 . . . . 25.0 112.296 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -1.67 22.85 Favored 'General case' 0 C--O 1.264 1.857 0 O-C-N 121.186 -0.946 . . . . 25.0 112.958 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -87.2 -9.57 54.83 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 121.683 0.754 . . . . 50.0 109.629 170.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.7 m -103.31 175.64 5.41 Favored 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 116.028 1.862 . . . . 25.0 116.028 -170.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 87.2 mt -71.36 162.6 29.17 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.441 0.639 . . . . 25.0 110.034 177.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.97 124.55 19.06 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 114.863 1.431 . . . . 25.0 114.863 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.17 -7.94 80.96 Favored Glycine 0 CA--C 1.529 0.933 0 O-C-N 124.28 0.987 . . . . 25.0 112.634 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 3.7 m -98.82 159.37 15.0 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 107.914 -1.143 . . . . 25.0 107.914 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.1 m -127.76 166.53 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.691 1.196 . . . . 25.0 109.895 -175.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.3 t -87.54 116.41 25.64 Favored 'General case' 0 C--O 1.255 1.355 0 N-CA-C 105.424 -2.065 . . . . 25.0 105.424 172.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.38 176.21 49.86 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 116.753 -0.203 . . . . 25.0 112.786 -173.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -75.25 -14.17 20.68 Favored 'Trans proline' 0 C--O 1.204 -1.185 0 CA-C-O 124.103 1.626 . . . . 25.0 114.068 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -72.16 -14.46 61.82 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 113.763 -1.562 . . . . 25.0 111.033 173.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.83 12.96 54.88 Favored Glycine 0 CA--C 1.503 -0.699 0 CA-C-O 122.207 0.893 . . . . 25.0 113.238 174.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.424 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 64.6 m-85 -130.47 155.74 45.95 Favored 'General case' 0 C--O 1.206 -1.212 0 CA-C-N 113.415 -1.392 . . . . 25.0 110.284 -174.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 94.0 m -61.92 148.92 42.06 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 124.033 0.833 . . . . 25.0 109.532 173.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.837 0 N-CA-C 109.745 -1.342 . . . . 50.0 109.745 179.382 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.55 0 N-CA-C 109.55 -1.42 . . . . 25.0 109.55 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.1 p -145.99 161.05 41.42 Favored Pre-proline 0 N--CA 1.481 1.077 0 CA-C-O 118.201 -0.904 . . . . 25.0 110.915 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.9 70.21 5.27 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 N-CA-C 115.194 1.19 . . . . 25.0 115.194 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -124.26 8.61 8.51 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.904 0.859 . . . . 25.0 110.203 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.39 49.02 0.48 Allowed Glycine 0 CA--C 1.497 -1.08 0 N-CA-C 116.415 1.326 . . . . 25.0 116.415 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 71.1 mtp85 -105.75 174.41 5.89 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.6 -2.0 . . . . 25.0 105.6 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -42.37 -61.59 2.39 Favored Glycine 0 C--O 1.209 -1.45 0 O-C-N 125.099 1.5 . . . . 25.0 114.668 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -99.26 4.41 46.58 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.243 1.022 . . . . 25.0 111.656 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -98.09 80.85 2.74 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 106.198 -1.778 . . . . 25.0 106.198 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.64 147.76 98.9 Favored Pre-proline 0 CA--C 1.559 1.308 0 N-CA-C 104.806 -2.294 . . . . 25.0 104.806 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.472 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 57.4 Cg_endo -72.94 166.98 28.54 Favored 'Trans proline' 0 CA--C 1.503 -1.046 0 C-N-CA 115.73 -2.38 . . . . 25.0 116.295 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.1 m -94.31 125.93 39.25 Favored 'General case' 0 C--O 1.266 1.94 0 O-C-N 121.33 -0.857 . . . . 25.0 110.395 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 p -67.12 136.28 54.88 Favored 'General case' 0 C--O 1.257 1.49 0 N-CA-C 106.643 -1.614 . . . . 25.0 106.643 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.6 p -143.98 171.82 13.73 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-O 122.824 1.297 . . . . 25.0 110.843 -175.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -130.52 -13.43 3.81 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 114.133 -1.394 . . . . 25.0 108.438 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -150.82 159.33 44.61 Favored 'General case' 0 C--O 1.259 1.602 0 C-N-CA 123.947 0.899 . . . . 25.0 109.218 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -60.64 -31.75 70.94 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 114.062 1.134 . . . . 25.0 114.062 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -15.98 64.05 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 113.036 0.754 . . . . 25.0 113.036 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -73.88 -18.21 60.95 Favored 'General case' 0 CA--C 1.563 1.478 0 O-C-N 124.042 0.838 . . . . 50.0 110.648 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.2 m -95.25 178.24 5.59 Favored 'General case' 0 CA--C 1.557 1.249 0 O-C-N 120.03 -1.669 . . . . 25.0 114.975 -170.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.2 mt -75.58 167.85 21.11 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 121.61 0.719 . . . . 25.0 109.373 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.72 121.78 11.24 Favored 'General case' 0 C--O 1.251 1.163 0 N-CA-C 114.815 1.413 . . . . 25.0 114.815 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.74 -7.29 82.35 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.08 -0.581 . . . . 25.0 113.633 175.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.2 m -95.31 160.43 14.54 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 105.521 -2.029 . . . . 25.0 105.521 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.4 m -129.21 169.36 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.758 0.823 . . . . 25.0 110.429 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 19.3 t -90.54 114.26 26.43 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 106.677 -1.601 . . . . 25.0 106.677 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.85 174.66 53.99 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 115.651 -0.704 . . . . 25.0 114.076 -173.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -73.41 -15.09 25.15 Favored 'Trans proline' 0 C--O 1.213 -0.762 0 CA-C-O 124.552 1.813 . . . . 25.0 114.603 -177.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -74.94 -7.78 54.59 Favored 'General case' 0 CA--C 1.559 1.315 0 CA-C-N 113.896 -1.502 . . . . 25.0 111.157 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.4 12.65 58.24 Favored Glycine 0 C--O 1.247 0.966 0 CA-C-O 122.657 1.143 . . . . 25.0 113.494 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.472 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 57.4 m-85 -130.92 154.66 47.87 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 113.491 -1.355 . . . . 25.0 111.402 -174.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 86.2 m -63.71 146.87 53.02 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.855 0.722 . . . . 25.0 110.628 174.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.649 0 N-CA-C 110.171 -1.172 . . . . 50.0 110.171 -178.649 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.792 0 N-CA-C 109.684 -1.366 . . . . 25.0 109.684 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -148.15 165.7 17.65 Favored Pre-proline 0 N--CA 1.476 0.843 0 CA-C-O 117.481 -1.247 . . . . 25.0 108.554 -177.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -77.55 59.95 6.93 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 N-CA-C 115.67 1.373 . . . . 25.0 115.67 -175.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -131.26 19.25 4.87 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 106.251 -1.759 . . . . 25.0 106.251 174.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.46 50.81 0.32 Allowed Glycine 0 CA--C 1.495 -1.175 0 C-N-CA 119.766 -1.207 . . . . 25.0 114.344 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -119.19 -169.31 1.72 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.982 -0.748 . . . . 25.0 108.982 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.94 -64.34 4.27 Favored Glycine 0 C--O 1.201 -1.96 0 O-C-N 125.036 1.46 . . . . 25.0 113.183 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -102.77 26.72 7.7 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.758 1.279 . . . . 25.0 110.354 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -127.81 81.12 2.0 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 105.668 -1.975 . . . . 25.0 105.668 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.88 152.75 95.37 Favored Pre-proline 0 C--O 1.254 1.292 0 CA-C-N 112.889 -1.959 . . . . 25.0 105.875 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.428 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 73.6 Cg_endo -74.58 170.45 20.26 Favored 'Trans proline' 0 CA--C 1.506 -0.925 0 C-N-CA 116.145 -2.103 . . . . 25.0 115.579 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.6 m -108.73 129.21 55.36 Favored 'General case' 0 C--O 1.26 1.639 0 O-C-N 121.7 -0.625 . . . . 25.0 110.899 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.8 p -66.28 133.63 50.97 Favored 'General case' 0 C--O 1.262 1.763 0 N-CA-C 106.245 -1.761 . . . . 25.0 106.245 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.6 p -139.81 176.58 8.62 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 122.143 0.973 . . . . 25.0 110.258 -174.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.0 m -132.39 -15.9 2.78 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 114.484 -1.235 . . . . 25.0 108.68 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -153.37 162.93 40.77 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 108.031 -1.1 . . . . 25.0 108.031 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -62.96 -32.22 73.49 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 113.806 1.039 . . . . 25.0 113.806 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.89 -10.15 59.08 Favored 'General case' 0 C--O 1.252 1.232 0 O-C-N 121.118 -0.989 . . . . 25.0 113.024 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -75.69 -15.67 60.27 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.239 1.019 . . . . 50.0 110.072 172.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 54.1 m -99.91 177.2 5.18 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 115.125 1.528 . . . . 25.0 115.125 -171.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.6 mt -75.57 168.87 19.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.457 -0.792 . . . . 25.0 112.662 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.38 121.56 9.86 Favored 'General case' 0 C--O 1.254 1.312 0 N-CA-C 113.416 0.895 . . . . 25.0 113.416 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.42 -10.38 74.94 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 120.0 -0.333 . . . . 25.0 113.043 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.4 m -89.26 156.3 18.84 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 106.413 -1.699 . . . . 25.0 106.413 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.8 m -129.38 164.55 31.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 106.581 -1.637 . . . . 25.0 106.581 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 18.3 t -87.59 115.07 24.78 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 104.4 -2.444 . . . . 25.0 104.4 174.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.37 179.3 53.21 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 120.668 -0.777 . . . . 25.0 114.408 -172.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.41 -13.63 22.8 Favored 'Trans proline' 0 C--O 1.206 -1.102 0 CA-C-O 124.868 1.945 . . . . 25.0 113.828 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -74.42 -9.85 58.99 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-N 112.931 -1.94 . . . . 25.0 111.816 171.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.46 22.24 58.88 Favored Glycine 0 CA--C 1.498 -0.996 0 CA-C-O 122.605 1.114 . . . . 25.0 112.416 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.428 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 15.0 m-85 -135.89 147.28 48.11 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 112.996 -1.602 . . . . 25.0 109.514 -173.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 92.4 m -61.5 147.68 44.49 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.686 0.616 . . . . 25.0 110.607 174.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.824 0 CA-C-O 117.24 -1.867 . . . . 50.0 110.608 175.306 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.711 0 CA-C-O 118.159 -1.356 . . . . 25.0 110.087 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.2 p -138.95 163.54 45.67 Favored Pre-proline 0 N--CA 1.481 1.103 0 CA-C-O 117.5 -1.238 . . . . 25.0 108.8 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.33 65.36 7.96 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 N-CA-C 114.762 1.024 . . . . 25.0 114.762 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -124.65 21.08 8.52 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 105.548 -2.019 . . . . 25.0 105.548 170.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.58 53.26 0.31 Allowed Glycine 0 CA--C 1.5 -0.877 0 CA-C-O 122.569 1.094 . . . . 25.0 113.209 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.8 mmm-85 -128.23 164.14 23.2 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 106.024 -1.843 . . . . 25.0 106.024 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -45.91 -55.1 7.57 Favored Glycine 0 C--O 1.203 -1.802 0 O-C-N 125.42 1.7 . . . . 25.0 114.572 -174.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -99.02 17.73 19.0 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 119.101 1.451 . . . . 25.0 110.316 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -126.53 78.6 1.8 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 107.35 -1.352 . . . . 25.0 107.35 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.02 151.06 95.96 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 103.911 -2.625 . . . . 25.0 103.911 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.42 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 58.1 Cg_endo -72.78 169.56 21.72 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 N-CA-C 116.971 1.873 . . . . 25.0 116.971 -175.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.9 m -100.05 128.76 46.09 Favored 'General case' 0 C--O 1.259 1.572 0 CA-C-N 115.655 -0.702 . . . . 25.0 110.553 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.2 p -68.33 137.72 54.86 Favored 'General case' 0 C--O 1.262 1.762 0 N-CA-C 107.051 -1.463 . . . . 25.0 107.051 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.1 p -142.16 170.39 15.79 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.14 0.971 . . . . 25.0 112.542 -175.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.5 m -128.27 -15.4 4.65 Favored 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 107.476 -1.305 . . . . 25.0 107.476 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -149.36 161.49 41.96 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 123.734 0.814 . . . . 25.0 109.218 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -64.38 -28.14 69.49 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 124.628 1.205 . . . . 25.0 112.496 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.4 t -65.43 -19.83 66.11 Favored 'General case' 0 C--O 1.258 1.529 0 O-C-N 121.63 -0.669 . . . . 25.0 111.137 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -71.0 -17.19 62.65 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 122.28 1.038 . . . . 50.0 111.7 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.3 m -97.52 174.22 6.77 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 120.592 -1.317 . . . . 25.0 114.233 -171.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.4 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 37.3 mt -69.74 167.41 17.17 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 121.588 0.709 . . . . 25.0 109.81 177.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.41 125.11 21.94 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 113.279 0.844 . . . . 25.0 113.279 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.32 -10.4 74.42 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 120.857 -0.687 . . . . 25.0 113.544 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 7.2 m -95.32 164.38 12.86 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.685 -1.598 . . . . 25.0 106.685 -178.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 m -131.75 165.27 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.637 0.775 . . . . 25.0 110.503 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.6 t -84.73 119.77 25.65 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 104.304 -2.48 . . . . 25.0 104.304 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.2 175.25 55.15 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 121.396 -0.43 . . . . 25.0 113.44 -174.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -74.79 -14.0 21.78 Favored 'Trans proline' 0 C--O 1.204 -1.176 0 CA-C-O 125.136 2.057 . . . . 25.0 113.845 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -79.45 -9.56 59.63 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-N 113.754 -1.566 . . . . 25.0 111.312 175.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.34 15.31 53.87 Favored Glycine 0 CA--C 1.493 -1.318 0 CA-C-O 122.497 1.054 . . . . 25.0 113.131 175.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.42 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 35.5 m-85 -127.68 146.91 50.41 Favored 'General case' 0 C--O 1.203 -1.389 0 CA-C-N 113.928 -1.136 . . . . 25.0 110.835 -176.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.5 m -60.34 147.37 40.81 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.981 0.8 . . . . 25.0 110.268 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -2.062 0 CA-C-O 118.012 -1.438 . . . . 50.0 110.731 179.451 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.665 0 CA-C-O 118.115 -1.38 . . . . 25.0 109.821 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.9 p -145.49 160.81 43.71 Favored Pre-proline 0 C--N 1.356 0.877 0 CA-C-N 118.221 1.011 . . . . 25.0 110.871 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.67 73.47 5.24 Favored 'Trans proline' 0 C--O 1.211 -0.87 0 N-CA-C 115.204 1.194 . . . . 25.0 115.204 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -121.7 15.65 11.05 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.719 -0.845 . . . . 25.0 108.719 171.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.86 35.24 0.93 Allowed Glycine 0 N--CA 1.467 0.737 0 C-N-CA 119.114 -1.517 . . . . 25.0 116.725 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -94.8 178.24 5.64 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.166 -1.05 . . . . 25.0 108.166 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.18 -54.6 33.04 Favored Glycine 0 C--O 1.201 -1.96 0 C-N-CA 119.712 -1.233 . . . . 25.0 113.083 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -95.57 13.57 25.73 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.208 1.504 . . . . 25.0 110.483 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -122.88 80.17 1.73 Allowed 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 105.989 -1.856 . . . . 25.0 105.989 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.66 148.3 98.23 Favored Pre-proline 0 C--O 1.254 1.298 0 N-CA-C 104.311 -2.477 . . . . 25.0 104.311 175.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 55.9 Cg_endo -71.43 168.39 23.65 Favored 'Trans proline' 0 CA--C 1.498 -1.292 0 C-N-CA 114.481 -3.213 . . . . 25.0 114.971 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.6 m -101.39 124.39 46.99 Favored 'General case' 0 C--O 1.255 1.371 0 O-C-N 121.648 -0.657 . . . . 25.0 110.273 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -66.92 140.41 57.76 Favored 'General case' 0 C--O 1.256 1.397 0 N-CA-C 106.666 -1.605 . . . . 25.0 106.666 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 p -150.09 172.0 15.97 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-O 122.767 1.27 . . . . 25.0 111.009 -175.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -132.27 -11.62 3.22 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.215 -1.357 . . . . 25.0 108.452 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -150.19 157.32 42.97 Favored 'General case' 0 C--O 1.262 1.716 0 N-CA-C 107.416 -1.327 . . . . 25.0 107.416 -177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -66.77 -25.33 66.43 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 113.781 1.03 . . . . 25.0 113.781 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 80.3 p -73.83 -9.1 58.31 Favored 'General case' 0 C--O 1.257 1.461 0 O-C-N 121.156 -0.965 . . . . 25.0 111.553 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -73.53 -16.16 61.28 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 108.841 -0.799 . . . . 50.0 108.841 172.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.7 m -100.55 177.51 4.99 Favored 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 116.08 1.881 . . . . 25.0 116.08 -169.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.6 mt -72.84 167.24 21.34 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.657 0.742 . . . . 25.0 110.476 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.27 118.55 7.58 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 114.328 1.233 . . . . 25.0 114.328 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.93 -6.6 64.41 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 111.413 -0.675 . . . . 25.0 111.413 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.1 m -105.7 157.39 17.46 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.103 -1.073 . . . . 25.0 108.103 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.1 m -131.35 167.88 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 123.352 0.661 . . . . 25.0 110.581 -173.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.9 t -89.48 114.98 26.56 Favored 'General case' 0 C--O 1.247 0.958 0 N-CA-C 107.413 -1.329 . . . . 25.0 107.413 175.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.66 179.6 52.3 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 120.848 -0.691 . . . . 25.0 113.655 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -75.77 -13.97 19.69 Favored 'Trans proline' 0 C--O 1.202 -1.3 0 CA-C-N 119.608 1.704 . . . . 25.0 113.54 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -75.57 -8.15 56.04 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 113.639 -1.619 . . . . 25.0 110.607 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.52 15.67 63.49 Favored Glycine 0 CA--C 1.49 -1.515 0 CA-C-O 123.043 1.357 . . . . 25.0 113.269 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 29.9 m-85 -126.43 147.61 49.77 Favored 'General case' 0 C--O 1.195 -1.8 0 CA-C-N 112.88 -1.66 . . . . 25.0 111.361 -175.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.1 m -63.18 148.77 47.12 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 124.692 1.245 . . . . 25.0 109.202 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.479 -2.157 0 CA-C-O 119.352 -0.693 . . . . 50.0 112.984 178.091 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.835 0 CA-C-O 118.146 -1.363 . . . . 25.0 110.003 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -149.26 164.74 19.82 Favored Pre-proline 0 N--CA 1.488 1.449 0 CA-C-N 118.823 1.312 . . . . 25.0 109.908 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.92 58.0 5.32 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 N-CA-C 115.7 1.385 . . . . 25.0 115.7 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -124.66 6.86 8.18 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 107.714 -1.217 . . . . 25.0 107.714 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.39 58.32 0.42 Allowed Glycine 0 CA--C 1.495 -1.209 0 C-N-CA 120.267 -0.968 . . . . 25.0 115.184 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.406 ' HB2' ' HB2' ' A' ' 9' ' ' TRP . 15.8 mtm-85 -126.07 169.49 12.72 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.66 -1.237 . . . . 25.0 107.66 178.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -38.75 -58.28 1.83 Allowed Glycine 0 C--O 1.212 -1.248 0 O-C-N 125.489 1.743 . . . . 25.0 116.287 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -110.75 31.18 6.19 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.473 1.637 . . . . 25.0 110.888 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.406 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 5.6 m-90 -122.95 78.0 1.51 Allowed 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 103.557 -2.757 . . . . 25.0 103.557 176.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.77 151.67 97.13 Favored Pre-proline 0 CA--C 1.562 1.429 0 N-CA-C 105.743 -1.947 . . . . 25.0 105.743 176.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 60.7 Cg_endo -73.81 170.19 20.62 Favored 'Trans proline' 0 CA--C 1.512 -0.621 0 N-CA-C 116.093 1.536 . . . . 25.0 116.093 -176.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.5 m -100.33 131.32 46.32 Favored 'General case' 0 C--O 1.263 1.779 0 CA-C-N 115.73 -0.668 . . . . 25.0 110.877 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.6 p -66.86 130.86 44.54 Favored 'General case' 0 C--O 1.271 2.185 0 N-CA-C 107.003 -1.481 . . . . 25.0 107.003 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.3 p -142.63 175.92 9.44 Favored 'General case' 0 CA--C 1.561 1.396 0 CA-C-O 122.416 1.103 . . . . 25.0 109.161 -177.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 m -130.64 -18.21 3.15 Favored 'General case' 0 C--O 1.189 -2.097 0 CA-C-N 114.321 -1.309 . . . . 25.0 108.509 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -143.17 158.13 43.89 Favored 'General case' 0 C--O 1.259 1.553 0 N-CA-C 108.032 -1.099 . . . . 25.0 108.032 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -62.96 -29.31 70.7 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 124.512 1.133 . . . . 25.0 111.948 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.4 t -71.15 -13.1 61.83 Favored 'General case' 0 C--O 1.249 1.067 0 O-C-N 121.06 -1.025 . . . . 25.0 112.36 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -74.05 -16.08 61.05 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.022 -0.733 . . . . 50.0 109.022 174.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.9 m -100.84 170.68 8.15 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 115.008 1.485 . . . . 25.0 115.008 -170.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.7 mt -66.17 165.63 13.37 Favored 'General case' 0 N--CA 1.424 -1.753 0 O-C-N 123.731 0.644 . . . . 25.0 110.792 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.96 119.72 8.83 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 114.548 1.314 . . . . 25.0 114.548 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.01 -7.74 73.17 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 121.191 -0.528 . . . . 25.0 113.155 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.3 m -99.21 160.7 14.08 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 105.615 -1.994 . . . . 25.0 105.615 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.11 166.72 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 123.199 0.6 . . . . 25.0 109.921 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 21.2 t -91.03 118.84 30.72 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 106.2 -1.778 . . . . 25.0 106.2 174.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.45 177.09 54.23 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.428 -0.892 . . . . 25.0 114.005 -174.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.22 -19.03 23.02 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 CA-C-O 124.995 1.998 . . . . 25.0 113.895 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -72.84 -10.14 59.46 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-N 113.778 -1.555 . . . . 25.0 110.604 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.2 17.02 44.69 Favored Glycine 0 CA--C 1.497 -1.081 0 CA-C-N 115.162 -0.926 . . . . 25.0 113.936 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 43.5 m-85 -130.11 146.81 51.79 Favored 'General case' 0 C--O 1.212 -0.919 0 CA-C-N 114.182 -1.009 . . . . 25.0 113.626 -172.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 96.1 m -63.28 143.38 57.85 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 124.297 1.039 . . . . 25.0 111.532 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.843 0 CA-C-O 117.618 -1.657 . . . . 50.0 110.865 179.432 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.016 0 N-CA-C 110.575 -1.01 . . . . 25.0 110.575 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.6 p -84.03 161.74 54.25 Favored Pre-proline 0 N--CA 1.47 0.527 0 CA-C-N 118.919 1.36 . . . . 25.0 113.154 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.41 70.99 6.04 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 N-CA-C 114.591 0.958 . . . . 25.0 114.591 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -119.85 -2.56 10.32 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-N 115.253 -0.885 . . . . 25.0 108.679 173.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -142.81 60.76 0.53 Allowed Glycine 0 CA--C 1.495 -1.161 0 C-N-CA 120.276 -0.964 . . . . 25.0 114.03 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -131.82 163.41 28.32 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.222 -0.659 . . . . 25.0 109.222 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -42.02 -47.69 5.29 Favored Glycine 0 C--O 1.211 -1.283 0 N-CA-C 116.628 1.411 . . . . 25.0 116.628 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -107.91 18.82 20.82 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 118.912 1.356 . . . . 25.0 109.717 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.7 m-90 -129.54 80.75 1.98 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.226 -1.398 . . . . 25.0 107.226 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.89 148.41 97.93 Favored Pre-proline 0 CA--C 1.57 1.716 0 N-CA-C 104.858 -2.275 . . . . 25.0 104.858 174.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 58.1 Cg_endo -72.5 168.36 24.56 Favored 'Trans proline' 0 CA--C 1.491 -1.636 0 N-CA-C 118.477 2.453 . . . . 25.0 118.477 -175.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 80.1 m -97.96 128.7 44.69 Favored 'General case' 0 C--O 1.264 1.861 0 CA-C-N 114.737 -1.12 . . . . 25.0 110.988 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.81 131.73 45.62 Favored 'General case' 0 C--O 1.256 1.407 0 N-CA-C 107.019 -1.474 . . . . 25.0 107.019 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.2 p -138.2 170.21 16.43 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 122.857 1.313 . . . . 25.0 110.461 -176.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.0 m -125.32 -17.24 5.69 Favored 'General case' 0 C--O 1.197 -1.705 0 N-CA-C 107.088 -1.449 . . . . 25.0 107.088 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -151.22 162.14 41.44 Favored 'General case' 0 C--O 1.254 1.33 0 C-N-CA 123.286 0.634 . . . . 25.0 110.041 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -57.63 -32.55 67.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 124.446 1.092 . . . . 25.0 112.805 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.9 t -63.95 -18.9 64.71 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-O 118.91 -0.567 . . . . 25.0 111.669 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -71.77 -13.24 61.64 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 113.27 0.841 . . . . 50.0 113.27 174.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.7 m -101.25 173.03 6.64 Favored 'General case' 0 C--O 1.251 1.148 0 N-CA-C 115.309 1.596 . . . . 25.0 115.309 -169.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.8 mt -67.66 163.92 20.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.033 0.921 . . . . 25.0 110.431 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.16 122.06 12.87 Favored 'General case' 0 C--O 1.252 1.229 0 N-CA-C 113.867 1.062 . . . . 25.0 113.867 -178.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.01 7.01 78.35 Favored Glycine 0 CA--C 1.522 0.505 0 O-C-N 123.195 0.309 . . . . 25.0 112.469 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.5 m -114.04 160.95 18.32 Favored 'General case' 0 C--N 1.354 0.793 0 N-CA-C 106.258 -1.756 . . . . 25.0 106.258 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.3 m -128.84 170.55 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.037 0.935 . . . . 25.0 110.773 -176.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.4 t -91.76 108.92 20.26 Favored 'General case' 0 C--O 1.249 1.03 0 N-CA-C 105.313 -2.106 . . . . 25.0 105.313 174.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.19 175.87 54.4 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 116.255 -0.429 . . . . 25.0 113.956 -173.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.54 -9.26 21.32 Favored 'Trans proline' 0 C--O 1.207 -1.048 0 CA-C-N 119.579 1.69 . . . . 25.0 115.574 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -76.58 -10.04 59.1 Favored 'General case' 0 CA--C 1.565 1.542 0 CA-C-N 113.895 -1.502 . . . . 25.0 110.046 173.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.35 17.46 57.2 Favored Glycine 0 C--O 1.247 0.924 0 CA-C-O 121.851 0.695 . . . . 25.0 112.285 176.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 42.9 m-85 -133.9 151.52 51.54 Favored 'General case' 0 C--O 1.211 -0.962 0 CA-C-N 113.553 -1.324 . . . . 25.0 110.215 -174.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.3 m -60.28 146.86 42.36 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 124.053 0.846 . . . . 25.0 111.174 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.964 0 CA-C-O 118.153 -1.359 . . . . 50.0 111.34 178.888 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.902 0 N-CA-C 109.634 -1.386 . . . . 25.0 109.634 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.47 160.48 69.97 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-O 117.261 -1.352 . . . . 25.0 111.359 176.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.68 68.06 7.74 Favored 'Trans proline' 0 N--CA 1.485 0.993 0 N-CA-C 114.898 1.076 . . . . 25.0 114.898 -175.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -122.78 19.46 10.22 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.676 -1.601 . . . . 25.0 106.676 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.71 42.9 0.56 Allowed Glycine 0 CA--C 1.507 -0.466 0 C-N-CA 119.964 -1.112 . . . . 25.0 114.158 177.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -103.35 -178.13 3.57 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.949 -1.13 . . . . 25.0 107.949 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.08 -62.6 6.18 Favored Glycine 0 C--O 1.212 -1.235 0 O-C-N 124.809 1.318 . . . . 25.0 112.761 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -94.57 10.06 36.2 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-N 118.956 1.378 . . . . 25.0 111.513 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.3 m-90 -111.73 82.09 1.56 Allowed 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 107.682 -1.229 . . . . 25.0 107.682 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.85 149.18 98.56 Favored Pre-proline 0 C--O 1.252 1.202 0 N-CA-C 104.791 -2.3 . . . . 25.0 104.791 174.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.472 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 64.4 Cg_endo -71.91 164.63 35.07 Favored 'Trans proline' 0 N--CA 1.481 0.759 0 C-N-CA 115.937 -2.242 . . . . 25.0 116.133 -176.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.4 m -94.91 129.74 41.8 Favored 'General case' 0 C--O 1.273 2.322 0 CA-C-N 115.842 -0.617 . . . . 25.0 111.028 177.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.8 p -69.68 132.61 46.42 Favored 'General case' 0 C--O 1.253 1.274 0 N-CA-C 106.699 -1.593 . . . . 25.0 106.699 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.8 p -138.39 172.02 13.52 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.095 0.95 . . . . 25.0 108.975 -174.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.5 m -128.73 -14.81 4.51 Favored 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 107.114 -1.439 . . . . 25.0 107.114 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.41 162.71 40.79 Favored 'General case' 0 C--O 1.255 1.383 0 CA-C-N 118.984 0.811 . . . . 25.0 109.735 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -58.44 -32.24 68.52 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.0 0.812 . . . . 25.0 112.626 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.8 t -66.33 -16.69 64.25 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 112.406 0.521 . . . . 25.0 112.406 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -77.79 -9.51 59.07 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 119.63 -0.828 . . . . 50.0 110.97 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.4 m -104.0 178.57 4.52 Favored 'General case' 0 CA--C 1.552 1.055 0 O-C-N 120.327 -1.483 . . . . 25.0 115.0 -171.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.5 mt -76.3 164.53 25.95 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-O 121.519 0.676 . . . . 25.0 109.711 175.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.8 132.33 53.51 Favored 'General case' 0 C--O 1.259 1.601 0 CA-C-O 119.085 -0.483 . . . . 25.0 110.87 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.54 -7.03 82.75 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 119.502 -0.61 . . . . 25.0 112.124 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.3 m -106.19 155.87 19.03 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.233 -1.765 . . . . 25.0 106.233 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.9 m -129.41 164.98 30.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 C-N-CA 124.937 1.295 . . . . 25.0 107.725 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.6 t -84.04 111.79 19.62 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 105.033 -2.21 . . . . 25.0 105.033 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.84 175.42 52.02 Favored Glycine 0 C--O 1.252 1.256 0 CA-C-N 115.525 -0.761 . . . . 25.0 113.264 -173.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.8 -14.44 19.46 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 CA-C-O 124.286 1.703 . . . . 25.0 114.151 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.2 p-10 -75.82 -8.76 57.65 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-N 114.009 -1.45 . . . . 25.0 110.549 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.24 22.05 39.32 Favored Glycine 0 C--O 1.247 0.966 0 CA-C-O 122.104 0.835 . . . . 25.0 113.463 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.472 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 46.9 m-85 -135.79 153.5 51.51 Favored 'General case' 0 C--O 1.208 -1.127 0 CA-C-N 114.019 -1.09 . . . . 25.0 110.67 -173.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 92.0 m -62.31 142.09 57.94 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.389 0.431 . . . . 25.0 110.214 172.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -2.022 0 CA-C-O 118.123 -1.376 . . . . 50.0 111.25 177.867 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.009 0 CA-C-O 118.124 -1.376 . . . . 25.0 110.532 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.1 p -68.28 162.93 56.97 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 118.719 1.259 . . . . 25.0 111.759 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -76.68 58.23 5.87 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 CA-C-N 119.974 1.027 . . . . 25.0 114.674 -176.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -125.17 16.03 8.42 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 104.572 -2.381 . . . . 25.0 104.572 172.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.02 69.74 0.18 Allowed Glycine 0 CA--C 1.49 -1.517 0 N-CA-C 111.053 -0.819 . . . . 25.0 111.053 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -137.27 163.39 31.07 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 105.831 -1.915 . . . . 25.0 105.831 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -41.58 -56.31 3.6 Favored Glycine 0 C--O 1.21 -1.38 0 CA-C-O 118.135 -1.369 . . . . 25.0 114.355 -177.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -97.75 13.81 29.11 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 119.925 1.863 . . . . 25.0 110.867 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -124.72 84.87 2.33 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 108.534 -0.913 . . . . 25.0 108.534 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.27 153.4 95.58 Favored Pre-proline 0 C--O 1.257 1.458 0 O-C-N 125.591 1.807 . . . . 25.0 106.609 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.26 171.01 18.88 Favored 'Trans proline' 0 CA--C 1.493 -1.575 0 N-CA-C 116.71 1.773 . . . . 25.0 116.71 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.7 m -108.21 131.33 54.78 Favored 'General case' 0 C--O 1.259 1.605 0 CA-C-N 115.274 -0.876 . . . . 25.0 110.288 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.14 140.03 56.16 Favored 'General case' 0 C--O 1.253 1.257 0 N-CA-C 106.554 -1.647 . . . . 25.0 106.554 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.1 p -144.79 174.23 11.17 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.234 -1.348 . . . . 25.0 110.778 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 m -132.95 -10.73 3.0 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 107.622 -1.251 . . . . 25.0 107.622 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -152.28 160.84 43.28 Favored 'General case' 0 C--O 1.259 1.598 0 N-CA-C 107.761 -1.2 . . . . 25.0 107.761 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -63.71 -30.25 71.38 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.264 0.554 . . . . 25.0 112.002 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.6 t -68.25 -18.2 64.49 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 119.17 -1.012 . . . . 25.0 112.066 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -70.53 -11.81 61.17 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.301 -0.629 . . . . 50.0 109.301 175.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.3 m -104.05 173.66 6.21 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.988 1.477 . . . . 25.0 114.988 -171.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.423 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 91.5 mt -72.86 167.8 20.22 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 121.946 0.879 . . . . 25.0 109.42 178.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.6 120.73 11.15 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 114.687 1.366 . . . . 25.0 114.687 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.85 -8.92 65.85 Favored Glycine 0 CA--C 1.532 1.151 0 N-CA-C 110.723 -0.951 . . . . 25.0 110.723 175.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 m -97.22 163.72 12.79 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 106.028 -1.842 . . . . 25.0 106.028 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.4 m -133.5 168.19 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.387 1.075 . . . . 25.0 109.631 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.2 t -90.62 115.2 27.56 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 105.317 -2.105 . . . . 25.0 105.317 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.59 176.83 50.15 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.884 -0.598 . . . . 25.0 112.69 -175.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.22 -14.71 18.47 Favored 'Trans proline' 0 C--O 1.206 -1.085 0 CA-C-O 124.965 1.985 . . . . 25.0 113.833 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -77.13 -8.73 58.0 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-N 113.518 -1.674 . . . . 25.0 110.221 173.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.24 19.95 56.04 Favored Glycine 0 CA--C 1.495 -1.192 0 CA-C-O 122.004 0.78 . . . . 25.0 113.44 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -122.94 147.33 46.74 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.683 -1.258 . . . . 25.0 110.498 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.3 m -63.13 148.9 46.62 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 124.151 0.907 . . . . 25.0 110.308 173.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.558 0 CA-C-O 117.969 -1.461 . . . . 50.0 112.382 173.68 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.695 0 CA-C-O 119.905 -0.386 . . . . 25.0 112.818 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.23 160.83 77.08 Favored Pre-proline 0 N--CA 1.473 0.712 0 CA-C-O 117.567 -1.206 . . . . 25.0 111.936 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.66 70.43 5.74 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 N-CA-C 115.26 1.215 . . . . 25.0 115.26 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -129.72 24.04 5.39 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 104.583 -2.377 . . . . 25.0 104.583 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -165.56 51.78 0.27 Allowed Glycine 0 CA--C 1.502 -0.777 0 C-N-CA 120.223 -0.989 . . . . 25.0 112.871 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.93 177.14 4.73 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 105.749 -1.945 . . . . 25.0 105.749 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -51.22 -56.09 16.28 Favored Glycine 0 C--O 1.21 -1.359 0 O-C-N 125.623 1.827 . . . . 25.0 113.104 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -98.67 -3.68 35.44 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 120.197 1.999 . . . . 25.0 112.563 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -98.24 81.95 2.86 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 106.514 -1.661 . . . . 25.0 106.514 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.09 149.58 98.41 Favored Pre-proline 0 C--O 1.254 1.308 0 N-CA-C 105.242 -2.132 . . . . 25.0 105.242 175.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 57.1 Cg_endo -69.94 163.05 39.86 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 116.316 -1.99 . . . . 25.0 114.605 -177.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.7 m -97.14 127.67 43.32 Favored 'General case' 0 C--O 1.258 1.531 0 CA-C-N 115.783 -0.644 . . . . 25.0 111.971 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.13 134.29 48.0 Favored 'General case' 0 C--O 1.26 1.616 0 N-CA-C 106.604 -1.628 . . . . 25.0 106.604 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.2 p -139.37 174.77 10.17 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 123.153 1.454 . . . . 25.0 111.817 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.7 m -129.8 -20.48 3.17 Favored 'General case' 0 C--O 1.196 -1.728 0 N-CA-C 107.372 -1.344 . . . . 25.0 107.372 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -144.43 163.13 34.71 Favored 'General case' 0 C--O 1.259 1.605 0 N-CA-C 108.703 -0.851 . . . . 25.0 108.703 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -62.67 -29.77 70.89 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-O 121.885 0.85 . . . . 25.0 111.853 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.4 t -66.06 -19.11 65.74 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.61 -0.723 . . . . 25.0 111.609 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -70.05 -17.94 63.27 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.623 0.725 . . . . 50.0 110.729 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.7 m -97.02 175.26 6.39 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 115.801 1.778 . . . . 25.0 115.801 -171.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.409 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 63.2 mt -74.15 168.78 18.88 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.533 0.682 . . . . 25.0 110.238 175.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.65 128.08 34.24 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 118.509 -0.757 . . . . 25.0 112.889 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.37 -4.22 76.65 Favored Glycine 0 C--N 1.342 0.878 0 C-N-CA 120.533 -0.841 . . . . 25.0 111.303 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 3.9 m -107.5 159.49 16.38 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.515 -1.661 . . . . 25.0 106.515 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.35 164.24 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 124.267 1.027 . . . . 25.0 109.203 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.5 t -87.36 119.31 27.48 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 105.151 -2.166 . . . . 25.0 105.151 174.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.48 176.44 48.17 Favored Glycine 0 C--O 1.255 1.454 0 C-N-CA 120.894 -0.67 . . . . 25.0 113.352 -173.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.01 -12.52 16.09 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 CA-C-O 124.671 1.863 . . . . 25.0 113.71 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -73.88 -13.17 60.87 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 113.705 -1.588 . . . . 25.0 109.345 173.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.34 14.5 47.74 Favored Glycine 0 C--O 1.251 1.187 0 CA-C-O 122.678 1.155 . . . . 25.0 111.963 174.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.425 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 45.4 m-85 -129.06 151.08 50.13 Favored 'General case' 0 C--O 1.204 -1.329 0 CA-C-N 113.474 -1.363 . . . . 25.0 113.098 -173.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 88.1 m -63.27 144.95 56.5 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 123.893 0.746 . . . . 25.0 111.125 172.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -2.088 0 CA-C-O 117.955 -1.47 . . . . 50.0 111.292 178.754 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.531 0 CA-C-O 118.629 -1.095 . . . . 25.0 110.459 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.0 p -75.0 162.24 74.24 Favored Pre-proline 0 N--CA 1.471 0.605 0 CA-C-N 118.576 1.188 . . . . 25.0 113.726 -178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.06 63.9 7.72 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 O-C-N 123.094 1.05 . . . . 25.0 114.753 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.8 mm-40 -123.71 26.55 7.67 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.937 -2.246 . . . . 25.0 104.937 172.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.06 57.22 0.19 Allowed Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.723 -1.227 . . . . 25.0 114.132 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -124.36 172.63 8.98 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 106.743 -1.577 . . . . 25.0 106.743 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.68 -49.27 28.04 Favored Glycine 0 C--O 1.214 -1.147 0 O-C-N 124.895 1.372 . . . . 25.0 114.637 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -104.49 13.77 31.21 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 118.733 1.267 . . . . 25.0 110.357 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -122.37 81.87 1.9 Allowed 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 106.854 -1.536 . . . . 25.0 106.854 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.38 149.7 95.76 Favored Pre-proline 0 CA--C 1.562 1.413 0 N-CA-C 105.779 -1.934 . . . . 25.0 105.779 176.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.472 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 68.4 Cg_endo -73.33 165.63 32.04 Favored 'Trans proline' 0 CA--C 1.507 -0.87 0 C-N-CA 116.656 -1.762 . . . . 25.0 116.195 -177.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.0 m -97.97 130.64 44.81 Favored 'General case' 0 C--O 1.272 2.252 0 O-C-N 120.918 -1.114 . . . . 25.0 110.609 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 m -66.11 131.19 45.62 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 107.155 -1.424 . . . . 25.0 107.155 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.1 p -136.61 172.14 13.45 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.298 -1.319 . . . . 25.0 110.936 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 m -126.83 -22.06 3.93 Favored 'General case' 0 C--O 1.197 -1.664 0 N-CA-C 106.864 -1.532 . . . . 25.0 106.864 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -145.67 160.85 41.1 Favored 'General case' 0 C--O 1.264 1.863 0 C-N-CA 123.116 0.566 . . . . 25.0 109.684 -175.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -65.51 -27.03 68.18 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.117 0.784 . . . . 25.0 113.117 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 97.4 p -73.1 -12.45 60.91 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 121.173 -0.954 . . . . 25.0 111.078 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -71.13 -19.74 62.4 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 119.109 -1.036 . . . . 50.0 109.363 171.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.6 m -96.92 169.48 9.82 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.913 1.449 . . . . 25.0 114.913 -173.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.2 mt -71.26 168.48 17.22 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.645 -0.707 . . . . 25.0 109.764 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.78 124.95 20.91 Favored 'General case' 0 C--O 1.254 1.311 0 N-CA-C 113.788 1.033 . . . . 25.0 113.788 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.34 -9.82 75.56 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.623 -0.543 . . . . 25.0 112.916 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.8 m -99.86 156.84 16.91 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 106.201 -1.778 . . . . 25.0 106.201 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -128.52 167.78 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.957 0.903 . . . . 25.0 110.134 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.0 t -86.39 113.67 22.54 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 105.844 -1.909 . . . . 25.0 105.844 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.17 -179.13 52.73 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 119.37 -0.683 . . . . 25.0 114.116 -171.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.83 -13.33 21.85 Favored 'Trans proline' 0 C--O 1.21 -0.909 0 CA-C-N 119.652 1.726 . . . . 25.0 114.269 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -81.0 -6.93 59.38 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-N 114.102 -1.408 . . . . 25.0 109.865 174.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.87 20.33 59.75 Favored Glycine 0 C--O 1.254 1.362 0 CA-C-O 122.717 1.176 . . . . 25.0 112.537 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.472 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 44.3 m-85 -130.17 149.02 52.06 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.247 -1.476 . . . . 25.0 110.006 -176.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.6 m -62.92 146.87 51.97 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.154 -0.476 . . . . 25.0 112.216 175.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.893 0 CA-C-O 118.691 -1.06 . . . . 50.0 111.308 171.941 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.289 0 N-CA-C 109.809 -1.316 . . . . 25.0 109.809 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 p -104.42 166.88 10.79 Favored Pre-proline 0 N--CA 1.487 1.398 0 CA-C-O 117.434 -1.269 . . . . 25.0 108.665 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.62 63.78 7.36 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 CA-C-N 120.8 1.321 . . . . 25.0 115.295 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -125.52 11.32 7.96 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 105.508 -2.034 . . . . 25.0 105.508 173.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -154.08 44.97 0.57 Allowed Glycine 0 N--CA 1.468 0.807 0 C-N-CA 120.031 -1.08 . . . . 25.0 114.792 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -104.86 174.47 5.86 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 104.637 -2.357 . . . . 25.0 104.637 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.17 -51.03 60.87 Favored Glycine 0 C--O 1.204 -1.768 0 O-C-N 124.637 1.211 . . . . 25.0 113.812 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.45 0.75 48.23 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 118.579 1.19 . . . . 25.0 111.9 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -105.77 88.14 2.75 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 106.437 -1.69 . . . . 25.0 106.437 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.62 149.35 98.35 Favored Pre-proline 0 CA--C 1.567 1.623 0 N-CA-C 104.518 -2.401 . . . . 25.0 104.518 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.446 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 55.9 Cg_endo -70.06 168.82 20.85 Favored 'Trans proline' 0 N--CA 1.479 0.621 0 N-CA-C 117.05 1.904 . . . . 25.0 117.05 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.2 m -100.44 128.26 46.55 Favored 'General case' 0 C--O 1.26 1.649 0 O-C-N 121.203 -0.936 . . . . 25.0 111.38 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.4 p -68.57 134.54 50.15 Favored 'General case' 0 C--O 1.26 1.627 0 N-CA-C 106.695 -1.595 . . . . 25.0 106.695 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.1 p -142.55 170.6 15.39 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.883 -1.053 . . . . 25.0 109.32 -176.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.1 m -130.51 -12.03 3.94 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 107.271 -1.381 . . . . 25.0 107.271 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -149.66 159.45 44.32 Favored 'General case' 0 C--O 1.256 1.4 0 C-N-CA 123.947 0.899 . . . . 25.0 108.905 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -61.84 -31.15 71.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 124.145 0.903 . . . . 25.0 111.18 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 t -68.99 -13.27 62.35 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 121.469 -0.769 . . . . 25.0 112.287 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -77.8 -8.25 57.76 Favored 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 120.123 -0.631 . . . . 50.0 110.347 174.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.1 m -104.91 171.74 7.16 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 116.654 2.094 . . . . 25.0 116.654 -172.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.435 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 83.5 mt -68.52 168.43 12.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 122.03 0.919 . . . . 25.0 110.855 177.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.64 124.5 20.88 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 114.011 1.115 . . . . 25.0 114.011 -177.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.19 -12.83 68.01 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 123.349 0.406 . . . . 25.0 112.732 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 4.5 m -90.08 160.13 16.46 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 106.638 -1.616 . . . . 25.0 106.638 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.9 m -128.76 171.89 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 124.617 1.167 . . . . 25.0 108.419 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.5 t -94.9 123.31 38.3 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 106.113 -1.81 . . . . 25.0 106.113 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.98 177.57 46.32 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 114.903 0.721 . . . . 25.0 114.903 -175.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.1 -8.4 16.49 Favored 'Trans proline' 0 C--O 1.211 -0.835 0 CA-C-O 124.414 1.756 . . . . 25.0 113.214 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -79.74 -9.83 59.7 Favored 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 113.909 -1.496 . . . . 25.0 110.201 171.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.92 16.25 58.26 Favored Glycine 0 CA--C 1.486 -1.753 0 CA-C-O 122.708 1.171 . . . . 25.0 113.411 175.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.446 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 45.3 m-85 -128.2 153.12 47.26 Favored 'General case' 0 C--O 1.201 -1.495 0 CA-C-N 113.792 -1.204 . . . . 25.0 111.21 -174.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.7 m -60.74 150.48 32.28 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 124.209 0.943 . . . . 25.0 110.432 172.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.728 0 CA-C-O 117.793 -1.559 . . . . 50.0 112.397 177.992 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.956 0 CA-C-O 118.36 -1.244 . . . . 25.0 110.424 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.9 p -152.22 165.15 18.12 Favored Pre-proline 0 N--CA 1.484 1.264 0 CA-C-O 117.717 -1.135 . . . . 25.0 108.458 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.43 64.19 5.49 Favored 'Trans proline' 0 CA--C 1.556 1.591 0 N-CA-C 115.936 1.476 . . . . 25.0 115.936 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -118.5 5.14 11.72 Favored 'General case' 0 C--O 1.202 -1.446 0 N-CA-C 107.49 -1.3 . . . . 25.0 107.49 174.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -153.6 42.17 0.64 Allowed Glycine 0 C--O 1.214 -1.119 0 C-N-CA 120.091 -1.052 . . . . 25.0 115.493 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -98.08 167.99 10.54 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 104.651 -2.352 . . . . 25.0 104.651 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -42.38 -56.05 4.22 Favored Glycine 0 C--O 1.206 -1.602 0 O-C-N 125.393 1.683 . . . . 25.0 115.709 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -99.75 14.69 29.36 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 118.383 1.092 . . . . 25.0 112.451 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -115.78 83.71 1.98 Allowed 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 106.063 -1.828 . . . . 25.0 106.063 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.96 147.53 99.08 Favored Pre-proline 0 CA--C 1.561 1.377 0 N-CA-C 106.337 -1.727 . . . . 25.0 106.337 176.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.409 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 54.9 Cg_endo -74.5 171.33 18.34 Favored 'Trans proline' 0 CA--C 1.499 -1.263 0 C-N-CA 116.026 -2.183 . . . . 25.0 116.326 -175.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m -105.24 130.85 53.3 Favored 'General case' 0 C--O 1.278 2.568 0 O-C-N 120.967 -1.083 . . . . 25.0 111.233 178.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 p -69.81 139.51 53.19 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 105.733 -1.951 . . . . 25.0 105.733 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 p -142.65 170.05 16.44 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 113.87 -1.514 . . . . 25.0 108.724 -174.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.1 m -133.03 -8.74 3.04 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-N 114.74 -1.118 . . . . 25.0 108.54 174.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -149.65 159.68 44.13 Favored 'General case' 0 C--O 1.26 1.62 0 N-CA-C 108.398 -0.964 . . . . 25.0 108.398 176.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -63.47 -30.66 71.75 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.457 1.098 . . . . 25.0 111.526 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.1 t -63.15 -21.97 66.55 Favored 'General case' 0 CA--C 1.556 1.2 0 O-C-N 121.142 -0.973 . . . . 25.0 111.933 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -72.6 -9.4 58.54 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 120.023 -0.671 . . . . 50.0 111.15 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.9 m -103.21 -179.6 4.0 Favored 'General case' 0 CA--C 1.562 1.436 0 N-CA-C 114.513 1.301 . . . . 25.0 114.513 -173.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 75.5 mt -76.98 166.43 23.34 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.485 -1.302 . . . . 25.0 107.485 176.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.69 129.13 38.85 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.648 0.61 . . . . 25.0 112.648 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.91 5.85 76.77 Favored Glycine 0 CA--C 1.536 1.367 0 O-C-N 124.287 0.992 . . . . 25.0 111.685 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.6 m -118.73 156.08 29.97 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 106.959 -1.497 . . . . 25.0 106.959 178.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.73 166.57 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.807 0.843 . . . . 25.0 109.678 -175.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.2 t -86.33 110.48 19.7 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 105.715 -1.958 . . . . 25.0 105.715 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.32 178.27 49.14 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 120.885 -0.674 . . . . 25.0 113.389 -171.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -73.71 -10.58 23.53 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 CA-C-O 124.836 1.932 . . . . 25.0 115.238 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -69.13 -15.74 63.49 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-N 113.934 -1.485 . . . . 25.0 111.492 169.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.96 18.21 56.47 Favored Glycine 0 CA--C 1.492 -1.375 0 CA-C-O 123.3 1.5 . . . . 25.0 109.758 176.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.409 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 26.5 m-85 -135.27 150.54 50.05 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 112.535 -1.832 . . . . 25.0 108.817 -171.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 91.3 m -61.75 148.78 41.82 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.61 1.194 . . . . 25.0 110.805 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.756 0 CA-C-O 119.006 -0.885 . . . . 50.0 111.6 173.457 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.471 0.609 0 N-CA-C 113.406 0.891 . . . . 25.0 113.406 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -77.56 69.47 7.25 Favored 'Trans proline' 0 C--O 1.209 -0.94 0 CA-C-O 122.202 0.834 . . . . 25.0 113.849 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -123.88 12.63 9.12 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.246 -0.888 . . . . 25.0 109.127 173.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.63 51.54 0.44 Allowed Glycine 0 CA--C 1.496 -1.098 0 C-N-CA 119.941 -1.123 . . . . 25.0 114.094 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -112.38 176.49 5.0 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 107.152 -1.425 . . . . 25.0 107.152 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.98 -57.52 10.95 Favored Glycine 0 C--O 1.207 -1.551 0 O-C-N 125.282 1.614 . . . . 25.0 114.173 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -100.59 12.63 36.96 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 117.784 0.792 . . . . 25.0 110.596 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -116.5 79.22 1.29 Allowed 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 106.633 -1.617 . . . . 25.0 106.633 176.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.52 150.99 96.87 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 105.994 -1.854 . . . . 25.0 105.994 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.439 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 52.5 Cg_endo -72.85 166.46 29.93 Favored 'Trans proline' 0 CA--C 1.499 -1.249 0 C-N-CA 115.629 -2.447 . . . . 25.0 115.681 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.6 m -100.03 127.16 46.28 Favored 'General case' 0 C--O 1.261 1.663 0 O-C-N 121.014 -1.054 . . . . 25.0 111.074 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.5 p -66.16 132.83 49.38 Favored 'General case' 0 C--O 1.261 1.698 0 N-CA-C 106.311 -1.737 . . . . 25.0 106.311 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.7 p -141.32 170.07 16.41 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.207 1.003 . . . . 25.0 111.033 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.1 m -128.76 -14.61 4.53 Favored 'General case' 0 C--O 1.193 -1.906 0 CA-C-N 114.105 -1.407 . . . . 25.0 107.954 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -150.68 164.13 36.87 Favored 'General case' 0 C--O 1.26 1.648 0 N-CA-C 109.612 -0.514 . . . . 25.0 109.612 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -61.34 -30.23 70.39 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.32 1.012 . . . . 25.0 113.281 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.8 t -62.5 -23.28 66.85 Favored 'General case' 0 C--O 1.248 0.975 0 O-C-N 121.715 -0.616 . . . . 25.0 111.556 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -71.83 -9.9 58.99 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 118.307 0.503 . . . . 50.0 111.236 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.9 m -107.85 170.23 8.12 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 115.27 1.581 . . . . 25.0 115.27 -172.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.44 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 64.1 mt -71.19 167.83 18.53 Favored 'General case' 0 C--O 1.253 1.25 0 CA-C-O 121.579 0.704 . . . . 25.0 109.769 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.3 128.0 34.54 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 114.547 1.314 . . . . 25.0 114.547 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.63 -7.53 81.67 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 121.04 -0.6 . . . . 25.0 112.238 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 3.4 m -100.96 155.77 17.78 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 105.742 -1.947 . . . . 25.0 105.742 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.0 m -128.89 166.98 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.441 1.096 . . . . 25.0 108.279 -177.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.5 t -87.97 115.22 25.29 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 105.567 -2.012 . . . . 25.0 105.567 173.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.88 179.88 52.89 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.551 -0.749 . . . . 25.0 113.571 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.53 -13.54 22.53 Favored 'Trans proline' 0 C--O 1.201 -1.364 0 CA-C-O 124.915 1.964 . . . . 25.0 112.732 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -78.07 -7.43 56.93 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 113.365 -1.743 . . . . 25.0 110.931 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.98 22.95 62.52 Favored Glycine 0 C--O 1.251 1.182 0 CA-C-O 123.573 1.651 . . . . 25.0 112.587 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.439 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 17.6 m-85 -131.87 150.09 52.26 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 112.108 -2.046 . . . . 25.0 108.325 -174.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.4 m -66.05 147.76 52.85 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 123.878 0.736 . . . . 25.0 110.443 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.479 -2.194 0 CA-C-O 117.415 -1.769 . . . . 50.0 112.767 177.949 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.475 0.798 0 CA-C-O 117.242 -1.361 . . . . 25.0 109.226 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.34 69.25 7.25 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 N-CA-C 115.54 1.323 . . . . 25.0 115.54 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -122.51 6.2 9.54 Favored 'General case' 0 C--O 1.206 -1.205 0 N-CA-C 108.175 -1.046 . . . . 25.0 108.175 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.7 55.89 0.45 Allowed Glycine 0 CA--C 1.496 -1.128 0 C-N-CA 120.616 -0.802 . . . . 25.0 113.986 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -116.35 -169.85 1.7 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 105.889 -1.893 . . . . 25.0 105.889 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.91 -70.76 0.91 Allowed Glycine 0 C--O 1.196 -2.252 0 O-C-N 125.267 1.605 . . . . 25.0 112.288 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -86.54 4.29 40.64 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 118.071 0.936 . . . . 25.0 110.768 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -104.58 82.49 1.91 Allowed 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.072 -1.455 . . . . 25.0 107.072 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.55 151.02 96.78 Favored Pre-proline 0 C--O 1.253 1.27 0 N-CA-C 105.732 -1.951 . . . . 25.0 105.732 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.55 166.06 30.26 Favored 'Trans proline' 0 CA--C 1.496 -1.397 0 C-N-CA 115.41 -2.593 . . . . 25.0 115.92 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 m -102.08 127.86 48.8 Favored 'General case' 0 C--O 1.266 1.926 0 O-C-N 121.064 -1.023 . . . . 25.0 109.766 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.6 p -68.88 140.37 55.17 Favored 'General case' 0 C--O 1.255 1.393 0 N-CA-C 106.238 -1.764 . . . . 25.0 106.238 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.3 p -145.74 168.51 20.57 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.513 -0.767 . . . . 25.0 110.254 -174.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.5 m -131.46 -5.81 3.74 Favored 'General case' 0 C--O 1.198 -1.625 0 CA-C-N 115.244 -0.889 . . . . 25.0 108.651 176.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -154.91 159.88 40.76 Favored 'General case' 0 C--O 1.261 1.692 0 N-CA-C 108.522 -0.918 . . . . 25.0 108.522 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -63.54 -29.3 70.58 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.627 0.58 . . . . 25.0 112.04 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.3 t -63.92 -20.47 65.88 Favored 'General case' 0 C--O 1.254 1.339 0 N-CA-C 112.026 0.38 . . . . 25.0 112.026 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -72.98 -20.9 60.94 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-O 121.734 0.778 . . . . 50.0 110.769 177.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.5 m -94.99 172.88 7.88 Favored 'General case' 0 C--O 1.252 1.203 0 N-CA-C 116.485 2.031 . . . . 25.0 116.485 -170.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.456 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 60.8 mt -71.16 166.7 20.93 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 122.169 0.985 . . . . 25.0 109.716 176.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.97 128.71 36.9 Favored 'General case' 0 C--O 1.25 1.126 0 O-C-N 121.581 -0.7 . . . . 25.0 112.689 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.91 3.38 73.69 Favored Glycine 0 C--N 1.34 0.767 0 C-N-CA 121.177 -0.535 . . . . 25.0 112.21 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 4.0 m -112.92 164.41 13.46 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 105.792 -1.929 . . . . 25.0 105.792 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.8 m -134.93 170.97 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 108.001 -1.111 . . . . 25.0 108.001 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.2 t -89.51 122.12 32.38 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 105.043 -2.206 . . . . 25.0 105.043 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.02 -179.44 45.74 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.257 -0.746 . . . . 25.0 114.349 -172.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -77.11 -13.19 17.3 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 CA-C-O 125.583 2.243 . . . . 25.0 113.198 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -75.54 -11.62 60.06 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 113.241 -1.8 . . . . 25.0 110.605 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.41 17.44 62.34 Favored Glycine 0 C--O 1.251 1.207 0 CA-C-O 123.285 1.492 . . . . 25.0 113.499 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -127.72 150.54 49.73 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 112.711 -1.745 . . . . 25.0 108.661 -174.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 86.7 m -62.29 148.8 43.87 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.642 1.214 . . . . 25.0 110.577 172.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.48 -2.13 0 CA-C-O 118.745 -1.031 . . . . 50.0 110.552 177.214 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 114.231 1.197 . . . . 25.0 114.231 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -78.49 66.24 8.51 Favored 'Trans proline' 0 CA--C 1.555 1.563 0 O-C-N 123.034 1.018 . . . . 25.0 113.992 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -119.69 -0.88 10.67 Favored 'General case' 0 C--O 1.197 -1.683 0 CA-C-N 114.689 -1.141 . . . . 25.0 108.607 172.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -136.89 50.87 0.82 Allowed Glycine 0 CA--C 1.502 -0.724 0 N-CA-C 115.007 0.763 . . . . 25.0 115.007 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -117.35 170.96 8.3 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.209 -1.404 . . . . 25.0 107.209 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.5 -51.65 53.2 Favored Glycine 0 C--O 1.215 -1.041 0 O-C-N 124.783 1.302 . . . . 25.0 113.415 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -94.74 11.17 32.31 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.836 1.318 . . . . 25.0 111.568 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -123.64 83.91 2.2 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 107.202 -1.407 . . . . 25.0 107.202 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.83 148.62 98.75 Favored Pre-proline 0 CA--C 1.563 1.476 0 N-CA-C 105.425 -2.065 . . . . 25.0 105.425 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 70.7 Cg_endo -73.81 166.94 28.47 Favored 'Trans proline' 0 N--CA 1.481 0.773 0 C-N-CA 115.803 -2.331 . . . . 25.0 116.404 -176.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.6 m -96.88 130.05 44.22 Favored 'General case' 0 C--O 1.26 1.622 0 O-C-N 121.576 -0.703 . . . . 25.0 110.437 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.9 p -70.07 137.67 51.41 Favored 'General case' 0 C--O 1.255 1.373 0 N-CA-C 106.03 -1.841 . . . . 25.0 106.03 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.8 p -141.38 170.84 14.96 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-O 122.027 0.918 . . . . 25.0 110.505 -175.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.4 m -123.6 -16.62 6.69 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.369 -1.287 . . . . 25.0 108.448 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -152.15 160.28 43.44 Favored 'General case' 0 C--O 1.266 1.921 0 N-CA-C 108.639 -0.874 . . . . 25.0 108.639 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -57.45 -35.13 69.72 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 124.144 0.902 . . . . 25.0 112.564 177.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -14.42 61.93 Favored 'General case' 0 C--O 1.259 1.576 0 O-C-N 120.944 -1.097 . . . . 25.0 113.775 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -77.67 -9.11 58.8 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 121.517 0.675 . . . . 50.0 109.407 175.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.1 m -104.37 172.46 6.79 Favored 'General case' 0 CA--C 1.555 1.161 0 O-C-N 119.912 -1.743 . . . . 25.0 114.981 -174.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 74.7 mt -71.7 166.96 20.87 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.318 0.58 . . . . 25.0 111.896 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.93 118.98 5.12 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 114.099 1.148 . . . . 25.0 114.099 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.2 -1.96 80.62 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 120.99 -0.624 . . . . 25.0 112.272 175.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.0 m -105.48 161.01 14.71 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.011 -2.218 . . . . 25.0 105.011 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.1 m -132.01 171.53 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 124.287 0.992 . . . . 25.0 109.368 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 29.8 t -94.72 115.45 27.54 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 105.852 -1.907 . . . . 25.0 105.852 174.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.8 176.69 52.24 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 119.268 -0.74 . . . . 25.0 114.1 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.46 -12.07 20.64 Favored 'Trans proline' 0 C--O 1.211 -0.835 0 CA-C-O 124.45 1.771 . . . . 25.0 114.204 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -74.47 -10.0 59.13 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-N 114.437 -1.256 . . . . 25.0 110.049 173.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.45 18.71 47.96 Favored Glycine 0 CA--C 1.498 -1.023 0 CA-C-O 122.693 1.163 . . . . 25.0 112.899 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 42.0 m-85 -135.88 153.28 51.51 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 112.48 -1.86 . . . . 25.0 110.486 -174.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.7 m -60.34 147.08 41.82 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.936 0.772 . . . . 25.0 110.469 173.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -2.015 0 CA-C-O 118.312 -1.271 . . . . 50.0 110.788 179.622 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.4 p . . . . . 0 C--O 1.221 -0.398 0 N-CA-C 113.62 0.97 . . . . 25.0 113.62 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.94 61.85 7.23 Favored 'Trans proline' 0 CA--C 1.554 1.522 0 N-CA-C 114.836 1.052 . . . . 25.0 114.836 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -120.83 24.61 10.14 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 105.323 -2.103 . . . . 25.0 105.323 172.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.1 69.32 0.16 Allowed Glycine 0 CA--C 1.497 -1.039 0 C-N-CA 120.395 -0.907 . . . . 25.0 112.368 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 44.4 mmt-85 -131.6 -177.67 4.52 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.227 -1.027 . . . . 25.0 108.227 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.68 -60.18 9.46 Favored Glycine 0 C--O 1.199 -2.078 0 O-C-N 125.18 1.55 . . . . 25.0 112.845 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -99.28 13.82 31.76 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 118.515 1.157 . . . . 25.0 111.088 -175.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -119.5 88.29 2.9 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 106.704 -1.591 . . . . 25.0 106.704 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.14 150.56 97.38 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 104.461 -2.422 . . . . 25.0 104.461 175.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.466 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 66.5 Cg_endo -70.86 164.65 34.89 Favored 'Trans proline' 0 CA--C 1.487 -1.83 0 C-N-CA 115.156 -2.763 . . . . 25.0 115.184 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.1 m -98.19 130.76 44.92 Favored 'General case' 0 C--O 1.254 1.327 0 CA-C-N 116.103 -0.498 . . . . 25.0 111.606 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.1 p -71.06 139.67 50.48 Favored 'General case' 0 C--O 1.251 1.151 0 N-CA-C 105.842 -1.91 . . . . 25.0 105.842 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.3 p -141.9 173.23 11.7 Favored 'General case' 0 CA--C 1.572 1.805 0 CA-C-O 122.386 1.088 . . . . 25.0 110.35 -175.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.8 m -132.74 -12.06 3.0 Favored 'General case' 0 C--O 1.201 -1.496 0 CA-C-N 114.407 -1.27 . . . . 25.0 108.064 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -149.42 157.17 43.07 Favored 'General case' 0 C--O 1.257 1.457 0 N-CA-C 107.946 -1.131 . . . . 25.0 107.946 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -60.09 -33.62 72.35 Favored 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 123.99 0.806 . . . . 25.0 111.489 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -63.1 -22.82 67.12 Favored 'General case' 0 C--O 1.248 1.026 0 O-C-N 121.246 -0.909 . . . . 25.0 111.804 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -63.57 -27.16 69.06 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.855 0.836 . . . . 50.0 109.031 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.6 m -89.14 176.03 7.14 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 114.414 1.265 . . . . 25.0 114.414 -172.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 78.5 mt -77.64 167.01 22.28 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-O 122.019 0.914 . . . . 25.0 110.359 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.62 125.02 22.9 Favored 'General case' 0 C--O 1.252 1.21 0 N-CA-C 113.213 0.82 . . . . 25.0 113.213 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.12 -8.73 57.58 Favored Glycine 0 C--O 1.244 0.756 0 N-CA-C 110.643 -0.983 . . . . 25.0 110.643 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -113.06 157.55 21.43 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 107.67 -1.234 . . . . 25.0 107.67 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.9 m -131.89 167.89 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 123.787 0.835 . . . . 25.0 109.708 -176.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.1 t -88.15 110.93 21.06 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 106.135 -1.802 . . . . 25.0 106.135 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.21 174.2 54.65 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.323 -0.853 . . . . 25.0 113.314 -173.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.76 -14.75 19.44 Favored 'Trans proline' 0 C--O 1.207 -1.036 0 CA-C-O 124.505 1.794 . . . . 25.0 114.803 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -70.34 -15.68 62.9 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 113.489 -1.687 . . . . 25.0 109.649 172.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.63 16.42 36.74 Favored Glycine 0 C--O 1.255 1.424 0 O-C-N 124.455 1.097 . . . . 25.0 112.846 176.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.466 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 67.2 m-85 -131.57 151.46 51.58 Favored 'General case' 0 C--O 1.203 -1.386 0 CA-C-N 113.557 -1.322 . . . . 25.0 113.16 -174.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 86.2 m -60.02 143.48 51.78 Favored 'General case' 0 C--N 1.311 -1.066 0 O-C-N 124.076 0.86 . . . . 25.0 111.075 173.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.48 -2.126 0 CA-C-O 118.346 -1.252 . . . . 50.0 111.474 179.203 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 106.839 -1.541 . . . . 25.0 106.839 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.83 49.71 2.27 Favored 'Trans proline' 0 CA--C 1.563 1.963 0 CA-C-N 120.71 1.289 . . . . 25.0 114.527 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -121.6 -2.86 9.35 Favored 'General case' 0 C--O 1.204 -1.34 0 C-N-CA 125.01 1.324 . . . . 25.0 107.524 170.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -142.61 50.61 0.7 Allowed Glycine 0 C--O 1.236 0.249 0 N-CA-C 115.208 0.843 . . . . 25.0 115.208 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -119.9 176.17 5.54 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.558 -1.275 . . . . 25.0 107.558 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.76 -48.55 65.71 Favored Glycine 0 C--O 1.214 -1.137 0 O-C-N 125.402 1.688 . . . . 25.0 114.282 -176.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -103.8 7.99 37.11 Favored 'General case' 0 C--O 1.249 1.069 0 CA-C-N 119.136 1.468 . . . . 25.0 109.842 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.8 m-90 -113.54 84.51 2.03 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.827 -1.175 . . . . 25.0 107.827 -176.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.48 151.68 96.93 Favored Pre-proline 0 CA--C 1.566 1.585 0 CA-C-N 113.428 -1.715 . . . . 25.0 106.793 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.424 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 79.6 Cg_endo -76.64 169.18 22.29 Favored 'Trans proline' 0 CA--C 1.511 -0.638 0 N-CA-C 116.205 1.579 . . . . 25.0 116.205 -176.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.3 m -105.93 131.43 53.24 Favored 'General case' 0 C--O 1.254 1.307 0 O-C-N 121.178 -0.952 . . . . 25.0 110.355 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.1 p -67.29 136.76 55.39 Favored 'General case' 0 C--O 1.257 1.47 0 N-CA-C 106.727 -1.582 . . . . 25.0 106.727 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.3 p -142.2 169.85 16.82 Favored 'General case' 0 CA--C 1.555 1.135 0 CA-C-O 122.747 1.26 . . . . 25.0 110.873 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.3 m -128.42 -15.01 4.65 Favored 'General case' 0 C--O 1.198 -1.653 0 CA-C-N 114.02 -1.446 . . . . 25.0 108.19 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -148.59 159.27 44.24 Favored 'General case' 0 C--O 1.258 1.506 0 N-CA-C 108.511 -0.922 . . . . 25.0 108.511 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -62.32 -29.54 70.52 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.134 0.896 . . . . 25.0 112.212 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.9 t -66.59 -16.29 64.07 Favored 'General case' 0 C--O 1.254 1.336 0 O-C-N 120.843 -1.161 . . . . 25.0 111.673 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -73.21 -15.19 61.45 Favored 'General case' 0 CA--C 1.557 1.216 0 CA-C-O 121.657 0.741 . . . . 50.0 109.999 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.4 m -99.55 176.04 5.62 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 115.187 1.551 . . . . 25.0 115.187 -172.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 79.4 mt -78.07 170.9 15.84 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.659 0.742 . . . . 25.0 110.538 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.63 121.58 14.26 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 113.25 0.833 . . . . 25.0 113.25 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.07 0.01 63.9 Favored Glycine 0 CA--C 1.525 0.659 0 O-C-N 124.275 0.985 . . . . 25.0 112.263 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.6 m -113.29 159.51 19.29 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 108.033 -1.099 . . . . 25.0 108.033 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.2 m -132.58 170.34 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 124.276 0.985 . . . . 25.0 109.872 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.1 t -89.39 111.65 22.56 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 107.016 -1.475 . . . . 25.0 107.016 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.51 177.7 48.8 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 114.525 0.57 . . . . 25.0 114.525 -173.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.35 -10.17 19.02 Favored 'Trans proline' 0 C--O 1.21 -0.919 0 CA-C-O 124.867 1.945 . . . . 25.0 114.085 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -78.43 -13.68 59.73 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 112.919 -1.946 . . . . 25.0 110.879 171.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.55 20.31 45.05 Favored Glycine 0 CA--C 1.501 -0.785 0 CA-C-N 115.728 -0.669 . . . . 25.0 113.533 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.424 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 37.1 m-85 -131.71 146.88 52.4 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.964 -1.118 . . . . 25.0 110.831 -174.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.7 m -64.44 145.52 55.95 Favored 'General case' 0 C--N 1.317 -0.835 0 O-C-N 124.253 0.971 . . . . 25.0 112.917 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.735 0 CA-C-O 118.355 -1.247 . . . . 50.0 110.708 174.442 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.7 p . . . . . 0 N--CA 1.472 0.655 0 CA-C-O 118.433 -0.794 . . . . 25.0 111.675 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.42 73.2 5.66 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 N-CA-C 114.616 0.968 . . . . 25.0 114.616 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -127.82 30.14 5.33 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.47 -1.678 . . . . 25.0 106.47 173.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.55 50.26 0.21 Allowed Glycine 0 CA--C 1.497 -1.055 0 C-N-CA 119.618 -1.277 . . . . 25.0 113.398 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -121.55 174.03 7.04 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.932 -0.766 . . . . 25.0 108.932 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -51.19 -50.44 39.91 Favored Glycine 0 C--O 1.207 -1.576 0 O-C-N 125.317 1.635 . . . . 25.0 113.722 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -101.62 0.59 36.53 Favored 'General case' 0 CA--C 1.558 1.27 0 CA-C-N 119.578 1.689 . . . . 25.0 110.917 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.1 m-90 -116.17 81.07 1.55 Allowed 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 107.352 -1.351 . . . . 25.0 107.352 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.03 154.63 94.07 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 104.394 -2.447 . . . . 25.0 104.394 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.438 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 50.9 Cg_endo -72.39 172.5 14.85 Favored 'Trans proline' 0 CA--C 1.508 -0.813 0 N-CA-C 116.713 1.774 . . . . 25.0 116.713 -177.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -106.25 133.23 51.27 Favored 'General case' 0 C--O 1.266 1.958 0 CA-C-N 115.887 -0.597 . . . . 25.0 110.458 176.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.0 p -70.29 141.64 52.35 Favored 'General case' 0 C--O 1.259 1.567 0 N-CA-C 107.286 -1.376 . . . . 25.0 107.286 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.9 p -144.48 172.29 13.16 Favored 'General case' 0 CA--C 1.556 1.177 0 CA-C-N 114.574 -1.193 . . . . 25.0 109.814 -175.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.1 m -128.1 -12.87 5.16 Favored 'General case' 0 C--O 1.2 -1.517 0 CA-C-N 114.619 -1.173 . . . . 25.0 107.915 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -151.13 162.66 40.46 Favored 'General case' 0 C--O 1.258 1.52 0 C-N-CA 124.116 0.967 . . . . 25.0 110.185 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -63.07 -29.25 70.66 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.5 1.125 . . . . 25.0 112.877 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 t -71.4 -12.39 61.39 Favored 'General case' 0 C--O 1.253 1.258 0 O-C-N 121.919 -0.488 . . . . 25.0 110.682 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -76.03 -12.7 60.17 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 121.639 0.733 . . . . 50.0 110.969 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.3 m -101.27 172.89 6.72 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.917 1.821 . . . . 25.0 115.917 -170.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.4 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 83.5 mt -69.83 168.14 15.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.674 0.749 . . . . 25.0 110.077 176.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.9 122.0 11.23 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 115.138 1.533 . . . . 25.0 115.138 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.37 -9.51 76.71 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 123.983 0.802 . . . . 25.0 112.876 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 2.1 m -95.68 151.88 18.96 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 m -124.34 165.69 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.844 0.858 . . . . 25.0 110.463 -176.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.2 t -86.83 114.88 23.86 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 105.198 -2.149 . . . . 25.0 105.198 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.17 178.39 53.88 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 115.883 -0.598 . . . . 25.0 112.888 -173.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.52 -11.78 18.73 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 CA-C-O 124.432 1.763 . . . . 25.0 114.213 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -78.18 -8.28 58.11 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 113.381 -1.736 . . . . 25.0 110.412 172.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.53 17.98 63.0 Favored Glycine 0 C--O 1.25 1.097 0 CA-C-O 122.82 1.234 . . . . 25.0 112.858 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.438 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 39.0 m-85 -126.31 149.76 48.94 Favored 'General case' 0 C--O 1.206 -1.208 0 CA-C-N 112.962 -1.619 . . . . 25.0 109.079 -176.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.5 m -64.5 149.82 47.86 Favored 'General case' 0 C--N 1.317 -0.822 0 O-C-N 124.41 1.069 . . . . 25.0 110.316 174.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.647 0 CA-C-O 118.641 -1.088 . . . . 50.0 113.44 175.332 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 117.089 -1.434 . . . . 25.0 108.804 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -78.59 57.72 6.45 Favored 'Trans proline' 0 N--CA 1.486 1.039 0 N-CA-C 115.844 1.44 . . . . 25.0 115.844 -174.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -124.42 8.12 8.39 Favored 'General case' 0 C--O 1.2 -1.519 0 N-CA-C 108.905 -0.776 . . . . 25.0 108.905 170.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.94 46.93 0.68 Allowed Glycine 0 C--O 1.218 -0.878 0 C-N-CA 120.664 -0.779 . . . . 25.0 114.939 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 mmp_? -108.79 -164.27 0.93 Allowed 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 105.632 -1.988 . . . . 25.0 105.632 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.02 -72.78 0.57 Allowed Glycine 0 C--O 1.205 -1.709 0 O-C-N 125.197 1.561 . . . . 25.0 112.755 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -97.86 10.94 38.95 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.431 1.115 . . . . 25.0 110.209 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -95.61 79.28 3.37 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 105.447 -2.057 . . . . 25.0 105.447 176.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.64 148.49 96.8 Favored Pre-proline 0 CA--C 1.558 1.288 0 CA-C-N 113.821 -1.536 . . . . 25.0 106.936 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.5 171.89 17.37 Favored 'Trans proline' 0 N--CA 1.482 0.795 0 N-CA-C 116.853 1.828 . . . . 25.0 116.853 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.0 m -106.62 130.0 54.44 Favored 'General case' 0 C--O 1.261 1.686 0 CA-C-N 115.184 -0.917 . . . . 25.0 110.55 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.7 p -68.48 130.53 43.15 Favored 'General case' 0 C--O 1.26 1.652 0 N-CA-C 105.735 -1.95 . . . . 25.0 105.735 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.6 p -136.39 173.23 11.93 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 122.574 1.178 . . . . 25.0 110.966 -173.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.5 m -131.31 -14.3 3.36 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 114.264 -1.334 . . . . 25.0 107.833 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -151.02 161.45 42.71 Favored 'General case' 0 C--O 1.253 1.262 0 O-C-N 121.026 -1.046 . . . . 25.0 109.977 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -63.36 -30.57 71.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 124.316 1.01 . . . . 25.0 112.58 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.1 t -65.51 -19.73 66.05 Favored 'General case' 0 C--O 1.252 1.19 0 O-C-N 121.648 -0.657 . . . . 25.0 111.487 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -72.61 -17.62 61.66 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-O 121.802 0.811 . . . . 50.0 110.169 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.1 m -103.54 176.39 5.17 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 115.221 1.563 . . . . 25.0 115.221 -170.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.3 mt -74.98 168.56 19.72 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 122.081 0.943 . . . . 25.0 111.159 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.01 136.21 53.51 Favored 'General case' 0 C--O 1.268 2.031 0 O-C-N 121.271 -0.893 . . . . 25.0 109.604 172.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.86 -9.9 76.43 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 111.831 -0.508 . . . . 25.0 111.831 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.2 m -108.54 158.42 17.57 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 104.518 -2.401 . . . . 25.0 104.518 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.07 171.21 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 106.523 -1.658 . . . . 25.0 106.523 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.8 t -84.69 115.06 22.47 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 105.338 -2.097 . . . . 25.0 105.338 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.24 175.56 54.6 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 112.397 -0.281 . . . . 25.0 112.397 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.92 -13.86 19.41 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 CA-C-O 125.358 2.149 . . . . 25.0 114.592 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -75.75 -10.73 59.68 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 113.595 -1.639 . . . . 25.0 111.151 172.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.47 18.83 51.42 Favored Glycine 0 CA--C 1.494 -1.276 0 CA-C-O 122.535 1.075 . . . . 25.0 112.794 174.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -127.9 150.7 49.75 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.644 -1.278 . . . . 25.0 109.146 -177.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.4 m -61.64 146.79 47.91 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 123.723 0.64 . . . . 25.0 110.555 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.905 0 CA-C-O 117.56 -1.689 . . . . 50.0 111.716 174.954 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.177 -1.392 . . . . 25.0 108.823 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.85 55.03 5.09 Favored 'Trans proline' 0 N--CA 1.488 1.167 0 N-CA-C 115.338 1.246 . . . . 25.0 115.338 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -115.37 19.36 15.55 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 106.607 -1.627 . . . . 25.0 106.607 175.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -158.46 40.53 0.51 Allowed Glycine 0 C--N 1.319 -0.394 0 C-N-CA 119.253 -1.451 . . . . 25.0 116.649 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -93.97 171.39 8.89 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.663 -1.606 . . . . 25.0 106.663 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.22 -55.73 14.9 Favored Glycine 0 C--O 1.201 -1.957 0 O-C-N 125.303 1.627 . . . . 25.0 113.413 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -105.35 27.6 8.15 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 117.867 0.834 . . . . 25.0 112.195 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -120.71 85.88 2.47 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 105.697 -1.964 . . . . 25.0 105.697 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.58 137.36 95.14 Favored Pre-proline 0 C--O 1.261 1.688 0 N-CA-C 106.943 -1.503 . . . . 25.0 106.943 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.424 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 70.0 Cg_endo -73.28 168.51 24.57 Favored 'Trans proline' 0 CA--C 1.505 -0.958 0 N-CA-C 117.017 1.891 . . . . 25.0 117.017 -175.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.5 m -94.71 129.03 41.79 Favored 'General case' 0 C--O 1.263 1.769 0 CA-C-N 115.301 -0.863 . . . . 25.0 111.453 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 p -72.01 134.31 45.83 Favored 'General case' 0 C--O 1.255 1.365 0 N-CA-C 106.065 -1.828 . . . . 25.0 106.065 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.7 p -138.16 170.13 16.58 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-O 121.872 0.844 . . . . 25.0 109.715 -173.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.1 m -125.84 -16.78 5.58 Favored 'General case' 0 C--O 1.204 -1.331 0 N-CA-C 106.879 -1.526 . . . . 25.0 106.879 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -149.29 160.76 43.12 Favored 'General case' 0 C--O 1.262 1.716 0 CA-C-N 118.7 0.682 . . . . 25.0 109.335 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -59.76 -30.26 68.74 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.816 0.817 . . . . 25.0 112.296 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -1.67 22.85 Favored 'General case' 0 C--O 1.264 1.857 0 O-C-N 121.186 -0.946 . . . . 25.0 112.958 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -87.2 -9.57 54.83 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 121.683 0.754 . . . . 50.0 109.629 170.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.7 m -103.31 175.64 5.41 Favored 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 116.028 1.862 . . . . 25.0 116.028 -170.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 87.2 mt -71.36 162.6 29.17 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.441 0.639 . . . . 25.0 110.034 177.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.97 124.55 19.06 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 114.863 1.431 . . . . 25.0 114.863 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.17 -7.94 80.96 Favored Glycine 0 CA--C 1.529 0.933 0 O-C-N 124.28 0.987 . . . . 25.0 112.634 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 3.7 m -98.82 159.37 15.0 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 107.914 -1.143 . . . . 25.0 107.914 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.1 m -127.76 166.53 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.691 1.196 . . . . 25.0 109.895 -175.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.3 t -87.54 116.41 25.64 Favored 'General case' 0 C--O 1.255 1.355 0 N-CA-C 105.424 -2.065 . . . . 25.0 105.424 172.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.38 176.21 49.86 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 116.753 -0.203 . . . . 25.0 112.786 -173.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -75.25 -14.17 20.68 Favored 'Trans proline' 0 C--O 1.204 -1.185 0 CA-C-O 124.103 1.626 . . . . 25.0 114.068 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -72.16 -14.46 61.82 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 113.763 -1.562 . . . . 25.0 111.033 173.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.83 12.96 54.88 Favored Glycine 0 CA--C 1.503 -0.699 0 CA-C-O 122.207 0.893 . . . . 25.0 113.238 174.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.424 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 64.6 m-85 -130.47 155.74 45.95 Favored 'General case' 0 C--O 1.206 -1.212 0 CA-C-N 113.415 -1.392 . . . . 25.0 110.284 -174.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 94.0 m -61.92 148.92 42.06 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 124.033 0.833 . . . . 25.0 109.532 173.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.837 0 N-CA-C 109.745 -1.342 . . . . 50.0 109.745 179.382 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 118.201 -0.904 . . . . 25.0 110.915 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.9 70.21 5.27 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 N-CA-C 115.194 1.19 . . . . 25.0 115.194 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -124.26 8.61 8.51 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.904 0.859 . . . . 25.0 110.203 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.39 49.02 0.48 Allowed Glycine 0 CA--C 1.497 -1.08 0 N-CA-C 116.415 1.326 . . . . 25.0 116.415 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 71.1 mtp85 -105.75 174.41 5.89 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.6 -2.0 . . . . 25.0 105.6 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -42.37 -61.59 2.39 Favored Glycine 0 C--O 1.209 -1.45 0 O-C-N 125.099 1.5 . . . . 25.0 114.668 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -99.26 4.41 46.58 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.243 1.022 . . . . 25.0 111.656 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -98.09 80.85 2.74 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 106.198 -1.778 . . . . 25.0 106.198 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.64 147.76 98.9 Favored Pre-proline 0 CA--C 1.559 1.308 0 N-CA-C 104.806 -2.294 . . . . 25.0 104.806 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.472 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 57.4 Cg_endo -72.94 166.98 28.54 Favored 'Trans proline' 0 CA--C 1.503 -1.046 0 C-N-CA 115.73 -2.38 . . . . 25.0 116.295 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.1 m -94.31 125.93 39.25 Favored 'General case' 0 C--O 1.266 1.94 0 O-C-N 121.33 -0.857 . . . . 25.0 110.395 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 p -67.12 136.28 54.88 Favored 'General case' 0 C--O 1.257 1.49 0 N-CA-C 106.643 -1.614 . . . . 25.0 106.643 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.6 p -143.98 171.82 13.73 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-O 122.824 1.297 . . . . 25.0 110.843 -175.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -130.52 -13.43 3.81 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 114.133 -1.394 . . . . 25.0 108.438 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -150.82 159.33 44.61 Favored 'General case' 0 C--O 1.259 1.602 0 C-N-CA 123.947 0.899 . . . . 25.0 109.218 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -60.64 -31.75 70.94 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 114.062 1.134 . . . . 25.0 114.062 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -15.98 64.05 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 113.036 0.754 . . . . 25.0 113.036 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -73.88 -18.21 60.95 Favored 'General case' 0 CA--C 1.563 1.478 0 O-C-N 124.042 0.838 . . . . 50.0 110.648 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.2 m -95.25 178.24 5.59 Favored 'General case' 0 CA--C 1.557 1.249 0 O-C-N 120.03 -1.669 . . . . 25.0 114.975 -170.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.2 mt -75.58 167.85 21.11 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 121.61 0.719 . . . . 25.0 109.373 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.72 121.78 11.24 Favored 'General case' 0 C--O 1.251 1.163 0 N-CA-C 114.815 1.413 . . . . 25.0 114.815 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.74 -7.29 82.35 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.08 -0.581 . . . . 25.0 113.633 175.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.2 m -95.31 160.43 14.54 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 105.521 -2.029 . . . . 25.0 105.521 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.4 m -129.21 169.36 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.758 0.823 . . . . 25.0 110.429 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 19.3 t -90.54 114.26 26.43 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 106.677 -1.601 . . . . 25.0 106.677 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.85 174.66 53.99 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 115.651 -0.704 . . . . 25.0 114.076 -173.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -73.41 -15.09 25.15 Favored 'Trans proline' 0 C--O 1.213 -0.762 0 CA-C-O 124.552 1.813 . . . . 25.0 114.603 -177.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -74.94 -7.78 54.59 Favored 'General case' 0 CA--C 1.559 1.315 0 CA-C-N 113.896 -1.502 . . . . 25.0 111.157 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.4 12.65 58.24 Favored Glycine 0 C--O 1.247 0.966 0 CA-C-O 122.657 1.143 . . . . 25.0 113.494 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.472 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 57.4 m-85 -130.92 154.66 47.87 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 113.491 -1.355 . . . . 25.0 111.402 -174.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 86.2 m -63.71 146.87 53.02 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.855 0.722 . . . . 25.0 110.628 174.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.649 0 N-CA-C 110.171 -1.172 . . . . 50.0 110.171 -178.649 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.476 0.843 0 CA-C-O 117.481 -1.247 . . . . 25.0 108.554 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -77.55 59.95 6.93 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 N-CA-C 115.67 1.373 . . . . 25.0 115.67 -175.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -131.26 19.25 4.87 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 106.251 -1.759 . . . . 25.0 106.251 174.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.46 50.81 0.32 Allowed Glycine 0 CA--C 1.495 -1.175 0 C-N-CA 119.766 -1.207 . . . . 25.0 114.344 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -119.19 -169.31 1.72 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.982 -0.748 . . . . 25.0 108.982 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.94 -64.34 4.27 Favored Glycine 0 C--O 1.201 -1.96 0 O-C-N 125.036 1.46 . . . . 25.0 113.183 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -102.77 26.72 7.7 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.758 1.279 . . . . 25.0 110.354 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -127.81 81.12 2.0 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 105.668 -1.975 . . . . 25.0 105.668 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.88 152.75 95.37 Favored Pre-proline 0 C--O 1.254 1.292 0 CA-C-N 112.889 -1.959 . . . . 25.0 105.875 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.428 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 73.6 Cg_endo -74.58 170.45 20.26 Favored 'Trans proline' 0 CA--C 1.506 -0.925 0 C-N-CA 116.145 -2.103 . . . . 25.0 115.579 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.6 m -108.73 129.21 55.36 Favored 'General case' 0 C--O 1.26 1.639 0 O-C-N 121.7 -0.625 . . . . 25.0 110.899 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.8 p -66.28 133.63 50.97 Favored 'General case' 0 C--O 1.262 1.763 0 N-CA-C 106.245 -1.761 . . . . 25.0 106.245 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.6 p -139.81 176.58 8.62 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 122.143 0.973 . . . . 25.0 110.258 -174.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.0 m -132.39 -15.9 2.78 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 114.484 -1.235 . . . . 25.0 108.68 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -153.37 162.93 40.77 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 108.031 -1.1 . . . . 25.0 108.031 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -62.96 -32.22 73.49 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 113.806 1.039 . . . . 25.0 113.806 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.89 -10.15 59.08 Favored 'General case' 0 C--O 1.252 1.232 0 O-C-N 121.118 -0.989 . . . . 25.0 113.024 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -75.69 -15.67 60.27 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.239 1.019 . . . . 50.0 110.072 172.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 54.1 m -99.91 177.2 5.18 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 115.125 1.528 . . . . 25.0 115.125 -171.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.6 mt -75.57 168.87 19.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.457 -0.792 . . . . 25.0 112.662 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.38 121.56 9.86 Favored 'General case' 0 C--O 1.254 1.312 0 N-CA-C 113.416 0.895 . . . . 25.0 113.416 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.42 -10.38 74.94 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 120.0 -0.333 . . . . 25.0 113.043 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.4 m -89.26 156.3 18.84 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 106.413 -1.699 . . . . 25.0 106.413 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.8 m -129.38 164.55 31.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 106.581 -1.637 . . . . 25.0 106.581 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 18.3 t -87.59 115.07 24.78 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 104.4 -2.444 . . . . 25.0 104.4 174.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.37 179.3 53.21 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 120.668 -0.777 . . . . 25.0 114.408 -172.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.41 -13.63 22.8 Favored 'Trans proline' 0 C--O 1.206 -1.102 0 CA-C-O 124.868 1.945 . . . . 25.0 113.828 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -74.42 -9.85 58.99 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-N 112.931 -1.94 . . . . 25.0 111.816 171.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.46 22.24 58.88 Favored Glycine 0 CA--C 1.498 -0.996 0 CA-C-O 122.605 1.114 . . . . 25.0 112.416 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.428 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 15.0 m-85 -135.89 147.28 48.11 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 112.996 -1.602 . . . . 25.0 109.514 -173.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 92.4 m -61.5 147.68 44.49 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.686 0.616 . . . . 25.0 110.607 174.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.824 0 CA-C-O 117.24 -1.867 . . . . 50.0 110.608 175.306 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.481 1.103 0 CA-C-O 117.5 -1.238 . . . . 25.0 108.8 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.33 65.36 7.96 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 N-CA-C 114.762 1.024 . . . . 25.0 114.762 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -124.65 21.08 8.52 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 105.548 -2.019 . . . . 25.0 105.548 170.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.58 53.26 0.31 Allowed Glycine 0 CA--C 1.5 -0.877 0 CA-C-O 122.569 1.094 . . . . 25.0 113.209 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.8 mmm-85 -128.23 164.14 23.2 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 106.024 -1.843 . . . . 25.0 106.024 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -45.91 -55.1 7.57 Favored Glycine 0 C--O 1.203 -1.802 0 O-C-N 125.42 1.7 . . . . 25.0 114.572 -174.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -99.02 17.73 19.0 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 119.101 1.451 . . . . 25.0 110.316 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -126.53 78.6 1.8 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 107.35 -1.352 . . . . 25.0 107.35 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.02 151.06 95.96 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 103.911 -2.625 . . . . 25.0 103.911 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.42 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 58.1 Cg_endo -72.78 169.56 21.72 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 N-CA-C 116.971 1.873 . . . . 25.0 116.971 -175.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.9 m -100.05 128.76 46.09 Favored 'General case' 0 C--O 1.259 1.572 0 CA-C-N 115.655 -0.702 . . . . 25.0 110.553 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.2 p -68.33 137.72 54.86 Favored 'General case' 0 C--O 1.262 1.762 0 N-CA-C 107.051 -1.463 . . . . 25.0 107.051 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.1 p -142.16 170.39 15.79 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.14 0.971 . . . . 25.0 112.542 -175.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.5 m -128.27 -15.4 4.65 Favored 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 107.476 -1.305 . . . . 25.0 107.476 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -149.36 161.49 41.96 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 123.734 0.814 . . . . 25.0 109.218 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -64.38 -28.14 69.49 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 124.628 1.205 . . . . 25.0 112.496 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.4 t -65.43 -19.83 66.11 Favored 'General case' 0 C--O 1.258 1.529 0 O-C-N 121.63 -0.669 . . . . 25.0 111.137 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -71.0 -17.19 62.65 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 122.28 1.038 . . . . 50.0 111.7 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.3 m -97.52 174.22 6.77 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 120.592 -1.317 . . . . 25.0 114.233 -171.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.4 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 37.3 mt -69.74 167.41 17.17 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 121.588 0.709 . . . . 25.0 109.81 177.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.41 125.11 21.94 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 113.279 0.844 . . . . 25.0 113.279 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.32 -10.4 74.42 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 120.857 -0.687 . . . . 25.0 113.544 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 7.2 m -95.32 164.38 12.86 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.685 -1.598 . . . . 25.0 106.685 -178.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 m -131.75 165.27 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.637 0.775 . . . . 25.0 110.503 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.6 t -84.73 119.77 25.65 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 104.304 -2.48 . . . . 25.0 104.304 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.2 175.25 55.15 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 121.396 -0.43 . . . . 25.0 113.44 -174.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -74.79 -14.0 21.78 Favored 'Trans proline' 0 C--O 1.204 -1.176 0 CA-C-O 125.136 2.057 . . . . 25.0 113.845 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -79.45 -9.56 59.63 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-N 113.754 -1.566 . . . . 25.0 111.312 175.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.34 15.31 53.87 Favored Glycine 0 CA--C 1.493 -1.318 0 CA-C-O 122.497 1.054 . . . . 25.0 113.131 175.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.42 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 35.5 m-85 -127.68 146.91 50.41 Favored 'General case' 0 C--O 1.203 -1.389 0 CA-C-N 113.928 -1.136 . . . . 25.0 110.835 -176.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.5 m -60.34 147.37 40.81 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.981 0.8 . . . . 25.0 110.268 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -2.062 0 CA-C-O 118.012 -1.438 . . . . 50.0 110.731 179.451 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 118.576 -0.726 . . . . 25.0 110.871 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.67 73.47 5.24 Favored 'Trans proline' 0 C--O 1.211 -0.87 0 N-CA-C 115.204 1.194 . . . . 25.0 115.204 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -121.7 15.65 11.05 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.719 -0.845 . . . . 25.0 108.719 171.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.86 35.24 0.93 Allowed Glycine 0 N--CA 1.467 0.737 0 C-N-CA 119.114 -1.517 . . . . 25.0 116.725 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -94.8 178.24 5.64 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.166 -1.05 . . . . 25.0 108.166 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.18 -54.6 33.04 Favored Glycine 0 C--O 1.201 -1.96 0 C-N-CA 119.712 -1.233 . . . . 25.0 113.083 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -95.57 13.57 25.73 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.208 1.504 . . . . 25.0 110.483 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -122.88 80.17 1.73 Allowed 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 105.989 -1.856 . . . . 25.0 105.989 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.66 148.3 98.23 Favored Pre-proline 0 C--O 1.254 1.298 0 N-CA-C 104.311 -2.477 . . . . 25.0 104.311 175.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 55.9 Cg_endo -71.43 168.39 23.65 Favored 'Trans proline' 0 CA--C 1.498 -1.292 0 C-N-CA 114.481 -3.213 . . . . 25.0 114.971 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.6 m -101.39 124.39 46.99 Favored 'General case' 0 C--O 1.255 1.371 0 O-C-N 121.648 -0.657 . . . . 25.0 110.273 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -66.92 140.41 57.76 Favored 'General case' 0 C--O 1.256 1.397 0 N-CA-C 106.666 -1.605 . . . . 25.0 106.666 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 p -150.09 172.0 15.97 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-O 122.767 1.27 . . . . 25.0 111.009 -175.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -132.27 -11.62 3.22 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.215 -1.357 . . . . 25.0 108.452 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -150.19 157.32 42.97 Favored 'General case' 0 C--O 1.262 1.716 0 N-CA-C 107.416 -1.327 . . . . 25.0 107.416 -177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -66.77 -25.33 66.43 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 113.781 1.03 . . . . 25.0 113.781 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 80.3 p -73.83 -9.1 58.31 Favored 'General case' 0 C--O 1.257 1.461 0 O-C-N 121.156 -0.965 . . . . 25.0 111.553 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -73.53 -16.16 61.28 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 108.841 -0.799 . . . . 50.0 108.841 172.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.7 m -100.55 177.51 4.99 Favored 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 116.08 1.881 . . . . 25.0 116.08 -169.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.6 mt -72.84 167.24 21.34 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.657 0.742 . . . . 25.0 110.476 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.27 118.55 7.58 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 114.328 1.233 . . . . 25.0 114.328 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.93 -6.6 64.41 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 111.413 -0.675 . . . . 25.0 111.413 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.1 m -105.7 157.39 17.46 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.103 -1.073 . . . . 25.0 108.103 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.1 m -131.35 167.88 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 123.352 0.661 . . . . 25.0 110.581 -173.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.9 t -89.48 114.98 26.56 Favored 'General case' 0 C--O 1.247 0.958 0 N-CA-C 107.413 -1.329 . . . . 25.0 107.413 175.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.66 179.6 52.3 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 120.848 -0.691 . . . . 25.0 113.655 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -75.77 -13.97 19.69 Favored 'Trans proline' 0 C--O 1.202 -1.3 0 CA-C-N 119.608 1.704 . . . . 25.0 113.54 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -75.57 -8.15 56.04 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 113.639 -1.619 . . . . 25.0 110.607 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.52 15.67 63.49 Favored Glycine 0 CA--C 1.49 -1.515 0 CA-C-O 123.043 1.357 . . . . 25.0 113.269 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 29.9 m-85 -126.43 147.61 49.77 Favored 'General case' 0 C--O 1.195 -1.8 0 CA-C-N 112.88 -1.66 . . . . 25.0 111.361 -175.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.1 m -63.18 148.77 47.12 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 124.692 1.245 . . . . 25.0 109.202 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.479 -2.157 0 CA-C-O 119.352 -0.693 . . . . 50.0 112.984 178.091 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 118.005 -0.997 . . . . 25.0 109.908 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.92 58.0 5.32 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 N-CA-C 115.7 1.385 . . . . 25.0 115.7 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -124.66 6.86 8.18 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 107.714 -1.217 . . . . 25.0 107.714 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.39 58.32 0.42 Allowed Glycine 0 CA--C 1.495 -1.209 0 C-N-CA 120.267 -0.968 . . . . 25.0 115.184 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.406 ' HB2' ' HB2' ' A' ' 9' ' ' TRP . 15.8 mtm-85 -126.07 169.49 12.72 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.66 -1.237 . . . . 25.0 107.66 178.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -38.75 -58.28 1.83 Allowed Glycine 0 C--O 1.212 -1.248 0 O-C-N 125.489 1.743 . . . . 25.0 116.287 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -110.75 31.18 6.19 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.473 1.637 . . . . 25.0 110.888 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.406 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 5.6 m-90 -122.95 78.0 1.51 Allowed 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 103.557 -2.757 . . . . 25.0 103.557 176.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.77 151.67 97.13 Favored Pre-proline 0 CA--C 1.562 1.429 0 N-CA-C 105.743 -1.947 . . . . 25.0 105.743 176.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 60.7 Cg_endo -73.81 170.19 20.62 Favored 'Trans proline' 0 CA--C 1.512 -0.621 0 N-CA-C 116.093 1.536 . . . . 25.0 116.093 -176.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.5 m -100.33 131.32 46.32 Favored 'General case' 0 C--O 1.263 1.779 0 CA-C-N 115.73 -0.668 . . . . 25.0 110.877 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.6 p -66.86 130.86 44.54 Favored 'General case' 0 C--O 1.271 2.185 0 N-CA-C 107.003 -1.481 . . . . 25.0 107.003 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.3 p -142.63 175.92 9.44 Favored 'General case' 0 CA--C 1.561 1.396 0 CA-C-O 122.416 1.103 . . . . 25.0 109.161 -177.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 m -130.64 -18.21 3.15 Favored 'General case' 0 C--O 1.189 -2.097 0 CA-C-N 114.321 -1.309 . . . . 25.0 108.509 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -143.17 158.13 43.89 Favored 'General case' 0 C--O 1.259 1.553 0 N-CA-C 108.032 -1.099 . . . . 25.0 108.032 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -62.96 -29.31 70.7 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 124.512 1.133 . . . . 25.0 111.948 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.4 t -71.15 -13.1 61.83 Favored 'General case' 0 C--O 1.249 1.067 0 O-C-N 121.06 -1.025 . . . . 25.0 112.36 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -74.05 -16.08 61.05 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.022 -0.733 . . . . 50.0 109.022 174.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.9 m -100.84 170.68 8.15 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 115.008 1.485 . . . . 25.0 115.008 -170.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.7 mt -66.17 165.63 13.37 Favored 'General case' 0 N--CA 1.424 -1.753 0 O-C-N 123.731 0.644 . . . . 25.0 110.792 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.96 119.72 8.83 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 114.548 1.314 . . . . 25.0 114.548 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.01 -7.74 73.17 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 121.191 -0.528 . . . . 25.0 113.155 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.3 m -99.21 160.7 14.08 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 105.615 -1.994 . . . . 25.0 105.615 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.11 166.72 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 123.199 0.6 . . . . 25.0 109.921 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 21.2 t -91.03 118.84 30.72 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 106.2 -1.778 . . . . 25.0 106.2 174.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.45 177.09 54.23 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.428 -0.892 . . . . 25.0 114.005 -174.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.22 -19.03 23.02 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 CA-C-O 124.995 1.998 . . . . 25.0 113.895 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -72.84 -10.14 59.46 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-N 113.778 -1.555 . . . . 25.0 110.604 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.2 17.02 44.69 Favored Glycine 0 CA--C 1.497 -1.081 0 CA-C-N 115.162 -0.926 . . . . 25.0 113.936 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 43.5 m-85 -130.11 146.81 51.79 Favored 'General case' 0 C--O 1.212 -0.919 0 CA-C-N 114.182 -1.009 . . . . 25.0 113.626 -172.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 96.1 m -63.28 143.38 57.85 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 124.297 1.039 . . . . 25.0 111.532 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.843 0 CA-C-O 117.618 -1.657 . . . . 50.0 110.865 179.432 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 118.096 -0.954 . . . . 25.0 113.154 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.41 70.99 6.04 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 N-CA-C 114.591 0.958 . . . . 25.0 114.591 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -119.85 -2.56 10.32 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-N 115.253 -0.885 . . . . 25.0 108.679 173.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -142.81 60.76 0.53 Allowed Glycine 0 CA--C 1.495 -1.161 0 C-N-CA 120.276 -0.964 . . . . 25.0 114.03 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -131.82 163.41 28.32 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.222 -0.659 . . . . 25.0 109.222 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -42.02 -47.69 5.29 Favored Glycine 0 C--O 1.211 -1.283 0 N-CA-C 116.628 1.411 . . . . 25.0 116.628 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -107.91 18.82 20.82 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 118.912 1.356 . . . . 25.0 109.717 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.7 m-90 -129.54 80.75 1.98 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.226 -1.398 . . . . 25.0 107.226 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.89 148.41 97.93 Favored Pre-proline 0 CA--C 1.57 1.716 0 N-CA-C 104.858 -2.275 . . . . 25.0 104.858 174.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 58.1 Cg_endo -72.5 168.36 24.56 Favored 'Trans proline' 0 CA--C 1.491 -1.636 0 N-CA-C 118.477 2.453 . . . . 25.0 118.477 -175.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 80.1 m -97.96 128.7 44.69 Favored 'General case' 0 C--O 1.264 1.861 0 CA-C-N 114.737 -1.12 . . . . 25.0 110.988 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.81 131.73 45.62 Favored 'General case' 0 C--O 1.256 1.407 0 N-CA-C 107.019 -1.474 . . . . 25.0 107.019 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.2 p -138.2 170.21 16.43 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 122.857 1.313 . . . . 25.0 110.461 -176.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.0 m -125.32 -17.24 5.69 Favored 'General case' 0 C--O 1.197 -1.705 0 N-CA-C 107.088 -1.449 . . . . 25.0 107.088 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -151.22 162.14 41.44 Favored 'General case' 0 C--O 1.254 1.33 0 C-N-CA 123.286 0.634 . . . . 25.0 110.041 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -57.63 -32.55 67.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 124.446 1.092 . . . . 25.0 112.805 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.9 t -63.95 -18.9 64.71 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-O 118.91 -0.567 . . . . 25.0 111.669 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -71.77 -13.24 61.64 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 113.27 0.841 . . . . 50.0 113.27 174.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.7 m -101.25 173.03 6.64 Favored 'General case' 0 C--O 1.251 1.148 0 N-CA-C 115.309 1.596 . . . . 25.0 115.309 -169.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.8 mt -67.66 163.92 20.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.033 0.921 . . . . 25.0 110.431 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.16 122.06 12.87 Favored 'General case' 0 C--O 1.252 1.229 0 N-CA-C 113.867 1.062 . . . . 25.0 113.867 -178.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.01 7.01 78.35 Favored Glycine 0 CA--C 1.522 0.505 0 O-C-N 123.195 0.309 . . . . 25.0 112.469 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.5 m -114.04 160.95 18.32 Favored 'General case' 0 C--N 1.354 0.793 0 N-CA-C 106.258 -1.756 . . . . 25.0 106.258 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.3 m -128.84 170.55 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.037 0.935 . . . . 25.0 110.773 -176.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.4 t -91.76 108.92 20.26 Favored 'General case' 0 C--O 1.249 1.03 0 N-CA-C 105.313 -2.106 . . . . 25.0 105.313 174.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.19 175.87 54.4 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 116.255 -0.429 . . . . 25.0 113.956 -173.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.54 -9.26 21.32 Favored 'Trans proline' 0 C--O 1.207 -1.048 0 CA-C-N 119.579 1.69 . . . . 25.0 115.574 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -76.58 -10.04 59.1 Favored 'General case' 0 CA--C 1.565 1.542 0 CA-C-N 113.895 -1.502 . . . . 25.0 110.046 173.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.35 17.46 57.2 Favored Glycine 0 C--O 1.247 0.924 0 CA-C-O 121.851 0.695 . . . . 25.0 112.285 176.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 42.9 m-85 -133.9 151.52 51.54 Favored 'General case' 0 C--O 1.211 -0.962 0 CA-C-N 113.553 -1.324 . . . . 25.0 110.215 -174.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.3 m -60.28 146.86 42.36 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 124.053 0.846 . . . . 25.0 111.174 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.964 0 CA-C-O 118.153 -1.359 . . . . 50.0 111.34 178.888 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 117.261 -1.352 . . . . 25.0 111.359 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.68 68.06 7.74 Favored 'Trans proline' 0 N--CA 1.485 0.993 0 N-CA-C 114.898 1.076 . . . . 25.0 114.898 -175.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -122.78 19.46 10.22 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.676 -1.601 . . . . 25.0 106.676 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.71 42.9 0.56 Allowed Glycine 0 CA--C 1.507 -0.466 0 C-N-CA 119.964 -1.112 . . . . 25.0 114.158 177.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -103.35 -178.13 3.57 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.949 -1.13 . . . . 25.0 107.949 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.08 -62.6 6.18 Favored Glycine 0 C--O 1.212 -1.235 0 O-C-N 124.809 1.318 . . . . 25.0 112.761 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -94.57 10.06 36.2 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-N 118.956 1.378 . . . . 25.0 111.513 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.3 m-90 -111.73 82.09 1.56 Allowed 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 107.682 -1.229 . . . . 25.0 107.682 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.85 149.18 98.56 Favored Pre-proline 0 C--O 1.252 1.202 0 N-CA-C 104.791 -2.3 . . . . 25.0 104.791 174.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.472 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 64.4 Cg_endo -71.91 164.63 35.07 Favored 'Trans proline' 0 N--CA 1.481 0.759 0 C-N-CA 115.937 -2.242 . . . . 25.0 116.133 -176.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.4 m -94.91 129.74 41.8 Favored 'General case' 0 C--O 1.273 2.322 0 CA-C-N 115.842 -0.617 . . . . 25.0 111.028 177.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.8 p -69.68 132.61 46.42 Favored 'General case' 0 C--O 1.253 1.274 0 N-CA-C 106.699 -1.593 . . . . 25.0 106.699 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.8 p -138.39 172.02 13.52 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.095 0.95 . . . . 25.0 108.975 -174.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.5 m -128.73 -14.81 4.51 Favored 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 107.114 -1.439 . . . . 25.0 107.114 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.41 162.71 40.79 Favored 'General case' 0 C--O 1.255 1.383 0 CA-C-N 118.984 0.811 . . . . 25.0 109.735 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -58.44 -32.24 68.52 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.0 0.812 . . . . 25.0 112.626 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.8 t -66.33 -16.69 64.25 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 112.406 0.521 . . . . 25.0 112.406 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -77.79 -9.51 59.07 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 119.63 -0.828 . . . . 50.0 110.97 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.4 m -104.0 178.57 4.52 Favored 'General case' 0 CA--C 1.552 1.055 0 O-C-N 120.327 -1.483 . . . . 25.0 115.0 -171.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.5 mt -76.3 164.53 25.95 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-O 121.519 0.676 . . . . 25.0 109.711 175.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.8 132.33 53.51 Favored 'General case' 0 C--O 1.259 1.601 0 CA-C-O 119.085 -0.483 . . . . 25.0 110.87 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.54 -7.03 82.75 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 119.502 -0.61 . . . . 25.0 112.124 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.3 m -106.19 155.87 19.03 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.233 -1.765 . . . . 25.0 106.233 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.9 m -129.41 164.98 30.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 C-N-CA 124.937 1.295 . . . . 25.0 107.725 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.6 t -84.04 111.79 19.62 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 105.033 -2.21 . . . . 25.0 105.033 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.84 175.42 52.02 Favored Glycine 0 C--O 1.252 1.256 0 CA-C-N 115.525 -0.761 . . . . 25.0 113.264 -173.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.8 -14.44 19.46 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 CA-C-O 124.286 1.703 . . . . 25.0 114.151 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.2 p-10 -75.82 -8.76 57.65 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-N 114.009 -1.45 . . . . 25.0 110.549 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.24 22.05 39.32 Favored Glycine 0 C--O 1.247 0.966 0 CA-C-O 122.104 0.835 . . . . 25.0 113.463 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.472 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 46.9 m-85 -135.79 153.5 51.51 Favored 'General case' 0 C--O 1.208 -1.127 0 CA-C-N 114.019 -1.09 . . . . 25.0 110.67 -173.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 92.0 m -62.31 142.09 57.94 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.389 0.431 . . . . 25.0 110.214 172.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -2.022 0 CA-C-O 118.123 -1.376 . . . . 50.0 111.25 177.867 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.1 p . . . . . 0 CA--C 1.509 -0.6 0 CA-C-O 117.555 -1.212 . . . . 25.0 111.759 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -76.68 58.23 5.87 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 CA-C-N 119.974 1.027 . . . . 25.0 114.674 -176.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -125.17 16.03 8.42 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 104.572 -2.381 . . . . 25.0 104.572 172.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.02 69.74 0.18 Allowed Glycine 0 CA--C 1.49 -1.517 0 N-CA-C 111.053 -0.819 . . . . 25.0 111.053 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -137.27 163.39 31.07 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 105.831 -1.915 . . . . 25.0 105.831 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -41.58 -56.31 3.6 Favored Glycine 0 C--O 1.21 -1.38 0 CA-C-O 118.135 -1.369 . . . . 25.0 114.355 -177.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -97.75 13.81 29.11 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 119.925 1.863 . . . . 25.0 110.867 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -124.72 84.87 2.33 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 108.534 -0.913 . . . . 25.0 108.534 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.27 153.4 95.58 Favored Pre-proline 0 C--O 1.257 1.458 0 O-C-N 125.591 1.807 . . . . 25.0 106.609 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.26 171.01 18.88 Favored 'Trans proline' 0 CA--C 1.493 -1.575 0 N-CA-C 116.71 1.773 . . . . 25.0 116.71 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.7 m -108.21 131.33 54.78 Favored 'General case' 0 C--O 1.259 1.605 0 CA-C-N 115.274 -0.876 . . . . 25.0 110.288 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.14 140.03 56.16 Favored 'General case' 0 C--O 1.253 1.257 0 N-CA-C 106.554 -1.647 . . . . 25.0 106.554 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.1 p -144.79 174.23 11.17 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.234 -1.348 . . . . 25.0 110.778 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 m -132.95 -10.73 3.0 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 107.622 -1.251 . . . . 25.0 107.622 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -152.28 160.84 43.28 Favored 'General case' 0 C--O 1.259 1.598 0 N-CA-C 107.761 -1.2 . . . . 25.0 107.761 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -63.71 -30.25 71.38 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.264 0.554 . . . . 25.0 112.002 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.6 t -68.25 -18.2 64.49 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 119.17 -1.012 . . . . 25.0 112.066 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -70.53 -11.81 61.17 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.301 -0.629 . . . . 50.0 109.301 175.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.3 m -104.05 173.66 6.21 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.988 1.477 . . . . 25.0 114.988 -171.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.423 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 91.5 mt -72.86 167.8 20.22 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 121.946 0.879 . . . . 25.0 109.42 178.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.6 120.73 11.15 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 114.687 1.366 . . . . 25.0 114.687 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.85 -8.92 65.85 Favored Glycine 0 CA--C 1.532 1.151 0 N-CA-C 110.723 -0.951 . . . . 25.0 110.723 175.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 m -97.22 163.72 12.79 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 106.028 -1.842 . . . . 25.0 106.028 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.4 m -133.5 168.19 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.387 1.075 . . . . 25.0 109.631 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.2 t -90.62 115.2 27.56 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 105.317 -2.105 . . . . 25.0 105.317 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.59 176.83 50.15 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.884 -0.598 . . . . 25.0 112.69 -175.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.22 -14.71 18.47 Favored 'Trans proline' 0 C--O 1.206 -1.085 0 CA-C-O 124.965 1.985 . . . . 25.0 113.833 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -77.13 -8.73 58.0 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-N 113.518 -1.674 . . . . 25.0 110.221 173.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.24 19.95 56.04 Favored Glycine 0 CA--C 1.495 -1.192 0 CA-C-O 122.004 0.78 . . . . 25.0 113.44 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -122.94 147.33 46.74 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.683 -1.258 . . . . 25.0 110.498 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.3 m -63.13 148.9 46.62 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 124.151 0.907 . . . . 25.0 110.308 173.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.558 0 CA-C-O 117.969 -1.461 . . . . 50.0 112.382 173.68 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 117.567 -1.206 . . . . 25.0 111.936 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.66 70.43 5.74 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 N-CA-C 115.26 1.215 . . . . 25.0 115.26 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -129.72 24.04 5.39 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 104.583 -2.377 . . . . 25.0 104.583 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -165.56 51.78 0.27 Allowed Glycine 0 CA--C 1.502 -0.777 0 C-N-CA 120.223 -0.989 . . . . 25.0 112.871 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.93 177.14 4.73 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 105.749 -1.945 . . . . 25.0 105.749 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -51.22 -56.09 16.28 Favored Glycine 0 C--O 1.21 -1.359 0 O-C-N 125.623 1.827 . . . . 25.0 113.104 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -98.67 -3.68 35.44 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 120.197 1.999 . . . . 25.0 112.563 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -98.24 81.95 2.86 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 106.514 -1.661 . . . . 25.0 106.514 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.09 149.58 98.41 Favored Pre-proline 0 C--O 1.254 1.308 0 N-CA-C 105.242 -2.132 . . . . 25.0 105.242 175.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 57.1 Cg_endo -69.94 163.05 39.86 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 116.316 -1.99 . . . . 25.0 114.605 -177.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.7 m -97.14 127.67 43.32 Favored 'General case' 0 C--O 1.258 1.531 0 CA-C-N 115.783 -0.644 . . . . 25.0 111.971 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.13 134.29 48.0 Favored 'General case' 0 C--O 1.26 1.616 0 N-CA-C 106.604 -1.628 . . . . 25.0 106.604 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.2 p -139.37 174.77 10.17 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 123.153 1.454 . . . . 25.0 111.817 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.7 m -129.8 -20.48 3.17 Favored 'General case' 0 C--O 1.196 -1.728 0 N-CA-C 107.372 -1.344 . . . . 25.0 107.372 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -144.43 163.13 34.71 Favored 'General case' 0 C--O 1.259 1.605 0 N-CA-C 108.703 -0.851 . . . . 25.0 108.703 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -62.67 -29.77 70.89 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-O 121.885 0.85 . . . . 25.0 111.853 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.4 t -66.06 -19.11 65.74 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.61 -0.723 . . . . 25.0 111.609 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -70.05 -17.94 63.27 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.623 0.725 . . . . 50.0 110.729 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.7 m -97.02 175.26 6.39 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 115.801 1.778 . . . . 25.0 115.801 -171.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.409 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 63.2 mt -74.15 168.78 18.88 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.533 0.682 . . . . 25.0 110.238 175.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.65 128.08 34.24 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 118.509 -0.757 . . . . 25.0 112.889 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.37 -4.22 76.65 Favored Glycine 0 C--N 1.342 0.878 0 C-N-CA 120.533 -0.841 . . . . 25.0 111.303 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 3.9 m -107.5 159.49 16.38 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.515 -1.661 . . . . 25.0 106.515 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.35 164.24 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 124.267 1.027 . . . . 25.0 109.203 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.5 t -87.36 119.31 27.48 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 105.151 -2.166 . . . . 25.0 105.151 174.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.48 176.44 48.17 Favored Glycine 0 C--O 1.255 1.454 0 C-N-CA 120.894 -0.67 . . . . 25.0 113.352 -173.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.01 -12.52 16.09 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 CA-C-O 124.671 1.863 . . . . 25.0 113.71 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -73.88 -13.17 60.87 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 113.705 -1.588 . . . . 25.0 109.345 173.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.34 14.5 47.74 Favored Glycine 0 C--O 1.251 1.187 0 CA-C-O 122.678 1.155 . . . . 25.0 111.963 174.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.425 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 45.4 m-85 -129.06 151.08 50.13 Favored 'General case' 0 C--O 1.204 -1.329 0 CA-C-N 113.474 -1.363 . . . . 25.0 113.098 -173.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 88.1 m -63.27 144.95 56.5 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 123.893 0.746 . . . . 25.0 111.125 172.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -2.088 0 CA-C-O 117.955 -1.47 . . . . 50.0 111.292 178.754 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 113.726 1.01 . . . . 25.0 113.726 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.06 63.9 7.72 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 O-C-N 123.094 1.05 . . . . 25.0 114.753 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.8 mm-40 -123.71 26.55 7.67 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.937 -2.246 . . . . 25.0 104.937 172.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.06 57.22 0.19 Allowed Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.723 -1.227 . . . . 25.0 114.132 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -124.36 172.63 8.98 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 106.743 -1.577 . . . . 25.0 106.743 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.68 -49.27 28.04 Favored Glycine 0 C--O 1.214 -1.147 0 O-C-N 124.895 1.372 . . . . 25.0 114.637 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -104.49 13.77 31.21 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 118.733 1.267 . . . . 25.0 110.357 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -122.37 81.87 1.9 Allowed 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 106.854 -1.536 . . . . 25.0 106.854 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.38 149.7 95.76 Favored Pre-proline 0 CA--C 1.562 1.413 0 N-CA-C 105.779 -1.934 . . . . 25.0 105.779 176.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.472 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 68.4 Cg_endo -73.33 165.63 32.04 Favored 'Trans proline' 0 CA--C 1.507 -0.87 0 C-N-CA 116.656 -1.762 . . . . 25.0 116.195 -177.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.0 m -97.97 130.64 44.81 Favored 'General case' 0 C--O 1.272 2.252 0 O-C-N 120.918 -1.114 . . . . 25.0 110.609 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 m -66.11 131.19 45.62 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 107.155 -1.424 . . . . 25.0 107.155 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.1 p -136.61 172.14 13.45 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.298 -1.319 . . . . 25.0 110.936 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 m -126.83 -22.06 3.93 Favored 'General case' 0 C--O 1.197 -1.664 0 N-CA-C 106.864 -1.532 . . . . 25.0 106.864 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -145.67 160.85 41.1 Favored 'General case' 0 C--O 1.264 1.863 0 C-N-CA 123.116 0.566 . . . . 25.0 109.684 -175.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -65.51 -27.03 68.18 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.117 0.784 . . . . 25.0 113.117 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 97.4 p -73.1 -12.45 60.91 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 121.173 -0.954 . . . . 25.0 111.078 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -71.13 -19.74 62.4 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 119.109 -1.036 . . . . 50.0 109.363 171.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.6 m -96.92 169.48 9.82 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.913 1.449 . . . . 25.0 114.913 -173.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.2 mt -71.26 168.48 17.22 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.645 -0.707 . . . . 25.0 109.764 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.78 124.95 20.91 Favored 'General case' 0 C--O 1.254 1.311 0 N-CA-C 113.788 1.033 . . . . 25.0 113.788 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.34 -9.82 75.56 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.623 -0.543 . . . . 25.0 112.916 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.8 m -99.86 156.84 16.91 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 106.201 -1.778 . . . . 25.0 106.201 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -128.52 167.78 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.957 0.903 . . . . 25.0 110.134 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.0 t -86.39 113.67 22.54 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 105.844 -1.909 . . . . 25.0 105.844 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.17 -179.13 52.73 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 119.37 -0.683 . . . . 25.0 114.116 -171.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.83 -13.33 21.85 Favored 'Trans proline' 0 C--O 1.21 -0.909 0 CA-C-N 119.652 1.726 . . . . 25.0 114.269 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -81.0 -6.93 59.38 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-N 114.102 -1.408 . . . . 25.0 109.865 174.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.87 20.33 59.75 Favored Glycine 0 C--O 1.254 1.362 0 CA-C-O 122.717 1.176 . . . . 25.0 112.537 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.472 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 44.3 m-85 -130.17 149.02 52.06 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.247 -1.476 . . . . 25.0 110.006 -176.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.6 m -62.92 146.87 51.97 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.154 -0.476 . . . . 25.0 112.216 175.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.893 0 CA-C-O 118.691 -1.06 . . . . 50.0 111.308 171.941 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 117.434 -1.269 . . . . 25.0 108.665 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.62 63.78 7.36 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 CA-C-N 120.8 1.321 . . . . 25.0 115.295 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -125.52 11.32 7.96 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 105.508 -2.034 . . . . 25.0 105.508 173.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -154.08 44.97 0.57 Allowed Glycine 0 N--CA 1.468 0.807 0 C-N-CA 120.031 -1.08 . . . . 25.0 114.792 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -104.86 174.47 5.86 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 104.637 -2.357 . . . . 25.0 104.637 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.17 -51.03 60.87 Favored Glycine 0 C--O 1.204 -1.768 0 O-C-N 124.637 1.211 . . . . 25.0 113.812 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.45 0.75 48.23 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 118.579 1.19 . . . . 25.0 111.9 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -105.77 88.14 2.75 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 106.437 -1.69 . . . . 25.0 106.437 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.62 149.35 98.35 Favored Pre-proline 0 CA--C 1.567 1.623 0 N-CA-C 104.518 -2.401 . . . . 25.0 104.518 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.446 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 55.9 Cg_endo -70.06 168.82 20.85 Favored 'Trans proline' 0 N--CA 1.479 0.621 0 N-CA-C 117.05 1.904 . . . . 25.0 117.05 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.2 m -100.44 128.26 46.55 Favored 'General case' 0 C--O 1.26 1.649 0 O-C-N 121.203 -0.936 . . . . 25.0 111.38 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.4 p -68.57 134.54 50.15 Favored 'General case' 0 C--O 1.26 1.627 0 N-CA-C 106.695 -1.595 . . . . 25.0 106.695 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.1 p -142.55 170.6 15.39 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.883 -1.053 . . . . 25.0 109.32 -176.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.1 m -130.51 -12.03 3.94 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 107.271 -1.381 . . . . 25.0 107.271 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -149.66 159.45 44.32 Favored 'General case' 0 C--O 1.256 1.4 0 C-N-CA 123.947 0.899 . . . . 25.0 108.905 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -61.84 -31.15 71.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 124.145 0.903 . . . . 25.0 111.18 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 t -68.99 -13.27 62.35 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 121.469 -0.769 . . . . 25.0 112.287 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -77.8 -8.25 57.76 Favored 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 120.123 -0.631 . . . . 50.0 110.347 174.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.1 m -104.91 171.74 7.16 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 116.654 2.094 . . . . 25.0 116.654 -172.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.435 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 83.5 mt -68.52 168.43 12.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 122.03 0.919 . . . . 25.0 110.855 177.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.64 124.5 20.88 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 114.011 1.115 . . . . 25.0 114.011 -177.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.19 -12.83 68.01 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 123.349 0.406 . . . . 25.0 112.732 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 4.5 m -90.08 160.13 16.46 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 106.638 -1.616 . . . . 25.0 106.638 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.9 m -128.76 171.89 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 124.617 1.167 . . . . 25.0 108.419 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.5 t -94.9 123.31 38.3 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 106.113 -1.81 . . . . 25.0 106.113 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.98 177.57 46.32 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 114.903 0.721 . . . . 25.0 114.903 -175.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.1 -8.4 16.49 Favored 'Trans proline' 0 C--O 1.211 -0.835 0 CA-C-O 124.414 1.756 . . . . 25.0 113.214 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -79.74 -9.83 59.7 Favored 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 113.909 -1.496 . . . . 25.0 110.201 171.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.92 16.25 58.26 Favored Glycine 0 CA--C 1.486 -1.753 0 CA-C-O 122.708 1.171 . . . . 25.0 113.411 175.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.446 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 45.3 m-85 -128.2 153.12 47.26 Favored 'General case' 0 C--O 1.201 -1.495 0 CA-C-N 113.792 -1.204 . . . . 25.0 111.21 -174.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.7 m -60.74 150.48 32.28 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 124.209 0.943 . . . . 25.0 110.432 172.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.728 0 CA-C-O 117.793 -1.559 . . . . 50.0 112.397 177.992 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.9 p . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 117.717 -1.135 . . . . 25.0 108.458 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.43 64.19 5.49 Favored 'Trans proline' 0 CA--C 1.556 1.591 0 N-CA-C 115.936 1.476 . . . . 25.0 115.936 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -118.5 5.14 11.72 Favored 'General case' 0 C--O 1.202 -1.446 0 N-CA-C 107.49 -1.3 . . . . 25.0 107.49 174.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -153.6 42.17 0.64 Allowed Glycine 0 C--O 1.214 -1.119 0 C-N-CA 120.091 -1.052 . . . . 25.0 115.493 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -98.08 167.99 10.54 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 104.651 -2.352 . . . . 25.0 104.651 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -42.38 -56.05 4.22 Favored Glycine 0 C--O 1.206 -1.602 0 O-C-N 125.393 1.683 . . . . 25.0 115.709 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -99.75 14.69 29.36 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 118.383 1.092 . . . . 25.0 112.451 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -115.78 83.71 1.98 Allowed 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 106.063 -1.828 . . . . 25.0 106.063 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.96 147.53 99.08 Favored Pre-proline 0 CA--C 1.561 1.377 0 N-CA-C 106.337 -1.727 . . . . 25.0 106.337 176.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.409 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 54.9 Cg_endo -74.5 171.33 18.34 Favored 'Trans proline' 0 CA--C 1.499 -1.263 0 C-N-CA 116.026 -2.183 . . . . 25.0 116.326 -175.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m -105.24 130.85 53.3 Favored 'General case' 0 C--O 1.278 2.568 0 O-C-N 120.967 -1.083 . . . . 25.0 111.233 178.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 p -69.81 139.51 53.19 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 105.733 -1.951 . . . . 25.0 105.733 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 p -142.65 170.05 16.44 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 113.87 -1.514 . . . . 25.0 108.724 -174.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.1 m -133.03 -8.74 3.04 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-N 114.74 -1.118 . . . . 25.0 108.54 174.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -149.65 159.68 44.13 Favored 'General case' 0 C--O 1.26 1.62 0 N-CA-C 108.398 -0.964 . . . . 25.0 108.398 176.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -63.47 -30.66 71.75 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.457 1.098 . . . . 25.0 111.526 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.1 t -63.15 -21.97 66.55 Favored 'General case' 0 CA--C 1.556 1.2 0 O-C-N 121.142 -0.973 . . . . 25.0 111.933 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -72.6 -9.4 58.54 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 120.023 -0.671 . . . . 50.0 111.15 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.9 m -103.21 -179.6 4.0 Favored 'General case' 0 CA--C 1.562 1.436 0 N-CA-C 114.513 1.301 . . . . 25.0 114.513 -173.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 75.5 mt -76.98 166.43 23.34 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.485 -1.302 . . . . 25.0 107.485 176.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.69 129.13 38.85 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.648 0.61 . . . . 25.0 112.648 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.91 5.85 76.77 Favored Glycine 0 CA--C 1.536 1.367 0 O-C-N 124.287 0.992 . . . . 25.0 111.685 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.6 m -118.73 156.08 29.97 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 106.959 -1.497 . . . . 25.0 106.959 178.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.73 166.57 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.807 0.843 . . . . 25.0 109.678 -175.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.2 t -86.33 110.48 19.7 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 105.715 -1.958 . . . . 25.0 105.715 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.32 178.27 49.14 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 120.885 -0.674 . . . . 25.0 113.389 -171.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -73.71 -10.58 23.53 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 CA-C-O 124.836 1.932 . . . . 25.0 115.238 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -69.13 -15.74 63.49 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-N 113.934 -1.485 . . . . 25.0 111.492 169.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.96 18.21 56.47 Favored Glycine 0 CA--C 1.492 -1.375 0 CA-C-O 123.3 1.5 . . . . 25.0 109.758 176.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.409 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 26.5 m-85 -135.27 150.54 50.05 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 112.535 -1.832 . . . . 25.0 108.817 -171.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 91.3 m -61.75 148.78 41.82 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.61 1.194 . . . . 25.0 110.805 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.756 0 CA-C-O 119.006 -0.885 . . . . 50.0 111.6 173.457 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.546 0 N-CA-C 109.75 -1.34 . . . . 25.0 109.75 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.8 p -68.4 156.8 89.59 Favored Pre-proline 0 N--CA 1.471 0.609 0 CA-C-N 118.569 1.184 . . . . 25.0 113.406 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -77.56 69.47 7.25 Favored 'Trans proline' 0 C--O 1.209 -0.94 0 CA-C-O 122.202 0.834 . . . . 25.0 113.849 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -123.88 12.63 9.12 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.246 -0.888 . . . . 25.0 109.127 173.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.63 51.54 0.44 Allowed Glycine 0 CA--C 1.496 -1.098 0 C-N-CA 119.941 -1.123 . . . . 25.0 114.094 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -112.38 176.49 5.0 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 107.152 -1.425 . . . . 25.0 107.152 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.98 -57.52 10.95 Favored Glycine 0 C--O 1.207 -1.551 0 O-C-N 125.282 1.614 . . . . 25.0 114.173 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -100.59 12.63 36.96 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 117.784 0.792 . . . . 25.0 110.596 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -116.5 79.22 1.29 Allowed 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 106.633 -1.617 . . . . 25.0 106.633 176.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.52 150.99 96.87 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 105.994 -1.854 . . . . 25.0 105.994 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.439 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 52.5 Cg_endo -72.85 166.46 29.93 Favored 'Trans proline' 0 CA--C 1.499 -1.249 0 C-N-CA 115.629 -2.447 . . . . 25.0 115.681 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.6 m -100.03 127.16 46.28 Favored 'General case' 0 C--O 1.261 1.663 0 O-C-N 121.014 -1.054 . . . . 25.0 111.074 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.5 p -66.16 132.83 49.38 Favored 'General case' 0 C--O 1.261 1.698 0 N-CA-C 106.311 -1.737 . . . . 25.0 106.311 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.7 p -141.32 170.07 16.41 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.207 1.003 . . . . 25.0 111.033 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.1 m -128.76 -14.61 4.53 Favored 'General case' 0 C--O 1.193 -1.906 0 CA-C-N 114.105 -1.407 . . . . 25.0 107.954 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -150.68 164.13 36.87 Favored 'General case' 0 C--O 1.26 1.648 0 N-CA-C 109.612 -0.514 . . . . 25.0 109.612 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -61.34 -30.23 70.39 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.32 1.012 . . . . 25.0 113.281 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.8 t -62.5 -23.28 66.85 Favored 'General case' 0 C--O 1.248 0.975 0 O-C-N 121.715 -0.616 . . . . 25.0 111.556 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -71.83 -9.9 58.99 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 118.307 0.503 . . . . 50.0 111.236 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.9 m -107.85 170.23 8.12 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 115.27 1.581 . . . . 25.0 115.27 -172.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.44 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 64.1 mt -71.19 167.83 18.53 Favored 'General case' 0 C--O 1.253 1.25 0 CA-C-O 121.579 0.704 . . . . 25.0 109.769 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.3 128.0 34.54 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 114.547 1.314 . . . . 25.0 114.547 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.63 -7.53 81.67 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 121.04 -0.6 . . . . 25.0 112.238 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 3.4 m -100.96 155.77 17.78 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 105.742 -1.947 . . . . 25.0 105.742 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.0 m -128.89 166.98 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.441 1.096 . . . . 25.0 108.279 -177.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.5 t -87.97 115.22 25.29 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 105.567 -2.012 . . . . 25.0 105.567 173.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.88 179.88 52.89 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.551 -0.749 . . . . 25.0 113.571 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.53 -13.54 22.53 Favored 'Trans proline' 0 C--O 1.201 -1.364 0 CA-C-O 124.915 1.964 . . . . 25.0 112.732 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -78.07 -7.43 56.93 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 113.365 -1.743 . . . . 25.0 110.931 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.98 22.95 62.52 Favored Glycine 0 C--O 1.251 1.182 0 CA-C-O 123.573 1.651 . . . . 25.0 112.587 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.439 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 17.6 m-85 -131.87 150.09 52.26 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 112.108 -2.046 . . . . 25.0 108.325 -174.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.4 m -66.05 147.76 52.85 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 123.878 0.736 . . . . 25.0 110.443 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.479 -2.194 0 CA-C-O 117.415 -1.769 . . . . 50.0 112.767 177.949 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.775 0 CA-C-O 118.12 -1.378 . . . . 25.0 109.66 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -147.14 164.54 22.71 Favored Pre-proline 0 N--CA 1.475 0.798 0 CA-C-O 117.242 -1.361 . . . . 25.0 109.226 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.34 69.25 7.25 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 N-CA-C 115.54 1.323 . . . . 25.0 115.54 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -122.51 6.2 9.54 Favored 'General case' 0 C--O 1.206 -1.205 0 N-CA-C 108.175 -1.046 . . . . 25.0 108.175 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.7 55.89 0.45 Allowed Glycine 0 CA--C 1.496 -1.128 0 C-N-CA 120.616 -0.802 . . . . 25.0 113.986 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -116.35 -169.85 1.7 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 105.889 -1.893 . . . . 25.0 105.889 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.91 -70.76 0.91 Allowed Glycine 0 C--O 1.196 -2.252 0 O-C-N 125.267 1.605 . . . . 25.0 112.288 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -86.54 4.29 40.64 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 118.071 0.936 . . . . 25.0 110.768 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -104.58 82.49 1.91 Allowed 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.072 -1.455 . . . . 25.0 107.072 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.55 151.02 96.78 Favored Pre-proline 0 C--O 1.253 1.27 0 N-CA-C 105.732 -1.951 . . . . 25.0 105.732 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.55 166.06 30.26 Favored 'Trans proline' 0 CA--C 1.496 -1.397 0 C-N-CA 115.41 -2.593 . . . . 25.0 115.92 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 m -102.08 127.86 48.8 Favored 'General case' 0 C--O 1.266 1.926 0 O-C-N 121.064 -1.023 . . . . 25.0 109.766 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.6 p -68.88 140.37 55.17 Favored 'General case' 0 C--O 1.255 1.393 0 N-CA-C 106.238 -1.764 . . . . 25.0 106.238 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.3 p -145.74 168.51 20.57 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.513 -0.767 . . . . 25.0 110.254 -174.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.5 m -131.46 -5.81 3.74 Favored 'General case' 0 C--O 1.198 -1.625 0 CA-C-N 115.244 -0.889 . . . . 25.0 108.651 176.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -154.91 159.88 40.76 Favored 'General case' 0 C--O 1.261 1.692 0 N-CA-C 108.522 -0.918 . . . . 25.0 108.522 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -63.54 -29.3 70.58 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.627 0.58 . . . . 25.0 112.04 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.3 t -63.92 -20.47 65.88 Favored 'General case' 0 C--O 1.254 1.339 0 N-CA-C 112.026 0.38 . . . . 25.0 112.026 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -72.98 -20.9 60.94 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-O 121.734 0.778 . . . . 50.0 110.769 177.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.5 m -94.99 172.88 7.88 Favored 'General case' 0 C--O 1.252 1.203 0 N-CA-C 116.485 2.031 . . . . 25.0 116.485 -170.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.456 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 60.8 mt -71.16 166.7 20.93 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 122.169 0.985 . . . . 25.0 109.716 176.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.97 128.71 36.9 Favored 'General case' 0 C--O 1.25 1.126 0 O-C-N 121.581 -0.7 . . . . 25.0 112.689 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.91 3.38 73.69 Favored Glycine 0 C--N 1.34 0.767 0 C-N-CA 121.177 -0.535 . . . . 25.0 112.21 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 4.0 m -112.92 164.41 13.46 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 105.792 -1.929 . . . . 25.0 105.792 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.8 m -134.93 170.97 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 108.001 -1.111 . . . . 25.0 108.001 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.2 t -89.51 122.12 32.38 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 105.043 -2.206 . . . . 25.0 105.043 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.02 -179.44 45.74 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.257 -0.746 . . . . 25.0 114.349 -172.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -77.11 -13.19 17.3 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 CA-C-O 125.583 2.243 . . . . 25.0 113.198 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -75.54 -11.62 60.06 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 113.241 -1.8 . . . . 25.0 110.605 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.41 17.44 62.34 Favored Glycine 0 C--O 1.251 1.207 0 CA-C-O 123.285 1.492 . . . . 25.0 113.499 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -127.72 150.54 49.73 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 112.711 -1.745 . . . . 25.0 108.661 -174.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 86.7 m -62.29 148.8 43.87 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.642 1.214 . . . . 25.0 110.577 172.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.48 -2.13 0 CA-C-O 118.745 -1.031 . . . . 50.0 110.552 177.214 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.235 0 CA-C-O 118.617 -1.102 . . . . 25.0 110.652 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.8 p -77.92 161.91 69.48 Favored Pre-proline 0 N--CA 1.474 0.745 0 CA-C-N 119.115 1.457 . . . . 25.0 114.231 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -78.49 66.24 8.51 Favored 'Trans proline' 0 CA--C 1.555 1.563 0 O-C-N 123.034 1.018 . . . . 25.0 113.992 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -119.69 -0.88 10.67 Favored 'General case' 0 C--O 1.197 -1.683 0 CA-C-N 114.689 -1.141 . . . . 25.0 108.607 172.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -136.89 50.87 0.82 Allowed Glycine 0 CA--C 1.502 -0.724 0 N-CA-C 115.007 0.763 . . . . 25.0 115.007 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -117.35 170.96 8.3 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.209 -1.404 . . . . 25.0 107.209 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.5 -51.65 53.2 Favored Glycine 0 C--O 1.215 -1.041 0 O-C-N 124.783 1.302 . . . . 25.0 113.415 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -94.74 11.17 32.31 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.836 1.318 . . . . 25.0 111.568 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -123.64 83.91 2.2 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 107.202 -1.407 . . . . 25.0 107.202 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.83 148.62 98.75 Favored Pre-proline 0 CA--C 1.563 1.476 0 N-CA-C 105.425 -2.065 . . . . 25.0 105.425 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 70.7 Cg_endo -73.81 166.94 28.47 Favored 'Trans proline' 0 N--CA 1.481 0.773 0 C-N-CA 115.803 -2.331 . . . . 25.0 116.404 -176.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.6 m -96.88 130.05 44.22 Favored 'General case' 0 C--O 1.26 1.622 0 O-C-N 121.576 -0.703 . . . . 25.0 110.437 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.9 p -70.07 137.67 51.41 Favored 'General case' 0 C--O 1.255 1.373 0 N-CA-C 106.03 -1.841 . . . . 25.0 106.03 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.8 p -141.38 170.84 14.96 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-O 122.027 0.918 . . . . 25.0 110.505 -175.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.4 m -123.6 -16.62 6.69 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.369 -1.287 . . . . 25.0 108.448 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -152.15 160.28 43.44 Favored 'General case' 0 C--O 1.266 1.921 0 N-CA-C 108.639 -0.874 . . . . 25.0 108.639 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -57.45 -35.13 69.72 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 124.144 0.902 . . . . 25.0 112.564 177.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -14.42 61.93 Favored 'General case' 0 C--O 1.259 1.576 0 O-C-N 120.944 -1.097 . . . . 25.0 113.775 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -77.67 -9.11 58.8 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 121.517 0.675 . . . . 50.0 109.407 175.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.1 m -104.37 172.46 6.79 Favored 'General case' 0 CA--C 1.555 1.161 0 O-C-N 119.912 -1.743 . . . . 25.0 114.981 -174.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 74.7 mt -71.7 166.96 20.87 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.318 0.58 . . . . 25.0 111.896 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.93 118.98 5.12 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 114.099 1.148 . . . . 25.0 114.099 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.2 -1.96 80.62 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 120.99 -0.624 . . . . 25.0 112.272 175.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.0 m -105.48 161.01 14.71 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.011 -2.218 . . . . 25.0 105.011 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.1 m -132.01 171.53 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 124.287 0.992 . . . . 25.0 109.368 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 29.8 t -94.72 115.45 27.54 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 105.852 -1.907 . . . . 25.0 105.852 174.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.8 176.69 52.24 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 119.268 -0.74 . . . . 25.0 114.1 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.46 -12.07 20.64 Favored 'Trans proline' 0 C--O 1.211 -0.835 0 CA-C-O 124.45 1.771 . . . . 25.0 114.204 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -74.47 -10.0 59.13 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-N 114.437 -1.256 . . . . 25.0 110.049 173.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.45 18.71 47.96 Favored Glycine 0 CA--C 1.498 -1.023 0 CA-C-O 122.693 1.163 . . . . 25.0 112.899 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 42.0 m-85 -135.88 153.28 51.51 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 112.48 -1.86 . . . . 25.0 110.486 -174.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.7 m -60.34 147.08 41.82 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.936 0.772 . . . . 25.0 110.469 173.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -2.015 0 CA-C-O 118.312 -1.271 . . . . 50.0 110.788 179.622 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.965 0 CA-C-O 117.633 -1.648 . . . . 25.0 110.988 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.4 p -69.35 159.82 81.72 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 119.462 1.631 . . . . 25.0 113.62 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.94 61.85 7.23 Favored 'Trans proline' 0 CA--C 1.554 1.522 0 N-CA-C 114.836 1.052 . . . . 25.0 114.836 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -120.83 24.61 10.14 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 105.323 -2.103 . . . . 25.0 105.323 172.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.1 69.32 0.16 Allowed Glycine 0 CA--C 1.497 -1.039 0 C-N-CA 120.395 -0.907 . . . . 25.0 112.368 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 44.4 mmt-85 -131.6 -177.67 4.52 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.227 -1.027 . . . . 25.0 108.227 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.68 -60.18 9.46 Favored Glycine 0 C--O 1.199 -2.078 0 O-C-N 125.18 1.55 . . . . 25.0 112.845 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -99.28 13.82 31.76 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 118.515 1.157 . . . . 25.0 111.088 -175.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -119.5 88.29 2.9 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 106.704 -1.591 . . . . 25.0 106.704 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.14 150.56 97.38 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 104.461 -2.422 . . . . 25.0 104.461 175.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.466 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 66.5 Cg_endo -70.86 164.65 34.89 Favored 'Trans proline' 0 CA--C 1.487 -1.83 0 C-N-CA 115.156 -2.763 . . . . 25.0 115.184 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.1 m -98.19 130.76 44.92 Favored 'General case' 0 C--O 1.254 1.327 0 CA-C-N 116.103 -0.498 . . . . 25.0 111.606 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.1 p -71.06 139.67 50.48 Favored 'General case' 0 C--O 1.251 1.151 0 N-CA-C 105.842 -1.91 . . . . 25.0 105.842 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.3 p -141.9 173.23 11.7 Favored 'General case' 0 CA--C 1.572 1.805 0 CA-C-O 122.386 1.088 . . . . 25.0 110.35 -175.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.8 m -132.74 -12.06 3.0 Favored 'General case' 0 C--O 1.201 -1.496 0 CA-C-N 114.407 -1.27 . . . . 25.0 108.064 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -149.42 157.17 43.07 Favored 'General case' 0 C--O 1.257 1.457 0 N-CA-C 107.946 -1.131 . . . . 25.0 107.946 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -60.09 -33.62 72.35 Favored 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 123.99 0.806 . . . . 25.0 111.489 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -63.1 -22.82 67.12 Favored 'General case' 0 C--O 1.248 1.026 0 O-C-N 121.246 -0.909 . . . . 25.0 111.804 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -63.57 -27.16 69.06 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.855 0.836 . . . . 50.0 109.031 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.6 m -89.14 176.03 7.14 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 114.414 1.265 . . . . 25.0 114.414 -172.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 78.5 mt -77.64 167.01 22.28 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-O 122.019 0.914 . . . . 25.0 110.359 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.62 125.02 22.9 Favored 'General case' 0 C--O 1.252 1.21 0 N-CA-C 113.213 0.82 . . . . 25.0 113.213 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.12 -8.73 57.58 Favored Glycine 0 C--O 1.244 0.756 0 N-CA-C 110.643 -0.983 . . . . 25.0 110.643 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -113.06 157.55 21.43 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 107.67 -1.234 . . . . 25.0 107.67 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.9 m -131.89 167.89 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 123.787 0.835 . . . . 25.0 109.708 -176.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.1 t -88.15 110.93 21.06 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 106.135 -1.802 . . . . 25.0 106.135 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.21 174.2 54.65 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.323 -0.853 . . . . 25.0 113.314 -173.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.76 -14.75 19.44 Favored 'Trans proline' 0 C--O 1.207 -1.036 0 CA-C-O 124.505 1.794 . . . . 25.0 114.803 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -70.34 -15.68 62.9 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 113.489 -1.687 . . . . 25.0 109.649 172.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.63 16.42 36.74 Favored Glycine 0 C--O 1.255 1.424 0 O-C-N 124.455 1.097 . . . . 25.0 112.846 176.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.466 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 67.2 m-85 -131.57 151.46 51.58 Favored 'General case' 0 C--O 1.203 -1.386 0 CA-C-N 113.557 -1.322 . . . . 25.0 113.16 -174.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 86.2 m -60.02 143.48 51.78 Favored 'General case' 0 C--N 1.311 -1.066 0 O-C-N 124.076 0.86 . . . . 25.0 111.075 173.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.48 -2.126 0 CA-C-O 118.346 -1.252 . . . . 50.0 111.474 179.203 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.543 0 N-CA-C 109.637 -1.385 . . . . 25.0 109.637 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.64 176.0 2.6 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 106.839 -1.541 . . . . 25.0 106.839 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.83 49.71 2.27 Favored 'Trans proline' 0 CA--C 1.563 1.963 0 CA-C-N 120.71 1.289 . . . . 25.0 114.527 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -121.6 -2.86 9.35 Favored 'General case' 0 C--O 1.204 -1.34 0 C-N-CA 125.01 1.324 . . . . 25.0 107.524 170.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -142.61 50.61 0.7 Allowed Glycine 0 C--O 1.236 0.249 0 N-CA-C 115.208 0.843 . . . . 25.0 115.208 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -119.9 176.17 5.54 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.558 -1.275 . . . . 25.0 107.558 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.76 -48.55 65.71 Favored Glycine 0 C--O 1.214 -1.137 0 O-C-N 125.402 1.688 . . . . 25.0 114.282 -176.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -103.8 7.99 37.11 Favored 'General case' 0 C--O 1.249 1.069 0 CA-C-N 119.136 1.468 . . . . 25.0 109.842 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.8 m-90 -113.54 84.51 2.03 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.827 -1.175 . . . . 25.0 107.827 -176.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.48 151.68 96.93 Favored Pre-proline 0 CA--C 1.566 1.585 0 CA-C-N 113.428 -1.715 . . . . 25.0 106.793 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.424 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 79.6 Cg_endo -76.64 169.18 22.29 Favored 'Trans proline' 0 CA--C 1.511 -0.638 0 N-CA-C 116.205 1.579 . . . . 25.0 116.205 -176.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.3 m -105.93 131.43 53.24 Favored 'General case' 0 C--O 1.254 1.307 0 O-C-N 121.178 -0.952 . . . . 25.0 110.355 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.1 p -67.29 136.76 55.39 Favored 'General case' 0 C--O 1.257 1.47 0 N-CA-C 106.727 -1.582 . . . . 25.0 106.727 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.3 p -142.2 169.85 16.82 Favored 'General case' 0 CA--C 1.555 1.135 0 CA-C-O 122.747 1.26 . . . . 25.0 110.873 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.3 m -128.42 -15.01 4.65 Favored 'General case' 0 C--O 1.198 -1.653 0 CA-C-N 114.02 -1.446 . . . . 25.0 108.19 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -148.59 159.27 44.24 Favored 'General case' 0 C--O 1.258 1.506 0 N-CA-C 108.511 -0.922 . . . . 25.0 108.511 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -62.32 -29.54 70.52 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.134 0.896 . . . . 25.0 112.212 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.9 t -66.59 -16.29 64.07 Favored 'General case' 0 C--O 1.254 1.336 0 O-C-N 120.843 -1.161 . . . . 25.0 111.673 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -73.21 -15.19 61.45 Favored 'General case' 0 CA--C 1.557 1.216 0 CA-C-O 121.657 0.741 . . . . 50.0 109.999 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.4 m -99.55 176.04 5.62 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 115.187 1.551 . . . . 25.0 115.187 -172.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 79.4 mt -78.07 170.9 15.84 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.659 0.742 . . . . 25.0 110.538 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.63 121.58 14.26 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 113.25 0.833 . . . . 25.0 113.25 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.07 0.01 63.9 Favored Glycine 0 CA--C 1.525 0.659 0 O-C-N 124.275 0.985 . . . . 25.0 112.263 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.6 m -113.29 159.51 19.29 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 108.033 -1.099 . . . . 25.0 108.033 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.2 m -132.58 170.34 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 124.276 0.985 . . . . 25.0 109.872 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.1 t -89.39 111.65 22.56 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 107.016 -1.475 . . . . 25.0 107.016 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.51 177.7 48.8 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 114.525 0.57 . . . . 25.0 114.525 -173.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.35 -10.17 19.02 Favored 'Trans proline' 0 C--O 1.21 -0.919 0 CA-C-O 124.867 1.945 . . . . 25.0 114.085 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -78.43 -13.68 59.73 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 112.919 -1.946 . . . . 25.0 110.879 171.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.55 20.31 45.05 Favored Glycine 0 CA--C 1.501 -0.785 0 CA-C-N 115.728 -0.669 . . . . 25.0 113.533 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.424 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 37.1 m-85 -131.71 146.88 52.4 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.964 -1.118 . . . . 25.0 110.831 -174.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.7 m -64.44 145.52 55.95 Favored 'General case' 0 C--N 1.317 -0.835 0 O-C-N 124.253 0.971 . . . . 25.0 112.917 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.735 0 CA-C-O 118.355 -1.247 . . . . 50.0 110.708 174.442 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.378 0 CA-C-O 118.325 -1.264 . . . . 25.0 110.165 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.7 p -74.35 161.79 76.62 Favored Pre-proline 0 N--CA 1.472 0.655 0 CA-C-N 119.557 1.679 . . . . 25.0 111.675 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.42 73.2 5.66 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 N-CA-C 114.616 0.968 . . . . 25.0 114.616 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -127.82 30.14 5.33 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.47 -1.678 . . . . 25.0 106.47 173.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.55 50.26 0.21 Allowed Glycine 0 CA--C 1.497 -1.055 0 C-N-CA 119.618 -1.277 . . . . 25.0 113.398 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -121.55 174.03 7.04 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.932 -0.766 . . . . 25.0 108.932 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -51.19 -50.44 39.91 Favored Glycine 0 C--O 1.207 -1.576 0 O-C-N 125.317 1.635 . . . . 25.0 113.722 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -101.62 0.59 36.53 Favored 'General case' 0 CA--C 1.558 1.27 0 CA-C-N 119.578 1.689 . . . . 25.0 110.917 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.1 m-90 -116.17 81.07 1.55 Allowed 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 107.352 -1.351 . . . . 25.0 107.352 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.03 154.63 94.07 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 104.394 -2.447 . . . . 25.0 104.394 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.438 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 50.9 Cg_endo -72.39 172.5 14.85 Favored 'Trans proline' 0 CA--C 1.508 -0.813 0 N-CA-C 116.713 1.774 . . . . 25.0 116.713 -177.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -106.25 133.23 51.27 Favored 'General case' 0 C--O 1.266 1.958 0 CA-C-N 115.887 -0.597 . . . . 25.0 110.458 176.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.0 p -70.29 141.64 52.35 Favored 'General case' 0 C--O 1.259 1.567 0 N-CA-C 107.286 -1.376 . . . . 25.0 107.286 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.9 p -144.48 172.29 13.16 Favored 'General case' 0 CA--C 1.556 1.177 0 CA-C-N 114.574 -1.193 . . . . 25.0 109.814 -175.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.1 m -128.1 -12.87 5.16 Favored 'General case' 0 C--O 1.2 -1.517 0 CA-C-N 114.619 -1.173 . . . . 25.0 107.915 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -151.13 162.66 40.46 Favored 'General case' 0 C--O 1.258 1.52 0 C-N-CA 124.116 0.967 . . . . 25.0 110.185 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -63.07 -29.25 70.66 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.5 1.125 . . . . 25.0 112.877 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 t -71.4 -12.39 61.39 Favored 'General case' 0 C--O 1.253 1.258 0 O-C-N 121.919 -0.488 . . . . 25.0 110.682 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -76.03 -12.7 60.17 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 121.639 0.733 . . . . 50.0 110.969 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.3 m -101.27 172.89 6.72 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.917 1.821 . . . . 25.0 115.917 -170.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.4 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 83.5 mt -69.83 168.14 15.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.674 0.749 . . . . 25.0 110.077 176.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.9 122.0 11.23 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 115.138 1.533 . . . . 25.0 115.138 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.37 -9.51 76.71 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 123.983 0.802 . . . . 25.0 112.876 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 2.1 m -95.68 151.88 18.96 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 m -124.34 165.69 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.844 0.858 . . . . 25.0 110.463 -176.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.2 t -86.83 114.88 23.86 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 105.198 -2.149 . . . . 25.0 105.198 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.17 178.39 53.88 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 115.883 -0.598 . . . . 25.0 112.888 -173.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.52 -11.78 18.73 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 CA-C-O 124.432 1.763 . . . . 25.0 114.213 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -78.18 -8.28 58.11 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 113.381 -1.736 . . . . 25.0 110.412 172.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.53 17.98 63.0 Favored Glycine 0 C--O 1.25 1.097 0 CA-C-O 122.82 1.234 . . . . 25.0 112.858 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.438 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 39.0 m-85 -126.31 149.76 48.94 Favored 'General case' 0 C--O 1.206 -1.208 0 CA-C-N 112.962 -1.619 . . . . 25.0 109.079 -176.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.5 m -64.5 149.82 47.86 Favored 'General case' 0 C--N 1.317 -0.822 0 O-C-N 124.41 1.069 . . . . 25.0 110.316 174.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.647 0 CA-C-O 118.641 -1.088 . . . . 50.0 113.44 175.332 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.992 0 N-CA-C 109.371 -1.491 . . . . 25.0 109.371 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.2 p -141.49 161.75 50.77 Favored Pre-proline 0 N--CA 1.483 1.181 0 CA-C-O 117.089 -1.434 . . . . 25.0 108.804 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -78.59 57.72 6.45 Favored 'Trans proline' 0 N--CA 1.486 1.039 0 N-CA-C 115.844 1.44 . . . . 25.0 115.844 -174.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -124.42 8.12 8.39 Favored 'General case' 0 C--O 1.2 -1.519 0 N-CA-C 108.905 -0.776 . . . . 25.0 108.905 170.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.94 46.93 0.68 Allowed Glycine 0 C--O 1.218 -0.878 0 C-N-CA 120.664 -0.779 . . . . 25.0 114.939 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 mmp_? -108.79 -164.27 0.93 Allowed 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 105.632 -1.988 . . . . 25.0 105.632 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.02 -72.78 0.57 Allowed Glycine 0 C--O 1.205 -1.709 0 O-C-N 125.197 1.561 . . . . 25.0 112.755 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -97.86 10.94 38.95 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.431 1.115 . . . . 25.0 110.209 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -95.61 79.28 3.37 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 105.447 -2.057 . . . . 25.0 105.447 176.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.64 148.49 96.8 Favored Pre-proline 0 CA--C 1.558 1.288 0 CA-C-N 113.821 -1.536 . . . . 25.0 106.936 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.5 171.89 17.37 Favored 'Trans proline' 0 N--CA 1.482 0.795 0 N-CA-C 116.853 1.828 . . . . 25.0 116.853 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.0 m -106.62 130.0 54.44 Favored 'General case' 0 C--O 1.261 1.686 0 CA-C-N 115.184 -0.917 . . . . 25.0 110.55 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.7 p -68.48 130.53 43.15 Favored 'General case' 0 C--O 1.26 1.652 0 N-CA-C 105.735 -1.95 . . . . 25.0 105.735 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.6 p -136.39 173.23 11.93 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 122.574 1.178 . . . . 25.0 110.966 -173.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.5 m -131.31 -14.3 3.36 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 114.264 -1.334 . . . . 25.0 107.833 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -151.02 161.45 42.71 Favored 'General case' 0 C--O 1.253 1.262 0 O-C-N 121.026 -1.046 . . . . 25.0 109.977 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -63.36 -30.57 71.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 124.316 1.01 . . . . 25.0 112.58 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.1 t -65.51 -19.73 66.05 Favored 'General case' 0 C--O 1.252 1.19 0 O-C-N 121.648 -0.657 . . . . 25.0 111.487 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -72.61 -17.62 61.66 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-O 121.802 0.811 . . . . 50.0 110.169 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.1 m -103.54 176.39 5.17 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 115.221 1.563 . . . . 25.0 115.221 -170.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.3 mt -74.98 168.56 19.72 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 122.081 0.943 . . . . 25.0 111.159 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.01 136.21 53.51 Favored 'General case' 0 C--O 1.268 2.031 0 O-C-N 121.271 -0.893 . . . . 25.0 109.604 172.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.86 -9.9 76.43 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 111.831 -0.508 . . . . 25.0 111.831 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.2 m -108.54 158.42 17.57 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 104.518 -2.401 . . . . 25.0 104.518 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.07 171.21 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 106.523 -1.658 . . . . 25.0 106.523 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.8 t -84.69 115.06 22.47 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 105.338 -2.097 . . . . 25.0 105.338 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.24 175.56 54.6 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 112.397 -0.281 . . . . 25.0 112.397 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.92 -13.86 19.41 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 CA-C-O 125.358 2.149 . . . . 25.0 114.592 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -75.75 -10.73 59.68 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 113.595 -1.639 . . . . 25.0 111.151 172.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.47 18.83 51.42 Favored Glycine 0 CA--C 1.494 -1.276 0 CA-C-O 122.535 1.075 . . . . 25.0 112.794 174.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -127.9 150.7 49.75 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.644 -1.278 . . . . 25.0 109.146 -177.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.4 m -61.64 146.79 47.91 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 123.723 0.64 . . . . 25.0 110.555 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.905 0 CA-C-O 117.56 -1.689 . . . . 50.0 111.716 174.954 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.85 0 N-CA-C 109.64 -1.384 . . . . 25.0 109.64 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 p -152.05 162.74 25.76 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-O 117.177 -1.392 . . . . 25.0 108.823 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.85 55.03 5.09 Favored 'Trans proline' 0 N--CA 1.488 1.167 0 N-CA-C 115.338 1.246 . . . . 25.0 115.338 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -115.37 19.36 15.55 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 106.607 -1.627 . . . . 25.0 106.607 175.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -158.46 40.53 0.51 Allowed Glycine 0 C--N 1.319 -0.394 0 C-N-CA 119.253 -1.451 . . . . 25.0 116.649 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -93.97 171.39 8.89 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.663 -1.606 . . . . 25.0 106.663 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.22 -55.73 14.9 Favored Glycine 0 C--O 1.201 -1.957 0 O-C-N 125.303 1.627 . . . . 25.0 113.413 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -105.35 27.6 8.15 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 117.867 0.834 . . . . 25.0 112.195 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -120.71 85.88 2.47 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 105.697 -1.964 . . . . 25.0 105.697 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.58 137.36 95.14 Favored Pre-proline 0 C--O 1.261 1.688 0 N-CA-C 106.943 -1.503 . . . . 25.0 106.943 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.424 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 70.0 Cg_endo -73.28 168.51 24.57 Favored 'Trans proline' 0 CA--C 1.505 -0.958 0 N-CA-C 117.017 1.891 . . . . 25.0 117.017 -175.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.5 m -94.71 129.03 41.79 Favored 'General case' 0 C--O 1.263 1.769 0 CA-C-N 115.301 -0.863 . . . . 25.0 111.453 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 p -72.01 134.31 45.83 Favored 'General case' 0 C--O 1.255 1.365 0 N-CA-C 106.065 -1.828 . . . . 25.0 106.065 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.7 p -138.16 170.13 16.58 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-O 121.872 0.844 . . . . 25.0 109.715 -173.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.1 m -125.84 -16.78 5.58 Favored 'General case' 0 C--O 1.204 -1.331 0 N-CA-C 106.879 -1.526 . . . . 25.0 106.879 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -149.29 160.76 43.12 Favored 'General case' 0 C--O 1.262 1.716 0 CA-C-N 118.7 0.682 . . . . 25.0 109.335 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -59.76 -30.26 68.74 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.816 0.817 . . . . 25.0 112.296 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -1.67 22.85 Favored 'General case' 0 C--O 1.264 1.857 0 O-C-N 121.186 -0.946 . . . . 25.0 112.958 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -87.2 -9.57 54.83 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 121.683 0.754 . . . . 50.0 109.629 170.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.7 m -103.31 175.64 5.41 Favored 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 116.028 1.862 . . . . 25.0 116.028 -170.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 87.2 mt -71.36 162.6 29.17 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.441 0.639 . . . . 25.0 110.034 177.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.97 124.55 19.06 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 114.863 1.431 . . . . 25.0 114.863 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.17 -7.94 80.96 Favored Glycine 0 CA--C 1.529 0.933 0 O-C-N 124.28 0.987 . . . . 25.0 112.634 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 3.7 m -98.82 159.37 15.0 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 107.914 -1.143 . . . . 25.0 107.914 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.1 m -127.76 166.53 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.691 1.196 . . . . 25.0 109.895 -175.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.3 t -87.54 116.41 25.64 Favored 'General case' 0 C--O 1.255 1.355 0 N-CA-C 105.424 -2.065 . . . . 25.0 105.424 172.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.38 176.21 49.86 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 116.753 -0.203 . . . . 25.0 112.786 -173.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -75.25 -14.17 20.68 Favored 'Trans proline' 0 C--O 1.204 -1.185 0 CA-C-O 124.103 1.626 . . . . 25.0 114.068 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -72.16 -14.46 61.82 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 113.763 -1.562 . . . . 25.0 111.033 173.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.83 12.96 54.88 Favored Glycine 0 CA--C 1.503 -0.699 0 CA-C-O 122.207 0.893 . . . . 25.0 113.238 174.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.424 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 64.6 m-85 -130.47 155.74 45.95 Favored 'General case' 0 C--O 1.206 -1.212 0 CA-C-N 113.415 -1.392 . . . . 25.0 110.284 -174.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 94.0 m -61.92 148.92 42.06 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 124.033 0.833 . . . . 25.0 109.532 173.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.837 0 N-CA-C 109.745 -1.342 . . . . 50.0 109.745 179.382 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.55 0 N-CA-C 109.55 -1.42 . . . . 25.0 109.55 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.1 p -145.99 161.05 41.42 Favored Pre-proline 0 N--CA 1.481 1.077 0 CA-C-O 118.201 -0.904 . . . . 25.0 110.915 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.9 70.21 5.27 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 N-CA-C 115.194 1.19 . . . . 25.0 115.194 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -124.26 8.61 8.51 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.904 0.859 . . . . 25.0 110.203 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.39 49.02 0.48 Allowed Glycine 0 CA--C 1.497 -1.08 0 N-CA-C 116.415 1.326 . . . . 25.0 116.415 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 71.1 mtp85 -105.75 174.41 5.89 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.6 -2.0 . . . . 25.0 105.6 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -42.37 -61.59 2.39 Favored Glycine 0 C--O 1.209 -1.45 0 O-C-N 125.099 1.5 . . . . 25.0 114.668 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -99.26 4.41 46.58 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.243 1.022 . . . . 25.0 111.656 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -98.09 80.85 2.74 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 106.198 -1.778 . . . . 25.0 106.198 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.64 147.76 98.9 Favored Pre-proline 0 CA--C 1.559 1.308 0 N-CA-C 104.806 -2.294 . . . . 25.0 104.806 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.472 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 57.4 Cg_endo -72.94 166.98 28.54 Favored 'Trans proline' 0 CA--C 1.503 -1.046 0 C-N-CA 115.73 -2.38 . . . . 25.0 116.295 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.1 m -94.31 125.93 39.25 Favored 'General case' 0 C--O 1.266 1.94 0 O-C-N 121.33 -0.857 . . . . 25.0 110.395 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 p -67.12 136.28 54.88 Favored 'General case' 0 C--O 1.257 1.49 0 N-CA-C 106.643 -1.614 . . . . 25.0 106.643 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.6 p -143.98 171.82 13.73 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-O 122.824 1.297 . . . . 25.0 110.843 -175.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -130.52 -13.43 3.81 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 114.133 -1.394 . . . . 25.0 108.438 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -150.82 159.33 44.61 Favored 'General case' 0 C--O 1.259 1.602 0 C-N-CA 123.947 0.899 . . . . 25.0 109.218 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -60.64 -31.75 70.94 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 114.062 1.134 . . . . 25.0 114.062 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -15.98 64.05 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 113.036 0.754 . . . . 25.0 113.036 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -73.88 -18.21 60.95 Favored 'General case' 0 CA--C 1.563 1.478 0 O-C-N 124.042 0.838 . . . . 50.0 110.648 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.2 m -95.25 178.24 5.59 Favored 'General case' 0 CA--C 1.557 1.249 0 O-C-N 120.03 -1.669 . . . . 25.0 114.975 -170.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.2 mt -75.58 167.85 21.11 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 121.61 0.719 . . . . 25.0 109.373 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.72 121.78 11.24 Favored 'General case' 0 C--O 1.251 1.163 0 N-CA-C 114.815 1.413 . . . . 25.0 114.815 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.74 -7.29 82.35 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.08 -0.581 . . . . 25.0 113.633 175.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.2 m -95.31 160.43 14.54 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 105.521 -2.029 . . . . 25.0 105.521 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.4 m -129.21 169.36 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.758 0.823 . . . . 25.0 110.429 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 19.3 t -90.54 114.26 26.43 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 106.677 -1.601 . . . . 25.0 106.677 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.85 174.66 53.99 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 115.651 -0.704 . . . . 25.0 114.076 -173.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -73.41 -15.09 25.15 Favored 'Trans proline' 0 C--O 1.213 -0.762 0 CA-C-O 124.552 1.813 . . . . 25.0 114.603 -177.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -74.94 -7.78 54.59 Favored 'General case' 0 CA--C 1.559 1.315 0 CA-C-N 113.896 -1.502 . . . . 25.0 111.157 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.4 12.65 58.24 Favored Glycine 0 C--O 1.247 0.966 0 CA-C-O 122.657 1.143 . . . . 25.0 113.494 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.472 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 57.4 m-85 -130.92 154.66 47.87 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 113.491 -1.355 . . . . 25.0 111.402 -174.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 86.2 m -63.71 146.87 53.02 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.855 0.722 . . . . 25.0 110.628 174.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.649 0 N-CA-C 110.171 -1.172 . . . . 50.0 110.171 -178.649 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.792 0 N-CA-C 109.684 -1.366 . . . . 25.0 109.684 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -148.15 165.7 17.65 Favored Pre-proline 0 N--CA 1.476 0.843 0 CA-C-O 117.481 -1.247 . . . . 25.0 108.554 -177.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -77.55 59.95 6.93 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 N-CA-C 115.67 1.373 . . . . 25.0 115.67 -175.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -131.26 19.25 4.87 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 106.251 -1.759 . . . . 25.0 106.251 174.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.46 50.81 0.32 Allowed Glycine 0 CA--C 1.495 -1.175 0 C-N-CA 119.766 -1.207 . . . . 25.0 114.344 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -119.19 -169.31 1.72 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.982 -0.748 . . . . 25.0 108.982 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.94 -64.34 4.27 Favored Glycine 0 C--O 1.201 -1.96 0 O-C-N 125.036 1.46 . . . . 25.0 113.183 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -102.77 26.72 7.7 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.758 1.279 . . . . 25.0 110.354 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -127.81 81.12 2.0 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 105.668 -1.975 . . . . 25.0 105.668 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.88 152.75 95.37 Favored Pre-proline 0 C--O 1.254 1.292 0 CA-C-N 112.889 -1.959 . . . . 25.0 105.875 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.428 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 73.6 Cg_endo -74.58 170.45 20.26 Favored 'Trans proline' 0 CA--C 1.506 -0.925 0 C-N-CA 116.145 -2.103 . . . . 25.0 115.579 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.6 m -108.73 129.21 55.36 Favored 'General case' 0 C--O 1.26 1.639 0 O-C-N 121.7 -0.625 . . . . 25.0 110.899 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.8 p -66.28 133.63 50.97 Favored 'General case' 0 C--O 1.262 1.763 0 N-CA-C 106.245 -1.761 . . . . 25.0 106.245 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.6 p -139.81 176.58 8.62 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 122.143 0.973 . . . . 25.0 110.258 -174.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.0 m -132.39 -15.9 2.78 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 114.484 -1.235 . . . . 25.0 108.68 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -153.37 162.93 40.77 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 108.031 -1.1 . . . . 25.0 108.031 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -62.96 -32.22 73.49 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 113.806 1.039 . . . . 25.0 113.806 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.89 -10.15 59.08 Favored 'General case' 0 C--O 1.252 1.232 0 O-C-N 121.118 -0.989 . . . . 25.0 113.024 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -75.69 -15.67 60.27 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.239 1.019 . . . . 50.0 110.072 172.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 54.1 m -99.91 177.2 5.18 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 115.125 1.528 . . . . 25.0 115.125 -171.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.6 mt -75.57 168.87 19.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.457 -0.792 . . . . 25.0 112.662 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.38 121.56 9.86 Favored 'General case' 0 C--O 1.254 1.312 0 N-CA-C 113.416 0.895 . . . . 25.0 113.416 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.42 -10.38 74.94 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 120.0 -0.333 . . . . 25.0 113.043 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.4 m -89.26 156.3 18.84 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 106.413 -1.699 . . . . 25.0 106.413 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.8 m -129.38 164.55 31.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 106.581 -1.637 . . . . 25.0 106.581 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 18.3 t -87.59 115.07 24.78 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 104.4 -2.444 . . . . 25.0 104.4 174.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.37 179.3 53.21 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 120.668 -0.777 . . . . 25.0 114.408 -172.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.41 -13.63 22.8 Favored 'Trans proline' 0 C--O 1.206 -1.102 0 CA-C-O 124.868 1.945 . . . . 25.0 113.828 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -74.42 -9.85 58.99 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-N 112.931 -1.94 . . . . 25.0 111.816 171.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.46 22.24 58.88 Favored Glycine 0 CA--C 1.498 -0.996 0 CA-C-O 122.605 1.114 . . . . 25.0 112.416 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.428 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 15.0 m-85 -135.89 147.28 48.11 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 112.996 -1.602 . . . . 25.0 109.514 -173.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 92.4 m -61.5 147.68 44.49 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.686 0.616 . . . . 25.0 110.607 174.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.824 0 CA-C-O 117.24 -1.867 . . . . 50.0 110.608 175.306 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.711 0 CA-C-O 118.159 -1.356 . . . . 25.0 110.087 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.2 p -138.95 163.54 45.67 Favored Pre-proline 0 N--CA 1.481 1.103 0 CA-C-O 117.5 -1.238 . . . . 25.0 108.8 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.33 65.36 7.96 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 N-CA-C 114.762 1.024 . . . . 25.0 114.762 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -124.65 21.08 8.52 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 105.548 -2.019 . . . . 25.0 105.548 170.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.58 53.26 0.31 Allowed Glycine 0 CA--C 1.5 -0.877 0 CA-C-O 122.569 1.094 . . . . 25.0 113.209 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.8 mmm-85 -128.23 164.14 23.2 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 106.024 -1.843 . . . . 25.0 106.024 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -45.91 -55.1 7.57 Favored Glycine 0 C--O 1.203 -1.802 0 O-C-N 125.42 1.7 . . . . 25.0 114.572 -174.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -99.02 17.73 19.0 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 119.101 1.451 . . . . 25.0 110.316 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -126.53 78.6 1.8 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 107.35 -1.352 . . . . 25.0 107.35 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.02 151.06 95.96 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 103.911 -2.625 . . . . 25.0 103.911 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.42 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 58.1 Cg_endo -72.78 169.56 21.72 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 N-CA-C 116.971 1.873 . . . . 25.0 116.971 -175.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.9 m -100.05 128.76 46.09 Favored 'General case' 0 C--O 1.259 1.572 0 CA-C-N 115.655 -0.702 . . . . 25.0 110.553 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.2 p -68.33 137.72 54.86 Favored 'General case' 0 C--O 1.262 1.762 0 N-CA-C 107.051 -1.463 . . . . 25.0 107.051 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.1 p -142.16 170.39 15.79 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.14 0.971 . . . . 25.0 112.542 -175.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.5 m -128.27 -15.4 4.65 Favored 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 107.476 -1.305 . . . . 25.0 107.476 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -149.36 161.49 41.96 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 123.734 0.814 . . . . 25.0 109.218 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -64.38 -28.14 69.49 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 124.628 1.205 . . . . 25.0 112.496 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.4 t -65.43 -19.83 66.11 Favored 'General case' 0 C--O 1.258 1.529 0 O-C-N 121.63 -0.669 . . . . 25.0 111.137 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -71.0 -17.19 62.65 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 122.28 1.038 . . . . 50.0 111.7 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.3 m -97.52 174.22 6.77 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 120.592 -1.317 . . . . 25.0 114.233 -171.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.4 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 37.3 mt -69.74 167.41 17.17 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 121.588 0.709 . . . . 25.0 109.81 177.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.41 125.11 21.94 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 113.279 0.844 . . . . 25.0 113.279 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.32 -10.4 74.42 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 120.857 -0.687 . . . . 25.0 113.544 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 7.2 m -95.32 164.38 12.86 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.685 -1.598 . . . . 25.0 106.685 -178.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 m -131.75 165.27 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.637 0.775 . . . . 25.0 110.503 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.6 t -84.73 119.77 25.65 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 104.304 -2.48 . . . . 25.0 104.304 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.2 175.25 55.15 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 121.396 -0.43 . . . . 25.0 113.44 -174.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -74.79 -14.0 21.78 Favored 'Trans proline' 0 C--O 1.204 -1.176 0 CA-C-O 125.136 2.057 . . . . 25.0 113.845 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -79.45 -9.56 59.63 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-N 113.754 -1.566 . . . . 25.0 111.312 175.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.34 15.31 53.87 Favored Glycine 0 CA--C 1.493 -1.318 0 CA-C-O 122.497 1.054 . . . . 25.0 113.131 175.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.42 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 35.5 m-85 -127.68 146.91 50.41 Favored 'General case' 0 C--O 1.203 -1.389 0 CA-C-N 113.928 -1.136 . . . . 25.0 110.835 -176.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.5 m -60.34 147.37 40.81 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.981 0.8 . . . . 25.0 110.268 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -2.062 0 CA-C-O 118.012 -1.438 . . . . 50.0 110.731 179.451 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.665 0 CA-C-O 118.115 -1.38 . . . . 25.0 109.821 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.9 p -145.49 160.81 43.71 Favored Pre-proline 0 C--N 1.356 0.877 0 CA-C-N 118.221 1.011 . . . . 25.0 110.871 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.67 73.47 5.24 Favored 'Trans proline' 0 C--O 1.211 -0.87 0 N-CA-C 115.204 1.194 . . . . 25.0 115.204 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -121.7 15.65 11.05 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.719 -0.845 . . . . 25.0 108.719 171.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.86 35.24 0.93 Allowed Glycine 0 N--CA 1.467 0.737 0 C-N-CA 119.114 -1.517 . . . . 25.0 116.725 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -94.8 178.24 5.64 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.166 -1.05 . . . . 25.0 108.166 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.18 -54.6 33.04 Favored Glycine 0 C--O 1.201 -1.96 0 C-N-CA 119.712 -1.233 . . . . 25.0 113.083 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -95.57 13.57 25.73 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.208 1.504 . . . . 25.0 110.483 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -122.88 80.17 1.73 Allowed 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 105.989 -1.856 . . . . 25.0 105.989 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.66 148.3 98.23 Favored Pre-proline 0 C--O 1.254 1.298 0 N-CA-C 104.311 -2.477 . . . . 25.0 104.311 175.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 55.9 Cg_endo -71.43 168.39 23.65 Favored 'Trans proline' 0 CA--C 1.498 -1.292 0 C-N-CA 114.481 -3.213 . . . . 25.0 114.971 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.6 m -101.39 124.39 46.99 Favored 'General case' 0 C--O 1.255 1.371 0 O-C-N 121.648 -0.657 . . . . 25.0 110.273 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -66.92 140.41 57.76 Favored 'General case' 0 C--O 1.256 1.397 0 N-CA-C 106.666 -1.605 . . . . 25.0 106.666 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 p -150.09 172.0 15.97 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-O 122.767 1.27 . . . . 25.0 111.009 -175.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -132.27 -11.62 3.22 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.215 -1.357 . . . . 25.0 108.452 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -150.19 157.32 42.97 Favored 'General case' 0 C--O 1.262 1.716 0 N-CA-C 107.416 -1.327 . . . . 25.0 107.416 -177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -66.77 -25.33 66.43 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 113.781 1.03 . . . . 25.0 113.781 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 80.3 p -73.83 -9.1 58.31 Favored 'General case' 0 C--O 1.257 1.461 0 O-C-N 121.156 -0.965 . . . . 25.0 111.553 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -73.53 -16.16 61.28 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 108.841 -0.799 . . . . 50.0 108.841 172.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.7 m -100.55 177.51 4.99 Favored 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 116.08 1.881 . . . . 25.0 116.08 -169.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.6 mt -72.84 167.24 21.34 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.657 0.742 . . . . 25.0 110.476 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.27 118.55 7.58 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 114.328 1.233 . . . . 25.0 114.328 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.93 -6.6 64.41 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 111.413 -0.675 . . . . 25.0 111.413 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.1 m -105.7 157.39 17.46 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.103 -1.073 . . . . 25.0 108.103 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.1 m -131.35 167.88 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 123.352 0.661 . . . . 25.0 110.581 -173.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.9 t -89.48 114.98 26.56 Favored 'General case' 0 C--O 1.247 0.958 0 N-CA-C 107.413 -1.329 . . . . 25.0 107.413 175.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.66 179.6 52.3 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 120.848 -0.691 . . . . 25.0 113.655 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -75.77 -13.97 19.69 Favored 'Trans proline' 0 C--O 1.202 -1.3 0 CA-C-N 119.608 1.704 . . . . 25.0 113.54 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -75.57 -8.15 56.04 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 113.639 -1.619 . . . . 25.0 110.607 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.52 15.67 63.49 Favored Glycine 0 CA--C 1.49 -1.515 0 CA-C-O 123.043 1.357 . . . . 25.0 113.269 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 29.9 m-85 -126.43 147.61 49.77 Favored 'General case' 0 C--O 1.195 -1.8 0 CA-C-N 112.88 -1.66 . . . . 25.0 111.361 -175.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.1 m -63.18 148.77 47.12 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 124.692 1.245 . . . . 25.0 109.202 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.479 -2.157 0 CA-C-O 119.352 -0.693 . . . . 50.0 112.984 178.091 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.835 0 CA-C-O 118.146 -1.363 . . . . 25.0 110.003 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -149.26 164.74 19.82 Favored Pre-proline 0 N--CA 1.488 1.449 0 CA-C-N 118.823 1.312 . . . . 25.0 109.908 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.92 58.0 5.32 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 N-CA-C 115.7 1.385 . . . . 25.0 115.7 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -124.66 6.86 8.18 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 107.714 -1.217 . . . . 25.0 107.714 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.39 58.32 0.42 Allowed Glycine 0 CA--C 1.495 -1.209 0 C-N-CA 120.267 -0.968 . . . . 25.0 115.184 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.406 ' HB2' ' HB2' ' A' ' 9' ' ' TRP . 15.8 mtm-85 -126.07 169.49 12.72 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.66 -1.237 . . . . 25.0 107.66 178.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -38.75 -58.28 1.83 Allowed Glycine 0 C--O 1.212 -1.248 0 O-C-N 125.489 1.743 . . . . 25.0 116.287 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -110.75 31.18 6.19 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.473 1.637 . . . . 25.0 110.888 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.406 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 5.6 m-90 -122.95 78.0 1.51 Allowed 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 103.557 -2.757 . . . . 25.0 103.557 176.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.77 151.67 97.13 Favored Pre-proline 0 CA--C 1.562 1.429 0 N-CA-C 105.743 -1.947 . . . . 25.0 105.743 176.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 60.7 Cg_endo -73.81 170.19 20.62 Favored 'Trans proline' 0 CA--C 1.512 -0.621 0 N-CA-C 116.093 1.536 . . . . 25.0 116.093 -176.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.5 m -100.33 131.32 46.32 Favored 'General case' 0 C--O 1.263 1.779 0 CA-C-N 115.73 -0.668 . . . . 25.0 110.877 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.6 p -66.86 130.86 44.54 Favored 'General case' 0 C--O 1.271 2.185 0 N-CA-C 107.003 -1.481 . . . . 25.0 107.003 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.3 p -142.63 175.92 9.44 Favored 'General case' 0 CA--C 1.561 1.396 0 CA-C-O 122.416 1.103 . . . . 25.0 109.161 -177.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 m -130.64 -18.21 3.15 Favored 'General case' 0 C--O 1.189 -2.097 0 CA-C-N 114.321 -1.309 . . . . 25.0 108.509 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -143.17 158.13 43.89 Favored 'General case' 0 C--O 1.259 1.553 0 N-CA-C 108.032 -1.099 . . . . 25.0 108.032 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -62.96 -29.31 70.7 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 124.512 1.133 . . . . 25.0 111.948 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.4 t -71.15 -13.1 61.83 Favored 'General case' 0 C--O 1.249 1.067 0 O-C-N 121.06 -1.025 . . . . 25.0 112.36 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -74.05 -16.08 61.05 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.022 -0.733 . . . . 50.0 109.022 174.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.9 m -100.84 170.68 8.15 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 115.008 1.485 . . . . 25.0 115.008 -170.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.7 mt -66.17 165.63 13.37 Favored 'General case' 0 N--CA 1.424 -1.753 0 O-C-N 123.731 0.644 . . . . 25.0 110.792 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.96 119.72 8.83 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 114.548 1.314 . . . . 25.0 114.548 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.01 -7.74 73.17 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 121.191 -0.528 . . . . 25.0 113.155 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.3 m -99.21 160.7 14.08 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 105.615 -1.994 . . . . 25.0 105.615 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.11 166.72 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 123.199 0.6 . . . . 25.0 109.921 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 21.2 t -91.03 118.84 30.72 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 106.2 -1.778 . . . . 25.0 106.2 174.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.45 177.09 54.23 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.428 -0.892 . . . . 25.0 114.005 -174.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.22 -19.03 23.02 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 CA-C-O 124.995 1.998 . . . . 25.0 113.895 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -72.84 -10.14 59.46 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-N 113.778 -1.555 . . . . 25.0 110.604 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.2 17.02 44.69 Favored Glycine 0 CA--C 1.497 -1.081 0 CA-C-N 115.162 -0.926 . . . . 25.0 113.936 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 43.5 m-85 -130.11 146.81 51.79 Favored 'General case' 0 C--O 1.212 -0.919 0 CA-C-N 114.182 -1.009 . . . . 25.0 113.626 -172.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 96.1 m -63.28 143.38 57.85 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 124.297 1.039 . . . . 25.0 111.532 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.843 0 CA-C-O 117.618 -1.657 . . . . 50.0 110.865 179.432 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.016 0 N-CA-C 110.575 -1.01 . . . . 25.0 110.575 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.6 p -84.03 161.74 54.25 Favored Pre-proline 0 N--CA 1.47 0.527 0 CA-C-N 118.919 1.36 . . . . 25.0 113.154 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.41 70.99 6.04 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 N-CA-C 114.591 0.958 . . . . 25.0 114.591 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -119.85 -2.56 10.32 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-N 115.253 -0.885 . . . . 25.0 108.679 173.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -142.81 60.76 0.53 Allowed Glycine 0 CA--C 1.495 -1.161 0 C-N-CA 120.276 -0.964 . . . . 25.0 114.03 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -131.82 163.41 28.32 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.222 -0.659 . . . . 25.0 109.222 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -42.02 -47.69 5.29 Favored Glycine 0 C--O 1.211 -1.283 0 N-CA-C 116.628 1.411 . . . . 25.0 116.628 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -107.91 18.82 20.82 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 118.912 1.356 . . . . 25.0 109.717 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.7 m-90 -129.54 80.75 1.98 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.226 -1.398 . . . . 25.0 107.226 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.89 148.41 97.93 Favored Pre-proline 0 CA--C 1.57 1.716 0 N-CA-C 104.858 -2.275 . . . . 25.0 104.858 174.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 58.1 Cg_endo -72.5 168.36 24.56 Favored 'Trans proline' 0 CA--C 1.491 -1.636 0 N-CA-C 118.477 2.453 . . . . 25.0 118.477 -175.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 80.1 m -97.96 128.7 44.69 Favored 'General case' 0 C--O 1.264 1.861 0 CA-C-N 114.737 -1.12 . . . . 25.0 110.988 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.81 131.73 45.62 Favored 'General case' 0 C--O 1.256 1.407 0 N-CA-C 107.019 -1.474 . . . . 25.0 107.019 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.2 p -138.2 170.21 16.43 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 122.857 1.313 . . . . 25.0 110.461 -176.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.0 m -125.32 -17.24 5.69 Favored 'General case' 0 C--O 1.197 -1.705 0 N-CA-C 107.088 -1.449 . . . . 25.0 107.088 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -151.22 162.14 41.44 Favored 'General case' 0 C--O 1.254 1.33 0 C-N-CA 123.286 0.634 . . . . 25.0 110.041 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -57.63 -32.55 67.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 124.446 1.092 . . . . 25.0 112.805 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.9 t -63.95 -18.9 64.71 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-O 118.91 -0.567 . . . . 25.0 111.669 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -71.77 -13.24 61.64 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 113.27 0.841 . . . . 50.0 113.27 174.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.7 m -101.25 173.03 6.64 Favored 'General case' 0 C--O 1.251 1.148 0 N-CA-C 115.309 1.596 . . . . 25.0 115.309 -169.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.8 mt -67.66 163.92 20.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.033 0.921 . . . . 25.0 110.431 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.16 122.06 12.87 Favored 'General case' 0 C--O 1.252 1.229 0 N-CA-C 113.867 1.062 . . . . 25.0 113.867 -178.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.01 7.01 78.35 Favored Glycine 0 CA--C 1.522 0.505 0 O-C-N 123.195 0.309 . . . . 25.0 112.469 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.5 m -114.04 160.95 18.32 Favored 'General case' 0 C--N 1.354 0.793 0 N-CA-C 106.258 -1.756 . . . . 25.0 106.258 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.3 m -128.84 170.55 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.037 0.935 . . . . 25.0 110.773 -176.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.4 t -91.76 108.92 20.26 Favored 'General case' 0 C--O 1.249 1.03 0 N-CA-C 105.313 -2.106 . . . . 25.0 105.313 174.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.19 175.87 54.4 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 116.255 -0.429 . . . . 25.0 113.956 -173.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.54 -9.26 21.32 Favored 'Trans proline' 0 C--O 1.207 -1.048 0 CA-C-N 119.579 1.69 . . . . 25.0 115.574 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -76.58 -10.04 59.1 Favored 'General case' 0 CA--C 1.565 1.542 0 CA-C-N 113.895 -1.502 . . . . 25.0 110.046 173.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.35 17.46 57.2 Favored Glycine 0 C--O 1.247 0.924 0 CA-C-O 121.851 0.695 . . . . 25.0 112.285 176.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 42.9 m-85 -133.9 151.52 51.54 Favored 'General case' 0 C--O 1.211 -0.962 0 CA-C-N 113.553 -1.324 . . . . 25.0 110.215 -174.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.3 m -60.28 146.86 42.36 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 124.053 0.846 . . . . 25.0 111.174 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.964 0 CA-C-O 118.153 -1.359 . . . . 50.0 111.34 178.888 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.902 0 N-CA-C 109.634 -1.386 . . . . 25.0 109.634 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.47 160.48 69.97 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-O 117.261 -1.352 . . . . 25.0 111.359 176.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.68 68.06 7.74 Favored 'Trans proline' 0 N--CA 1.485 0.993 0 N-CA-C 114.898 1.076 . . . . 25.0 114.898 -175.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -122.78 19.46 10.22 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.676 -1.601 . . . . 25.0 106.676 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.71 42.9 0.56 Allowed Glycine 0 CA--C 1.507 -0.466 0 C-N-CA 119.964 -1.112 . . . . 25.0 114.158 177.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -103.35 -178.13 3.57 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.949 -1.13 . . . . 25.0 107.949 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.08 -62.6 6.18 Favored Glycine 0 C--O 1.212 -1.235 0 O-C-N 124.809 1.318 . . . . 25.0 112.761 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -94.57 10.06 36.2 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-N 118.956 1.378 . . . . 25.0 111.513 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.3 m-90 -111.73 82.09 1.56 Allowed 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 107.682 -1.229 . . . . 25.0 107.682 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.85 149.18 98.56 Favored Pre-proline 0 C--O 1.252 1.202 0 N-CA-C 104.791 -2.3 . . . . 25.0 104.791 174.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.472 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 64.4 Cg_endo -71.91 164.63 35.07 Favored 'Trans proline' 0 N--CA 1.481 0.759 0 C-N-CA 115.937 -2.242 . . . . 25.0 116.133 -176.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.4 m -94.91 129.74 41.8 Favored 'General case' 0 C--O 1.273 2.322 0 CA-C-N 115.842 -0.617 . . . . 25.0 111.028 177.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.8 p -69.68 132.61 46.42 Favored 'General case' 0 C--O 1.253 1.274 0 N-CA-C 106.699 -1.593 . . . . 25.0 106.699 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.8 p -138.39 172.02 13.52 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.095 0.95 . . . . 25.0 108.975 -174.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.5 m -128.73 -14.81 4.51 Favored 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 107.114 -1.439 . . . . 25.0 107.114 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.41 162.71 40.79 Favored 'General case' 0 C--O 1.255 1.383 0 CA-C-N 118.984 0.811 . . . . 25.0 109.735 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -58.44 -32.24 68.52 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.0 0.812 . . . . 25.0 112.626 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.8 t -66.33 -16.69 64.25 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 112.406 0.521 . . . . 25.0 112.406 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -77.79 -9.51 59.07 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 119.63 -0.828 . . . . 50.0 110.97 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.4 m -104.0 178.57 4.52 Favored 'General case' 0 CA--C 1.552 1.055 0 O-C-N 120.327 -1.483 . . . . 25.0 115.0 -171.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.5 mt -76.3 164.53 25.95 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-O 121.519 0.676 . . . . 25.0 109.711 175.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.8 132.33 53.51 Favored 'General case' 0 C--O 1.259 1.601 0 CA-C-O 119.085 -0.483 . . . . 25.0 110.87 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.54 -7.03 82.75 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 119.502 -0.61 . . . . 25.0 112.124 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.3 m -106.19 155.87 19.03 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.233 -1.765 . . . . 25.0 106.233 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.9 m -129.41 164.98 30.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 C-N-CA 124.937 1.295 . . . . 25.0 107.725 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.6 t -84.04 111.79 19.62 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 105.033 -2.21 . . . . 25.0 105.033 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.84 175.42 52.02 Favored Glycine 0 C--O 1.252 1.256 0 CA-C-N 115.525 -0.761 . . . . 25.0 113.264 -173.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.8 -14.44 19.46 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 CA-C-O 124.286 1.703 . . . . 25.0 114.151 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.2 p-10 -75.82 -8.76 57.65 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-N 114.009 -1.45 . . . . 25.0 110.549 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.24 22.05 39.32 Favored Glycine 0 C--O 1.247 0.966 0 CA-C-O 122.104 0.835 . . . . 25.0 113.463 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.472 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 46.9 m-85 -135.79 153.5 51.51 Favored 'General case' 0 C--O 1.208 -1.127 0 CA-C-N 114.019 -1.09 . . . . 25.0 110.67 -173.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 92.0 m -62.31 142.09 57.94 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.389 0.431 . . . . 25.0 110.214 172.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -2.022 0 CA-C-O 118.123 -1.376 . . . . 50.0 111.25 177.867 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.009 0 CA-C-O 118.124 -1.376 . . . . 25.0 110.532 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.1 p -68.28 162.93 56.97 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 118.719 1.259 . . . . 25.0 111.759 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -76.68 58.23 5.87 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 CA-C-N 119.974 1.027 . . . . 25.0 114.674 -176.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -125.17 16.03 8.42 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 104.572 -2.381 . . . . 25.0 104.572 172.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.02 69.74 0.18 Allowed Glycine 0 CA--C 1.49 -1.517 0 N-CA-C 111.053 -0.819 . . . . 25.0 111.053 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -137.27 163.39 31.07 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 105.831 -1.915 . . . . 25.0 105.831 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -41.58 -56.31 3.6 Favored Glycine 0 C--O 1.21 -1.38 0 CA-C-O 118.135 -1.369 . . . . 25.0 114.355 -177.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -97.75 13.81 29.11 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 119.925 1.863 . . . . 25.0 110.867 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -124.72 84.87 2.33 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 108.534 -0.913 . . . . 25.0 108.534 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.27 153.4 95.58 Favored Pre-proline 0 C--O 1.257 1.458 0 O-C-N 125.591 1.807 . . . . 25.0 106.609 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.26 171.01 18.88 Favored 'Trans proline' 0 CA--C 1.493 -1.575 0 N-CA-C 116.71 1.773 . . . . 25.0 116.71 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.7 m -108.21 131.33 54.78 Favored 'General case' 0 C--O 1.259 1.605 0 CA-C-N 115.274 -0.876 . . . . 25.0 110.288 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.14 140.03 56.16 Favored 'General case' 0 C--O 1.253 1.257 0 N-CA-C 106.554 -1.647 . . . . 25.0 106.554 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.1 p -144.79 174.23 11.17 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.234 -1.348 . . . . 25.0 110.778 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 m -132.95 -10.73 3.0 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 107.622 -1.251 . . . . 25.0 107.622 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -152.28 160.84 43.28 Favored 'General case' 0 C--O 1.259 1.598 0 N-CA-C 107.761 -1.2 . . . . 25.0 107.761 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -63.71 -30.25 71.38 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.264 0.554 . . . . 25.0 112.002 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.6 t -68.25 -18.2 64.49 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 119.17 -1.012 . . . . 25.0 112.066 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -70.53 -11.81 61.17 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.301 -0.629 . . . . 50.0 109.301 175.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.3 m -104.05 173.66 6.21 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.988 1.477 . . . . 25.0 114.988 -171.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.423 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 91.5 mt -72.86 167.8 20.22 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 121.946 0.879 . . . . 25.0 109.42 178.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.6 120.73 11.15 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 114.687 1.366 . . . . 25.0 114.687 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.85 -8.92 65.85 Favored Glycine 0 CA--C 1.532 1.151 0 N-CA-C 110.723 -0.951 . . . . 25.0 110.723 175.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 m -97.22 163.72 12.79 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 106.028 -1.842 . . . . 25.0 106.028 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.4 m -133.5 168.19 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.387 1.075 . . . . 25.0 109.631 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.2 t -90.62 115.2 27.56 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 105.317 -2.105 . . . . 25.0 105.317 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.59 176.83 50.15 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.884 -0.598 . . . . 25.0 112.69 -175.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.22 -14.71 18.47 Favored 'Trans proline' 0 C--O 1.206 -1.085 0 CA-C-O 124.965 1.985 . . . . 25.0 113.833 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -77.13 -8.73 58.0 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-N 113.518 -1.674 . . . . 25.0 110.221 173.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.24 19.95 56.04 Favored Glycine 0 CA--C 1.495 -1.192 0 CA-C-O 122.004 0.78 . . . . 25.0 113.44 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -122.94 147.33 46.74 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.683 -1.258 . . . . 25.0 110.498 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.3 m -63.13 148.9 46.62 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 124.151 0.907 . . . . 25.0 110.308 173.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.558 0 CA-C-O 117.969 -1.461 . . . . 50.0 112.382 173.68 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.695 0 CA-C-O 119.905 -0.386 . . . . 25.0 112.818 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.23 160.83 77.08 Favored Pre-proline 0 N--CA 1.473 0.712 0 CA-C-O 117.567 -1.206 . . . . 25.0 111.936 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.66 70.43 5.74 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 N-CA-C 115.26 1.215 . . . . 25.0 115.26 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -129.72 24.04 5.39 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 104.583 -2.377 . . . . 25.0 104.583 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -165.56 51.78 0.27 Allowed Glycine 0 CA--C 1.502 -0.777 0 C-N-CA 120.223 -0.989 . . . . 25.0 112.871 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.93 177.14 4.73 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 105.749 -1.945 . . . . 25.0 105.749 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -51.22 -56.09 16.28 Favored Glycine 0 C--O 1.21 -1.359 0 O-C-N 125.623 1.827 . . . . 25.0 113.104 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -98.67 -3.68 35.44 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 120.197 1.999 . . . . 25.0 112.563 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -98.24 81.95 2.86 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 106.514 -1.661 . . . . 25.0 106.514 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.09 149.58 98.41 Favored Pre-proline 0 C--O 1.254 1.308 0 N-CA-C 105.242 -2.132 . . . . 25.0 105.242 175.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 57.1 Cg_endo -69.94 163.05 39.86 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 116.316 -1.99 . . . . 25.0 114.605 -177.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.7 m -97.14 127.67 43.32 Favored 'General case' 0 C--O 1.258 1.531 0 CA-C-N 115.783 -0.644 . . . . 25.0 111.971 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.13 134.29 48.0 Favored 'General case' 0 C--O 1.26 1.616 0 N-CA-C 106.604 -1.628 . . . . 25.0 106.604 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.2 p -139.37 174.77 10.17 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 123.153 1.454 . . . . 25.0 111.817 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.7 m -129.8 -20.48 3.17 Favored 'General case' 0 C--O 1.196 -1.728 0 N-CA-C 107.372 -1.344 . . . . 25.0 107.372 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -144.43 163.13 34.71 Favored 'General case' 0 C--O 1.259 1.605 0 N-CA-C 108.703 -0.851 . . . . 25.0 108.703 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -62.67 -29.77 70.89 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-O 121.885 0.85 . . . . 25.0 111.853 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.4 t -66.06 -19.11 65.74 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.61 -0.723 . . . . 25.0 111.609 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -70.05 -17.94 63.27 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.623 0.725 . . . . 50.0 110.729 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.7 m -97.02 175.26 6.39 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 115.801 1.778 . . . . 25.0 115.801 -171.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.409 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 63.2 mt -74.15 168.78 18.88 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.533 0.682 . . . . 25.0 110.238 175.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.65 128.08 34.24 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 118.509 -0.757 . . . . 25.0 112.889 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.37 -4.22 76.65 Favored Glycine 0 C--N 1.342 0.878 0 C-N-CA 120.533 -0.841 . . . . 25.0 111.303 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 3.9 m -107.5 159.49 16.38 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.515 -1.661 . . . . 25.0 106.515 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.35 164.24 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 124.267 1.027 . . . . 25.0 109.203 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.5 t -87.36 119.31 27.48 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 105.151 -2.166 . . . . 25.0 105.151 174.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.48 176.44 48.17 Favored Glycine 0 C--O 1.255 1.454 0 C-N-CA 120.894 -0.67 . . . . 25.0 113.352 -173.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.01 -12.52 16.09 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 CA-C-O 124.671 1.863 . . . . 25.0 113.71 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -73.88 -13.17 60.87 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 113.705 -1.588 . . . . 25.0 109.345 173.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.34 14.5 47.74 Favored Glycine 0 C--O 1.251 1.187 0 CA-C-O 122.678 1.155 . . . . 25.0 111.963 174.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.425 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 45.4 m-85 -129.06 151.08 50.13 Favored 'General case' 0 C--O 1.204 -1.329 0 CA-C-N 113.474 -1.363 . . . . 25.0 113.098 -173.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 88.1 m -63.27 144.95 56.5 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 123.893 0.746 . . . . 25.0 111.125 172.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -2.088 0 CA-C-O 117.955 -1.47 . . . . 50.0 111.292 178.754 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.531 0 CA-C-O 118.629 -1.095 . . . . 25.0 110.459 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.0 p -75.0 162.24 74.24 Favored Pre-proline 0 N--CA 1.471 0.605 0 CA-C-N 118.576 1.188 . . . . 25.0 113.726 -178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.06 63.9 7.72 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 O-C-N 123.094 1.05 . . . . 25.0 114.753 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.8 mm-40 -123.71 26.55 7.67 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.937 -2.246 . . . . 25.0 104.937 172.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.06 57.22 0.19 Allowed Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.723 -1.227 . . . . 25.0 114.132 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -124.36 172.63 8.98 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 106.743 -1.577 . . . . 25.0 106.743 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.68 -49.27 28.04 Favored Glycine 0 C--O 1.214 -1.147 0 O-C-N 124.895 1.372 . . . . 25.0 114.637 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -104.49 13.77 31.21 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 118.733 1.267 . . . . 25.0 110.357 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -122.37 81.87 1.9 Allowed 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 106.854 -1.536 . . . . 25.0 106.854 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.38 149.7 95.76 Favored Pre-proline 0 CA--C 1.562 1.413 0 N-CA-C 105.779 -1.934 . . . . 25.0 105.779 176.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.472 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 68.4 Cg_endo -73.33 165.63 32.04 Favored 'Trans proline' 0 CA--C 1.507 -0.87 0 C-N-CA 116.656 -1.762 . . . . 25.0 116.195 -177.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.0 m -97.97 130.64 44.81 Favored 'General case' 0 C--O 1.272 2.252 0 O-C-N 120.918 -1.114 . . . . 25.0 110.609 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 m -66.11 131.19 45.62 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 107.155 -1.424 . . . . 25.0 107.155 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.1 p -136.61 172.14 13.45 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.298 -1.319 . . . . 25.0 110.936 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 m -126.83 -22.06 3.93 Favored 'General case' 0 C--O 1.197 -1.664 0 N-CA-C 106.864 -1.532 . . . . 25.0 106.864 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -145.67 160.85 41.1 Favored 'General case' 0 C--O 1.264 1.863 0 C-N-CA 123.116 0.566 . . . . 25.0 109.684 -175.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -65.51 -27.03 68.18 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.117 0.784 . . . . 25.0 113.117 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 97.4 p -73.1 -12.45 60.91 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 121.173 -0.954 . . . . 25.0 111.078 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -71.13 -19.74 62.4 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 119.109 -1.036 . . . . 50.0 109.363 171.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.6 m -96.92 169.48 9.82 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.913 1.449 . . . . 25.0 114.913 -173.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.2 mt -71.26 168.48 17.22 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.645 -0.707 . . . . 25.0 109.764 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.78 124.95 20.91 Favored 'General case' 0 C--O 1.254 1.311 0 N-CA-C 113.788 1.033 . . . . 25.0 113.788 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.34 -9.82 75.56 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.623 -0.543 . . . . 25.0 112.916 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.8 m -99.86 156.84 16.91 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 106.201 -1.778 . . . . 25.0 106.201 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -128.52 167.78 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.957 0.903 . . . . 25.0 110.134 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.0 t -86.39 113.67 22.54 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 105.844 -1.909 . . . . 25.0 105.844 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.17 -179.13 52.73 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 119.37 -0.683 . . . . 25.0 114.116 -171.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.83 -13.33 21.85 Favored 'Trans proline' 0 C--O 1.21 -0.909 0 CA-C-N 119.652 1.726 . . . . 25.0 114.269 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -81.0 -6.93 59.38 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-N 114.102 -1.408 . . . . 25.0 109.865 174.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.87 20.33 59.75 Favored Glycine 0 C--O 1.254 1.362 0 CA-C-O 122.717 1.176 . . . . 25.0 112.537 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.472 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 44.3 m-85 -130.17 149.02 52.06 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.247 -1.476 . . . . 25.0 110.006 -176.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.6 m -62.92 146.87 51.97 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.154 -0.476 . . . . 25.0 112.216 175.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.893 0 CA-C-O 118.691 -1.06 . . . . 50.0 111.308 171.941 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.289 0 N-CA-C 109.809 -1.316 . . . . 25.0 109.809 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 p -104.42 166.88 10.79 Favored Pre-proline 0 N--CA 1.487 1.398 0 CA-C-O 117.434 -1.269 . . . . 25.0 108.665 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.62 63.78 7.36 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 CA-C-N 120.8 1.321 . . . . 25.0 115.295 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -125.52 11.32 7.96 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 105.508 -2.034 . . . . 25.0 105.508 173.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -154.08 44.97 0.57 Allowed Glycine 0 N--CA 1.468 0.807 0 C-N-CA 120.031 -1.08 . . . . 25.0 114.792 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -104.86 174.47 5.86 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 104.637 -2.357 . . . . 25.0 104.637 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.17 -51.03 60.87 Favored Glycine 0 C--O 1.204 -1.768 0 O-C-N 124.637 1.211 . . . . 25.0 113.812 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.45 0.75 48.23 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 118.579 1.19 . . . . 25.0 111.9 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -105.77 88.14 2.75 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 106.437 -1.69 . . . . 25.0 106.437 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.62 149.35 98.35 Favored Pre-proline 0 CA--C 1.567 1.623 0 N-CA-C 104.518 -2.401 . . . . 25.0 104.518 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.446 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 55.9 Cg_endo -70.06 168.82 20.85 Favored 'Trans proline' 0 N--CA 1.479 0.621 0 N-CA-C 117.05 1.904 . . . . 25.0 117.05 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.2 m -100.44 128.26 46.55 Favored 'General case' 0 C--O 1.26 1.649 0 O-C-N 121.203 -0.936 . . . . 25.0 111.38 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.4 p -68.57 134.54 50.15 Favored 'General case' 0 C--O 1.26 1.627 0 N-CA-C 106.695 -1.595 . . . . 25.0 106.695 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.1 p -142.55 170.6 15.39 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.883 -1.053 . . . . 25.0 109.32 -176.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.1 m -130.51 -12.03 3.94 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 107.271 -1.381 . . . . 25.0 107.271 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -149.66 159.45 44.32 Favored 'General case' 0 C--O 1.256 1.4 0 C-N-CA 123.947 0.899 . . . . 25.0 108.905 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -61.84 -31.15 71.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 124.145 0.903 . . . . 25.0 111.18 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 t -68.99 -13.27 62.35 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 121.469 -0.769 . . . . 25.0 112.287 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -77.8 -8.25 57.76 Favored 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 120.123 -0.631 . . . . 50.0 110.347 174.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.1 m -104.91 171.74 7.16 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 116.654 2.094 . . . . 25.0 116.654 -172.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.435 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 83.5 mt -68.52 168.43 12.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 122.03 0.919 . . . . 25.0 110.855 177.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.64 124.5 20.88 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 114.011 1.115 . . . . 25.0 114.011 -177.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.19 -12.83 68.01 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 123.349 0.406 . . . . 25.0 112.732 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 21' ' ' LEU . 4.5 m -90.08 160.13 16.46 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 106.638 -1.616 . . . . 25.0 106.638 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.9 m -128.76 171.89 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 124.617 1.167 . . . . 25.0 108.419 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.5 t -94.9 123.31 38.3 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 106.113 -1.81 . . . . 25.0 106.113 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.98 177.57 46.32 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 114.903 0.721 . . . . 25.0 114.903 -175.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.1 -8.4 16.49 Favored 'Trans proline' 0 C--O 1.211 -0.835 0 CA-C-O 124.414 1.756 . . . . 25.0 113.214 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -79.74 -9.83 59.7 Favored 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 113.909 -1.496 . . . . 25.0 110.201 171.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.92 16.25 58.26 Favored Glycine 0 CA--C 1.486 -1.753 0 CA-C-O 122.708 1.171 . . . . 25.0 113.411 175.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.446 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 45.3 m-85 -128.2 153.12 47.26 Favored 'General case' 0 C--O 1.201 -1.495 0 CA-C-N 113.792 -1.204 . . . . 25.0 111.21 -174.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.7 m -60.74 150.48 32.28 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 124.209 0.943 . . . . 25.0 110.432 172.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.728 0 CA-C-O 117.793 -1.559 . . . . 50.0 112.397 177.992 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.956 0 CA-C-O 118.36 -1.244 . . . . 25.0 110.424 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.9 p -152.22 165.15 18.12 Favored Pre-proline 0 N--CA 1.484 1.264 0 CA-C-O 117.717 -1.135 . . . . 25.0 108.458 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.43 64.19 5.49 Favored 'Trans proline' 0 CA--C 1.556 1.591 0 N-CA-C 115.936 1.476 . . . . 25.0 115.936 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -118.5 5.14 11.72 Favored 'General case' 0 C--O 1.202 -1.446 0 N-CA-C 107.49 -1.3 . . . . 25.0 107.49 174.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -153.6 42.17 0.64 Allowed Glycine 0 C--O 1.214 -1.119 0 C-N-CA 120.091 -1.052 . . . . 25.0 115.493 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -98.08 167.99 10.54 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 104.651 -2.352 . . . . 25.0 104.651 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -42.38 -56.05 4.22 Favored Glycine 0 C--O 1.206 -1.602 0 O-C-N 125.393 1.683 . . . . 25.0 115.709 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -99.75 14.69 29.36 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 118.383 1.092 . . . . 25.0 112.451 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -115.78 83.71 1.98 Allowed 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 106.063 -1.828 . . . . 25.0 106.063 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.96 147.53 99.08 Favored Pre-proline 0 CA--C 1.561 1.377 0 N-CA-C 106.337 -1.727 . . . . 25.0 106.337 176.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.409 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 54.9 Cg_endo -74.5 171.33 18.34 Favored 'Trans proline' 0 CA--C 1.499 -1.263 0 C-N-CA 116.026 -2.183 . . . . 25.0 116.326 -175.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m -105.24 130.85 53.3 Favored 'General case' 0 C--O 1.278 2.568 0 O-C-N 120.967 -1.083 . . . . 25.0 111.233 178.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 p -69.81 139.51 53.19 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 105.733 -1.951 . . . . 25.0 105.733 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 p -142.65 170.05 16.44 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 113.87 -1.514 . . . . 25.0 108.724 -174.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.1 m -133.03 -8.74 3.04 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-N 114.74 -1.118 . . . . 25.0 108.54 174.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -149.65 159.68 44.13 Favored 'General case' 0 C--O 1.26 1.62 0 N-CA-C 108.398 -0.964 . . . . 25.0 108.398 176.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -63.47 -30.66 71.75 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.457 1.098 . . . . 25.0 111.526 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.1 t -63.15 -21.97 66.55 Favored 'General case' 0 CA--C 1.556 1.2 0 O-C-N 121.142 -0.973 . . . . 25.0 111.933 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -72.6 -9.4 58.54 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 120.023 -0.671 . . . . 50.0 111.15 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.9 m -103.21 -179.6 4.0 Favored 'General case' 0 CA--C 1.562 1.436 0 N-CA-C 114.513 1.301 . . . . 25.0 114.513 -173.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 75.5 mt -76.98 166.43 23.34 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.485 -1.302 . . . . 25.0 107.485 176.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.69 129.13 38.85 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.648 0.61 . . . . 25.0 112.648 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.91 5.85 76.77 Favored Glycine 0 CA--C 1.536 1.367 0 O-C-N 124.287 0.992 . . . . 25.0 111.685 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.6 m -118.73 156.08 29.97 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 106.959 -1.497 . . . . 25.0 106.959 178.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.73 166.57 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.807 0.843 . . . . 25.0 109.678 -175.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.2 t -86.33 110.48 19.7 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 105.715 -1.958 . . . . 25.0 105.715 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.32 178.27 49.14 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 120.885 -0.674 . . . . 25.0 113.389 -171.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -73.71 -10.58 23.53 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 CA-C-O 124.836 1.932 . . . . 25.0 115.238 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -69.13 -15.74 63.49 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-N 113.934 -1.485 . . . . 25.0 111.492 169.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.96 18.21 56.47 Favored Glycine 0 CA--C 1.492 -1.375 0 CA-C-O 123.3 1.5 . . . . 25.0 109.758 176.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.409 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 26.5 m-85 -135.27 150.54 50.05 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 112.535 -1.832 . . . . 25.0 108.817 -171.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 91.3 m -61.75 148.78 41.82 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.61 1.194 . . . . 25.0 110.805 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.756 0 CA-C-O 119.006 -0.885 . . . . 50.0 111.6 173.457 . . . . . . . . 0 0 . 1 stop_ save_